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The route to the key bicyclic intermediate was streamlined to eight steps in 16% 
yield, using a TMSI promoted coupling of a furan and an enone. Additionally, 
methodology for the selective ozonolysis of the bicyclic intermediate was developed via 
ozone titration. Work on the dihydroxylation step led to the discovery and development 
of a new pH-neutral Sharpless-style asymmetric dihydroxylation. 
The synthesis of pentacyclic core of citreamicin µ  was accomplished in 12 steps. 
New methodologies were developed, including: an ortho- selective bromination of a 
vanillin derivative and the use of 4-(Phenylazo)diphenylamine (PDA) as an internal 
indicator for the acetylide coupling. The usefulness of PDA led to its development as a 
general all-purpose indicator for the titration of strong bases, Lewis acids and reducing 
agents. The discovery of (n-Bu)4NOAc as a privileged additive led to the development of 
new methods for the synthesis of isocoumarins and new methodology for the 
condensation of amino acids using LiMe4 was developed. 
 viii 
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CHAPTER 1: SYNTHETIC STUDIES TOWARD THE SYNTHESIS OF 
CORTISTATIN A (1.1) 
1.1: Isolation and Biological Activity  
Cortistatins A, B, C and D (1.1-1.4) were isolated from the marine sponge corticum 
simplex by Kobayashi et al in 2006,1 followed by cortisatins E-L in 2007 (Figure 1.1).2,3  All 
members of the cortistatin family feature an unusual 9-(10→19)-abeo-androstane steroidal 
structure featuring an oxabicyclo-[3.2.1]-octene core. Cortistatins A-D (1.1-1.4) and J-L (1.5, 
1.8, 1.9) feature a β-isoquinoline at C17 while, cortistatins E-H (1.6, 1.7, 1.10, 1.11) have an 
alkyl-pyridine or piperidine substitution.  
All members of the cortistatin family possess anti-angiogenic activity against human 
umbilical vein endothelial (HUVEC) cells, and cortistatin A (1.1) is the most potent member 
with an IC50 of 1.8 nM. In general, cortistatins A-D (1.1-1.4) and J-L (1.5, 1.8, 1.9) are much 
more biologically active than cortistatins E-H (1.6, 1.7, 1.10, 1.11) (Figure 1.1) Cortistatin A 
(1.1) also exhibited impressive selectivity by showing little to no toxicity towards normal human 
dermal fibroblast (NHDF), KB epidermoid carcinoma cells (KB3-1), human chronic 
myelogenous leukemia cells (K562), and murine neuroblastoma cells (Neuro2A). Cortistatins E-
H (1.6, 1.7, 1.10, 1.11), which have differing substitution at C17, showed significantly less 










Figure 1.1: Members of the cortistatin family and their IC50 values against HUVEC 
 
1.2: Biosynthetic hypothesis 
Though the biosynthetic origin of the cortistatins in not known, information may be 
gleaned from a collection of structurally similar 9-(10→19)-abeo-pregnane alkaloids isolated 
from the Buxaceae family of plants (Figure 1.2).5-16 Interestingly, alongside the 9-(10→19)-
abeo-pregnane alkaloids, compounds such as cyclobuxine-D (1.16) were also isolated, 
suggesting that the 9(10→19) abeo-pregnane skeleton might originate from a 
cyclopropylcarbinyl rearrangement of a cyclopropane ring.6 A key intermediate of plant sterol 
synthesis is cycloartenol (1.15) which is formed from oxido squalene (1.12) (Scheme 1.2).17-20 
The cyclopropane ring in cycloartenol (1.15) is thought to form during the cationic cyclization 
cascade via base promoted cyclization of the C19 methyl group onto the carbocation at C9. The 
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Buxus alkaloids may be formed either directly downstream of cycloartenol or by selective 
oxidation of C9 followed by base promoted cyclization as in 1.14→1.15. 
Figure 1.2: Known biosynthesis of cycloartenol and Buxane alkaloids 
 
 
Due to the similar skeletons of the Buxus alkaloids and the fact that alkaloids such as 
1.19 have been isolated in Corticum simplex, Kobayashi hypothesized that the cortistatins might 
be formed from a precursor such as 1.21 (Scheme 1.1).2 Allylic oxidation of 1.21, followed by 
base promoted cyclization as in 1.14→1.15 (Figure 1.2) gives cyclopropanated intermediate 
1.22. The 9-(10→19)-abeo-androstane structure in the cortistatins may come via an analogous 
cyclopropylcarbinyl rearrangement. The fact that cortisatins E-H (1.6, 1.7, 1.10, 1.11) are 
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generally in lower oxidation states than cortistatins A-D (1.1-1.4) and J-L (1.5, 1.8, 1.9), 
Kobayashi hypothesized that the alkyl-piperidine substituent in cortistatins E (1.10) and F (1.11) 
may be biosynthetic precursors of the pyridine in cortistatins G (1.6) and H (1.7) and ultimately 
the source of the isoquinoline in cortistatins A-D (1.1-1.4). The C26 methyl group of alkaloid 
1.21 may be oxidized to the piperidine in cortistatins E (1.10) and F (1.11) (note the alternate 
C23 cyclization in natural product 1.19). Further oxidation of the piperidine ring to the pyridine 
ring gives cortistatins G (1.6) and H (1.7). Subsequent oxidative removal of the methyl group 
and electrocyclization to form cortistatins A-D (1.1-1.4) and J-L (1.5, 1.8, 1.9).21-25  





1.3: Previous syntheses 
Due to the combination of its unusual steroidal core and its impressive biological activity, 
cortistatin A (1.1) has attracted significant interest in the synthetic community. As of 2016, there 
have been five total syntheses,26-32 four formal syntheses34-37 and 11 synthetic studies towards the 
core38-55 (Figure 1.4). Additionally, these has been numerous syntheses of medicinally relevant 
analogues.56-61 Cortistatins J (1.5), K (1.8) and L (1.9) have also been synthesized, usually via a 
common intermediate en route to cortistatin A (1.1), with the exemption of Funk’s synthesis of 
cortistatin J in 2011.33 For sake of brevity, only the total and formal syntheses of cortistatin A 
















Figure 1.3: Summary of the synthetic work towards cortistatin A (1.1), J (1.5), K (1.8) and L 
(1.9) 
 
1.3.1: BARAN’S TOTAL SYNTHESIS 
Only two years after Kobayashi published the isolation of cortistatin A (1.1) in 2006, 
Baran completed the first total synthesis in 2008,26 which was followed by an improved scalable 
 7 
route in 2011.27 Baran’s synthetic strategy was inspired by the historical precedent of using 
abundantly available steroidal precursors such as diosgenin and cholesterol as starting materials 
for the synthesis of cortisone and progesterone, as well as Kobayashi’s intriguing biosynthetic 
proposal. 
Baran’s synthesis began with prednisone (1.25), which was selectively reduced at C20 
and oxidatively cleaved to the ketone under Johnson-Lemieux74 conditions (OsO4, NaIO4). 
Protection of the resulting ketone as the dioxolane gave intermediate 1.26 (Scheme 1.3). 
Nucleophilic epoxidation of the less substituted double bond with t-butylhydroperoxide and 1,8-
diazabicyclo [5.4.0] undec-7-ene (DBU) lead to α-epoxy enone 1.27. This offered an 
improvement over previously reported procedures utilizing dimethyldioxirane (DMDO). The 
epoxide proved to be acid and base sensitive, with a tendency for the C11 ketone to cyclize onto 
the C1 position of the epoxide to form a dihydrofuran. The first generation conditions for the 
reductive amination/formylation sequence reported in 2008 used NH4OAc/NaBH3CN for the 
reductive amination and ethylformate for the formylation to provide 1.28 in 73% yield. The 
improved procedure in the second generation synthesis used the mild Lewis acid Ti(OiPr)4 to 
form the imine with ammonia, followed by reductive workup with NaBH4. Coupling of formic 
acid with 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT), n-methylmorpholine (NMM) and 
N,N-dimethylaminopyridine (DMAP) furnished 1.28 in 95% yield. Initially, opening the epoxide 
with tetrabutylammonium acetate (TBAA) occurred exclusively at C1 but in only 48% yield. To 
improve the yield, Baran discovered that opening the epoxide with triethylamine (Et3N) and 
acetic acid (AcOH) gave an equilibrium mixture (2:1) of 1.30 and 1.29 in a combined 96% yield. 






Scheme 1.3: Synthesis of intermediate 1.30 from Prednisone 1.25  
 
Hydration of the C4-C5 olefin in intermediate 1.30 under Mukaiyama70 conditions 
(Co(acac)2, PhSiH3, O2) provided the axial C5 alcohol. Protection of the C1, C5 alcohol and the 
C3 formamide as the orthoimide followed by removal of the C2 acetate furnished key cyclization 
precursor 1.31 (Scheme 1.4). The axial alcohol was used to selectively di-brominate the C19 
methyl group under Suarez-like (PhI(OAc)2, I2)
85 conditions. Protection of the C2 hydroxyl 
group in situ before the intramolecular enolate alkylation was necessary to prevent the alcohol 
from cyclizing onto the dibrominated C19 methyl group. Traditional Suarez conditions favored 
the O-alkylated product exclusively. Intramolecular alkylation of the brominated methyl group 
with DBU gave key bromo-cyclopropane 1.32.  
Reductive fragmentation of 1.32 with SmI2 led to a radical cyclopropylcarbinyl 
rearrangement (1.33 → 1.35) to give the extended enolate 1.35, which was subsequently 
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quenched with tetrabromocyclohexadiene (TBCHD) to provide the expanded α-bromo ketone 
1.36. The bromide was then eliminated with Li2CO3 to give diene 1.37. During model studies of 
the ring expansion, if the C19 methyl group was only mono-brominated, Baran was unable to 
form the C10-C19 double bond after oxidation of the samarium enolate.  
Scheme 1.4: Baran’s key biomimetic ring expansion 
  
Reduction of orthoimide 1.37 with AlH3 proceeded to give the dimethylamino moiety at 
C3 and resulted in the concomitant reduction of the C11 ketone in one step (Scheme 1.5). 
Closure of the oxabicyclo [3.2.1] octene core initially proceeded stepwise via the acetylation of 
all the free hydroxyl groups followed by ionization of the C11 acetate with MgBr2•Et2O and di-t-
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butyl pyridine (DTBP) as a proton sponge to give key intermediate cortistatinone 1.21 in 65% 
yield for the three step sequence. The 2011 publication demonstrated a more streamlined 
procedure, both ionizing the alcohol directly using BiCl3 as the Lewis acid as well as 
deprotecting the dioxolane acetal in 62% yield in only one step. Installation of the isoquinoline 
moiety began with transforming the ketone to the vinyl iodide via the Barton procedure 
(H2NNH2, I2, base),
65 followed by a Stille coupling with the stannyl isoquinoline 1.38 provided 
the C16-C17 dehydro intermediate 1.39 (Scheme 1.5). Reducing the C16-C17 double bond 
proved challenging. Reductants such as Pd/C or diimide gave over-reduction or low yield. 
Ultimately, Raney-Ni gave clean reduction to give cortistatin A (1.1) in 50% yield. Barans’s 
synthesis of cortistatin A (1.1) was completed in just 15 steps from prednisone (1.25) and in 















Scheme 1.5: Baran’s completion of Cortistatin A (1.1) 
 
 
1.3.2: NICOLAOU’S TOTAL SYNTHESIS 
Nicolaou published his total synthesis of cortistatin A (1.1) in 200828 and followed up 
with a full paper in 200929 where he also synthesized cortistatin J and examined the biological 
activity of several intermediates. Using the previously reported synthesis of 1.47 by Danishefsky, 
the Hajos-Parrish ketone (1.44) was reduced diastereoselectively and the resulting alcohol 
protected as the TBS ether to furnish 1.47 (Scheme 1.7). The enone was then α-carboxylated 
with methylmagnesium carbonate (MMC) to provide dienone 1.46. The double bond was 
reduced using Rosenmund’s catalyst (Pd/BaSO4) followed by a piperidine catalyzed 
aldol/decarboxylation sequence with formaldehyde to give the exo-methylene compound 1.47. 
The exo-methylene group was diastereoselectively dihydroxylated under Upjohn conditions 
(OsO4, NMO)
63 and protected as an acetonide to give 1.48. Conversion of the ketone to the vinyl 
triflate with NaHMDS and McMurray’s reagent (PhNTf2)
84 followed by methoxycarbonylation 
provided 1.49. Reduction of the ester with diisobutylaluminum hydride (DIBAL-H) followed by 
reoxidation with Dess-martin periodinane (DMP) gave 1.50. 
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Scheme 1.7: Synthesis of intermediate 1.50 from Hajos-Parrish ketone (1.44) 
O
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Protection of the aldehyde in 1.50 with BF3•Et2O and 1,2-dithioethane resulted in 
concomitant removal of the dioxolane ketal to unmask the diol. Oxidation of the primary alcohol 
to α-hydroxy aldehyde under Parikh-Doering conditions (SO3•Pyridine, DMSO)
64 gave 1.51 
(Scheme 1.8). Conversion of the aldehyde to the acetylene with the Ohira-Bestmann76 reagent 
(made in situ with dimethyl-2-oxopropylphosphonate and tosyl azide) then gave the CD ring 
fragment 1.42. Sonogashira coupling of 1.42 with β-keto vinyl triflate 1.43 gave yne-enone 1.52. 
Oxidative deprotection of the dithiolane with 2-iodoxybenzoic acid (IBX) followed by reduction 
of the C6-C7 alkyne to the alkane was accomplished with Rosenmund’s catalyst to give 1.46. 
Ultimately, the key oxy-Michael/ aldol cascade proceeded cleanly with K2CO3 in dioxane to give 





Scheme 1.8: Synthesis of the Nicolaou-Chen intermediate (1.40) 
   
Installation of the isoquinoline ring was achieved by a similar sequence to Baran’s 
endgame. Protection of the ketone under Noyori’s conditions (TMSOTf, 1,2 disiloxyethane)77 as 
the dioxolane and subsequent deprotection of the TBS ether to alcohol gave 1.53 (Scheme 1.9). 
Parikh-Doering oxidation of the alcohol to the ketone, followed by conversion to the vinyl 
triflate with NaHMDS and McMurray’s reagent provided 1.54. Suzuki coupling of the borate 
ester 1.55 with vinyl triflate 1.54 furnished the C16-C17 dehydro intermediate 1.56.  Hydrolysis 
of the dioxolane followed by selective reduction of the C16-C17 double bond with Pd/C installed 
the isoquinoline with the desired β-stereochemistry. Curiously, while Nicolaou does not report 





Scheme 1.9: Installation of the Isoquinoline 
  
Installation of the C2 α-hydroxy and C3 β-dimethylamino groups took considerable 
development. Conversion of the ketone to the silyl enol ether followed by a Saegusa oxidation 
failed to provide the enone 1.58. Ultimately, IBX•MPO (MPO = p-methoxypyridine N-oxide)75 
was successful in forming 1.58 (Scheme 1.10). The conjugate addition of nitrogen nucleophiles 
was initially investigated for the installation of the C3 dimethylamino group, but this resulted in 
the undesired addition to the β-face. Taking advantage of the observed facial selectivity, the 
enone 1.58 was epoxidized under nucleophilic conditions to provide the β-epoxide, setting up the 
future trans relationship between C2 and C3. After screening multiple reductants, the only 
conditions that gave decent yield of 1.60 were Luche conditions (NaBH4, CeCl3•7H2O, 
MeOH),69 giving a mixture of diastereomers 1.59 and 1.60 (1:1 dr, 80% combined yield). 
Undesired diastereomer 1.59 can be recycled by re-oxidation with DMP, but in his 2009 paper, 
Nicolaou uses 1.59 as an intermediate toward the synthesis of cortistatin J. Lewis acid-catalyzed 
opening of the epoxide to synthesize cortistatin A (1.1) proved to be poorly selective, giving a 
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mixture of C3 and C2 attack (1.26:1 ratio C3:C2 attack, 83% combined yield). Protecting the 
alcohol at C1 with TBS disfavored attack of the epoxide at C2 (4:1 C3:C2) but proceeded to add 
two extra steps to the synthesis.  
Scheme 1.10: Nicolaou’s completion of Cortistatin A (1.1) 
  
With one of the highest step counts and the lowest yield (30 steps (from Hajos-Parrish 
ketone (1.44)) and 0.009% yield), Nicolaou’s synthetic strategy leaves room for improvement. 
Of the 31 steps from Hajos-Parrish ketone (1.44), eight are protection/deprotection steps and 13 
are oxidation state adjustments. Several intermediates such as 1.57 (7 nM GI50 against 
HUVEC’s), 1.58 (8 nM), and 1.59 (8 nM) showed equipotency to cortistatin A (1.1), revealing 
that the isoquinoline seems to be important for activity, while the substituents on the A ring are 
somewhat less consequential.   
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1.3.3: SHAIR’S TOTAL SYNTHESIS 
In 2008,30 Shair published his approach to cortistatin A (1.1). Like Baran, Shair 
envisioned cortistatin to come from a late stage installation of the isoquinoline ring from 
cortistatinone 1.21 (Scheme 1.11). Hajos-Parrish ketone 1.44 was diastereoselectively reduced 
and subsequently protected as the TBS ether to furnish 1.45 (Scheme 1.12). α-Alkylation of the 
enone moiety under Molander’s82 conditions with bromodioxolane 1.63 and formation of the 
extended silyl enol ether gave 1.64.  Selective reduction of the C14-C15 double bond followed 
by a Rubottom71 oxidation provided the Robinson annulation precursor 1.65. Protection of the 
alcohol as the methoxyethoxymethyl ether (MEM) followed by deprotection of the ketone set up 
the formation of the B-ring via an intramolecular aldol to give BCD ring intermediate 1.66. 
Elimination of the alcohol with SOCl2 to form the enone followed by conversion to the vinyl 
triflate with NaHMDS and McMurray’s reagent provided 1.67. Kumada coupling with the silyl 













Scheme 1.12: Shair’s synthesis of intermediate 1.69 from Hajos-Parrish ketone 1.44 
 
Allyl siloxane 1.69 then underwent a cyclopropanation with dibromo carbene to give 1.71 
(Scheme 1.13). The key siloxy-directed cyclopropylcarbinyl rearrangement required proper 
choice of the silicon group. When TMS was used instead of the siloxane at C4, the ring 
expansion favored deprotonation by fluoride at C6, rather than elimination of the TMS group to 
provide the endocyclic olefin 1.75. The enhanced Lewis acidity of the siloxane favors the 
formation of the “ate” complex 1.76 with fluoride anion which eliminates to the exocyclic olefin 




Scheme 1.13: Shair’s key siloxy-directed ring expansion 
 
 
Suzuki coupling of 1.77 with vinyl boronate 1.78 followed by Sharpless asymmetric 
dihydroxylation provided triol 1.79. Deprotection of the TES ether to the primary alcohol, 
followed by selective oxidation gave key transannular aza-Prins precursor 1.80 (Scheme 1.14). 
Ultimately, the aza-Prins reaction proceeded with excellent diastereocontrol, along with 




Scheme 1.14: Shair’s key transannular aza-Prins 
 
Completion of Shair’s total synthesis mirrors the endgame of Baran, even intercepting 
cortistatinone 1.21 as an intermediate (Scheme 1.15). Deprotection of the TBS group to the 
alcohol, followed by a Ley oxidation (TPAP, NMO)68 provided ketone 1.82. Deprotection of the 
acetyl groups with K2CO3 and MeOH gave cortistatinone 1.21. Conversion of the ketone to vinyl 
iodide under Barton’s conditions followed by Stille coupling gave C16-C17 dehydro compound 
1.39. Selective reduction of the double bond proved challenging for Shair, reporting that only 
diimide reduced the C16-C17 double bond to give cortistatin A (1.1) in 25 steps and 0.0078% 





Scheme 1.15: Shair’s completion of cortistatin A (1.1) 
 
1.3.4: MYERS’S TOTAL SYNTHESIS 
Myers goal in his 201031 publication was to develop a highly divergent synthesis from a 
common intermediate 1.85 (later intercepted by Yang) (Scheme 1.16). Myers managed to not 
only synthesize cortistatin A (1.1) and J but also K, L and other analogues for testing. Synthesis 
of key coupling partner 1.87 began with iodo phenol 1.89 (Scheme 1.17). Protection of the 
phenol as the triisopropyl silylether (TIPS) followed by a Negishi coupling with vinylzinc 
bromide gave carbomethoxy styrene 1.90. The ester was reduced to the benzyl alcohol and then 




Scheme 1.17: Synthesis of benzylic coupling partner 1.87 
  
Synthesis of the divinyl triflate 1.88 proceeded via TESOTf mediated conjugate addition 
of triphenylphosphine to enone 1.47 to provide an intermediate phosphonium salt 1.92 that was 
then used in a Wittig olefination with formaldehyde to furnish the TES dienol ether 1.93 
(Scheme 1.18). Formation of the vinyl triflate under Corey’s conditions (CsF, PhNTf2)
79 
provided 1.88. 
Scheme 1.18: Synthesis of vinyl triflate 1.88 from Hajos-Parrish ketone 1.44 
 
Conversion of the benzyl bromide 1.91 into the organozinc reagent took significant 
experimentation. Direct insertion of zinc under Knochel’s conditions failed.78 Formation of the 
Grignard reagent was sensitive to temperature and solvent and was plagued by Wurtz coupling as 
a side reaction. Only by etching the magnesium surface with ethylene dibromide to form 
magnesium with a great deal of surface area, was Myers able to form the benzylic Grignard 
reagent in good yield. Transmetalation of the Grignard reagent to the organozinc reagent with 
ZnCl2 followed by Negishi coupling with vinyl triflate 1.88 provided 1.94 in 70% yield (Scheme 
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1.19). Initially, Myers tried to close the B ring via RCM and then selectively reduce the C6-C7 
double bond, but he was unable to do so. Fortuitously, Myers found that the C8-C9 double bond 
reacted selectively with dimethyldioxirane (DMDO) to provide the epoxide 1.95 as a single 
diastereomer. Hydrogenation of the C6-C7 olefin with Wilkinson’s catalyst and NaHCO3 as an 
acid scavenger, followed by selective elimination of the epoxide at C19 gave allyl alcohol 1.96. 
Phenolic oxidation with bis-trifluoroacetyl iodosylbenzene (PIFA) proceeded in 50% yield to 
give the intermediate 1.85. 
Scheme 1.19: Synthesis of the Myers-Flyer intermediate (1.85) 
  
Conjugate reduction of the C3-C4 double bond in 1.85 with triethylsilane and 
Wilkinson’s catalyst followed by bromination of the silyl enol ether gave the bromo-ketone 1.97 
with the desired β-stereochemistry (Scheme 1.20). The inclusion of pyridine to complex the 
Wilkinson’s catalyst proved to be essential for good diastereoselectivity. Displacement of the C3 
bromide with tetramethylguanidinium azide (TMGA) followed by a diastereoselective reduction 
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of the enone with the Corey-Bakshi-Shibata (CBS) catalyst provided key intermediate 1.98. 
Protection of the alcohol moiety of 1.98 with chloroacetyl chloride followed by deprotection of 
the alcohol on the D ring gave 1.99. The C17 alcohol was then oxidized with DMP to the ketone 
and exposure to NBS in MeCN/MeOH led to selective bromination at C1 and methanol capture 
at C9 to furnish intermediate 1.84. 
Scheme 1.20: Synthesis of intermediate 1.84 
  
Nucleophilic displacement of the bromide group in 1.84 with KO2 followed by Lewis 
acid-mediated elimination of the methyl ether to form the C9-C11 double bond gave 1.100 
(Scheme 1.21). Staudinger73 reduction of the azide moiety followed by in situ reductive 
amination installed the C3 dimethylamino group. Protection of the C1 and C2 alcohols as the 
TES ethers provided 1.101. Cognizant of the difficulties in reducing the C16-C17 double bond, 
Myers was inspired by the work of Hirama, who developed an alternate procedure for installing 
the isoquinoline ring (see Scheme 1.25 and 1.26 1.53→1.123). Addition of the lithiated 
isoquinoline 1.102 to the ketone 1.101 in the presence of tetramethylethylenediamine (TMEDA) 
gave 1.103, followed by the Jang80,81 modification of the Barton deoxygenation gave cortistatin 
A (1.1) in 28 steps and in 0.105% yield from Hajos-Parrish ketone 1.44. 
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Scheme 1.21: Myers’s completion of Cortistatin A (1.1) 
 
1.3.5: HIRAMA’S TOTAL SYNTHESIS 
Hirama published his progress to the core of cortistatin A (1.1) (1.1) in 200853 followed 
by a formal synthesis in 200934 where he intercepted the Nicolaou-Chen intermediate 1.40, and a 
total in 2011.32 Hajos-Parrish ketone (1.44) was reduced and protected to give 1.45 (Scheme 
1.23). The enone was alkylated at C8 under Molander’s82 conditions with TBS protected 2-
iodoethanol to provide enone 1.106. Reduction of the C9-C14 double bond in enone 1.106 turned 
out to be poorly diastereoselective. Reduction with Pd/C-H2 favored addition of hydrogen to the 
β-face by 2.4:1. Nickel boride at –78 ºC managed to reverse the selectivity to 1:4 in favor 
addition to the α-face to furnish ketone 1.107. Conversion of the ketone in 1.107 to the silyl enol 
ether under thermodynamic conditions, followed by a Saegusa72 oxidation provided enone 1.108 
with the C11-C12 double bond. Deprotonation of 1.108 with LDA followed by quenching with 
triflic anhydride (Tf2O) gave a vinyl triflate that was subsequently methoxycarbonylated to give 
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ester 1.109. Reduction of the ester with DIBAL-H followed by oxidation to the aldehyde with 
DMP furnished 1.110. 
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The piperidine catalyzed Knoevenagel/electrocyclic cyclization of 1.110 with 1,3-
cyclohexadione and aldehyde 1.110 initially proceeded in 68% yield, forming significant 
amounts of byproduct 1.115, which was thought to be formed via tautomerization of the iminium 
intermediate 1.112 (Scheme 1.24). Fortunately dilution from 200 mM to 15 mM favored 





















































































































Selective deprotection of the primary TBS ether with HF•Pyridine, followed by 
iodination gave 1.103 (Scheme 1.25). Interestingly, Hirama observed epimerization at C8 due to 
reversible electrocyclization at room temperature. Hirama found that cooling to low temperatures 
favored the desired β-diastereomer and thus used a low temperature radical initiator (Et3B, O2) to 
cyclize 1.103 to the Nicolaou-Chen intermediate 1.40 as a single diastereomer. 
 In 2011, Hirama continued his work, applying his isoquinoline addition methodology 
and improving the endgame. Protection of the ketone of 1.40 as the dioxolane under Noyori’s 
conditions followed by deprotection and oxidation of the C17 hydroxyl group provided 1.53. 
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Addition of the organocerate 1.120 to ketone 1.53 gave 1.121 as a mixture (1.8:1) β:α of epimers 
at C17. The chlorine substitution was necessary due to addition of n-BuLi into the isoquinoline. 





i) HF pyridine, THF, r.t.






































































































Formation of the tertiary thiohydroxamate ester followed by Barton66,67 deoxygenation 
furnished 1.122 as a single diastereomer (Scheme 1.26). Hydrogen was added selectively to the 
α-face regardless of the stereochemistry of the C17 thiohydroxamate ester. Hirama’s method of 
installing the isoquinoline offers significant improvements over the methods of Baran and 
Nicolaou (73% yield over three steps vs. 27% over three steps). Deprotection of the dioxolane 
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and oxidation with Mukaiyama’s reagent83 to give enone 1.58 also offers an improvement over 
Nicolaou IBX•MPO sequence (80% vs. 46%). 
Scheme 1.26: Synthesis of Nicolaou-Chen intermediate 1.58 and endgame improvement 














































Like Nicolaou, Hirama attempted to add nitrogen nucleophiles to the enone in 1.58 to 
install the dimethylamino group. He was able to successfully add dimethylamine or TMSN3 into 
the enone with the requisite stereochemistry at C3, but was unable to oxidize the α-position of 
the ketone. Following, the failure to add nucleophiles to the enone, Hirama decided to follow 
Nicolaou’s endgame and epoxidized the enone to give 1.124. He found that by cooling the 
reaction mixture to –78 ºC during the Luche reduction improved the diastereomeric ratio from 
1:1 to 1.5:1 in favor of the desired 1.61 (Scheme 1.27). Finally, opening the epoxide with 
dimethylamine using Yb(OTf)3 as a Lewis acid instead of Ti(OiPr)4 offered slight improvement 
in the regioselectivity (2.3:1  vs. 1.3:1) to provide cortistatin A (1.1) in 25 steps in 1.01% yield 






Scheme 1.27: Hirama’s completion of Cortistatin A (1.1) 
 
 
1.3.6: SARPONG’S FORMAL SYNTHESIS 
Sarpong published a model study in 200852 and a formal synthesis of cortistatin A in 
2010.35 The synthesis began with conjugate addition of vinyllithium into 2-
methylcyclopentenone 1.130, followed by alkylation with bromomethyl acetate to provide 1.131 
(Scheme 1.29). Diastereoselective reduction, of 1.131 followed by protection as the TBS ether 
gave ester 1.132. Oxidative cleavage of the vinyl group under Johnson-Lemieux74 conditions 
followed by conversion to the alkyne with the Ohira-Bestmann provided 1.133. Reduction of the 






Scheme 1.29: Sarpong’s synthesis of coupling partner 1.128 
 
Synthesis of the indanone coupling partner 1.138 began with protection of guaiacol 1.129 
as the TIPS ether, followed by ortho-lithiation and quenching with DMF to give aldehyde 1.134 
(Scheme 1.30). Horner-Wadsworth-Emmons olefination of the aldehyde with phosphonate ester 
1.135 resulted in a benzyl cinnamate ester that was subsequently reduced and debenzylated with 
Pearlman’s catalyst (Pd(OH)2/C) to furnish 1.136. Conversion of 1.136 to the acetyl chloride 
followed by intramolecular Friedel-Crafts furnished indanone 1.137. The TIPS ether was 
exchanged for the benzyl group to provide indanone 1.138 due to concerns with its stability in 








Scheme 1.30: Synthesis of indanone 1.138 
 
Indanone 1.138 and aldehyde 1.128 were coupled via aldol condensation and the 
resulting double bond in the enone was reduced with K-Selectride to provide 1.139 (Scheme 
1.31). Indanone 1.139 was reduced to the corresponding alcohol followed by acid catalyzed 
elimination to furnish indene 1.140. 
Scheme 1.31: Synthesis of key cycloisomerization precursor 1.140 
 
 
Several carbophilic Lewis acids were screened for the key cycloisomerization step, and 
PtCl2 was found to convert indene 1.140 cleanly to the 1.146 in 82% yield (Scheme 1.32). The 
unusual transformation is thought to start with activation of the alkyne via the carbophilic Lewis 
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acid to provide 1.141. Attack of the alkyne-metal complex (1.141 → 1.143) by the indene is 
thought to form a transient pentacyclic metal carbenoid 1.143, which rearranges to the desired 
product 1.146.    















































































Selective reduction of the C6-C7 double bond with diimide followed by reductive 
removal of the benzyl group with Na/naphthalene furnished tetracycle 1.147 (Scheme 1.33). 
Protection of the phenol as the TES ether allowed for diastereoselective epoxidation to deliver 
1.148. Selective elimination of the epoxide at C19 with n-BuLi occurred with concomitant 
removal of the TES group to set up the key oxidative arene cyclization. Methanol, as the solvent, 
was too nucleophilic and led to solvent incorporation into the aromatic ring. The non-
nucleophilic but acidic alcohol trifluoroethanol (TFE) furnished the desired product 1.124 but 
numerous other side products were also formed. Optimum conditions were found by using an 
alcohol co-solvent in addition to TFE. The C9-C11 double bond was installed by first 
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epoxidation of the C19-C9 double bond to provide the epoxide 1.149. Acid catalyzed ring 
opening with CSA followed by elimination of the resulting C9 alcohol gave enone 1.150.  
Scheme 1.33: Sarpong’s key oxidative arene cyclization 
 
Reducing the enone 1.150 to intercept the Nicolaou-Chen intermediate 1.40 proved 
challenging (Scheme 1.34). The transformation was achieved by first reducing the enone under 
Luche conditions, followed by conversion of the allyl alcohol into the allylic carbonate 1.151. 
Transfer-hydrogenation of the π-allyl cation intermediate furnished the divinyl ether 1.152. 
Reduction of the C3-C4 double bond with Wilkinson’s catalyst, followed by acid catalyzed 
deprotection provided the Nicolaou-Chen intermediate 1.40, completing a formal synthesis of 




Scheme 1.34: Sarpong’s formal synthesis of Cortistatin A (1.1) via the Nicolaou-Chen 
intermediate 1.40 
 
Like Danishefsky and Myers, Sarpong saw an oxidative arene cyclization from 1.125 to 
1.124 as the key step toward the formation of the oxabicyclo-[3.2.1]-octene core (Scheme 1.28). 
The arene oxidation precursor was planned to come from indene 1.126 via Sarpong’s novel 
cycloisomerization methodology, which he developed for the synthesis of the icetexanes.62 
Indene 1.126 was envisaged come from the coupling of aldehyde 1.128 and indanone 1.127, 
which was planned to come from the simple starting materials of guaiacol 1.129 and 2-methyl-
cyclopenenone 1.130. 
1.3.7: YANG’S FORMAL SYNTHESIS 
Yang published model studies in 200951 and a formal in 2011,36 where he intercepted the 
Myers-Flyer intermediate 1.85. Alkylation of Hajos-Parrish ketone (1.44) at C8 with furan 1.156 
under Molander’s conditions furnished the enone 1.157 (Scheme 1.36).82 Yang reports the low 
yield is due to the propensity of 1.156 to eliminate to the vinyl furan under basic conditions. 
Conversion of the enone to the extended vinyl triflate with collidine and triflic anhydride 
followed by methoxycarbonylation gave the ester 1.158. Reduction of the ester with DIBAL-H 
followed by oxidation to the aldehyde with MnO2 furnished enal 1.159. Addition of TMS lithium 
acetylide, followed by reoxidation with MnO2 provided 1.160. 
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Scheme 1.36: Yang’s synthesis of Diels-Alder intermediate 1.160 
 
Unlike the model system studies, which spontaneously cyclized after the oxidation to the 
ynone, 1.160 did not cyclize (Scheme 1.37). A Lewis acid screen showed that EtAlCl2 was an 
excellent Lewis acid for promoting the IMDA, which was accompanied by aromatization and 
TMS removal to give 1.166. When the TMS group was deprotected before the Diels-Alder 
reaction, the reaction either stalled at the cycloadduct 1.162 or became mixtures of the 
cycloadduct 1.162 and the aromatized product 1.166. Reasons for this difference are not clear, 
but may be due to the stabilizing effect of the TMS group on cationic intermediate 1.164. A 1,2 
hydride shift then gives the α-TMS oxonium intermediate 1.165 which is subsequently enolized 








Scheme 1.37: Yang’s key intramolecular Diels-Alder (IMDA) 
  
With the tetracycle 1.166 in hand, selective reduction of the C8-C9 double bond was 
achieved with Rosenmund’s catalyst to provide 1.154 (Scheme 1.38). Arene oxidation with 
phenyliodo-bis-trifluoroacetate (PIFA) in the presence of water gave a  mixture (1.5:1) of 
diastereomers of α and β-hydroxyl intermediates 1.167 and 1.168. The undesired β-hydroxyl 
intermediate 1.167 could be recycled back to 1.154 by treatment with Zn metal in pyridine/H2O. 
Cyclization of the hydroxyl compound 1.168 with NaOAc furnished the core 1.153. Finally 
selective reduction of the C19 carbonyl over the C2 carbonyl was achieved with LiEt3BH. 
Elimination of the alcohol with MsCl and Li2CO3, successfully intercepted the Myers 




Scheme 1.38: Formal synthesis of Cortistatin A (1.1) via the Myers-Flyer intermediate 1.86 
 
1.3.8: CHIU’S FORMAL SYNTHESIS 
Chiu published a route to the core of cortistatin A (1.1) in 201138 and finished a formal in 
2015.37 Chiu sought to intercept Nicolaou’s synthesis utilizing Hirama’s improvements via 
intermediate 1.59. Enantioselective reduction of the commercial dienone 1.173 via transfer 
hydrogenation with the R,R-Ts-Deneb catalyst 1.174, proceeded in excellent enantioselectivity 
(>99% ee) and diastereoselectivity (4.6:1 dr) (Scheme 1.40). This offered an improvement over 
her 2011 communication38 that used the CBS catalyst and gave comparable enantiomeric excess 
but also over-reduced to the diol (~12%). Protection of the alcohol as the TBS ether provided 
ketone 1.175. Conversion of the ketone moiety to a vinyl triflate with NaHMDS and 
McMurray’s reagent,84 followed by Stille coupling of the vinyl triflate with furan 1.176 
furnished cyclopentene 1.177. This also offered an improvement over the 2011 communication 
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in that direct addition of the lithio-furan gave poor conversion (50%) and returned material. 
Cross metathesis of 1.117 with methyl acrylate then gave enone 1.178. 
Scheme 1.40: Synthesis of [3+4] cyclization precursor 1.178 
 
Asymmetric nucleophilic epoxidation of enone 1.178 under Deng’s conditions,86 
followed by conversion of the ketone to the silyl enol ether gave 1.180 (Scheme 1.41). Treatment 
of 1.180 with TESOTf triggered the key [3+4] cycloaddition to furnish 1.181 as a single 
diastereomer. Elimination of the alcohol with florisil, followed by deprotection of the silyl 
groups with camphorsulfonic acid (CSA) gave 1.182. Diastereoselective reduction of the C14-
C15 double bond in cyclopentene 1.182 proved problematic. Pd/C-H2 delivered hydrogen to the 
undesired β-face and over-reduction. Fortunately, directed reduction with Crabtree’s catalyst 
provided clean addition of hydrogen form the α-face of the C14-C15 double bond as well as 
fortuitous reduction of the C6-C7 double bond. Oxidation of the C17 alcohol with DMP then 
triggered a spontaneous intramolecular aldol reaction to provide 1.183 as a single diastereomer. 
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Directed reduction of 1.183 with Me4NBH(OAc)3 gave the desired selectivity, and protection of 
the alcohol as the TES ether then gave 1.184 as a single diastereomer. 
Scheme 1.41: Chiu’s key [3+4] cycloaddition 
 
 Ketone 1.184 was converted to the vinyl triflate with NaHMDS and McMurray’s reagent 
followed by Suzuki coupling with isoquinoline-borate ester 1.55 to give 1.185 (Scheme 1.42). 
Despite numerous reports of the C16-C17 double bond reduction being problematic, Pd/C-H2 
furnished the desired reduction in good yield. Selective deprotection of the C1 alcohol and 
oxidation to the ketone with DMP furnished 1.86. Conversion of the ketone 1.186 to enone 1.187 
was accomplished with LDA and Mukaiyama’s reagent. Elimination of the  C19 alcohol with 
trifluoroacetic acid (TFA) provided the intermediate 1.58, which intercepted the Hiyama and 
Nicolaou total synthesis of cortistatin A (1.1) (1.1) in 24 steps and 2.03% yield. 
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i) NaHMDS, THF, 78 C, PhNTf2
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1.3.9: STOLTZ’S SYNTHESIS OF THE ABCD CORE WITH  ENE-YNE METATHESIS 
Concurrently with the studies in the Martin group, the Stoltz group published a model 
study toward the core of cortistatin A (1.1) in 2010,54 utilizing a similar strategy of an ene-yne 
metathesis to close up the ABC and D rings in a single step. Cyclohexanone 1.192 was converted 
to β-bromo enal in a Vilsmeier-like reaction followed by reduction to give the allyl alcohol 1.193 
(Scheme 1.44). The alcohol was protected as the para-methoxybenzyl (PMB) ether with 4-
methoxybenzyl trichloroacetimidate and catalytic La(OTf)3, followed by a Stille coupling to 
furnish vinyl compound 1.194. Hydroboration/oxidation of 1.194 followed by conversion to the 





Scheme 1.44: Synthesis of  A-ring fragment 1.195 
O i) PBr3, DMF, HCCl3, 70 C
ii) DIBAL-H, Et2O, 0 C r.t
63%
OHBr






OPMB i) Cy2BH, THF,0 C r.t; NaBO3 H2O













Synthesis of the D ring coupling partner began with desymmetrization of 
cyclopentadione 1.173 by enzymatic reduction with baker’s yeast. Activation of the alcohol as 
the methanesulfonyl ester 1.196 allowed for displacement with cyanide (Scheme 1.45). 
Strangely, the reaction proceeded with retention of stereochemistry at C14, presumably through 
an intermediate such as 1.197. Despite having the wrong stereochemistry at C14, the synthesis 
was continued by protecting the ketone was protected as the dioxolane and reducing the nitrile 
with DIBAL-H to provide the aldehyde 1.198. A TIPS protected alkynyl magnesium bromide 
was then added into the aldehyde and the resulting alcohol was oxidized with MnO2 to provide 









Scheme 1.45: Synthesis of D-ring fragment 1.191 
 
 
The alkyl lithium reagent 1.190, was added into ynone 1.191 to give 1.200 as a  ratio 
(2.2:1) of α and β-epimers in 77% combined yield (Scheme 1.46). After isolation of the desired 
α-epimer, the PMB group was removed, and the primary alcohol was acylated to give 1.201. 
Allyl acetate 1.201 was then ionized with MgBr2•Et2O with ditert butylpyridine (DTBP) as an 
acid scavenger to give 1.202 and 1.189 as mixture (1:1) of diastereomers. The diastereomers 
























































































Even though the mixture of 1.202 and 1.189 was subjected to the reaction mixture, the 
key ene-yne metathesis impressively furnished the tetracyclic compound 1.188 in 36% yield 
(74% based on theoretically pure 1.189) along with undesired compound 1.208 in 44% yield 
(88% based on theoretically pure 202). Stoltz’s route provides a simplified core of cortistatin A 










Scheme 1.46: Stoltz’s key ene-yne metathesis 
  
 
1.4: Prior art in the Martin group
 
1.4.1: FIRST GENERATION SYNTHETIC PLAN 
The approach the Martin group adopted for the synthesis of cortistatin A (1.1) begins 
with a late stage addition of isoquinoline to cortistatinone 1.2 in a similar strategy to Hiyama 
(Scheme 1.47, see Section 1.3.5).34,32 The α-stereochemistry of the C1 (cortistatin numbering) 
hydroxyl group was envisioned as arising from a regioselective opening of a β-epoxide with 
acetate ion. Strategic use of the Mitsunobu methodology developed by Fukuyama,89 allows for 
the displacement of the C3 alcohol with inversion of stereochemistry to install the C3 
dimethylamino group. The β-stereochemistry of the C3 alcohol can be used to direct the 
epoxidation to the desired face from 1.209. In the key step, the plan called for forming all four 
rings in 1.209 by an ene-yne metathesis from 1.210. The olefins at C2 and C11 would then come 
from a reduction with Lindlar’s catalyst from the corresponding alkynes. The alkynes at C9 and 
C10 would be formed by treatment the bis-aldehyde produced by selective ozonolysis of the 
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bicyclic intermediate 1.211 with the Ohira-Bestmann reagent. The stereochemistry in 1.211 
would arise from the diastereoselective intermolecular Diels-Alder reaction of furan 1.212 with a 
chiral sulfoxide. The stereochemistry at the C3 alcohol would be set by an enantioselective 
alkyne addition on aldehyde.90-94 The stereochemistry at C14 can come from an enantioselective 
conjugate addition of furan 1.213 into enone 1.130, followed by a diastereoselective alkylation.  
At the outset of this work in 2009, no one had utilized ene-yne metathesis as a strategy 
toward cortistatin A (1.1). Although Stoltz later applied this strategy towards the synthesis of a 
core-like structure in 2010, the stereochemistry at C14 was incorrect and thus a successful 
application of ene-yne metathesis towards the total synthesis of cortistatin A (1.1) had yet to be 
accomplished. An additional challenge to the synthetic plan was the lack of enantioselective 
methods to add heteroaromatic moieties to enones. There were also few reports of intermolecular 
enantioselective and diastereoselective Diels-Alder reactions on furans with chiral sulfoxides. 













Scheme 1.47: 1st generation Martin group retro-synthetic strategy  
 
In 2009, Dr. Anna Smith developed the synthetic methodology for the enantioselective 
addition of heteroaryl-zincs and titanates to a variety of enones using a Rh(I) precatalyst, the 
ligand MeO-biphep, and TMSCl (Scheme 1.48).95 Generally, the enantioselectivities were better 
with the titanates due to a significant background reaction with the organo-zinc reagents that lead 
to racemic products. Mechanistically, the Rh(I) species 1.217 is presumed to be the active 
catalyst (Scheme 1.48). Transmetalation of the heteroaryl-metal species 1.218 then gives 1.219, 
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which then undergoes a 1,4-addition with cyclopentenone 1.224 to give the rhodium enolate 
1.221. The rhodium enolate then reacts with TMSCl to regenerate the catalyst and release the 
product as the silyl enol ether 1.222. Upon workup, the ketone 1.223 was isolated in 90% yield 





















Scheme 1.48: Dr Anna Smith’s enantioselective conjugate addition methodology 
 
Disappointingly, attempts to add furan 1.225 to cyclopentenone 1.130 to install the C13 
methyl group gave no desired product 1.226 (Figure 1.4, A). Based on the proposed mechanism, 
it is possible that α-substitution on the enone causes unfavorable steric interactions in complex 
1.220 (Scheme 1.48). Conceivably, the C13 methyl group could be installed via alkylation of 
ketone 1.223, but substituents in the β-position are poor directors of enolate geometry 
(selectivities range from 1:1 to 7:1 favoring formation of the enolate on the same side of the β-
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substituent).96 Fortunately, because the reaction produces the silyl enol ether with the desired 
regiochemistry, the reaction was modified to isolate the TES enol ether by substituting TESCl in 
place of TMSCl (Figure 1.4, B). Unfortunately, attempts to isolate the silyl enol ether from the 
conjugate addition of 2-substituted furans (with the exception of 2-methyl furan 1.225) were 
unsuccessful (Figure 1.4, C). Lithiation of vinyl 1.231 or 2-allylfuran 1.232 in the 5-position lead 



















Figure 1.4: Conjugate addition of substituted furans with cyclopentenones 1.130 and 1.224 
 
  
The inability 5-substituted furans other than 5-methylfuran to participate in the conjugate 
addition necessitated the functionalization of the 5-position of 1.223 after methylation. Initial 
attempts at methylating silyl enol ether 1.228 gave either ketone 1.223, polyalkylated material, or 
complex mixtures (Scheme 1.49). After screening unmasking agents (CsF, TBAT and MeLi), 
solvents (MeCN, CH2Cl2, THF, PhMe, THF, HMPA) and other additives (Et3N, NaH, DIPEA, 
TiCl(OiPr)3,
100 Dr. Smith found that  unmasking the enolate with MeLi in toluene, followed by 
transmetalation with TiCl(OiPr)3, and alkylating with MeI provided ketone 1.237 as a single 
diastereomer in 70% yield (Assigned as trans isomer based on 1H-NMR shift of the methyl peak: 
1.13, see also Chapter 2, Scheme 2.6 and discussion). The metal additive suppresses 
polyalkylation but reduces the reactivity of the enolate, so the inclusion of HMPA as a co-solvent 
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was essential to promote sufficient reactivity. Alkylation of 1.237 also proved problematic. 
Several bases and solvents were screened for the generation of the thermodynamic enolate and 
subsequent alkylation with TMS-propargyl iodide. Fortunately, adding NaHMDS to the ketone 
1.237 at –78 ºC, followed by warming to room temperature and alkylation with TMS-propargyl 
iodide provided the ketone 1.238 in 81% yield as a single diastereomer (relative stereochemistry 
assigned based on crystal structure of downstream intermediate, see Chapter 2, Figure 2.2).  
Scheme 1.49: Synthesis of ketone 1.238 
 
Attempts to metalate the 5-position of furan 1.238 directly or to protect the ketone as the 
enolate in situ led to complex mixtures of products (Scheme 2.4). The ketone was protected as 
the dioxolane 1.239, but extended reaction times and low yields of this protection made this 
route unattractive. Due to the poor yield of the conversion of 1.238 to 1.239, the sequence was 










Scheme 1.50: 1st Attempt of the synthesis of ketone 1.241 
 
 
Protection of 1.237 as the dioxolane 1.242 proceeded in quantitative yield (Scheme 1.51). 
Lithiation of furan 1.242 at the 2-position and quenching with allylbromide then gave 2-
allylfuran 1.243, which was subsequently hydrolyzed to furnish ketone 1.244. Formation of the 
thermodynamic enolate of 1.244 with NaHMDS and alkylation with propargyl iodide gave key 
intermediate 1.241 in 81% yield. Attempts to determine the relative stereochemistry of 1.241 by 
crystallization of the phenylhydrazone or by NOE were inconclusive (relative stereochemistry 
determined later by crystal structure, see Chapter 2, Figure 2.2).  Attempts to oxidatively cleave 
the allyl group with ozone, Johnson-Lemieux conditions (OsO4, NaIO4), or “purple benzene” (n-
Bu4NMnO4) all led to complex mixtures. However, a two step procedure of dihydroxylation with 
AD-mix α followed by cleavage with NaIO4 gave aldehyde 1.212 in 39% yield after two steps. 
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Scheme 1.51: Synthesis of aldehyde 1.212 
 
Several attempts to use Carreira’s90-93 or Shibasaki’s94 enantioselective alkyne addition 
methodology met with little success (Equation 1.1). Varying the Lewis acid, ligand, or the base 
led to decomposition of aldehyde 1.212. The aldehyde 1.212 was very sensitive to the Lewis 









Equation 1.1: Failure of enantioselective alkyne addition with aldehyde 1.212 
 
While an alternate strategy to set the C3 stereocenter was being devised, work on the 
enantioselective intermolecular Diels-Alder reaction was underway. Generally speaking, the 
reaction was thought to take place with the furan as the diene and an enantiopure sulfoxide acting 
as the dienophile. Method development would be needed as there were only a few examples of 
enantioselective intermolecular Diels-Alder reaction reactions of vinyl equivalents. 
1.4.2: DIELS-ALDER REACTION CYCLIZATION OF ENANTIOPURE VINYL SULFONATES WITH 
FURANS 
The Martin group strategy for setting the stereochemistry at C5 and C8 was inspired by 
the work of Kagan, who used enantiopure O-methylsulfoxonium tetrafluoroborates 1.247 as 
dienophiles in diastereoselective intermolecular Diels-Alder reaction with furans.102 Before using 
O-methylsulfoxonium tetrafluoroborates 1.247 as a formal source of chiral ethylene, certain 
obstacles have to be addressed. Consider furan 1.248 with alkyl substitution in the 2- and 5-
positions (Figure 1.5). Assuming 100% diastereomeric excess an exo-selective Diels-Alder 
reaction with the preferred regiochemistry being with the sulfoxide on the same side as “X” 
would provide the Diels-Alder adduct 1.249, which after desulfurization would provide 1.250. 
An endo-selective Diels-Alder reaction with the preferred regiochemistry being with the 
sulfoxide on the same side as “Y” would provide the Diels-Alder adduct 2.47, which after 
desulfurization would provide the same product 1.250 as the exo-X selective Diels-Alder. Hence, 
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in order for the Diels-Alder reaction strategy to work, it must be enantioselective, endo/exo 
selective, and regioselective. 
Figure 1.5: Regiochemical and stereochemical issues with Diels-Alder reaction 
 
To investigate these issues, Dr. Smith applied Kagan’s methodology to 2,5- 
dimethylfuran 1.255, which provided the adducts 1.256 and 1.257 (1:2 exo:endo, 82% de, 77%) 
in 73% combined yield (Scheme 1.52). When furan 1.258 was subjected to Kagan’s conditions, 
the adduct 1.259 was isolated, but as a mixture of stereoisomers and regioisomers, indicating that 













Using this problem as a platform for methodological development, Dr. Noah Benjamin 
investigated the diastereoselective Diels-Alder reaction of furans with enantiopure sulfoxides 
(Scheme 1.53).103 After screening several sulfoxides and Lewis acids, the combination of 
sulfoxide 1.260 and TBSOTf with furans 1.261 or 1.263 gave Diels-Alder reaction adducts 1.262 
and 1.264 in excellent diastereoselectivity and yields. Use of 2,6-di-tert-butylpyridine (DTBP) 
was essential to achieve high yields because the furans were very sensitive to traces of triflic 
acid. The use of Lewis acid and low temperatures made the exo/endo selectivity very good, but 
unfortunately, unless the furan was electronically biased as in the case of 1.263, the 




Scheme 1.53: Dr. Noah Benjamin’s improved diastereoselective Diels-Alder reaction 
 
1.4.3: SECOND GENERATION SYNTHETIC PLAN 
Due to the failure of the enantioselective alkyne addition on aldehyde 1.212 and the 
inability of the enantioselective Diels-Alder reaction to give good regioselectivity, the 
retrosynthetic strategy was revised (Scheme 1.54). Instead of an intermolecular Diels-Alder 
reaction, an intramolecular Diels-Alder reaction (IMDA) of vinyl sulfonate 1.269 would enforce 
the desired regioselectivity. The IMDA of vinyl sulfonates and furans has been studied by Metz 
and used in the synthesis of eriolanin and pamamycin.104-113  The facial selectivity would then be 
directed by the stereochemistry of the alcohol at C3 in diol 1.245, which would be set by a 




Scheme 1.54: 2nd Generation Martin group retro-synthetic strategy utilizing an IMDA 
 
After determining that AD-mix β would give the desired stereochemistry at C3 
(cortistatin numbering), ketone 1.241 was subjected to the dihydroxylation conditions (Scheme 
1.55). Unfortunately, the reaction was very sluggish, providing only a 50% yield of 1.245 after 
four days at room temperature. Selective protection of the primary C2 alcohol over the C3 
alcohol as the TES ether provided 1.270. Conversion of the C3 alcohol of 1.270 to the sulfonate 
proceeded quantitatively, and heating in benzene then gave the Diels-Alder reaction adducts 
1.272 and 1.273 as a mixture (1:1) of diastereomers  in 95% yield (stereochemistry assigned 
based on a crystal structure of an analogue of 1.272, see Chapter 2, Figure 2.2). Attempts to 
isolate a crystal of the Diels-Alder reaction adducts 1.272 or 1.273, was unsuccessful, so the 




Scheme 1.53: Synthesis of Diels-Alder reaction intermediate 1.272 and 1.273 
 
1.4.4: SUMMARY 
An enantioselective method for the conjugate addition of furans to enones was 
developed, as well as an enantioselective Diels-Alder reaction of furans with enantiopure 
sulfoxides. Though the enantioselective Diels-Alder reaction methodology did not contribute the 
forward synthesis, the IMDA of vinyl sulfate 1.271 provided the important precursor 1.272 and 
1.273 in 10 steps and 16% yield (Scheme 1.56).  
Despite this promising result, major obstacles remained when we took over the project: 
the relative stereochemistry between the groups at C13 and C14 in ketone 1.241 and groups at 
C8 and C14 in the Diels-Alder reaction adducts 1.272 and 1.273 were unverified; the 
enantiopurity of the Diels-Alder adducts after the dihydroxylation was unknown and which of 
the isolated diastereomers (1.272 or 1.273) contained the relative stereochemistry required to 
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pursue the total synthesis of cortistatin A (1.1) (Note: at the time, the relative stereochemistries 
of 1.272 and 1.273 had not been determined). 




CHAPTER 2: CURRENT SYNTHETIC WORK TOWARD CORTISTATIN 
A IN THE MARTIN GROUP 
2.1: First generation synthesis towards the Diels-Alder adduct  
2.1.1: CONFIRMATION OF THE RELATIVE STEREOCHEMISTRY  
The confirmation of which, if any, of the Diels-Alder reaction adducts 2.10 and 2.11 
contained the requisite stereochemistry required for cortistatin A (see Chapter 1, Figure 1.1) was 
tantamount for the continuation of the project. Due to the cost of Rh (I) salts, the conjugate 
addition of furan 2.1 into enone 2.2 was adapted to use Knochel’s114 conditions, which make use 
of organo-zinc reagents to give ketone 2.3 in as a mixture of diastereomers (1:0.6 trans:cis) in 
82% yield, which was subsequently protected as the acetal 2.4 (Scheme 2.1, see also Scheme 
1.56 for comparison). Problems were encountered in reproducing several of yields in the later 
steps on scale. For example, alkylation of ketone 2.6 furnished low yields (10-40%) of 2. 7 
compared to the 81% yield reported by Dr. Smith, and the vinyl sulfonate formation from 2.9 
and subsequent Diels-Alder reaction sequence only furnished the desired mixture of adducts 2.10 
and 2.11 in 30% yield. Despite the unexpected low yields of several of the steps, enough material 
was made to investigate the Diels-Alder reaction in detail and obtain crystals of 2.10 or 2.11 











Scheme 2.1: Synthesis of Diels-Alder reaction adducts 2.10 and 2.11 
 
 
Heating the vinyl sulfonate ester 2.12 (Figure 2.1, A) in benzene for 24 h produces 2.10 
and 2.11 (Figure 2.1, B), which were separable by chromatography.  Diastereomer 2.11 (Figure 
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2.1, C) had characteristic doublets at 6.60 ppm and 6.10 ppm and diastereomer 2.10 (Figure 2.1, 
D) had characteristic doublets at 6.55 ppm and 6.05 ppm, which match the values obtained by 
Dr. Smith. Despite numerous attempts to crystallize 2.10 or 2.11, no crystals could be grown. A 
sample of 2.10 originally synthesized by Dr. Smith was found, but the product had partially 
degraded to a more polar product by TLC (Rf = 0.2 in 3:1 EtOAc/Hexanes compared to an Rf of 



















Figure 2.1: 1H NMR traces of the vinyl sulfonate ester 2.12, Diels-Alder reaction adducts 2.11 
and 2.10 and by-product 2.13 
 
a) 1H NMR of  a (1:1) mixture of vinyl sulfonate diastereomers 2.12; b) 1H NMR of a (1:1) mixture of vinyl 
sulfonates diastereomers 2.12 after heating at 80 °C for 24h; c) 1H NMR of 2.11; d) 1H NMR of 2.10; e) 1H NMR of 
partially degraded sample of 2.10 from Dr. Smith  
 
Although no crystals of x-ray quality were able to be grown from a sample from either 
2.10 or 2.11, the purified sample from Dr. Smith (originally thought to be a derivative of 2.10) 
crystallized nicely. X-ray analysis gave structure 2.13 (Figure 2.2, A). Although the relative 
stereochemistry was correct, it appeared that over six months in the freezer, the alkyne moiety 
had amazingly hydrated to the ketone. A sample of 2.10 was re-purified and unexpectedly, the 
TES group was lost giving 2.14. Fortuitously, while the TES protected compound was not 
crystalline, the deprotected compound 2.14 crystallized, and x-ray analysis that confirmed the 
origin of ketone 2.13 was alkyne 2.10 (Figure 2.2, B). This confirmed that the relative 
stereochemistry between the furan and methyl group of 2. 7 after the propargylation is in the 
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desired trans relationship, and it also confirms that diastereomer 2.10 has the requisite 
stereochemistry required for cortistatin A (2.1).  
























a) Crystal structure grown from purified degraded sample originally synthesized by Dr. Smith; b) Crystal structure 
grown of deprotected 2.14 
 
2.1.2: ATTEMPTS TO OZONOLYZE THE DIELS-ALDER REACTION ADDUCT 2.10 
Ozonolysis was first demonstrated to be selective for alkenes over alkynes by Mc curry 
Jr. in the synthesis of cis-jasmone (Figure 2.3, B).115 Krause also leveraged this selectivity in his 
synthesis of the epi-jasmones (Figure 2.3, C).116 Alkynes can react with ozone to produce 1,2-
diketones, anhydrides, and peroxy acids if no other reactive groups are present, making control 
of ozone equivalents important.117-120 Veysoglu tested the rates of ozonolysis of various 
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functional groups and found a set of azo dyes that will react with ozone to de-color after the 
desired functional group has reacted but before the undesired one has.121 He found that solvent 
red 23 2.17 was ideal for use as an indicator in selective ozonolysis of alkenes over alkynes 
(Figure 2.3, A). That alkenes are more reactive than alkynes, however, is not always the case. 
When Banfi tried to ozonolyze 2.22 he recovered varying amounts of the alkyne cleavage 
product 2.26 even in the presence of solvent red 23 (Figure 2.3, D).122 Subjecting the TMS-
deprotected alkyne 2.23 to the same conditions gave the desired 2.25 in 92% yield, indicating 

























































2.24: R = TMS


















2.22: R = TMS
2.23: R = H  
 
a) Selective ozonolysis by Veysoglu (1980), using solvent red 23 as an internal indicator;121 b) Selective ozonolysis 
by McCurry Jr (1974) for the synthesis of cis-Jasmone;115 c) Selective ozonolysis by Krause (2001), for the 
synthesis of epijasmonates;116 d) Selective ozonolysis by Banfi (2002), for the synthesis of intramolecularly 
activated lactenediynes and example of TMS-alkyne cleavage.122 
Multiple attempts were made to ozonolyze both the desired diastereomer 2.10 and the 
undesired diastereomer 2.11, with no identifiable products being isolated (Equation 2.1). Use of 
solvent red 23 2.17 to monitor the consumption of starting material provided no endpoint to the 
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ozonolysis of the alkene over the alkyne. Use of different solvents, additives and reductive 
workups offered no improvements.  
Equation 2.1: Attempted ozonolysis Diels-Alder reaction adduct 2.14 
 
When bringing up more material, the TES group was exchanged for the more robust TBS 
group to avoid deprotection during purification. Fortunately, use of TBSCl instead of TESCl in 
the conditions developed previously by Dr. Smith, gave selective protection of the primary 
alcohol (Scheme 2.2). Vinyl sulfonate formation followed by Diels-Alder reaction cyclization 
was again low yielding. Unfortunately, ozonolysis of either Diels-Alder reaction adduct 2.29 or 














Scheme 2.2: Synthesis of Diels-Alder reaction adduct 2.29 and 2.30 and attempted ozonolysis  
  
 
Although no products were isolated from the ozonolysis of 2.29, 2.30 or 2.14, Banfi’s 
observation that TMS-substituted alkynes may react with ozone at similar rate to alkenes 
suggests that removal of the TMS group prior to ozonolysis may be beneficial to the reaction 
(see Figure 2.3, D). Attempts to remove the TMS group in 2.10 or 2.11 with TBAF or K2CO3 in 
MeOH led to complex mixtures of unidentifiable products. Therefore, the forward synthesis was 
redesigned to remove the TMS group after the alkylation of ketone 2.6 (Scheme 2.3). 
Additionally, the conjugate addition of 2-allylfuran 2.32 into enone 2.2 was reinvestigated to 
reduce overall step count. The more robust TBDPS protecting group of the primary alcohol 
would be used instead of the TES or TBS group to avoid any hydrolysis during the Diels-Alder 
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reaction or purification and will also provide a chromophore will allow the easy development of 
an HPLC method to determine the enantioselectivity of the dihydroxylation.   
 





 generation synthesis toward the Diels-Alder adduct 
2.2.1: SYNTHESIS OF KETONE 2.6 
Lithiation of furan 2.1 in the 2-position followed by alkylation with allyl bromide 
provided 2-allylfuran 2.32 in only 40-50% yields (Equation 2.2, Condition A). Subjection of 2-
allylfuran to the reaction conditions revealed that it was unstable to n-BuLi. The pKa of the 
benzylic-type protons of similar compounds such as benzyl furan are 30, while the aromatic 
protons in the 2-position of furan have a pKa of 36, so the product is more acidic than the starting 
material. To solve this problem, the 2-furyllithium species was transmetalated to a 2-furylzinc 
reagent with ZnCl2 to attenuate the basicity of the furyl anion. Although the 2-furylzinc species 
was unreactive toward allylbromide, addition of a catalytic amount of CuCN provided 2-




Equation 2.2: Synthesis of 2-allylfuran 2.32 
  
Several attempts were made to lithiate 2-allylfuran 2.32 at the 5-position but they all gave 
complex mixtures (Scheme 2.4). Thinking that the acidity of the benzylic position might be 
responsible for the unwanted side reactions, 2-allylfuran 2.32 was added into two equivalents of 
n-BuLi in an attempt to generate the dianion. The presumed dianion was then transmetalated to 
the organo zinc reagent using fused zinc chloride, which was added to cyclopentenone 2.35 in 
the presence of TESCl. A single compound was isolated as a mixture of diastereomers (1:1). The 
compound seemed to incorporate the cyclopentanone and TES group, so it initially seemed to be 
a 1,2-adduct of 2-allylfuran 2.32 and cyclopentenone 2.35. After collecting 1D and 2D NMR 
spectra however, the structure of the isolated compound has been tentatively assigned as being 










Scheme 2.4: Attempted 5-Lithiation of 2-allylfuran 2.32 
 
The IR spectrum of this product showed no peaks consistent with a carbonyl group and 
instead displayed a very strong OH stretch along with an alkyne stretch. Additionally, the 
presence of only nine carbon peaks between 150 ppm and 120 ppm was low compared to the 
expected 16 carbons (eight if both diastereomers overlapped perfectly) (Figure 2.4). Especially 
telling was that there was only a single carbon peak at 149.7 ppm, indicating that there was only 
one sp2 hybridized carbon attached to an oxygen atom instead of the expected two to four if the 
furan was still intact. Additionally the carbon spectrum contained seven carbons between 90 ppm 









Figure 2.4: Spectroscopic evidence of by-product 2.37 
 
 Rearrangements of this type are unusual but not unprecedented. In 1979, 
Kuwajima discovered that exposure of benzyl furan 2.38 to excess n-BuLi facilitated a 
rearrangement, which after quenching with TMSCl, provided the enyne 2.39 in 85% yield 
(Figure 2.5, A).123 Similar fragmentations are also seen with other heterocycles such as the side 
reaction reported by Snieckus in 1985 (Figure 2.5, B),124 the lithium-halogen exchange of 3-
bromobenzofuran 2.42 reported by Gilman in 1948 (Figure 2.5, C)125 and the lithium-halogen 













Figure 2.5: Anionic fragmentations of 2- and 3-lithioheterocycles 
 
a)Example from Kuwajima123 (1979); b) example from Snieckus124 (1985); c) example from Gilman125 
(1948); d) example from Gronowitz126 (1984) 
Based on the work of Kuwajima,123 the first step in the formation of 2.37 is most likely 
deprotonation of the allylic position to give allylic anion 2.46, followed by elimination to the 
allene-enolate 2.47 (Scheme 2.5). The oxygen atom in 2.47 might direct a second deprotonation 
of the allenic proton to give dianion 2.49, which is in equilibrium with the enyne 2.50. The ratio 
of the allene and enyne forms is determined by the stabilizing ability of the group in the 2-
position of furan. Transmetalation with ZnCl2 followed by 1,2-addition to with cyclopentenone 
and formation of the TES enol ether and the allyl anion subsequently adds in a 1,2 fashion to the 





Scheme 2.5: Putative mechanism of formation of 2.37 
 
 
Since lithiation of 2-allylfuran 2.32 facilitates rearrangement to the enyne, acidic methods 
for the direct coupling with enone 2.2 may be more successful. Several Lewis and Bronsted acids 
are known to facilitate the Friedel-Crafts alkylation between enones and furans (Table 2.1). 
Transition metals such as palladium (entries 9 and 11), gold (entries 3 and 8) and vanadium 
(entry 7) give good yields with both cyclic and acyclic enones, but these catalysis are expensive.  
Of particular interest was the method of Dujardin (entry 4) and Kraus (entry 1) for their mild 
conditions and inexpensive reagents.127-129 The method developed by Kraus was particularly 
interesting because it allows for the direct isolation of the silyl enol ether, which could be useful 









Table 2.1: Friedel-Crafts reactions between furans and enones 
 
reference L.A. Cond. Additive yield 
Kraus127 TMSI CH2Cl2, -78 °C 2-methyl-2-butene 67-92% 
Deshpande132 Cu(OTf)2 CH2Cl2, r.t. N/A 53-77% 
Dyker133 AuCl3 MeCN, r.t. N/A 80-90% 
Dujardin128,129 BF3•Et2O MeNO2, 0 °C EtOH 59-75% 
Zefirou134 H2SO4 neat, 30-60 °C Hydroquinone 59-75% 
Vassilikogiannakis135 AcOH AcOH/H2O, 140 °C Hydroquinone 75-90% 
Chen136 VO(OTf)2 CH2Cl2, r.t. N/A 90-98% 
Aguilar137,138 [Au] MeCN, r.t. AgOTf 60-84% 
Bao139 PdCl2 MeOH, r.t. N/A 42-98% 
Hoffmann140 AlCl3 PhH, r.t. N/A 37-43% 
Roy141 PdCl2(MeCN)2 MeCN, r.t. SnCl2 50-90% 
 
The mild conditions developed by Dujardin were tried first because the Magnus group 
used this procedure in their synthesis of the core of cortistatin A (Scheme 2.6).128,129 Reaction of 
2-allylfuran 2.32 with enone 2.2 in the presence of BF3•OEt2 provided ketone 2.6 in 45% yield. 
Altering reaction times, temperatures, or use of the protic acid CSA in place of BF3•OEt2 did not 
improve the yield. The modest yields provided by the Dujardin conditions prompted the 
investigation of the methodology developed by Kraus. Strict adherence to the Kraus conditions 
afforded the ketone 2.6 as a mixture of diastereomers (7.5:1 trans:cis) in 50-60% yield. After 
optimization, the ketone 2.6 was synthesized in 93% yield on gram scale. The key variables 
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were: the time of incubation of the enone 2.2 with TMSI, the time stirred at –78 °C, and rapid 
addition of both 2-methyl-2-butene and 2-allylfuran in succession. Including 2-methyl-2-butene 
during the incubation of TMSI with the enone 2.2 resulted in lower yields. In the 1H-NMR 
spectrum, the methyl peak shift of the major isomer is at 1.13 ppm while the minor isomer is at 
0.86 ppm. Due to similar observations of the shielding effect of arenes on cis-methyl groups in 
3,4-disubstituted cyclopentanes,143-146 the major isomer of ketone 2.6 is tentatively assigned as 
trans.     
Scheme 2.6: Lewis acid promoted coupling of 2-allylfuran 2.32 and enone 2.2 
 
 
2-Methyl-2-butene acted as a non-basic sponge for the hydroiodic acid produced as a 
byproduct during the reaction. Use of other bases led to rapid polymerization (Scheme 2.7). Even 
the presence of chloride ion in the form of tetrabutylammonium chloride (TBAC) or TMSCl 
proved too basic and caused polymerization. Presumably, TMSI and the enone react to form the 
β-iodo-silyl enol ether 2.53. This intermediate is in equilibrium with oxonium species 2.54, 
which, while being an excellent Friedel-Crafts partner, is very acidic. Deprotonation forms the 
highly reactive cyclopentadiene 2.55 that can then polymerize via multiple pathways.  
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Scheme 2.7: Products identified in the presence of base during TMSI coupling 
 
    
2.2.2: INVESTIGATION OF THE ENOLATE ALKYLATION OF 2.6 
With access to multiple grams of the ketone 2.6, the next problem to be solved was α-
alkylation. The conditions developed by Dr. Anna Smith utilized substoichiometric amounts of 
NaHMDS in THF to allow the less substituted kinetic enolates equilibrate to the more substituted 
thermodynamic enolates before alkylating with TMS propargyl iodide. On scale up, however, 
alkylation of ketone 2.6 under the same conditions consistently afforded low (10-40%) yields of 
ketone 2.7 (Equation 2.3). Analysis of the reaction mixture revealed that a significant portion of 







Equation 2.3: Initial enolate alkylation of ketone 2.6  
 
There are two primary side reactions that occur during enolate alkylations involving 
cyclopentanones: polyalkylation and aldol condensation (Scheme 2.8). Under equilibrating 
conditions, aldol condensation (2.59 → 2.61) is in direct competition with proton exchange (2.58 
→ 2.59/2.60). Polyalkylation occurs because the rate of alkylation is slower than the proton 
exchange between ketone and enolate. In 1965, House suggested that the reason polyalkylation is 
such a problem is because the enolate becomes less aggregated and more reactive as substitution 
increases around the ketone.147-152, 154 This hypothesis is supported by the work of Streitwieser, 












Scheme 2.8: Side-reactions during the alkylations of ketones 
 
 
k1 = rate of proton exchange between enolate and ketone; k2 = rate of monoalkylation; k3 = rate of dialkylation; k4 = 
rate of aldol condensation; k1>k3>k2>k4  
One strategy to limit the amount of polyalkylation is by adding Lewis acids to the enolate 
before adding the alkylating agent (Table 2.2). The Lewis acids are thought to reduce the basicity 
of the enolate, thereby preventing proton exchange between the alkylated product and the 







99 (Table 2.2). The Lewis 
acids ZnMe2 and TiCl(OiPr)3 are unattractive because of the requirement of HMPA as a co-
solvent to enhance reactivity, large excesses of alkylating agent and prolonged cryogenic 
conditions (–78 ºC) (Table 2.2, entries 1,2). Conditions utilizing Bu3SnCl and AlEt3 are milder 0 
ºC vs –78 ºC), but still require HMPA as a co-solvent (Table 1.2, entries 3,4). Manganese 
dichloride, which was independently developed by Reetz and Cahiez, only requires 
stoichiometric amounts of the alkylating agent and uses DMSO or DMPU as cosolvents so it was 
chosen as the Lewis acid to suppress polyalkylation (Table 2.2, entry 5). At first, the 
NaHMDS/THF conditions were used in conjunction with MnCl2•2LiCl (MnCl2 source soluble in 
THF), but no improvement was noted. Since most of the examples using Lewis acids to suppress 
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polyalkylation use the lithium enolate, it was theorized that the sodium enolate might make the 
resultant complex too basic to suppress polyalkylation. Accordingly, conditions were sought for 
the generation of the thermodynamic lithium enolate. 




conditions  yield 
Noyori100 ZnMe2  MeI THF/HMPA, -78 
°C, 10h 94% 
Noyori100 ClTi(OiPr)3 MeI THF/HMPA, -78 
°C, 10h 94% 
Tardella99 Bu3SnCl MeI DME, 0 
°C, 1h 93% 
Tardella99 AlEt3 MeI DME/HMPA, 0 
°C, 48h 94% 
Reetz/Cahiez97,98,101 MnCl2 MeI THF/DMSO, r.t., 2h 93% 
There are several methods to form thermodynamic enolates,153-164 but many of them 
involve the use of sodium, potassium or magnesium bases that may make the Lewis acid 
complexes reactive towards electrophiles (Table 2.3). The only example with lithium enolates is 
Yamamoto’s use of aluminum tris(2,6-diphenylphenoxide) (ATPH) and lithium 
diisopropylamide (LDA) (Table 1.3, entry 6).159 Unfortunately, ketone 2.6 proved to be a 
uniquely frustrating substrate. Exposure of 2.6 to stronger bases than lithium 
hexamethyldisilazane (LiHMDS) (such as LDA or dimsyl anion) resulted in the formation of 
unidentifiable by-products, most likely related to the proclivity of 2-allylfuran to rearrange under 





Table 2.3: Methods for the generation of the thermodynamic enolate  
 






Stork161 NaH N/A DME, reflux TMSCl 73:27 
Brown162 KH N/A THF, r.t. TMSCl 67:33 
Krafft160 (i-Pr)2NMgBr Et3N Et2O/HMPA, r.t. TMSCl 97:3 
Bordeau158 (2-pyr)2Mg N/A -50 °C, THF MeI, TMSCl 95:5 
Negishi157 KH BEt3 THF, r.t. MeI, TMSCl 93:7 
Yamamoto159 LDA ATPH -78 °C, THF MeI 100:0 
Turner164 KH N/A THF/HMPA, -78 
°C → r.t. 
TBSCl 98:2 
Krafft163 FeCl3/MeMgBr Et3N Et2O/HMPA, r.t. TMSCl 93:7 
a) Ratio of T (Thermodynamic) (products 2.128 or 2.129) to K (Kinetic) (products 2.130 or 2.131) 
To develop conditions to generate the thermodynamic lithium enolate, ketone 2.6 was 
added to a sub-stoichiometric amount of LiHMDS in THF at 0 °C. 1,3-dimethyl-3,4,5,6-
tetrahydro-2-pyrimidinone  (DMPU) was then added, and the mixture was stirred at 0 °C. 
Aliquots were quenched with TESCl and analyzed by 1H NMR to determine the ratio of 
thermodynamic to kinetic silyl enol ethers. These initial experiments revealed that equilibrium 
was established after four h. Transmetallation of the lithium enolate after the four h incubation 
with MnCl2•2LiCl and subsequent alkylation with TMS-propargyl bromide gave ketone 2.7 in 
79% yield (Scheme 2.9). Unfortunately, these results were difficult to reproduce. When the batch 
of n-BuLi that was initially used to generate LiHMDS ran out, use of a fresh bottle resulted in 
incomplete conversion of the starting material. Titration of similarly “aged” and fresh n-BuLi 
revealed that the “aged” n-BuLi contained less n-BuLi than the fresh bottle (0.93M vs 2.18M)  
but contained more basic species overall (2.94M vs 2.53M). The basic species are most likely a 
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mixture of LiH from β-hydride elimination, LiOH from traces of water and n-BuOLi from the 
reaction of n-BuLi with oxygen. 
Scheme 2.9: Initial use of MnCl2•2LiCl in suppression of polyalkylation 
 
The success of the alkylation of 2.6 with the aged n-BuLi may be due to the presence of 
the extra base, which quenches quenching adventitious proton sources contained within the 
reaction mixture. Rigorous drying of the glassware, purification of ketone 2.6 via Kügelrohr 
distillation and/or use of internal indicators to ensure proper stoichiometry of base was attained 
had no effect on the reaction. That none of these interventions had any effect on the reaction 
course led to the conclusion that the source of the adventitious proton source was the 
MnCl2•2LiCl. Unfortunately, rigorous drying of MnCl2 by heating at elevated temperatures under 
vacuum for extended periods of time did not improve conversion of the starting material. Other 
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drying procedures such as, refluxing SOCl2,
165-166 or slurrying the solution of MnCl2•2LiCl over 
4 Å molecular sieves also had no beneficial effect.167  
A second tactic to remove adventitious proton sources from the MnCl2•2LiCl solution 
would be to add an amount of base equivalent to the amount of proton sources contained within 
the MnCl2•2LiCl solution. In order for this strategy to succeed, the exact amount of proton 
sources would have to be determined. Initial attempts to assay the solution of MnCl2•2LiCl was 
complicated by the fact that most colorimetric indicators had no endpoint in the presence of 
MnCl2•2LiCl, and the addition of organometallics, such as n-BuLi, caused a purple-violet 
precipitate to form, presumably a Mn0 species. To circumvent this problem, a method was 
devised by generating the camphor enolate and quenching with the MnCl2•2LiCl solution, 
followed by TESCl and analyzing the relative ratios of camphor and silyl enol ether. Fortunately, 
the bridgehead proton for camphor 2.73 (Figure 2.6, A) and the silyl enol ether 2.74 proton 
(Figure 2.6, B) were distinct and did not overlap in the 1H NMR spectrum, allowing the ratio of 
protonated and deprotonated ketone to be assessed easily. The assay revealed that protic impurity 












Figure 2.6: Titration of MnCl2•2LiCl with camphor 2.73 
 
a) NMR of camphor; b) NMR of camphor + LiHMDS (1eq) and quenched with TESCl; c) NMR of camphor + 
LiHMDS (1eq), followed by MnCl2•2LiCl (1eq) and quenched with TESCl  
Alkylation of 2.6 with one equivalent of MnCl2•2LiCl neutralized with 0.25 equivalents 
of LiHMDS gave polyalkylation products 2.57 in equal amounts to the desired product 2.7 (23% 
of 2.7 and 23% 2.57) (Scheme 2.10, A). Use of two equivalents of MnCl2•2LiCl neutralized with 
0.5 equivalents of LiHMDS gave more polyalkylation products 2.57 than the desired product 2.7 
(14% of 2.7 and 51% 2.57) (Scheme 2.10, B). Fortunately, limiting the reaction time to two h as 
opposed to 16 h eliminated this problem, and the ketone 2.7 was reproducibly isolated in 40-50% 
yield (Scheme 2.10, C). Basic species present in the neutralized MnCl2•2LiCl must be able to 
deprotonate the ketone during prolonged reaction times. Analysis of the reaction mixture 
revealed very little polyalkylation, but a significant amount of baseline material was observed by 
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thin layer chromatography (TLC). Attempts to isolate this baseline material revealed a mixture of 
unidentifiable products. Analysis of the material by IR showed a carbonyl stretch of 1713 cm–1, 
shifted from where the cyclopentanone carbonyl stretch appears at 1741 cm–1 and more 
indicative of enones. Analysis of the material by LCMS showed several peaks, the most 
prominent being m/z = 413 and 443. The mass at 413 may be of the aldol dimer + sodium, and 
although the origin of the mass at 443 in not clear, it is significantly higher than the 204, which is 
the mass of the starting material. These facts seem to indicate that the missing mass is due to 

















Scheme 2.10: Alkylation of 2.6 with MnCl2•2LiCl neutralized with LiHMDS 
 
The fact that there was such a big difference between using the bottle of aged and fresh n-
BuLi in the initial MnCl2•2LiCl alkylation could also mean that the enolate equilibration was 
also affected by the quality of the n-BuLi. The sediments present in the aged n-BuLi are most 
likely composed of lithium hydroxide, lithium hydride and lithium n-butoxide (n-BuOLi). 
Previous experiments showed that lithium hydride did not affect the deprotonation of ketone 2.6, 
so n-BuOLi was identified as the contaminant most likely to affect the reaction.  To better 
understand the role of n-BuOLi, ketone 2.6 was deprotonated with LiHMDS under a variety of 
conditions and then quenched with TESCl to analyze the formation of the thermodynamic 
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enolate through the formation of silyl enol ethers 2.75 and 2.76 (Table 2.4). Addition of ketone 
2.4 to LiHMDS made from fresh n-BuLi gave the kinetic enolate almost exclusively (Table 2.4, 
entry 1). Interestingly, repeating the same experiment with aged n-BuLi reduced the ratio of 
2.76: 2.75 from 19:1 to 12:1 (Table 2.4, entry 2). Addition of LiHMDS to a mixture of n-BuOH 
and ketone also drastically eroded the selectivity, even at –78 °C, from 19:1 to 3.8-5.2:1 (Table 
2.4, entries 3-5). Interestingly, n-BuOLi made in situ with n-BuLi was strong enough to 
deprotonate the ketone (~67% by crude NMR) and gave a 1:1.1 ratio of 2.76:2.75 (Table 2.4, 
entry 6). Adding LiHMDS to a mixture of the ketone 2.6 and n-BuOH at 0 °C gave almost 
quantitative thermodynamic enolate but only showed ~60% deprotonation by crude 1H-NMR 
















Table 2.4: Examination of the kinetic and thermodynamic lithium enolates  
 
base eq Additive  eq solvent T
º 
t (min) 2.75:2.76 
LiHMDSa,d  0.95 N/A N/A THF 0 °C 10  1:19 
LiHMDSa,e 0.95 N/A N/A THF 0 °C 10  1:12 
LiHMDSb,d 2 n-BuOH 1 THF -78 °C 10  1:4.6 
LiHMDSb,d 2 n-BuOH 1 THF/DMPU -78 °C 10  1:3.8 
LiHMDSc,d 2 n-BuOH 1 THF -78 °C 10  1:5.2 
n-BuOLia,d 1 N/A N/A THF 0 °C 10  1.1:1f 
LiHMDSc,d 0.95 n-BuOH 0.1 THF 0 °C 60 20:1g 
a) add starting material to base in one portion; b) add base to starting material dropwise; c) add base to starting 
material in one portion; d) base made with “fresh” n-BuLi; e) base made with “aged” n-BuLi; f) ~67% 
deprotonation; g) ~60% deprotonation 
The equilibration behavior of the enolates was observed in more detail by adding 0.9 eq 
LiHMDS to ketone 2.6 and quenching aliquots with TESCl. The ratios of 2.76 (methyl peak 
labeled A in Figure 2.7) and 2.75 (alkenyl proton labeled B in Figure 2.7) were analyzed by 1H-
NMR. Initially the ratio starts at 1:11.1 (2.76: 2.75), which is consistent with the results in Table 
1.4. After one hour the enolate ratio increases to 1.61:1 (2.76: 2.75). Interestingly, the 
thermodynamic silyl enol ether peak B seems to disappear and recede into the baseline as time 
progressed. This seemed to correlate with increased amounts of the baseline material by TLC. 
The most likely explanation for these results and the lower yields with the neutralized 
MnCl2•2LiCl is that aldol reactions are taking place before the enolates 2.76 and 2.75 have 
reached equilibrium. These results indicate that generation of the thermodynamic enolate via 
incubation with substoichiometric base to the ketone will result in large amounts of aldol 
reactions and that the original success of the reaction (see Scheme 2.9) could be due to enolate 
equilibration after the addition of MnCl2•2LiCl. 
 90 
Figure 2.7: Examination of the kinetic and thermodynamic enolates as a function of time 
 
At T = 0 min, 2.76:2.75 is 1:11.1; At T = 60 min; 1: 1.61; At T = 120 min; 1:9.1; At T = 180 min; 1:9.3; At T = 240 
min; 1:8.1 
To circumvent the aldol problem, the generation of the thermodynamic enolate by 
isolating the silyl enol ether and unmasking using an alkyllithium reagent was investigated. Use 
of strongly basic conditions to form the silyl enol ether, such as Kraftt’s conditions (Table 2.3, 
entry 1) polymerized the starting material.163 Turner’s conditions (see Table 2.3) reduced 
polymerization, providing the TBS ether 2.78 in 85% yield, but the omission of HMPA resulted 
in a drop in selectivity for the thermodynamic silyl enol ether (3.3:1 ratio of 2.78:2.80).164 Soft 
enolization conditions for the formation of the silyl enol ether are known to be mild and selective 
for the more substituted isomer, but the choice of base proved to be key for isolating the silyl 
enol ether 2.77 in high yields. Bases such as K2CO3, Et3N and DBU provided selective formation 
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of the thermodynamic silyl enol ether 2.77, but also significant amounts polymerized material 
were formed (Table 1.5). Other bases such as 2,6-lutidine and pyridine gave incomplete 
conversions. Only HMDS furnished silyl enol ether 2.77 in high yields.    








2.6 2.77: R3Si = TMS
2.78: R3Si = TBS
H
2.79: R3Si = TMS
2.80: R3Si = TBS
H
 
SiR3X base solvent temp t (h) T:K
a 
yield 
TESCl MeMgBr/FeCl3 Et2O/HMPA r.t. 2 N/A N/A 
TBSCl KH THF –78 °C→ 0 °C 1 3.3:1 85% 
TMSCl/KI Et3N MeCN reflux 2 20:1 N/A 
TESCl/TBAI K2CO3 MeCN r.t. 1 3.7:1 N/A 
TMSCl/NaI HMDS CH2Cl2/MeCN r.t. 2 20:1 79% 
a) T = more substituted isomer, K = less substituted isomer 
Having identified conditions for the generation of silyl enol ether 2.77 in high yield and 
selectivity, it was reasoned that it may be possible to isolate the silyl enol ether 2.77 directly 
from the Kraus reaction between 2-allylfuran 2.32 and enone 2.8. Previously, attempts to 
generate TMSI in situ utilizing a Finklestein-like reaction between TMSCl and NaI in MeCN led 
to polymerization of the enone due to the basicity of the chloride counterion relative to the acidic 
species in the reaction mixture (see Scheme 2.7). The use of a R3SiX source with a non-basic 
counterion may facilitate the Kraus reaction to allow the isolation of the silyl enol ether 2.77. 
TMSOTf seemed an excellent substitution for TMSCl because the OTf counterion is almost 
inert. 
To test whether TMSOTf delivers silyl enol ether 2.77, the ketone 2.6 was subjected to 
the same conditions used previously except TMSOTf was used in place of TMSCl (Figure 2.8, 
A). Gratifyingly, the silyl enol ether 2.77 was isolated in 83% yield and with the same selectivity 
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as the conditions developed with TMSCl/NaI (Table 1.5, entry 5). After a determining that the 
maximum amount of MeCN in CH2Cl2 that stays liquid at –78 ºC to be 3:2, 2-allylfuran 2.32 and 
enone 2.8 were subjected to the modified Kraus conditions using TMSOTf/NaI in place of TMSI 
to provide the ketone 2.6 in 83% yield (Figure 2.8, B). The Kraus alkylation with TMSOTf/NaI 
in CH2Cl2/MeCN was significantly faster than with TMSI in CH2Cl2, taking only two h at –78 ºC 
compared to the eight h using TMSI in CH2Cl2. Initial attempts to isolate the silyl enol ether 2.77 
from the Kraus reaction by quenching with HMDS led to substantial amounts of ketone 2.6. 
Although 2-methyl-2-butene functions as an HI sponge during the reaction, it remains possible 
that HI may protonate the silyl enol ether to generate the ketone. To fully convert the reaction 
mixture to the silyl enol ether, an additional one equivalent of TMSOTf was added to the 
reaction mixture after the HMDS quench, and the mixture was stirred for an additional one h at 
room temperature (Figure 2.8, C). Gratifyingly, the silyl enol ether 2.77 was then obtained in 
83% yield.  
Figure 2.8: Modification of Kraus reaction using TMSOTf/NaI to isolate either ketone 2.6 or 
silyl enol ether 2.77 
 
 
a) Synthesis of silyl enol ether 2.77 from ketone 2.6. b) Synthesis of ketone 2.6 from 2-allyl furan 2.32 and 
enone 2.8 utilizing modified Kraus alkylation conditions. c) Synthesis of silyl enol ether 2.77 from 2-allyl furan 2.32 
and enone 2.8 utilizing modified Kraus alkylation conditions and HMDS quench. 
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Unfortunately, the TMS silyl enol ether 2.77 was unstable to the enolate unmasking 
conditions using alkyllithium reagents. Recalling that n-BuLi led to the rearrangement of 2-
allylfuran 2.32 to the enyne 2.37, it was hypothesized that the 2-allylfuran moiety in 2.32 may be 
decomposing via similar pathways (see Scheme 2. 4). The base sensitivity of silyl enol ether 2.77 
led to the exploration of other nucleophiles that are not as basic as alkyllithiums. Potassium tert-
butoxide (tert-BuOK) is known to cleave silyl enol ethers to their potassium enolates, so 
alkoxides such as n-BuOLi, LiNMe(OMe), Li-imidazole and LiOTMS were investigated to 
unmask the silyl enol ether 2.77 by assessing the recovery of ketone 2.6 (Table 1.6).259-262 Use of 
n-BuOLi in THF at 0 ºC furnished the ketone 2.6, but only in 65% yield. The addition of DMPU 
to the reaction mixture, which was the co-solvent required for alkylation with MnCl2•2LiCl, 
decreased the yield to 50%. Gratifyingly, it was found that cooling the reaction mixture to –78 
ºC, n-BuOLi furnished the ketone 2.6 in 90% yield.  Other nucleophiles such as LiOTMS and 
LiNMe(OMe) proved inferior to n-BuOLi. Li-imidazole, however, deprotected the silyl enol 
ether 2.77 in near quantitative yield. Ultimately, n-BuOLi was chosen as the regent for the 
enolate unmasking due to the ease of purification of n-BuOH and the ability to inject n-BuOH 











Table 2.6: Identification of conditions to unmask enolate from silyl enol ether 2.77 
 
SiR3 RLi solvent temp T (min) yield 
TMS n-BuLi THF –78 °C 10  decomp 
TBS n-BuOLia THF 0 °C → rt 960 71% (rsm) 
TMS n-BuOLia THF/DMPU 0 °C 60 50% 
TMS n-BuOLia THF 0 °C 60 65% 
TMS n-BuOLia THF/DMPU –78 °C → 0 °C 30  90% 
TMS LiNMe(OMe)b THF/DMPU –78 °C → rt 16 h 54% 
TMS TMSOLi THF/DMPU –78 °C → 0 °C 2 h 59% 
TMS Li-imid.c THF/DMPU –78 °C → 0 °C 30  99% 
a) Made in situ by adding n-BuLi to a mixture of n-BuOH in THF with triphenylmethane (Ph3CH) as an internal 
indicator; b) Made in situ by adding n-BuLi to a mixture of MeNHOMe•HCl in THF with triphenylmethane 
(Ph3CH) as an internal indicator; c) Made in situ by adding n-BuLi to a mixture of imidazole in THF with 
triphenylmethane (Ph3CH) as an internal indicator   
Unfortunately, unmasking the silyl enol ether 2.77 with n-BuOLi in THF/DMPU, 
followed by transmetalation with neutralized MnCl2•2LiCl and alkylating with TMS-propargyl 
bromide furnished mixtures of  the desired alkylated product 2.7 along with the TMS-
deprotected product 2.33 and starting material as an inseparable mixture (Equation 2.4). Efforts 
to minimize formation of the deprotected compound 2.37 or push the reaction to completion by 






Equation 2.4: Alkylation of 2.77 via silyl enol ether unmasking with lithium alkoxide 
 
Optimal conditions required to generate the thermodynamic enolate remains challenging, 
though it is clear that allowing the enolate to equilibrate for an extended period of time results in 
a significant amount of aldol condensation. A successful strategy requires rapid generation of the 
thermodynamic enolate. The evidence gathered thus far seems to indicate that adding base to the 
ketone at 0 °C and/or the presence of alkoxides favors the generation of the thermodynamic 
enolate, but more development would be needed to suppress the aldol reactions. MnCl2•2LiCl 
proved to be an effective additive for the suppression of polyalkylation, but protic impurities 
contained within, caused incomplete conversion of the starting material. The amount of 
adventitious proton sources was determined by using camphor and neutralization with LiHMDS 
before transmetalation prevents the enolate from being quenched and improved the yield, but 
yields of alkylated product 2.7 will remain between 40-50% until a proper method for the 
generation of the thermodynamic enolate is developed. 
2.2.3: IMPROVEMENT OF THE FORWARD SYNTHESIS TO DIELS-ALDER REACTION ADDUCTS 2.34 
AND 2.89 
Despite the difficulties with the enolate alkylation, enough material was made to push 
forward. Deprotection of the TMS group in 2.7 under standard conditions (K2CO3/MeOH) 
provided the ketone 2.33 in 0–65% yield (Table 2.7, entry 1,2). Resubjection of the product 2.33 
to the reaction conditions revealed that the ketone slowly decomposes to unidentifiable products, 
presumably via aldol condensation (see Scheme 2.19 and discussion). To avoid aldol 
condensation, acidic or buffered methods to remove the TMS group were investigated. 
Interestingly, reactions that were too acidic, such as pyridine•HF resulted in no removal of the 
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TMS group (Table 2.7, entry 6). Only TBAF buffered with acetic acid gave the desired product 
2.33 in good yield. 
 Table 2.7: TMS Deprotection of 2.7 
 
Reagent solvent temperature time yield 
K2CO3 MeOH R.T 24 hrs 30–65% 
K2CO3 MeOH Reflux 3 hrs 0% 
TBAF/NH4Cl THF R.T. 3 hrs 33% 
TBAF/AcOH THF R.T. 24 hrs 76% 
TBAF/AcOH THF Reflux 3 hrs 91% 
Pyridine•HF THF R.T. 24 hrs N/R 
The conditions for the dihydroxylation of 2.33 were previously established by Dr. Smith 
and used AD-mix β, which gave low yields of diol 2.81 and required up to four days  and 
additives known to accelerate the reaction such as methanesulfonamide263 and 
tetrabutylammonium acetate264 had little effect on the yield or the reaction time (Figure 2.9, A). 
By stirring ketone 2.33 in tert-BuOH/H2O with only K2CO3, in the absence of AD-mix, it was 
determined that at least some of the low yield is due to base-catalyzed aldol condensation 
reactions. An extensive literature search revealed the work by Bittman, who found that 
supplementing the commercial AD-mix with potassium persulfate (K2S2O8) greatly enhanced the 
yield.172  Supplementing the AD-mix β with  K2S2O8 (1:1 w/w to AD-mix) to the dihydroxylation 
of 2.33 with AD-mix increased the yield of diol 2.81 to 55% (Figure 2.9, B). Commercial AD-
mix only contains 0.002 mol% of the pre-catalyst K2OsO2(OH), which may contribute to the 
long reaction times and low yields so a “custom” batch of AD-mix was formulated by 
pulverizing K2S2O8 with 0.1 equivalents K3Fe(CN)6, three equivalents K2CO3 and 0.05 
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equivalents K2OsO2(OH)4 together using a mortar and pestle. Use of this “custom” AD-mix gave 
diol 2.81 as a mixture (1:1) of diastereomers in 76% yield (90% based on recovered starting 
material) after only 16 h (Figure 2.9, C), representing a major improvement over earlier 
protocols. Because no ligand was used, the mixture of diastereomers produced in the reaction are 
not enantioenriched.   
Figure 2.9: Improvement of dihydroxylation with using K2S2O8 
 
a) Dihydroxylation of 2.33 with AD-mix. b) Dihydroxylation of 2.33 with AD-mix, supplemented with K2S2O8. c) 
Dihydroxylation of 2.33 with “custom” AD-mix containing no ligand. 
The next task involved developing conditions for the selective TBDPS protection of the 
primary alcohol. While the selective TES protection of diol 2.36 (see Scheme 2.9), developed by 
Dr. Smith, used TESCl and Et3N in CH2Cl2 and was complete within two h, the selective TBDPS 
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protection did not go to completion, even after stirring overnight (Table 2.8, entry 1). Use of 
imidazole as the base and DMF as the solvent increased the reaction rate but caused a significant 
amount of the bis-TBDPS protected diol 2.83 to be formed (Table 2.8, entry 2). To inhibit the 
second TBDPS protection, the reaction was cooled to – 40 ºC in a mixture (1:3) of DMF and 
CH2Cl2, and although some of the bis-protected alcohol by-product 2.83 was still seen, the major 
product   2.82 was isolated in 74% yield (Table 2.8, entry 3). The bis-protected alcohol by-
product 2.83 could be recycled back to the diol 2.81 using the TBAF/AcOH conditions 
developed for the TMS deprotection of 2.7. 
Table 2.8: Selective protection of diol 2.82 
 
Solvent base temp T (h) Yield 2.82 Yield 2.83 
CH2Cl2 Et3N 0 °C 6 42% (93% brsm) 0% 
DMF imidazole r.t. 2 24% 52% 
CH2Cl2/DMF (3:1) imidazole –40 °C 6 74% 32% 
 
Previously, the yields for the vinyl sulfonate formation were irreproducible and low 
yielding (10–40%) (see Scheme 2.1). Upon addition of vinylsulfonyl chloride to a mixture of 
alcohol 2.82 and triethylamine, a white precipitate formed. When this precipitate was isolated 
and analyzed by LCMS, it was found that the substance had a mass of 706 (positive ESI), 
corresponding to the mass of the vinyl sulfonate plus triethylamine. The current hypothesis for 
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structure of this species is the triethylamine adduct 2.87 (Scheme 2.11). It was initially thought 
that the reason for the low yield was that the desired product 2.88 formed rapidly, but after 
prolonged stirring, the excess Et3N reacted with the product to form adduct 2.87. Screening less 
nucleophilic bases such as N-methyl imidazole and 2,6-lutidine, however, revealed that 
ammonium adducts analogous to 2.87 were formed in each case. Closer examination of the 
reaction with triethylamine showed that adduct 2.87 will slowly produce 2.88 in the presence of 
Et3N over eight h. The fact that prolonged stirring with excess Et3N forms the desired compound 
2.88 and not 2.87 suggests that the mechanism for the formation of 2.88 might actually go 
though the sulfene-like intermediate 2.86, which rapidly reacts with alcohol 2.82 to form the 
ammonium salt 2.87. The vinyl sulfonate was prone to elimination and other side reactions so it 
was telescoped directly into the Diels-Alder reaction. 
Scheme 2.11: Vinyl sulfonate formation 
 
Heating the vinyl sulfonate 2.88 in PhMe delivered the Diels-Alder adducts 2.89 and 
2.34, but the starting material always remained. Heating the Diels-Alder adduct 2.89 produced 
mixtures of 2.89 and the vinyl sulfonate 2.88, leading to the conclusion that the product and the 
starting material were in equilibrium under the reaction conditions, an observation corroborated 
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by Metz who developed the vinyl sulfonate/furan IMDA methodology.109 Fortunately, the 
reaction was pushed to completion serendipitously by adding silica to the reaction in an effort to 
quickly purify the reaction mixture by column (Equation 2.5). Strangely, adding the silica to the 
solution of 2.88 in toluene and heating had no effect. The effect was only seen when enough 
silica was added to the reaction while hot that the solvent was completely absorbed. Diels-Alder 
reaction reactions are known to be accelerated by being adsorbed on silica,193 and perhaps adding 
enough silica mimicked adsorption, and shifted the vinyl sulfonate/Diels-Alder reaction adduct 
equilibrium by functioning as a Lewis acid. Further improvements were seen when butylated 
hydroxytoluene (BHT) was added to the reaction mixture, presumably preventing detrimental 
radical side reactions. Using these modifications, both the vinyl sulfonate formation and the 
Diels-Alder reaction were optimized and 2.89 and 2.34 were isolated as a mixture (1:1) of 
diastereomers in 86% yield.  
Equation 2.5: Optimization of Diels-Alder reaction adduct formation 
 
 
2.2.4: INVESTIGATION OF ENANTIOSELECTIVE AND NEUTRAL DIHYDROXYLATION  
After the synthesis of the Diels-Alder reaction adducts 2.89 and 2.34 was streamlined, the 
investigation returned to the enantioselective dihydroxylation of 2.33. The “custom” conditions 
(see Figure 2.9, C) used no ligand, so both the Diels-Alder adducts 2.89 and 2.34 were racemic. 
Adding a ligand should render the dihydroxylation enantioselective, and several ligands are 
available, the most common being (DHQD)2PHAL 2.91 (Figure 2.10).
177 A review of the 
literature, however, revealed that (DHQD)2PHAL 2.91 is a poor ligand for dihydroxylation of 
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allyl aromatic substrates. Generally speaking, (DHQD)2PHAL 2.91 and (DHQD)2DPP
182 2.92 
are best used for aromatic substrates where the double bond is attached to an arene ring (Table 
2.9). (DHQD)2PYR
181 2.95 is best suited for substrates containing significant steric encumbrance 
at the α-position, whereas (DHQD)2AQN
175 2.93 is best for aliphatic substrates. Other ligands 
such as (DHQD)IND177 2.90 and Corey’s ligand176 2.94 are useful for the dihydroxylation of cis-
olefins and trisubstituted cyclic aliphatic olefins respectively. Because the ligand (DHQD)2AQN 
2.93 is known to work well with allylbenzene, we began our investigation of the enantioselective 
dihydroxylation using this ligand. 
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Two questions need to be answered before attempting the enantioselective 
dihydroxylation of 2.33: Does the use of K2S2O8 in place of K3Fe(CN)6 effect the 
enantioselectivity, and is the 2-allylfuran moiety in 2.33 a suitable substrate? To answer these 
questions, 2-allylfuran 2.32 and allylbenzene 2.96 were chosen as model substrates. A custom 
batch of AD-mix was formulated by pulverizing K2S2O8, 0.1 equivalents K3Fe(CN)6, three 
equivalents K2CO3, 0.075 equivalents of (DHQD)2PHAL 2.91 and 0.05 equivalents 
K2OsO2(OH)4 together using a mortar and pestle. Dihydroxylation of allylbenzene using this 
mixture gave the dihydroxy compound 2.97 in 74% yield and 42% ee, matching the literature 
results of 74% and 44% ee (Table 2.10, entry 1). Subjection of 2-allylfuran 2.32 to these 
conditions also provided diol 2.98 with low enantioselectivity (30% ee) (Table 2.10, entry 4). 
Gratifyingly, use of (DHQD)2AQN 2.93 gave enhanced enantiomeric excess for both 
allylbenzene and 2-allylfuran (75% and 84% ee; Table 2.10, entries 3,6).  Additives such as 
phenylboronic acid (PhB(OH)2) are known to accelerate the reaction and protect the diol in situ, 
but these additives did not enhance the enantioselectivity (Table 2.10, entries 2,5).190,191 
 
 103 
Table 2.10: Model studies on enantioselective dihydroxylation 
 
 
R Ligand Additive yield ee Lit.
175 
Ph: 2.96 (DHQD)2Phal N/A 74% 42% 44% 
Ph: 2.96 (DHQD)2Phal PhB(OH)2 71% 42% N/A 
Ph: 2.96 (DHQD)2AQN N/A 74% 75% 78% 
2-Furyl: 2.32 (DHQD)2Phal N/A 49% 30% N/A 
2-Furyl: 2.32 (DHQD)2Phal PhB(OH)2 34% 25% N/A 
2-Furyl: 2.32 (DHQD)2AQN N/A 67% 84% N/A 
With the improved enantioselectivity for the dihydroxylation of 2-allylfuran confirmed 
using (DHQD)2AQN (2.93) as the ligand, we attempted to apply the reaction to the real system. 
In that event, the ligands (DHQD)2PHAL (2.91), (DHQD)2AQN (2.93) and Corey’s ligand 2.94 
were chosen, and 2.33 was dihydroxylated under the same conditions used for 2-allylfuran 2.32. 
Enantioenriched diol 2.81 was thus obtained in slightly lower yields compared to the conditions 
that used no ligand (see Figure 2.9, C) (Scheme 2.12). Selective protection of the primary 
hydroxy group moiety in 2.81 furnished alcohol 2.82, which was then converted to the vinyl 
sulfonate and cyclized to furnish diastereomers 2.34 and 2.99 (1:1-2.4:1 ratios) (Table 2.10).  
Unexpectedly, (DHQD)2PHAL (2.91) provided almost no enantioselectivity or 
diastereoselectivity (Table 2.10, entry 1), and use of (DHQD)2AQN (2.93) only gave slight 
improvement, affording 2.89 (5% ee) and 2.34 (11% ee). Use of Corey’s ligand 2.94 gave the 
highest enantioselectivities of 2.89 (18% ee) and 2.34 (14% ee), but these values are still well 
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below the enantioselectivities demonstrated with 2-allylfuran 2.32. Precisely how the 
cyclopentanone moiety negatively affects the enantioselective dihydroxylation is not clear. It is 
known that branching in close proximity to the olefin can affect the enantioselectivity of the 
dihydroxylation reaction, and it stands to reason that the α-disubstituted cyclopentenone moiety 
in substrate 2.33 might interfere with the subtle CH-π and π-π interactions required for facial 
discrimination of the terminal olefin.  More work needs to be done to investigate the remote 
influence of the cyclopentanone moiety and whether new ligands would be needed for 
enantioselective discrimination of the two faces of the olefin. 













































1eq K2S2O8 (1.5 eq), K2CO3 (3eq),














(DHQD)2PHAL 1% 7% 1:1 
(DHQD)2AQN 5% 11% 1:1 
Corey 18% 14% 2.41:1 
a) ee was determined by HPLC using chiralcel OD-H; b) ratios determined by the separation of the diastereomers by 
column chromatography 
 105 
Despite the disappointing results of the enantioselective dihydroxylation of 2.33, the 
impressive effect of K2S2O8 on the dihydroxylation warranted further study. A problem 
encountered during the dihydroxylation of ketone 2.33 was the tendency to decompose under the 
basic conditions (see also Table 2.4 and section 2.2.2).  Although Sharpless reports that the 
reaction conditions can be buffered with sodium bicarbonate (NaHCO3),
192 the reaction shuts 
down if NaHCO3 is used as the sole base.
177 Osmium catalyzed dihydroxylations are known 
under almost neutral and even acidic conditions,173 so reasons for the reaction shutting down at 
lower pH are not due to problems with the hydrolysis of the osmate ester (Figure 2.11). This 
observation along with the rate acceleration seen by using K2S2O8 as the stoichiometric oxidant 
led us to propose the following: Cyanide ion produced by K4Fe(CN)6 is the reason for inability 
for the Sharpless dihydroxylation to function at lower pH, and acceleration seen by using K2S2O8 
is due to the lower concentration of cyanide ion present in the reaction mixture. Corollary to 
these proposals is that the pH of the reaction mixture could be dropped without a significant 
amount of cyanide present.  
Though slightly basic or neutral dihydroxylation conditions, such as the Upjohn-like 
conditions (OsO4, NMO) (Figure 2.11, Catalytic cycle A) are known, they often suffer from slow 
reaction rates and inferior enantioselectivities when a ligand is used compared to the Sharpless 
conditions (Figure 2.13, Catalytic cycle C). The reason is because of the so-called “second 
catalytic cycle” (Figure 2.11, catalytic cycle B) which occurs when the oxidant is in the same 
phase as the osmium catalyst.169,177 Therefore a slightly basic or neutral Sharpless-type 







Figure 2.11: Osmium catalytic dihydroxylation cycles 
 
 
a) Homogeneous oxidant catalytic cycle; b) Low enantioselectivity catalytic cycle; c) Heterogeneous oxidant 
catalytic cycle which results in high ee 
Gratifyingly, the dihydroxylation of 2-allylfuran 2.32 using Na2HPO4 instead of K2CO3 
as the base provided diol 2.98 with comparable enantioselectivities but only 26% yield due to 
poor conversion (Table 2.11, entries 1,2). A quick solvent screen revealed that tert-BuOH, is the 







Table 2.11: Study of the effect of solvent on Enantioselective dihydroxylation with Na2HPO4 
 
 
Base Solvent yield ee 
NaHCO3 tert-BuOH 26% N/A 
Na2HPO4 tert-BuOH 26% 71% 
Na2HPO4 CH2Cl2 N/A 58% 
Na2HPO4 PhMe N/A 27% 
Na2HPO4 MeCN N/A 41% 
 
In an effort to improve the yield, several additives that are known to enhance the rate of 
osmium catalyzed dihydroxylation were screened (Table 2.12). Of the additives tried, only 
quinuclidine171 and methanesulfonamide170,177 provided a significant rate enhancement. Though 
methanesulfonamide is known to accelerate the rate of osmium catalyzed dihydroxylation by 
acting as a phase transfer catalyst between the hydroxide ion in the aqueous layer and the osmate 
ester in the organic layer,170 recent evidence shows that it can also act as a general Lewis acid to 
facilitate hydrolysis of the osmate ester.170 
With methanesulfonamide and quinuclidine identified as general additives to accelerate 
the dihydroxylation, styrene, α-methyl styrene and phenylcyclohexene were chosen as model 
substrates to test these conditions. The conditions using quinuclidine as the ligand provided the 
diols 2.112-4 in 67-99% yields (Table 2.12, entries 2,4,6). Substituting (DHQD)2PHAL (2.91) 
quinuclidine for  gave the diols in slightly lower yields compared to quinuclidine (61-80%) and 
comparable enantioselectivities to those reported in the literature (Table 2.12, entries 1,3,5). It is 
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interesting that switching from the racemic dihydroxylation to the enantioselective variant 
provided the diols in lower yields when the opposite is true normally.171  
Table 2.12: Optimization of modified dihydroxylation conditions 
 
 
R1 R2 Ligand eq yield ee Lit
263 
H H (DHQD)2PHAL 0.075 80% 97% 97%
 
H H Quinuclidine 0.3 99% N/A N/A 
Me H (DHQD)2PHAL 0.075 72% 90% 94%
 
Me H Quinuclidine 0.3 89% N/A N/A 
=R2=(CH2)4 =R1=(CH2)4 (DHQD)2PHAL 0.075 61% 94% 99%
 
=R2=(CH2)4 =R1=(CH2)4 Quinuclidine 0.3 67% N/A N/A
a 
a) 0.2 eq K3Fe(CN)6 was used 
Following the hypothesis that the presence of cyanide ion impedes catalytic turnover, it 
may be possible to improve the reaction rate by replacing K3Fe(CN)6 altogether. Therefore, 
several catalytic co-oxidants were examined as possible replacements for K3Fe(CN)6 (Table 
2.14).174-189 Interestingly, only NaIO4, KBrO3, and NaClO2 afforded any product when used as 
co-catalyst. Further investigation revealed that NaIO4 and KBrO3 function as catalytic co-
oxidants with K2S2O8, but NaClO2 only acted stoichiometrically.  
Methyl cinnamate 2.115, which gave only 66% yield under the conditions used in Table 
2.13 (see table 2.13, entry 2), was dihydroxylated using NaIO4 and KBrO3 as catalytic co-
oxidants. The use of KBrO3 gave a low yield of the diol 2.116 due to the large degree of 
oxidative cleavage resulting in benzaldehyde (Table 2.13, entry 5). The oxidant NaIO4, gave 
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comparable yields of diol to K3Fe(CN)6 (Table 2.13, entry 6). Further optimization of the 
stoichiometry of the co-oxidant and base showed that using NaIO4 (0.2 eq) with Na2HPO4 (3 eq) 
provided the diol 2.116 in 87% yield while K3Fe(CN)6 (0.2 eq) with Na2HPO4 (4 eq) provided 
the diol 2.116 in 91% yield. 
That the diol 2.116 can be isolated in good yields is surprising. Under very similar 
conditions, the Johnson-Lemieux oxidation (NaIO4, OsO4) cleaves olefins to the corresponding 
ketones and aldehydes. The pH during a Johnson-Lemieux oxidation was found to be 5.7, 
compared to a pH of 8.5 for the dihydroxylation conditions. Dropping the pH of the modified 
dihydroxylation using NaIO4 as the catalytic co-oxidant by adding phosphoric acid resulted in an 
increase in benzaldehyde formation but raising the pH by adding K2CO3 caused the reaction to 
shut down. There is thus a critical pH range where NaIO4 acts as a catalytic co-oxidant but does 














Table 2.13: Further optimization of neutral dihydroxylation 
 
 
Co-oxidant Y X yield 
K3Fe(CN)6 0 3 N/R 
K3Fe(CN)6 0.1 3 66% 
K3Fe(CN)6 0.2 3 70% 
K3Fe(CN)6 0.2 4 91% 
KBrO3 0.1 3 17% 
NaIO4 0.1 3 63% 
NaIO4 0.2 3 87% 
NaIO4 0.1 4 66% 
NaIO4 0.1 3  eq K2CO3 2% 
Use of NaIO4 as the catalytic co-oxidant in the enantioselective dihydroxylation of 2.115 
using (DHQD)2PHAL (2.91)  gave enantioselectivities comparable to the literature but in only 
68% yield compared to 87% yield obtained using quinuclidine (Table 2.14). Use of K3Fe(CN)6 
with (DHQD)2PHAL (2.91) led to a similar drop in yield. Interestingly, use of 0.3 eq of 





Table 2.14: Enantioselective optimized dihydroxylation 
 
 
X Co-Oxidant Y Z yield ee Lit 
3 NaIO4 0.1 0.075 68% 96% 97%
263 
4 K3Fe(CN)6 0.2 0.075 68% N/A N/A 
4 K3Fe(CN)6 0.1 0.3 51% N/A N/A 
 
To demonstrate the potential utility of these mild dihydroxylation conditions, 9-decenal 
2.117 was chosen as a challenge substrate, due to the base sensitivity of the aldehyde moiety. As 
expected, dihydroxylation of 2.117 using AD-mix β with or without NaHCO3 as a buffer 
provided diol 2.118 in 33% and 51% yields (Table 2.15, entry 1,2). Use of the optimized 
conditions with quinuclidine as the ligand and either NaIO4 or K3Fe(CN)6, as the catalytic co-
oxidant, however, initially gave similar results to the AD-mix β (Table 2.15, entry 3-9). Though 
the aldehyde 2.117 was stable under the mildly basic reaction conditions, it slowly decomposed 
over time. Using four eq Na2HPO4 with quinuclidine K3Fe(CN)6 provided the optimum 
compromise between reaction rate and pH, delivering the diol 2.118 in 82% yield (Table 2.15, 
entry 9). Due to the significant rate acceleration seen when the ligand (DHQD)2Phal (2.91) is 
used, only three equivalents of base was needed to achieve a 71% yield (Table 2.15, entry 10). 
Strangely, the choice of catalytic co-oxidant during the enantioselective dihydroxylation had a 
big impact on the yield. Use of K3Fe(CN)6 provided the diol 2.118 in 34-49% whereas, while 
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NaIO4 gave the diol 2.118 in 71% yield. Interestingly, MeSO2NH2 had a slight detrimental effect 
on the yield overall, and minimal rate acceleration was seen. (Table 2.15, entries 3,4 and 10,12).  




Base Co-Oxidant Ligand X Yield ee 
AD-Mix β N/A N/A N/A N/A 33%
b  
AD-Mix β N/A N/A N/A N/A 51%
b,c  
K2S2O8 Na2HPO4 NaIO4 quinuclidine 0.3 40%
b N/A 
K2S2O8 Na2HPO4 NaIO4 quinuclidine 0.3 45% N/A 
K2S2O8 Na2HPO4 K3Fe(CN)6 N/A N/A 45%
d N/A 
K2S2O8 Na2HPO4 K3Fe(CN)6 quinuclidine 0.3 51% N/A 
K2S2O8 K2CO3 K3Fe(CN)6 N/A N/A 63%
d N/A 
K2S2O8 K2CO3 K3Fe(CN)6 N/A N/A 66%
c,d N/A 
K2S2O8 Na2HPO4 K3Fe(CN)6 quinuclidine 0.3 82%
e N/A 
K2S2O8 Na2HPO4 K3Fe(CN)6 (DHQD)2PHAL 0.075 49%  
K2S2O8 Na2HPO4 NaIO4 (DHQD)2PHAL 0.75 71%  
K2S2O8 Na2HPO4 K3Fe(CN)6 (DHQD)2PHAL 0.075 34%
b  
a) 1.5 eq K2S2O8 was used or 1.4 g/mmol substrate AD-mix b) MeSO2NH2 was added. c) 3 eq NaHCO3 was added. 
d) Only 0.1 eq K3Fe(CN)6 was used. e) 4 eq of Na2HPO4 was used 
 
The reasons for the differences in yield between the dihydroxylation with quinuclidine 
and (DHQD)2PHAL (2.91) are not yet clear. The fact that when more (DHQD)2PHAL (2.91) is 
added, the yield drops further and more oxidative cleavage is seen seems to indicate that 
(DHQD)2PHAL (2.91) is affecting the reaction in a way that is detrimental. A sample of the 
organic layer tested positive for oxidants with a starch-iodine test strip. Isolation of the ligand 
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after the reaction revealed that none of the ligand had been oxidized, so the organic-soluble 
oxidizing species remains elusive.188 The ligand (DHQD)2PHAL (2.91) is more lipophilic than 
quinuclidine and might act as a phase transfer agent for some oxidizing species in the reaction 
that facilitates the oxidative cleavage,  but more research is needed to elucidate this pathway.   
Though more work needs to be done to enhance the yield in the enantioselective 
dihydroxylation, The optimized conditions (0.2 eq K3Fe(CN)6 or NaIO4, 3 eq Na2HPO4, 
MeSO2NH2) with quinuclidine provided excellent yields (67-98%) of a variety of diols and use 
of (DHQD)2PHAL (2.91) gave enantioselectivities comparable to those found in the literature 
and may be a useful alternative to NMO in enantioselective dihydroxylations. The 
dihydroxylation was even demonstrated on the aldehyde 2.117, which is extremely base 
sensitive. The ability to use NaIO4 as a catalytic co-oxidant with comparable efficiency to 
K3Fe(CN)6 was a surprising discovery, and fact that dropping the pH results in more oxidative 
cleavage products suggests that it may be possible to develop a new Johnson-Lemieux protocol 
that is catalytic in NaIO4 and uses K2S2O8 as the terminal oxidant.
 
 
2.2.5: ELABORATION OF DIELS-ALDER REACTION INTERMEDIATE 2.34 
Although the methodology for the intermolecular Diels-Alder reaction between the 
enantiopure aryl, vinyl-sulfoxides with furans developed by Dr. Noah Benjamin was not 
applicable for the synthesis of cortistatin A, his work to elaborate the core served as a model 
system for the later steps in the synthesis (Scheme 2.13).88,103 He found that ozonolysis of 2.119 
using a mixture of acetone/water (95:5) in the presence of 2,6-lutidine gave optimum yields of 
the cleavage product 2.120, which was transformed to the bis-alkyne 2.122 using the Ohira-
Bestmann reagent. Additionally, he found that the oxa-bicyclic ring in 2.119 underwent a 
regioselective ring-opening metathesis with a variety of alkenes to give products such as 2.123, 
which can be desulfurized to tetrahydrofuran 2.124. 
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Scheme 2.13: Dr. Noah Benjamin’s elaboration of oxa bicyclic intermediate 2.119 
 
 
Use of Dr. Benjamin’s conditions (acetone/H2O (95:5),
198 –78 ºC, 2,6 lutidine) for the 
ozonolysis of Diels-Alder reaction adduct 2.34 gave small amounts of desired product 2.125, 
which stands in contrast to the ozonolysis of the TMS-protected alkyne 2.14 utilizing the same 
conditions (see Scheme 2.2 and Equation 2.1) (Equation 2.6). Other solvents, amine oxide 
additives and reductive quenches were screened, but the original conditions proved superior.103 
Following the reaction by TLC showed that the main issue was control of reaction time. 
Stopping the reaction after ca. 50% conversion returned primarily product and starting material, 
indicating that the loss in yields is due to over-oxidation of the product. Use of color indicators to 
monitor the consumption of the olefin was not helpful because the dyes de-colored either before 
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2.34 reacted or after the 2.34 had been consumed by ozone. Even using 1-hexyne as a sacrificial 
olefin to prevent over-oxidation had no impact on the yield.  
Equation 2.6: Ozonolysis of Diels-Alder reaction intermediate 2.34 
 
 
Control of ozone stoichiometry is of critical importance for the success of this selective 
ozonolysis. Though previous examples (see Figure 2.1) reported that alkynes were unaffected by 
the presence of excess ozone, careful monitoring of the reaction revealed that consumption of the 
product commenced quickly after the starting material was ozonolyzed. A possible solution to 
this dilemma was found in the total synthesis of bryostatin by Wender, and the synthesis of 
acutumine by Castle (Figure 2.12),197,201 both of which report selective ozonolysis of very 
complex intermediates with multiple double bonds. They were able to determine the 
concentration of a saturated solution of ozone by removing aliquots and adding to a solution of 
styrene. The ozone solution was added until the styrene had been consumed by TLC. By 
knowing the concentration ozone dissolved in the organic solvent both Wender and Castle were 
able to control the stoichiometry between ozone and the olefin without risking oxidation of other 


























































a) Wender’s ozone titration in his synthesis of bryostatin Analogues; b) Castles’s ozone titration in his 
synthesis of acutumine 
In trying to replicate the titration procedure, several obstacles arose: Monitoring the 
consumption of styrene by TLC proved tedious and inaccurate, and the stability of ozone in 
acetone/H2O (95:5) was unknown. The addition of solvent red 23 (2.17) to styrene, however, 
allowed for a quick and accurate colorimetric titration of the ozone solutions (Figure 2.13 A → 
B).To test the stability of ozone in acetone/H2O (95:5), a saturated solution of ozone in acetone 
was kept at –78 oC, and the titre was checked every 30 min for three h; there was no appreciable 







Figure 2.13: Successful application of ozone titration to the ozonolysis of styrene 
 
 
a) Solution of styrene and solvent red 23 (2.17) in acetone; b) Solution of styrene and solvent red 23 (2.17) in 
acetone after ozone has been added to the endpoint; c) Solution of ozone in acetone at -78 oC  
Ozone was bubbled through acetone at –78 ºC until saturated and and aliquots were 
removed and added to a 0.1 M solution of styrene with solvent red 23 as an indicator until the red 
color disappeared. After determining the concentration, a volume equal to one equivalent of 
ozone in acetone was added to 2.34 in acetone/H2O (95:5) in the presence of 2,6 lutidine at –78 
ºC via a jacketed addition funnel that had been cooled to –78 ºC. Gratifyingly, aldehyde hydrate 
2.125 was isolated in 77% yield (Equation 2.7). Pyridine is known to give enhanced selectivity in 







Equation 2.7: Successful application of ozone titration in the ozonolysis of 2.34 
 
 
The role of amines and other additives in ozonolysis is summarized in Figure 2.16. Basic 
amines can react with molozonide 2.133 to give an aldehyde 2.135 and a carboxylic acid 2.134 
(Figure 2.14, pathway A).194 When the molozonide collapses to the carbonyl oxide 2.136, several 
mechanistic pathways are available for the production of an aldehyde depending on the additive 
used. In the presence of water, the carbonyl oxide 2.136 is intercepted to form the peroxy 
hemiacetal, which collapses to provide the aldehyde 2.135 and hydrogen peroxide (Figure 2.14, 
pathway B).198 In the presence of non-basic amines or amine oxides, the carbonyl oxide 2.136 is 
intercepted to give an intermediate such as 2.198 (Figure 2.16, pathway C).196 Breakdown of 
2.198 releases the aldehyde 2.135, amine 2.199 and singlet oxygen as the by-products. Pyridine 
however, has a unique effect on the reaction course (Figure 2.14, pathway D).203 In addition to 
forming complexes with ozone (Figure 2.14, pathway E), pyridine is thought to intercept the 
carbonyl oxide 2.136 to form 2.140. Pyridinium 2.140 then intercepts another carbonyl oxide 







Figure 2.14: Roles of amine, amine-oxides, water and pyridine in ozonolysis 
 
 
a) Decomposition pathway of secondary ozonides in the presence of strong bases; b) hydrolysis of carbonyl oxide in 
presence of water; c) Pathway in presence of amine oxides; d) Pathway in presence of pyridine; e) equilibrium of 
pyridine and ozone to form complex 
Due to the fact that the ozonolyzed product 2.125 exists as a mixture of aldehyde hydrate 
diastereomers, the Diels-Alder reaction adduct 2.34 was used as a model system to determine the 
best conditions for partial reduction of the alkyne. Lindlar’s catalyst (Pd/CaCO3 poisoned with 
lead) is well known to facilitate the partial reduction of alkynes,205-208 but hydrogenation of 2.34 
under a balloon of hydrogen and quinoline gave no reaction. P2-nickel boride,210,211 which is also 
known to reduce alkynes to alkenes, also gave no reaction. Hydrogenation of 2.34 with Lindlar’s 
catalyst under a higher pressure of hydrogen (30-40 psi) reduced the alkyne, however, the 1H-
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NMR spectrum of the reaction showed a complex mixture of products and a lack of olefin 
protons, indicating over-reduction had occurred. In order to combat over-reduction of the olefin, 
1-octene was added as a co-solvent to serve as a sacrificial olefin to protect against over 
reduction.209 Thus, hydrogenation of 2.34 with Lindlar’s catalyst and quinoline in 1:1 EtOAc/1-
octene at of 30-40 psi H2 cleanly gave 2.144 in 62% yield (Equation 2.8).  
Equation 2.8: Successful partial reduction of alkyne moiety in Diels-Alder adduct 2.34 
 
 
With conditions for the hydrogenation of the alkyne to the alkene developed, work to 
investigate the transformation of the ozonolysis product 2.125 to the bis- alkyne was initiated. 
Despite considerable effort, all attempts to convert 2.125 into the bis-alkyne 2.146 were 
unsuccessful (Equation 2.9). Only trace amounts of product were isolated after reaction of 2.146 
with the Ohira-Bestmann reagent in the presence of K2CO3 in MeOH. Changing the base to 
Cs2CO3, which is known to accelerate the reaction and reduce by-products, offered no 
improvement.214 The methoxide present in the reaction mixture, which is necessary to transform 
the Ohira-Bestmann reagent into the Seyferth-Gilbert212,213 reagent in situ, may be incompatible 
with the several base sensitive functionalities present in 2.125.  Zhang developed reagent 2.145, 
which does not require methanol to transform into the (diazomethyl)phosphonate and thus may 
be used in any solvent.215 Unfortunately, despite extensive screening of solvents and bases with 




Equation 2.9: Attempted conversion of bis-aldehyde hydrate 2.125 to bis-alkyne 2.146 
 
 
The failure to convert the ozonolysis product 2.125 to the bis-alkyne 2.146 using both 
protic and aprotic conditions was attributed to the base sensitivity of the sultone moiety. 
Sulfonate esters are powerful alkylating agents and may interact with nucleophiles either at 
carbon or at sulfur. Additionally, the α-position is potentially acidic enough to deprotonate under 
mild basic conditions causing β-elimination of the oxo-bicycle or other side-reactions. Therefore, 
removing the sultone before the Ohira-Bestmann homologation could potentially suppress these 
undesired side reactions.  
2.2.6: ATTEMPTED DESULFURIZATION OF 2.34 
Many other methods exist to reductively cleave carbon- sulfur bond, as well as the one 
developed by Dr. Benjamin. The methods generally fall into two categories: single electron 
transfer agents (Table 2.16, entries 1-8) and hydrogenolysis (Table 2.16, entries 9-15). 
Hydrogenolysis is most commonly effected with homogeneous or heterogeneous nickel and is 
probably the most widely used method for desulfurization. Depending on the method, the 
reactivity of the nickel can be modified to suit the system. Raney-nickel (Mozingo) is the most 
active nickel based desulfurization agent.226 Caubere has pioneered the development of the Ni 
Containing Complex Reducing Agents (NiCRA,s) in an effort to develop milder, more consistent 
reductant than Raney-Nickel.224,225,230 Nickel-boride is the least active of the heterogeneous 
nickel reducing agents.227 Although in some instances compounds can be desulfurized in the 
presence olefins by de-activating the catalyst via refluxing in acetone,257,258 re-activated catalysts 
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have, thus far, not been shown to reduce sulfonate esters which precludes use with the Diels-
Alder reaction adduct 2.34.238,239 Fortunately, single electron reducing agents also offer some 
flexibility. The reactivity of single election reductant can be modulated by the choice of metal 
(Na,216,220 Mg,217,222 Al218 or SmI2
221) and the use of protic additives.220, Further modulation of 
the reactivity can be done by adding transition metal additives such as titanium to generate low 



















Table 2.16: Compilation of desulfurization Methods 
 
 
Refrence X reagent additive conditions yield 
Trost216 Ar Na/Hg Na2HPO4 MeOH, 0 °C 49-93% 
Lee/Pak217 Ar Mg/HgCl2 Na2HPO4 EtOH, rt 98-100% 
Corey218 Ar Al HgCl2 THF, rt
a 70-98% 
Carpino219 Ar Mg N/A MeOH, 50 °C 68-91% 
Suh220 Alk Na/Hg B(OH)3 MeOH, rt 87% 
Kunzer221 Ar SmI2 HMPA THF, rt 50-91% 
Pathak222 Alk Mg NiBr2 MeOH, rt 44-75% 
Zhang223 Alk TiCl4/Zn N/A THF, rt 74-92% 
Caubere224,225 Ar/Alk NaH/Ni(OAc)2 t-AmONa THF, 65 °C 60-100% 
Mozingo226 Ar Raney-Nib N/A EtOH, reflux 65-80% 
Back227 Ar NiCl2/NaBH4 N/A MeOH, rt 0-14% 
Luh228 Ar Cp2Ni/LiAlH4 N/A THF, rt 38-63% 
Luh229 Ar/Alk NiBr2•DME/LiAlH4 Ph3P THF, rt 55-92% 
Caubere230 Ar NaH/Ni(OAc)2 NMHPNa
c THF, 65 °C 60-100% 
Park231 Ar iPrMgBr Dppf•NiCl2 Et2O, reflux 31-95% 
Wolinsky232,233 RO LiAlH4 or AlH3 N/A Et2O, reflux 0-45% 
Okamoto234 R2N Mg/Ti(OiPr)4 TMSCl THF, 50 °C 29-94% 
Nayak235 RO Li TiCl3 THF, rt 32-91% 
DuBois236 Cl Zn Cu(OAc)2 AcOH, rt 55% 
a) Mixture of solvent and water; b) W2 Raney nickel; c) NMHPNa is n-Methyl 3-Hydroxy piperidine sodium salt 
Compared to sulfones, the reductive desulfurization of sultones or sulfonate esters is an 
underdeveloped area of chemistry. The same reagents for reductive desulfurization of sulfones 
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also apply to sulfonate esters: aluminum hydrides (Table 2.17, entry 16), single electron transfer 
(SET) reduction (Table 2.17, entry 17,18,19, Figure 2.15, B),112 Raney nickel (Figure 2.15, A) 
but the conditions are noticeably harsher and lower yielding than for the sulfones.108 One 
interesting procedure, however, is a two step protocol devised by Wolinsky for his synthesis of 
β-santalol (Figure 2.15, C).237 To circumvent the low yielding one-step reduction of the sultone, 
it was first converted to a sulfone that was subsequently removed with Na/Hg. 
Figure 2.15: Literature examples of reductive desulfurization with sultones 
 
 
a) Desulfurization of sultone 2.147 by Metz in the synthesis of methyl nonactate;108 b) Desulfurization of sultone 
2.148 by Metz in his study of reductive desulfurization of sultones;112 c) Desulfurization of sultone 2.151 by 
Wolinsky in the synthesis of β-santalol.237 
 
As mentioned earlier, the olefins present in 2.34 preclude use of aluminum hydrides and 
hydrogenolysis methods for reductive desulfurization due to the robustness of sulfonate esters 
compared to sulfones and other sulfur containing groups so SET strategies were investigated 
first. Subjection of 2.34 to SET reduction conditions using either Na/Hg or Mg/Hg as the 
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reducing agent did not produce any of the desired product 2.154 (Scheme 1.24). Addition of 
Ti(OiPr)4, NiBr2 or CeCl3  as additives to the SET reduction provided multiple products that 
could not be identified. Protic additives seemed to provide cleaner mixtures of products, and 
several that were screened include B(OiPr)3 (for anhydrous B(OH)3,  TMSCl (for anhydrous 
HCl), H2O, BHT, Na2HPO4, citric acid, phosphoric acid and TFA.  Of the protic additives, only 
phosphoric acid in conjunction with Mg/Hg gave a single product, which was determined to be 
2.155 in 78% yield. 






































The alkyne hydration product 2.155 was assigned based on its mass of 622 (M+H2O) and 
the similarity of its 1H NMR spectra to that of 2.72, the structure of which was confirmed by X-
ray crystallography (Figure 2.16). The key diagnostic peaks in the 1H-NMR spectra that 
distinguishes 2.34 from 2.155 and 2.13 are the diastereotopic protons next to the alkyne (Figure 
2.16, A for 2.34, B  for 2.155 and C for 2.13). In the starting material, both protons appear as a 
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doublet of doublets at 2.49 and 2.26 ppm because they are being split by each other and the 
alkyne sp-proton. The peaks representing the protons in by-product 2.155 and 2.72 have shifted 
downfield to 3.08 and 2.85 ppm, respectively, and appear as doublet, indicating that the alkyne 
splitting has been lost.  
Figure 2.16: Proton NMR of Diels-Alder reaction adduct and alkyne hydrated products 
 
 
a) 1H NMR of starting material 2.34; b) 1H NMR of 2.155; c) 1H NMR of decomposition product 2.72 
The exact pathway for forming 2.155 has not been elucidated; however trace amounts of 
HgII from the HgCl2 added to the reaction mixture could have participated in an oxymercuration 
reaction to give the α-keto-organomercury compound 2.158 (Scheme 2.15).  Mercury compound 
2.158 could then be reduced by the Mgo to the enolate and protonated by MeOH to give the 
ketone compound and Hg0. Alternatively, protic additives may protonate the Hg-C bond to 
generate the ketone and the HgII species. 
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The fact that none of the milder SET conditions showed any evidence for the desired 
reduction led to the investigation of the Birch reduction, which has been shown to desulfurized 
similar substrates (see Figure 2.15 B). Disappointingly, addition of a solution of 2.34 in THF to a 
cooled solution of lithium in ammonia resulted in complex mixtures with no identifiable 
products (Equation 10). Isolation of the crude reaction mixture showed additional Csp2-H peaks 
in addition to those already present in the 1H-NMR, indicating that the arene groups on the 
TBDPS protecting group might have been reduced in addition to other side reactions. The 
addition of alcohols to modulate the reduction potential of the reaction mixture only produced 
more complicated 1H NMR spectra. 
Equation 2.10: Attempted Birch reduction of 2.34 
 
 
The inability to desulfurized the Diels-Alder adduct 2.34 via single electron transfer 
methods led to the investigation of the two step procedure developed by Wolinsky (see Figure 
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2.17, C).237 There are relatively few examples of cleaving sulfate esters with organometallics 
reagents and most studies on the addition of nucleophiles to sulfate esters involve phenyl 
sulfonates and not alkyl sulfonates.238-248  A variety of phenyl nucleophiles were screened in 
order to convert the sulfate ester to the phenylsulfone. Exposure of 2.89 to phenylzinc chloride 
resulted in no reaction, and the addition of phenyllithium, with and without LiHMDS to protect 
the ketone in situ, generated unidentifiable products. Organocerium reagents are known to have 
reduced basicity and enhanced nucleophilicity, and reaction of the phenyl organocerium reagent 
with 2.89 gave a mixture of products that were determined to be the 1,2-adduct 2.162 and the 
ring-opened product 2.161 (Equation 2.11).167 Use of phenylmagnesium bromide to make the 
organocerium compound provided a reagent that was far less reactive than the reagent made with 
the phenyllithium. Interestingly, use of mesityllithium to generate the organocerium reagent 















Equation 2.11: Attempted conversion of sultone to sulfone 
 
 
Evidence for the structure 2.161 are as follows: The mass of the product was 587 which 
is indicative of no additional phenyl group and matches the molecular weight of the starting 
material minus water suggesting an ionizable alcohol. The 1H-NMR chemical shifts of the 
olefinic protons have shifted from 6.57 and 6.09 ppm in 2.89 to 6.18 and 5.91 ppm and the 
coupling constants of the olefinic protons have also changed  (5.5 → 10.0 Hz). Coupling 
constants of 5-6 Hz are typical for norbornenes and cyclopentenes whereas a coupling constant 
of 10 Hz is more indicative of a cyclohexene.251-255 The 13C-NMR shows that the olefinic carbon 
peaks have also shifted upfield (141.6, 135.9 → 138.6, 125.11 ppm). There are a total of 12 sp2 
carbons between 140 and 120 ppm but 8 of these carbons belong to the diastereotopic phenyl 
groups of the TBDPS group. Of the four carbons remaining, two are the olefinic protons leaving 
two extra quaternary olefinic carbons. Additionally, the bridgehead carbon atoms of the oxo-
norbornene in the starting material are characteristic at 90.6 and 87.7 ppm, but there are no 
carbons in this region in the spectrum of 2.161. 
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 The probable mechanism for the formation of 2.161 is likely deprotonation of the sultone 
at the α-position, followed by elimination to form the cyclohexadiene moiety. The tendency for 
these systems to eliminate in this fashion was leveraged by Metz in his synthesis of nonactate 
and pamamycin.107-111,256 Metz found that treatment of the oxabicycle 2.163 with organometallic 
agents facilitated the ring opening and 1,6-conjugate addition into the extended vinyl sulfonate 
ester (Scheme 2.16). 




In correspondence with Dr. Metz, he revealed that the discovery of this reaction was the 
result of his initial attempts to desufurize the sultone and that removing the sulfur without ring 










Dear Mr. Blumberg, 
  
Desulfurization of a furan-derived sultone without breaking the oxygen bridge is an 
unsolved problem as far as I know. About 20 years ago when we worked on the synthesis 
of nonactic acid, we tried a lot of conditions but we could never avoid the beta-
elimination with ring-opening. During this work, we actually discovered the Red-Al 
domino elimination/alkoxide-directed hydride addition that turned out to be quite helpful 
later. This also led us to the idea of doing similar chemistry with organolithium reagents, 
which was developed into key steps for the nactic [sic] acid and pamamycin [sic] 
syntheses eventually. 
Even if the intended addition of an arylmetal species to the delta-sultone with formation 
of a hydroxyl sulfone would work (earlier we added phenyllithium to a cyclopentadiene-
derived delta-sultone to isolate about 20% of the desired sulfone), the subsequent 
desulfurization might be rather tricky again. 
I do not know your target, but maybe you can also utilize an elimination reaction with 
ring-opening just as we did for our 2,5-disubstituted THF targets. 
  
All the best, 
Peter Metz 
 
Unfortunately, due to the inability of removing the sulfur from Diels-Alder reaction 
adduct 2.34 or transform the ozonolysis product 2.125 into the bis-alkyne 2.146, the project was 
not pursued further. The key problems seem to stem from the base sensitivity of the sultone 
which severely limits the synthetic transformations compatible with the system. The Wolinsky-
like strategy of transforming the sultone into the phenyl sulfone seems unlikely to work as even 
organocerium reagents are basic enough to deprotonate the oxa-bicyclic ring, followed by ring 
opening to 2.161.  
2.2.7: SUMMARY 
In summary, a crystal of x-ray quality was grown of 2.14, confirming that the relative 
stereochemistry of the C13 propargyl group and the C14 furan as trans and confirming 
diastereomers 2.10 and 2.34 as having the desired stereochemistry required for cortistatin A. A 
two-step scaleable route to ketone 2.6 was established, shortening the sequence by three steps 
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using cost effective protocols by utilizing the Kraus alkylation (Scheme 2.17). Although a 
repeatable alkylation of ketone 2.6 proved difficult, insights into the generation of 
thermodynamic lithium enolates were gained, namely, that the addition of base to the ketone 
rather than incubation with substoichiometric base proved superior for the generation of the 
thermodynamic enolate. The dihydroxylation of ketone 2.33 was initially sluggish and low 
yielding, but an improved procedure was developed using potassium persulfate (K2S2O8) as the 
stoichiometric oxidant which improved yields of diol 2.81 and improved reaction rates. 
Successful formation of the vinyl sulfonate in was found to be contingent on the elimination of 
polar ammonium salt 2.87 with excess base and subsequent Diels-Alder reaction furnished 2.34 





















The Sharpless asymmetric dihydroxylation can be used with a variety of olefins but the 
high pH (10-11.2) of the reactions conditions precludes use with base sensitive functionalities. 
Accordingly, a very mild (pH 8-9) Sharpless-style dihydroxylation was developed using 
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potassium persulfate (K2S2O8) as the stoichiometric oxidant, hydrogen phosphate (Na2HPO4) as 
the base and either Potassium ferricyanide (K3Fe(CN)6) or sodium periodate (NaIO4)  as the 
catalytic co-oxidant (Equation 2.12). Use of quinuclidine as the ligand provided racemic diols in 
excellent yield, while use of (DHQD)2PHAL (2.91) generated the diols with enantioselectivities 
almost identical to those reported in the literature. These conditions were demonstrated to work 
even in the presence of base sensitive functionalities such as aldehydes and will be of use for the 
greater synthetic community.   
Equation 2.12: Racemic and enantioselective Upjohn-like dihydroxylation conditions 
 
 
     
The selective ozonolysis of the Diels-Alder reaction adduct 2.34 was initially low 
yielding, owing to the difficulty in controlling the amount of ozone the substrate is exposed too. 
To control the ozone equivalents, a colorimetric titration was developed using Sudan III as an 
indicator and styrene as the consumption. The titration was utilized to add 1 equivalent of an 
ozone solution in acetone to a mixture of 2.34 in acetone/H2O (95:5) and 2,6-lutidine at –78 ºC to 
provide the aldehyde hydrate 2.125 in 77% yield (Figure 2.17). The addition of pyridine further 











CHAPTER 3: THE CITREAMICINS AND OTHER POLYCYCLIC 
XANTHONE NATURAL PRODUCTS 
3.1: Isolation and Biological Activity  
Citreamicin α 3.5 was isolated from a culture of Micromonospora citrea taken from Lake 
Manyara in Tanzania, Africa in 1989 by Lechevalier.265 The structure was miss-characterized 
and originally called LL-E19085α before being correctly assigned to the structure shown in 
Figure 2.1 by Carter in 1990.266 Citreamicins β (3.6), γ (3.7), ζ (3.8) and η (3.2) were also 
isolated and characterized by Carter in that same paper. In 2008, citreamicins δ (3.9) and ε (3.3) 
were isolated from a culture of Streptomyces vinaceus by Moek.267 Neocitreamicins I (3.10) and 
II (3.11) were isolated in 2008 form a sandy soil sample collected in Falmouth, Massachusetts by 
Moore.268 Citreamicin ε (3.3) and its epimer at C25 Citreamicin B (3.4), were isolated form a 
culture of Streptomyces caelestes taken from the coastal waters of the Red Sea in 2013 by 
Qian.269 
The distinguishing characteristic of the citreamicins is the dihydrooxazolo-[3,2-b]-
isoquinolinone moiety (the GAB rings), which is unique to this class of natural products and 
contains an (S)-α-methylserine. The hydroxyl group at C29 can be acylated with a variety of 
carboxylic acids. The other point of diversification is in the F ring. In paticular of the 
citreamicins contain substitution at C11 and C12 (citreamicins α, β, γ, ζ, and η) whereas 
citreamicins ε, B, and neocitreamicins I and II have substitution at C10 and C11. Interestingly, 
neocitreamicin II is the only glycosylated member of the citreamicin family isolated thus far.    
All known citreamicins have shown potent antibiotic activity against several gram-
positive strains. Most notably, citreamicin η (3.2) exhibits a median inhibitory concentration 
(MIC) of 26 nM,266 whereas citreamicins δ and ε have shown MIC values of 101 nM – 3.4 µM 
against multidrug-resistant Staphylococcus aureus (MDRSA) and vancomycin-resistant 
Enterococcus faecalis (VRE).267 In 2013, Qian demonstrated that citreamicins ε and B displayed 
potent cytotoxic activity against HeLa and Hep62 cells in the 30-100 nM range.269 Further 
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studies revealed that they induced HeLa cell apoptosis via CAS-3 dependent pathways and that 
the hydroquinone analogues increase reactive oxygen species generation (ROS) by 40% while 


























Figure 3.1: Isolated members of the citreamicin family  
 
The citreamicins belong to a class of type II polyketides called polycyclic xanthones and 
are characterized by an angularly fused hexacyclic structure, with the xanthone moiety 
comprising the D, E and F rings (Figure 2.2, Table 2.1). Though the citreamicins are the only 
members that feature the dihydrooxazolo-[3,2-b]- isoquinolinone moiety, the cervinomycins270-
272 (3.17-3.19) (Figure 2.2, Table 2.1, entry 3) and the kigamicins (3.20)273,274 (Figure 2.3, Table 
2.1, entry 10) feature a similar tetrahydrooxazolo-[3,2-b]-isoquinolinone moiety. Despite being 
isolated from different organisms and from different parts of the world, the compounds display a 
surprising degree of structural similarity. The A and F rings are the most diverse, with the A ring 
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being either 2-pyridone-based, or lactone-based as seen with FD-594 (3.13)275,276 and IB-00208 
(3.14)277 (Figure 2.2, Table 2.1, entries 9, 11). The F ring can be aromatic, mono-unsaturated or 
bis-unsaturated and can have substitution at all positions on the ring. The D and E rings display 
the most consistency: The E ring remains the same, and the D ring is either a hydroquinone 
derivative or a quinone. One interesting feature of some members of this class is the 
methylenedioxy ring that spans C17 and C19 and is found in the kigamicins (3.20), xantholipin 
(3.16),278 actinoplanone (3.26),279 albofungin (3.27)280 and lysolipin (3.15)281 (Figure 2.2, 2.3, 
Table 2.1, entries 10, 12, 4, 1 and 2). Simaomicin (3.22) is the only member to have this bridge 
span C22 and C24 (Figure 2.3, Table 2.1, entry 6).281 Virtually all members of this family 


































3.23: 19,20 (Kibdelone A, 1.6 - 5 nM)283,284
3.24: (Kibdelone B, 1.6 - 5 nM)283,284













































kigamicins (R = glycosides)273,274
















3.26: X = Cl, R1 = OMe, R2 = H, R3 = OH, R4 = H (actinoplanone A, IC50 0.072 nM)
279








Table 3.1: Chronological list of polycyclic xanthone natural products 
Name Compound Isolated Location Strain 
Gureuich280 albofungin 1972   
Zahner281 lysolipin 1975  
Streptomyces 
violaceoniger 
Omura270,272 cervinomycin 1982 




Nishino279 actinoplanone 1988 
Forest soil in Okinawa 
prefecture, Japan Actinoplanes sp. 
Carter266 citreamicin 1990 




Kantor282 simaomicin 1990 Soil, San Simao, Brazil 
Actinomadura 
madure 
Katrukha271 167-A,B 1993 Soil, Bulgaria 
Amylcocata 
autotrophica 
Chu285 Sch-56036 1998 Tarlac on Philippine island Actinoplanes sp. 
Mizoue275,276 FD-594 1998 
Soil, Urawa city, Saitama 
prefecture, Japan Streptomyces sp. 
Kunimoto273,274 kigamicin 2003 
City of Tuba, Mie 
prefecture, Japan Amicolatopsis sp. 
Romero277 IB-00208 2003 Northern coast of Spain Actinomadura sp. 
Terui278 xantholipin 2003 
Soil, Shandong province, 
China Streptomyces sp. 
Capon283,284 Kibdelone 2007 




Moek267 citreamicin δ 2008  
streptomyces 
vinaceus 
Moore268 neocitreamicin 2008 
Sandy soil, Falmouth, 
Massachusetts  






3.2: Biosynthetic Studies of the Citreamicins 
In 1991, Carter fed a culture of Micromonospora citrea 13C enriched acetates and isolated 
citreamicin to see where the 13C atoms were incorporated (Figure 2.4).289 Feeding acetate 
enriched in 13C at the carbonyl showed incorporation all around the molecule, confirming that 
citreamicin is a type II polyketide (Figure 2.4, 3.28). This feeding experiment revealed that the 
“amino acid” moiety that comprises the G ring is in fact acetate based. Strangely, this experiment 
revealed incorporation at C7, C8 and C16, which would not be expected unless some 
rearrangement had taken place. Feeding the bacterial culture acetate enriched in 13C at the methyl 
group showed no incorporation at those positions, confirming the previous result. Interestingly 
this experiment also revealed that the origin of both the geminal groups at C27 are the methyl 
groups of acetate (Figure 2.4, 3.29). Radiolabeled methionine revealed that the methyl groups on 
C11 and C12 are most likely introduced via S-adenosyl methionine (SAM) (Figure 2.4, 3.31).289 
Feeding the bacterial culture acetate enriched in 18O or under an 18O atmosphere revealed that, as 
expected, most oxygen atoms originate from acetate, however, the oxygen atoms at C11 and C17 
come from molecular oxygen (Figure 2.4, 3.32). This stands in contrast to the feeding 
experiments done on lysolipin (3.15), which determined that the isoquinolone ring may come 
from an amino acid and that both of the oxygen atoms in the xanthone moiety come from 
molecular oxygen.287,289, 290 These feeding studies reveal that despite the structural similarity 







Figure 3.4: 13C and 18O labeled feeding studies on the biosynthesis of citreamicin 
 
These results led Carter and Pearce to propose the following putative biosynthetic 
sequence (Scheme 3.1).289 Acetates are coupled together by polyketide synthase to form 3.33, 
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and the chain then cyclizes to form a structure like 3.34. One of the carbon atoms is oxidatively 
excised to give a compound like 3.35. Intermediate 3.35 then cyclizes to the spirocycle 3.36, 
which rearranges to 3.37. The exact order of events is not certain, but at some point, the 
compound is oxidized at C17 and C12 by oxygenase enzymes to form a structure like 3.38. The 
oxygen atoms are then methylated by SAM and acetates condensed onto C27 to form the G ring 































































































3.3: Previous synthesis of polycyclic xanthone natural products 
The impressive biological activity and the challenging densely-functionalized hexacyclic 
core of the polycyclic xanthone natural products caught the attention of the Martin group that 
culminated in the synthesis of IB-00208 (3.14) aglycon (Figure 2.5).345,346 The total syntheses of 
cervinomycin (3.17),291,300,304 kibdelones A (3.23) and C (3.25),307,314,317 simaomicin α (3.22),318 
and FD-594 (3.13)323 have been reported by other groups as well as synthetic studies toward 
lysolipin (3.15)329-332 and Sch-56036333 (Figure 2.5, 2.6). As of 2016, no syntheses of 
citreamicin, xantholipin (3.16), albofungin (3.27), kigamicins (3.20), or actinoplanone (3.26) 
















Figure 3.5: Summary of the synthetic work towards polycyclic xanthone natural products 
 
 
In addition to the total syntheses, studies on the synthesis of the AB rings in Sch-56036 
(3.21)333 and the BCD rings of lysolipin (3.15)329-332 have also been accomplished (Figure 2.6). 
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Though TMC-66 (3.40) is not in the polycyclic xanthone family of natural products, the 
synthesis of the G ring is informative.  
Figure 3.6: Summary of approaches to the core or other relevant synthetic work towards 
polycyclic xanthone natural products 










Barrett 2005 (AB core) 8 steps LLC,
11 steps total 35%333

















3.3.1: CERVINOMYCIN, KELLY 
Cervinomycin (3.17) is the polycyclic xanthone natural product that shares the most 
similarity to citreamicin, the only difference being the tetrahydrooxazolo-[3,2-b]- isoquinolinone 
moiety in the G-ring. Cervinomycin (3.17) was the first member of the polycyclic xanthones to 
succumb to total synthesis by Kelly in 1989.291 Kelly’s key strategy involved joining the GAB 
and DEF ring fragments together via a Heck coupling, followed by an electrocyclization to form 
the C ring.  
The triple ortholithiation sequence from 3.41 to 3.44 was originally developed by Kelly 
in 1988 for the synthesis of fredericamycin A.292 Protection of alkoxy-phenol 3.41, as the tert-
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butyldiphenylsilyl (TBDPS) and MOM ether respectively furnished 3.42 (Scheme 3.2). Ortho-
lithiation of compound 3.42 under kinetic conditions occurred selectively at C2, and quenching 
with tert-butyl isocyanate gave the tert-butyl amide 3.43. The selectivity (C2 vs. C4) of the 
ortho-lithiation of meta-substituted MOM-ethers is determined by the chelating or electron 
withdrawing ability of the group at C21.293-295 The tert-butyl amide moiety in 3.43 directed the 
next two subsequent lithiations, first at C23, which was methylated with methyl iodide, then at 
the methyl group to form the benzyl anion, which was quenched with ethyl acetate to give the 
aryl acetone 3.44. The tert-butylamide was converted to an N-alkyl-N-nitroso amide by treatment 
with dinitrogen tetroxide (N2O4), which fragments to release nitrogen gas and form the tert-butyl 
ester.269-268 The tert-butyl ester, MOM group and the TBDPS group were all removed with acidic 
methanol, and subsequent cyclization gave isocoumarin 3.45. Finally, Grieco elimination 















Scheme 3.2: Synthesis of isocoumarin 3.47 from 3.41  
 
Transformation of the isocoumarin 3.47 to the tetrahydrooxazolo-[3,2-b]- isoquinolinone 
2.50 was not straightforward (Scheme 3.3). Condensation of 3.47 with ethanolamine under 
reflux, or under acidic conditions failed to provide the desired product, instead leading to the 
isoquinolone 3.49. Rather than make the alcohol at C26 the nucleophile, Kelly utilized the 
tertiary alcohol at C25 as the nucleophile in a Mitsunobu reaction to give the desired 








Scheme 3.3: Synthesis of GAB ring fragment 3.50 
 
The synthesis of the xanthone coupling partner began with a conjugate addition of phenol 
3.52 to bis-iodo quinone 3.51 to furnish quinone 3.53 (Scheme 3.4). The quinone moiety was 
reduced to the hydroquinone with sodium bisulfite and subsequent Friedel-Crafts cyclization 
with sulfuric acid provided the xanthone 3.54. The xanthone was then protected as the bis-MOM 












Scheme 3.4: Synthesis of xanthone fragment 3.55 
 
 
Heck coupling of fragment 3.55 and styrene 3.50 gave the key step precursor 3.56 as a 
mixture of double bond isomers (Scheme 3.5). Oxidative photo-electrocyclization of 3.56 
resulted in concomitant deprotection of both MOM groups and gave cervinomycin (3.17) in only 













Scheme 3.5: Kelly’s completion of (±)-cervinomycin (3.17) 
 
Kelly’s landmark synthesis remains the shortest of the total synthesis of the cervinomycin 
(3.17) and also the shortest synthesis of any member of the polycyclic xanthone family. This is 
attributed to the strategic use of protecting groups and minimal redox manipulations. The 
synthesis features the first use of a photo-electrocyclization to close the C ring after joining the 
GAB (3.5) and DEF (3.55) fragments together. Kelly also utilized an interesting “umpolung” 
strategy to close the G ring by using Mitsunobu conditions to turn the pendant alcohol of 
ethanolamine in 3.48 from a nucleophile to and electrophile, avoiding the formation of the 
isoquinolone byproduct 3.49.   
3.3.2: CERVINOMYCIN, RAO 
Rao published his synthetic studies towards the GABC rings of cervinomycin (3.17) in 
1988,301 when he completed the synthesis of the tetrahydrooxazolo-[3,2-b]- isoquinolinone 
moiety, and in 1991 he published a total synthesis.300,302  
The di-methoxy naphthalene 3.56 was brominated and selectively acylated at C21 under 
conditions reported by Zollinger to give the aceto-napthalene compound 3.57 (Scheme 3.5).303 
The acetyl moiety was oxidatively isomerized with Tl(NO3)3 to the aryl acetate 3.58, which was 
then hydrolyzed and converted to the ketone 3.59 by reaction with methyllithium. Olefination of 
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the ketone moiety in 3.59 with the phosphonium salt 3.60 provided 3.61 as an inconsequential 
mixture of olefin isomers that was hydrogenated with Adams catalyst (PtO2). The ester was 
hydrolyzed to the acid and Friedel-Crafts cyclization with polyphosphoric ester (PPE) provided 
tricyclic compound 3.62. Claisen condensation of compound 3.62 with diethylcarbonate 
furnished the BCD ring fragment 3.63. 
Scheme 3.5: Synthesis of the BCD ring fragment 3.63 from napthalene 3.56 
 
The malonate 3.63 was brominated at C2 with pyridinium hydrogen perbromide 
(Pyr•HBr3) (Scheme 3.6). Treatment of the resulting α-bromo compound with DBU formed the 
phenol 3.64, which was protected as the methyl ether 3.65. Deprotonation at the benzyl position, 
followed by quenching with the Weinreb amide 3.66 gave a homo phthalate that was reduced to 
the lactone 3.67. The hydroquinone methyl ether in 3.68 was then unmasked with CAN and 
coupled to phenol 3.69 via an addition-elimination to furnish 3.70. The quinone was then 
reduced and reprotected as the bis-methyl ether 3.71.  
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Scheme 3.6: Synthesis of the ABCDF ring fragment 3.71 
   
The ester moiety in 3.71 was hydrolyzed and cyclized to the xanthone with 
polyphosphate ester (PPE) to provide the core compound 3.72 (Scheme 3.7). The lactone was 
hydrolyzed and the C25 alcohol was oxidized to provide the aryl-acetone compound 3.73. 
Condensation of 3.73 with ethanolamine formed the tetrahydrooxazolo-[3,2-b]- isoquinolinone 
3.74, which was prone to aromatization to form an isoquinolone in the presence of acid, heat and 
even silica (see Figure 3.7). Deprotection of the hydroquinone methyl ether with CAN provided 
cervinomycin monomethyl ether 3.75, and deprotection of the C3 methoxy group with 




Scheme 3.7: Rao’s completion of (±)-cervinomycin (3.17) 
 
Although no new methodology was developed in Rao’s synthesis of cervinomycin (3.17), 
he did establish important conditional tolerances for late-stage oxidations of the hydroquinone 
and for the tetrahydrooxazolo-[3,2-b]-isoquinolinone moiety, Namely, compound 3.75 was 
stable to oxidation with CAN and selective demethylation using BCl3•Et3N. The high step count 
is a result of seven protection/deprotection steps and six redox adjustments, which together, 
make up half of the total step count.  
The initial plan was to condense ethanolamine onto the isocoumarin counterpart to give 
3.73 (see Scheme 3.6, 3.73 → 3.74). Condensation in methanol at room temperature led to the 
desired product in nearly quantitative yield. Condensation of ethanolamine with the aryl-acetone 
3.73 in refluxing methanol or from the analogous isocoumarin, however, led to the byproduct 
analogous to 3.79. Rao’s hypothesis for the observed difference stems from a mechanistic 
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difference between the condensation of ethanolamine on the isocoumarin and the aryl-acetone 
(Figure 3.7). Condensation of ethanolamine onto the homo-phthalate 3.80 led to the N,O-ketal 
3.81, which subsequently cyclizes onto the ester to form the GAB ring compound 3.82 with 
minimal formation of the isoquinolone 3.79 (Figure 3.7, B). Addition of ethanolamine into the 
isocoumarin leads to the N,O-hemiaminal 3.77 via the N-acyliminium ion 3.78, which is very 
acidic and can either cyclize to form 3.82 or be deprotonated to form the isoquinolone 3.79 
(Figure 3.7, A). 
Figure 3.7: Mechanistic differences between isocoumarin and aryl-acetone condensation 
 
3.3.3: CERVINOMYCIN METHYL ETHER, MEHTA 
In 1991,304,305 Mehta published his approach to cervinomycin (3.17) methyl ether, 
beginning with the known ester 3.86, which was synthesized in a five step sequence from orcinol 
(3.83) (Scheme 3.8).306 Kolbe-Schmitt carboxylation of orcinol (3.83) followed by methylation 
gave ester 3.84. Oxidation of ester 3.84 with Fremy’s salt (Na2NO(SO3)2) then furnished quinone 
3.85. Reduction of the quinone to the hydroquinone and subsequent protection as the dimethyl 
ether gave 3.86. The ester moiety was hydrolyzed and transformed to the acyl chloride 3.87, 
which was then coupled to 1,2,5-trihydroxy benzene 3.88 via a Friedel-Craft reaction to form a 
mixture of C14 hydroxyl and methoxy compounds. Cyclization of the mixture gave the xanthone 
3.89 and returned C14 methoxy compound, which could be demethylated and resubjected to the 
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reaction conditions. Radical bromination of the C19 methyl group and displacement with 
triphenylphosphine gave Wittig precursor 3.90. 
Scheme 3.8: Mehta’s synthesis of xanthone coupling fragment 3.90 
 
The B ring fragment was synthesized via a Diels-Alder reaction of pyrone 3.91 and allene 
3.92 to give the homo phthalate ester 3.93 (Scheme 3.9).  Radical bromination of the C20 methyl 
group of 3.93, followed by oxidation of the benzyl bromide to the aldehyde with 
tetrabutylammonium dichromate ((n-Bu4N)2Cr2O7) furnished 3.94. Initial attempts to condense 
ethanolamine onto 3.93 to form the G ring before oxidation with((n-Bu4N)2Cr2O7) or radical 
bromination led to undesired oxidation of the C20 methyl group and/or decomposition of the 
sensitive tetrahydrooxazolo-[3,2-b]-isoquinolinone ring system. The aldehyde 2.94 was coupled 
to phosphonium salt 3.90 to give BDEF fragment 3.95 as a mixture of cis and trans double bond 
isomers, with trans predominating (ratio not reported). Hydrolysis of the ester moiety and a 
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Dakin-West condensation with acetic anhydride gave cyclic anhydride 3.96. Base induced 
hydrolysis of the anhydride led to decarboxylation of the malonate moiety to provide the keto-
acid, which was esterified with diazomethane to give 3.97. 
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Condensation of the keto-ester 3.97 with ethanolamine gave the GABDEF ring 
compound 3.98 (Scheme 3.10). Interestingly, Mehta reported difficulties in condensing 
ethanolamine with the isocoumarin, giving him almost exclusive byproduct formation. Photo-
electrocyclization gave the cervinomycin trimethylether 3.99, which was oxidatively deprotected 




Scheme 3.10: Mehta’s completion of (±)-cervinomycin (3.17) 
 
No new methodology was developed for the synthesis and the photo-electrocyclization 
key step is almost identical to the one used by Kelly. Of the 19 steps, four were protecting group 
manipulations and three were redox adjustments. It is interesting that in Kelly’s case, 
photocyclization resulted in oxidation of the hydroquinone to the quinone in addition to the 
cyclization, while in Mehta’s case, only cyclization occurred. This may be due to the removal of 
the MOM groups under the reaction conditions to the hydroquinone in Kelly’s case, while the 
methyl ethers are too robust to be oxidized or hydrolyzed under the reaction conditions. The final 
deprotection conditions are intriguing as they reveal that the G ring, which has been 
demonstrated to be acid sensitive, can tolerate Lewis acids strong enough to remove alkyl groups 
in the final product.  
3.3.4: (–)-KIBDELONE C, READY 
(+)-Kibdelone C (3.25), together with (–)-kibdelone A (3.23) and B (3.24) were isolated 
from a timber wool shed near Port Augusta, Australia by the Capon group in 2007.283 All three 
kibdelones have nanomolar activity against a number of cancer cell lines. Interestingly, 
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kibdelones A, B, and C exist as a 3:2:1 equilibrium mixture of redox isomers upon standing in 
MeOH.283,284 In 2011 Ready published his total synthesis of (–)-kibdelone C, helping to confirm 
the absolute stereochemistry of the natural compound as (+)-kibdelone C (3.25).307    
To synthesize the F ring, Ready relied on Myers’s asymmetric α-hydroxylation 
methodology using Shi’s catalyst 3.102 on the bis-silyl enolether 3.101 (Scheme 3.11).308 
Reduction of the resulting bis-epoxide in situ gave the C2-symmetric tetrol 3.103. Selective 
tosylation of the less-hindered, axial C14 alcohol, followed by Swern oxidation of the C10 
alcohol, resulted in concomitant elimination of the tosylate to give enone 3.104. Iodination of the 
enone at C9, followed by Luche reduction then gave F ring coupling partner 3.105.69  
Scheme 3.11: Synthesis of F ring fragment 3.105 








i) 3.102, oxone, K2CO3,
(aq) Na2B4O7/EDTA buffer,
CH3CN/DMM, 0 C
ii) BH3 THF, Et2O, 0 C
i) TsCl, pyr., CH2Cl2, r.t.









i) I2, pyr., CH2Cl2, r.t.











































Synthesis of the D ring coupling partner started with Dakin oxidation of the aldehyde 
3.106 followed by ortho-selective Friedel-Crafts to give benzyl alcohol 3.107 (Scheme 3.12). 
MOM protection of the phenol, followed by oxidation of the benzyl alcohol to the aldehyde gave 
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the D ring coupling partner 3.108. Lithium-halogen exchange of the F ring fragment 3.105 by 
first deprotonating with methyllithium, which undergoes exchange slowly, followed by treatment 
with tert-BuLi, and by adding the aldehyde 3.108 gave benzyl alcohol 3.109. Oxidation of both 
the C8 and C10 alcohols with dess martin periodinane (DMP) furnished the α,β-unsaturated 
malonate 3.110. Exposure of 3.110 to HClO4 in tert-BuOH/acetone deprotected the MOM and 
TBS ethers and facilitated condensation of the phenol onto the C10 ketone to give 3.111, which 
was in equilibrium with oxonium 3.122 under the reaction conditions. Acetone condensed onto 
the C13 alcohol of 3.112 to form the hemi-ketal, which cyclized onto C14 to deliver the 
tetrahydro xanthone 3.113. The inclusion of tert-BuOH in the deprotection/cyclization step was 
important to suppress the liberated formaldehyde (from the MOM group) from cyclizing onto the 
C14 and C13 alcohols. Acetone was necessary to obtain the compound as a single diastereomer 
because condensation onto the C13 alcohol in 3.112 ensured that the trajectory of the attack by 
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Synthesis of the AB ring fragment began with bromination of aldehyde 3.115, followed 
by Pinnick309,310 oxidation give 3.116 (Scheme 3.13). Activation of the acid as the acid chloride 
followed by coupling with amine 3.117 gave amide 3.118. Ley68 oxidation of the alcohol to the 
aldehyde set up a Pomeranz-Fritsch like cyclization. Several Lewis acids were screened to affect 
the cyclization and the removal of the C3 methoxy group, however, only BCl3 provided the 
desired product while BBr3 removed both methyl groups. Acid-catalyzed dehydration of the 
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resulting alcohol gave isoquinolone 3.119, and Sonagashira coupling with TIPS-protected 
acetylene followed by TBAF deprotection gave AB ring coupling partner 3.120. 
Scheme 3.13: Synthesis of the AB ring fragment 3.120 
 
 
Sonagashira coupling of AB ring fragment 3.120 and DEF ring fragment 3.114 under 
Soheili’s conditions provided the coupled product in 77% yield,311 which after reduction of the 
alkyne then gave the ABDEF ring compound 3.121 (Scheme 3.14). Copper free conditions were 
necessary to achieve high yields due to competitive copper-mediated oxidative dimerization of 
the AB ring fragment. The ortho-iodination was discovered serendipitously while initially trying 
to form the C4-C5 biaryl bond via oxidation with Koga’s reagent (CuCl(OH)•TMEDA in the 




Scheme 3.14: Coupling of AB ring fragment 3.120 to DEF ring fragment 3.114 
 
The iodination at C4 allowed the biaryl coupling to form the hexacyclic compound 3.123 
(Scheme 3.15). Critical for the success of the reaction was protection of the phenol as the Boc 
carbonate because other protecting groups were unstable to the reaction conditions or gave low 
yields of 3.123. Cyclization of the free phenol analogue of 3.122 was very sluggish and resulted 
in significant amount of de-iodinated material. Chlorination of the isoquinolone at C24 with 
hexachlorocyclohexadienone 3.124 delivered 3.125 in good yields, but purification led to 
numerous byproducts stemming from hydration at C25. Global deprotection of the MOM group, 
acetone ketal, and the Boc group led to a mixture of MOM protected compounds at C11, 
formaldehyde cyclized product between the C13 and C14 alcohols, and fully deprotected 
compound. Subjection of the mixture to phenyliodine(III)diacetate (PIDA) furnished the quinone 
3.126 as a mixture of compounds, which were fully deprotected with BCl3 with concomitant 
demethylation of the C6 methoxy group. Reductive workup with Na2S2O4 delivered (–)-





Scheme 3.15: Ready’s completion of (–)-kibdelone C (3.25) 
 
 
The new methodology developed for the total synthesis involves the serendipitous 
discovery of Koga’s reagent (CuCl(OH)•(TMEDA) to facilitate an ortho iodination reaction and 
subsequent C-H arylation to form the C ring. Although the general strategy for the synthesis of 
the tetrahydroxanthone unit was originally developed by Nicolaou in 2008 for the synthesis of 
diversonol and blennolide C,312 Ready’s use of acetone to control the diastereoselectivity at C14 
was a useful modification. 
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The highly convergent nature of the synthesis manages to mask the 33 total steps. The 
excessive number of oxidation steps , and six protecting group manipulations accounts for half of 
the total step count. Additionally, in order to synthesize the natural (+)- kibdelone C (3.25), one 
would need to use the enantiomer of the Shi’s catalyst derived from D-fructose, and this requires 
10 steps to synthesize.   
3.3.5: (+)-KIBDELONE C, PORCO JR. 
Porco Jr. published his first synthetic studies toward (+)-kibdelone C (3.25) in 2011 when 
he established the methodology requisite for the fragment couplings as well as biological testing 
of several intermediates,313 followed by a total synthesis later in 2011, wherein he confirms the 
absolute stereochemistry as (+)-kibdelone C.314 
Synthesis of what would become the F-ring in (+)-kibdelone C began with a chelation-
controlled addition of the alkynyl zinc reagent 3.128 into aldehyde 3.127 (Scheme 3.16). 
Protection of the resulting C13 alcohol as the benzyl ether, followed by deprotection of the TBS-
protected propargyl alcohol with TBAF gave 3.129. Oxidation of the propargyl alcohol with 
IBX, followed by Pinnick oxidation and acid-catalyzed esterification proceeded with 
concomitant acetal deprotection to give diol 3.130. Protection of the diol moiety in 3.130 as the 
benzaldehyde acetal, followed by a reductive ring-opening gave 3.131. Oxidation of the C10 
alcohol to the aldehyde with IBX, followed by MgI2 catalyzed cyclization gave β-iodoenone 
3.132. Several Lewis acids were screened for the O-benzyl deprotection but, only BCl3 gave 







Scheme 3.16: Synthesis of F ring fragment 3.133 
 
Synthesis of the D ring fragment began with demethylation of aldehyde 3.134 with AlCl3 
(Scheme 3.17). Selective methylation of the more acidic C17 phenol, followed by protection of 
the C16 phenol as the tert-butyldiphenylsilyl (TBDPS) ether afforded 3.135. Dakin oxidation of 







Scheme 3.17: Synthesis of D ring fragment 3.136 
 
Synthesis of the AB ring fragment began with ortho-lithiation of the bromo-arene 3.137 
at C23 with LiTMP in the presence of dimethyl malonate (Scheme 3.17).  The o-lithiated 
bromoarene undergoes an elimination reaction to form benzyne 3.139 that then undergoes a 
[2+2] cyclization reaction with the enolate of diethyl malonate 3.140 to form the benzo 
cyclobutane intermediate 3.141, which then underwent a retro-Claisen to give, the homo 
phthalate 3.142. Hydrolysis of the esters with aqueous KOH followed by a Dakin-West 
condensation with butyric anhydride formed an isocoumarin compound that was subsequently 
condensed with methylamine to form isoquinolone 3.144. Selective demethylation of the C3 
methoxy with BCl3, and PIDA oxidation to the quinone mono acetal provided 3.145. Finally, 











Scheme 3.17: Synthesis of AB ring fragment 3.146 
 
 
Initially, Porco attempted a cationic Lewis acid catalyzed [4+2] reaction between styrene 
3.136 and quininone acetal 3.146 but he found that only small amounts of the conjugate addition 
product 3.147 were formed (Scheme 3.18). Optimization of the reaction lead to the identification 
of PtBr4 as the optimal Lewis acid for the addition. The right amount of water was critical for the 
isolation of 3.147 in high yields Screening different quantities of water in the reaction revealed 
that 10 mol% water (2:1 ratio of water to catalyst) maximized the yield, indicating that the active 
catalyst may be PtBr4•2H2O. Photo-electrocyclization of the compound 3.147, followed by 
deprotection of the TBDPS group with TBAF gave ABCD ring fragment 3.148. Attempts to 
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cyclize 3.147 in the presence of oxygen to afford kibdelone A (3.23) did not provide any ∆19,20-
oxidized product (not shown).  Conjugate addition of the ABCD ring fragment into the F ring 
fragment took significant optimization. The reaction was unsuccessful using benzyl protected 
alcohol 3.132: Porco speculated that C13 benzyl alcohol was providing steric and/or electronic 
constraints on the attack of the phenolate anion onto the C14 carbon of the F ring fragment. 
Fortunately, the allylic alcohol did give some of the desired product 3.149, but in low yields. 
Several bases and solvent were screened, finding that potassium phosphate (K3PO4) in DMSO 
followed by quenching with potassium bisulfate (KHSO4) gave the best results. 
Scheme 3.18: Coupling of AB ring fragment 3.146, D ring fragment 3.136 and F ring fragment 
3.133  
 
Due to the acid sensitivity of 3.149, neutral conditions were needed for the Friedel-Crafts 
cyclization to form the xanthone (Scheme 3.19). After much experimentation, Porco found that 
hydrolysis of the ester, and activation of the resulting acid with cyanuric chloride induced the 
requisite Friedel-Crafts reaction to furnish 3.150. Deprotection of the C10-C11 acetal, followed 
by selective oxidative demethylation of the B ring, followed by reductive workup with Na2S2O4 
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furnished kibdeleone C in 1.4% yield over 17 steps. Key to the selective oxidative demethylation 
was the inclusion of acetic acid to obviate B and D ring oxidation. 
Scheme 3.19: Porco’s completion of (+)-kibdelone C (3.25) 
 
New methodology developed for the synthesis included the conjugate addition of the 
phenol 3.136 to the quinone mono acetal 3.146 and the use of cyanuric chloride for the 
intramolecular Friedel-Crafts reaction under relatively neutral conditions. Additionally, the use 
of the photo-electrocyclization to form the C ring via C20-C21 closure, as opposed to the C19-
C20 photo-electrocyclization seen in the syntheses of cervinomycin (3.17), offers a novel 
disconnect towards polycyclic xanthones. Porco’s highly convergent synthesis managed to mask 
a total step count of 32, which is about the same as Ready’s total step count of 33 steps. The 
synthesis could be improved by reducing the amount of protection/deprotection steps (eight total) 
and finding a quicker synthesis of the F ring fragment 3.133, which takes 12 steps to synthesize.  
Porco tested several derivatives of intermediate 3.148 for biological activity in an NCI 
60-cell screen and found that while most exhibited some cytotoxic activity (GI50 4.5-10µM), they 
were less potent and less selective when compared to kibdelone C (3.25) which displayed 100-
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fold selectivity between the most and least sensitive cell lines and a GI50 of 2.4 nM, indicating 
that the F ring plays an important role in the activity and selectivity. 
 
3.3.5: (+)-KIBDELONE A, PORCO JR. 
In 2013, Porco published a synthesis of (+)-kibdelone A (3.23).317 Working with 
Hudlicky, they developed an improved route to the F ring fragment using the microbial oxidation 
developed by Hudlicky.315  
Oxidation of the bromomethyl benzoate 3.151 with an JM109 E. coli strain 
(pDTG601A), which was engineered to over-express toluene dioxygenase, yielded a mixture of 
C10/C11 and C12/C13 dihydroxylated compounds in a 3.5:1 ratio (23% combined yield) 
(Scheme 3.20). Pure compound 3.152 could be separated from the C12/C13 dihydroxy 
compound by chromatography in 16% yield. Interestingly, the iodobenzoate gave a ratio of 
C10/C11 and C12/C13 (1:4) dihydroxylated compounds, yielding the analogous iodo compound 
of 3.152 in 3.5% yield. The reason for the selectivity switch is due to what is known as Boyd’s 
rule,316 which states that the largest group directs the enzymatic dihydroxylation. The larger size 
of the iodine directed the oxidation at C12/C13. Protection of the diol as the acetal, and 
Mukaiyama hydration of the olefin at C13 gave acetonide 3.153. The selectivity is due to the 
cobalt hydride species formed in the reaction preferring to add hydrogen at C12 to form the most 
stable radical at C13. The stereochemistry is due to the cobalt preferring the convex face of the 
molecule. Hydrolysis of the methyl ester and DCC mediated esterification with 






Scheme 3.20: Hudlucky’s improved synthesis of F ring fragment 3.154 
 
The Friedel-Crafts reaction of phenol 3.136 and the quinone mono acetal 3.146 was 
optimized by using InCl3 and solvent mixture of hexafluoroisopropanol (HFIP) and MeCN to 
give 3.147 in of 70% yield (increased from 54% with PtBr4) (Scheme 3.21). Initially, photo-
electrocyclization of 3.147 with iodine under similar conditions to those Kelly291 et al and 
Mehta304 et al used (see Schemes 3.5 and 3.10), allowed for the oxidation of the C19-C20 carbon 
atoms to give the fully aromatic analogue 3.155 in low yields (38%). The inclusion of THF as a 
co-solvent allowed for higher yields (73%) of the tetracyclic compound, most likely because 
THF scavenges the HI produced as a byproduct of the reduction of iodine.  Deprotection of the 
TBDPS group with TBAF then gave 3.155. Coupling of the phenol moiety in 3.155 with the 
activated ester 3.154 gave an improved yield of 53% vs. 44% for the previous iteration. 
Hydrolysis of the ester, and cyanuric chloride-mediated Friedel-Crafts reaction gave the 3.156. 
Hydrolysis of the acetal and oxidation of the B ring with CAN under the same conditions used 
for kibdelone C (3.25), strangely gave mixtures of B and D ring oxidized products. Fortunately, 
omission of the acid form the CAN oxidation gave (+)-kibdelone A (3.23) in only 15 steps and in 
0.8% yield. Compound 3.156 was found to be equipotent to (+)-kibdelone A (3.23) in a NCI 60 
cell panel, with a mean GI50 of 3.2 nM. 
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Scheme 3.21: Coupling of AB ring fragment 3.146, D ring fragment 3.136 and F ring fragment 
3.154 and completion of (+)-Kibdelone A 
 
Additionally, Porco improved on several of the steps developed for the synthesis of (+)-
kibdelone C (3.25). The conjugate addition of the phenol into the quinone mono acetal 3.146 
from 54% yield to 70% yield by using InCl3 as the Lewis acid and HFIP as the solvent. His 
modification of the conditions for the oxidative electrocyclization by the inclusion of THF as an 
HI scavenger offered an improvement over Kelly’s and Mehta’s reported conditions (30-40% 
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yield vs. 73% yield). Most notably, using Hudlicky’s synthesis of the F ring reduced the overall 
step count by seven steps to a total of 25. 
3.3.6:(–) -SIMAOMICIN Α, READY 
(+)-Simaomicin α was isolated in San Simao, Brazil by Kantor in 1990,282 where it was 
determined to be a potent anticoccicidal agent. Tomoda and co-workers found that while 
simaomicin α (3.22) α had little cytotoxic activity, it synergized with the DNA-damaging agent 
bleomycin so that together they have 0.6 nM activity.320 In 2013, ready published his total 
synthesis of (–)-Simaomicin α.318 
Ready’s synthesis began with an enzymatic resolution of α-acetoxy enone 3.157 with pig 
liver esterase (PLE), followed by protection of the hydroxy group as the benzyl ether to give 
3.158 (Scheme 3.22). Iodination of the enone with iodine and DMAP, followed by a Luche 
reduction gave the F ring fragment 3.159.  






i) PLE, pH 7 phosphate buffer
ii) BnBr, Ag2O, CH2Cl2, r.t..
42%
i) I2, DMAP, CH2Cl2, r.t.

















ortho-Formylation of the mono-benzylated hydroquinone 3.160 fortuitously gave 
salicylaldehyde, the result of the benzyl alcohol undergoing an Oppenauer oxidation under the 
reaction conditions (Scheme 3.23). ortho-Bromination of the phenol provided 3.161. Protection 
of the phenol as the methyl ether and a Dakin oxidation gave phenol 3.162. A second ortho-
formylation followed by protection methylation of the phenol furnished the benzyl alcohol 3.163. 





Scheme 3.23: Synthesis of D ring fragment 3.164 
 
Coupling of the F ring fragment 3.159 and the E ring fragment 3.164 utilized the same 
methodology for the synthesis of kibdelone C (3.25) to give 3.165 (Scheme 3.24). Oxidation of 
the benzyl alcohol to the ketone with DMP, followed by acid catalyzed cyclization occurred to 
provide 3.166 as a mixture of epimers at C14. Oxidation of the C14 alcohol, followed by an 
enantioselective reduction with Noyori’s catalyst 3.167 and protection of the resulting alcohol as 
the BOM ether furnished 3.168 as a single diastereomer.321 Coupling of the aryl bromide at C18 
with allyl-tributyltin provided 3.169. Initial attempts to oxidatively cleave the olefin under 
Johnson-Lemieux conditions led only to the aryl aldehyde, but a two-step procedure gave the 









Scheme 3.24: Synthesis of DEF ring fragment 3.170 
  
Bromination of aldehyde 3.115 at C21, followed by Pinnick oxidation gave carboxylic 
acid 3.116 (Scheme 3.25). Conversion of the acid to the acid chloride, followed by condensation 
with amine 3.171 gave amide 3.172. Ley oxidation of the alcohol to the aldehyde followed by a 





















i) Br2, AcOH, 0 C r.t.
















































Several Lewis acids were screened for the addition of the organolithium of 3.174 to the 
aldehyde 3.170 to give 3.175, LaCl3•2LiCl delivered 3.175 in 76% yield.
167 Oxidation of the 
resulting alcohol to the ketone, followed by reduction with Noyori catalyst set the 
stereochemistry at C20 in 3.176. Removal of the TIPS group with TBAF provided the 
monomethyl hydroquinone with was oxidized to the C3/C22 quinone with CAN, which after a 
reductive workup with Na2S2O4 and subsequent alkylation with ICH2Cl and Cs2CO3 provided 
3.177. Use of a alkylating more active alkylating agent (eg. CH2I2), for alkylation step led to 
polymerization of the hydroquinone, while weaker bases or alkylating agents led to low yields of 
3.177. Heating 3.177 with Pd(OAc)2 in DMSO resulted in an oxidative bi-aryl coupling to form 
the C4-C5 bond, which after treatment with excess BCl3 delivered (–)-simaomicin α in 25 steps 
and in 6.8% yield. Comparison of the optical rotations of (–)-simaomicin α and a sample of the 
natural product revealed that (–)-simaomicin α had the opposite rotation of the natural product in 
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a similar magnitude, indicating the actual natural product is (+)-simaomicin α (3.22) with the 
opposite configuration.  
 
Scheme 3.26: Ready’s completion of simaomicin α (3.22) 
 
The absolute stereochemistry of (+)-simaomicin α (3.22) was not known until Ready 
published his synthesis of (–)-simaomicin α which had the opposite rotation of the natural 
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compound.282 Interestingly, the unnatural (–)-simaomicin α demonstrated similar activity (IC50 
13-87 nM, anti-cancer; MIC 280 nM, antibacterial), to the natural (+)-simaomicin α when tested 
against colon cancer cell lines (HCT116) lung cancer (H460, H1819) and Bacillus subtilis. 
Ready’s synthesis of (–)-simaomicin α represents the first synthesis of the methylene 
dioxy sub-class of polycyclic xanthone natural products that include the kigamicins (3.20), 
xantholipin (3.16), actinoplanone (3.26), albofungin (3.27) and lysolipin (3.15). Experiments on 
the oxidative bi-aryl coupling done in model systems for (–)-simaomicin α, indicated that the 
methylene dioxy ring has a beneficial effect for the cyclization, which may explain why such a 
strategy failed when applied to the synthesis of kibdelone C (3.25). The weaknesses of this 
synthesis, however, are the excessive number of oxidations and reductions (12 total) and six 
protecting group manipulations accounting for over half of the total step count of 32. 
Additionally, the lack of stereocontrol for the cyclization to form the tetrahydroxanthone and the 
addition into the aldehyde necessitated the oxidation and use of Noyori’s catalyst for an 
asymmetric reduction to set stereocenters at C20 and C10.   
3.3.7: FD-594 AGLYCON, SUZUKI 
FD-594 was isolated in 1998 in Urawa city, Saitama prefecture Japan by Mizoue.275 In 
2008, Suziki developed a general methodology to synthesize xanthones using an intramolecular 
nucleophilic aromatic substitution (SnAr)
322 reaction and he completed a total synthesis of FD-
594 aglycon (3.202) in 2009.323  
Suzuki’s synthesis of FD-594 aglycon (3.202) began with bromination of isovanillin 
(3.178) at C23, followed by protection of the aldehyde as the acetal (Scheme 3.27). Protection of 
the phenol as the MOM ether then gave 3.179. Lithium-halogen exchange of the aryl bromide, 
followed by addition of epoxide 3.180 led to an alkylated intermediate, and selective 
deprotection of the MOM ether under Miyake’s neutral conditions then gave 3.181.324 Triflation 
of the phenol with McMurray’s reagent, followed by intramolecular alkoxy carbonylation gave 
the lactone 3.182. Selective demethylation of 3.182, followed by deprotection of the acetal and 
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reduction with NaBH4 gave benzyl alcohol 3.183. ortho-Selective iodination of the phenol with 
BnNMe3ICl2, followed by TIPS protection of the benzyl alcohol gave iodo-phenol 3.184. 
Scheme 3.27: Synthesis of AB ring fragment 3.184 
 
Synthesis of the D ring fragment began with bis-malonate 3.185 (Scheme 3.28). 
Oxidation to the bis-salicylic acid with N-Chlorosuccinimide (NCS), followed by mono-
reduction with NaBH4 gave benzyl alcohol 3.186. Protection of the benzyl alcohol and the 
phenol as an acetonide, followed by selective bromination at C16 with pyridinium 
hydroperbromide (Pyr•HBr3) gave 3.187. O-Methylation of the phenol, followed by deprotection 
of the acetal then gave benzyl alcohol 3.188. Benzylic oxidation to the aldehyde with MnO2, 
followed by protection of the phenol as the benzyl ether then gave 3.189.  
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Scheme 3.28: Synthesis of D ring fragment 3.189 
 
Addition of ortho-lithiated compound 3.190 into aldehyde 3.189 gave benzyl alcohol 
3.191 (Scheme 3.29). Oxidation of the benzyl alcohol 3.191 with IBX, followed by deprotection 
of the MOM group with aqueous sulfuric acid gave 3.192. Initial synthetic studies on the 
cyclization of 3.192 to form a xanthone found that the phenoxide can attack at C16 or C6. The 
selectivity was highly dependent on the solvent, with polar protic solvents favoring cyclization at 
C6 and polar aprotic solvents preferring to cyclize at C16. Accordingly, use of MeOH with 
Cs2CO3 as the base gave a mixture (1:1) of cyclization at C16 and C6. Switching the solvent to 
DMF gave a slight improvement (3:1, C16:C6), but cyclohexane was identified as the optimum 
solvent, furnishing the xanthone moiety in 84% yield and 23:1 selectivity. Saponification of the 
ester gave 3.193. Activation of the acid as the acid chloride and esterification with the AB ring 
fragment 3.189, followed by debenzylation with BBr3 furnished 3.194. Palladium catalyzed 
intramolecular aryl coupling at C5 set up the Bringmann diastereoselective lactone opening.325 
Opening the lactone with valinol to set the axial chirality was solvent dependant. Fortunately, 























































i) SOCl2, DMF, CH2Cl2;
3.184, DMAP, pyridine, r.t.
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Cyclization of the valinol moiety in 3.195 to an oxazoline, followed by benzyl protection 
of the C3 and C6 phenols gave 3.196 (Scheme 3.30). Methylation of the oxazoline, followed by 
reduction with NaBH(OMe)3 and hydrolysis gave the aldehyde 3.197. The C20 alcohol was 
oxidized to the aldehyde, but many attempts to induce the pinacol coupling were unsuccessful. 
Accordingly, the xanthone and the aldehyde were reduced with L-Selectride and the C8 alcohol 
was removed with acetic acid and NaBH3CN to give the xanthene 3.198. Deprotection of the 
TIPS group, followed by global Swern oxidation gave 3.199.   
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Scheme 3.30: Synthesis of pinicol coupling precursor 3.199 
 
Initial attempts to induce the samarium mediated pinacol coupling provided the diol with 
poor diastereoselectivity (3.5:1) in 68% combined yield (Scheme 3.31). Addition of the crown 
ether 24-c-8 improved the diastereoselectivity to 8.2:1 in 74% combined yield. Addition of 
(R,R)-iPr-pybox led to a slight decrease in diastereoselectivity (7.1:1) but increased the overall 
yield to 81%. Protection of the alcohols as acetates, followed by benzylic oxidation with 
dichlorodicyanoquinone (DDQ) gave xanthone 3.200. Oxidative deprotection of the 
methylenedioxy group with Pb(OAc)4, and hydrolysis gave catechol 3.201. Removal of the 
acetate groups and hydrogenolysis of the benzyl groups gave FD-594 aglycon (3.202) in 33 steps 
(longest linear sequence) and in 10.7% yield.  
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Suzuki developed several new methodologies towards the synthesis of FD-594 aglycon 
(3.202). Developing the conditions for the intramolecular nucleophilic aromatic substitution 
(SnAr) reaction via displacement of the C16 bromide rather than the C6 benzyloxy group was 
critical for the formation of the xanthone with the right regiochemistry. Suzuki also demonstrated 
that axial chirality can be used to direct the stereochemistry of the C19 and C20 alcohols during 
the pinacol coupling of the bis-aldehyde 3.199, and the addition of ligands improved the 
diastereoselectivity. The main weakness of Suzuki’s synthesis, despite the high yield, is the high 
step count. The total step count is 45 steps is due to the overuse of protecting groups (16 steps) 
and great deal of redox manipulations (13 steps). 
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3.3.8: TMC-66, HOSOKAWA/TATSUTA 
TMC-66 was isolated in 1999 by the Tanabe/Seikaku group and shows activity toward 
inhibition of endothelin converting enzyme (ECE) with an IC50 of 2.9 µM.
327 Hosokawa/Tatsuta 
published their short total synthesis of TMC-66 in 2007.326 
The Hosokawa/Tatsuta synthesis of TMC-66 began with bis-triflation of the phenol 3.203 
and selective Sonagashira coupling with TMS-acetylene at C21 gave the aryl-acetylene 3.204 
(Scheme 3.32). A modified Migita coupling (isopropenylacetate, Bu3SnOMe, P(o-tol)3) in the 
presence of LiCl and the Buchwald ligand 3.207 provided the homo phthalate 3.205.328 
Condensation of 3.205 with serine formed the G ring, with concomitant deprotection of the TMS 
group. Benzyl protection of the carboxylic acid furnished the GAB ring coupling partner 3.206 
with the cis relationship between the C25 methyl group and the ester of the G ring.  
 
Scheme 3.32: Synthesis of GAB ring fragment 3.206 
  
The stereochemical outcome of the cyclization of serine onto 3.205 can be rationalized by 
an analysis of conformational preferences. The most stable conformer 3.211, the hydrogen is 
eclipsing the imine to minimize A1,3 strain from either the carboxylate or the alkoxymethyene 
groups. Cyclization of the alcohol moiety and condensation onto the ester gives the desired GAB 
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ring fragment 3.206 with cis stereochemistry. The other conformer 3.210 is too high in energy, 
having serious A1,3 like interactions between the carboxylate and the alcohol group, so none of 
the GAB ring fragment 3.212 is seen with the undesired trans geometry.  









































Synthesis of the DEF ring fragment began with oxidation of the tetralone 3.213, followed 
by reaction with acetic anhydride quench to give the quinone 3.214 (Scheme 3.34). A Diels-
Alder reaction between the quinone 3.214 and the silyl enol ether 3.215 gave the anthraquinone 
3.216. Presumably, the acetate at C7 makes the carbon at C16 more electrophilic, which favors 
bond formation at the more electron rich C17 carbon atom of the diene. Selective triflation of the 
less acidic C18 phenol over the more acidic C6 phenol was accomplished via formation of the 

























































Sonagashira coupling of the alkyne 3.206 and the triflate 3.217, followed by 
hydrogenation with Wilkinson’s catalyst provided 3.218 (Scheme 3.35). Of several oxidants 
screened for the oxidative intramolecular bi-aryl coupling, only Koga’s reagent 
(CuCl(OH)•(TMEDA)) gave the desired product, but in only 20% yield. By screening ligands 
for the CuII oxidant, Hosokawa and Tatsuta found that use of N-methylimidazole (NMI) to form 
CuCl(OH)•(NMI)2 was the ideal reagent for this transformation. Finally, deprotection of the 
benzyl group and the C13 methoxy group with BBr3 gave TMC-66 in only nine steps from 3.203 










Scheme 3.35: Hosokawa/Tatsuta’s completion of TMC-66 2.40 
  
At only 9 steps, 12 steps total, the synthesis of TMC-66 is highly efficient. 
Hosokawa/Tatsuta’s modification of the Migata coupling may prove useful for the formation of 
the A rings of other polycyclic xanthone natural products such which contain a methyl group at 
C25 (citreamicin numbering). Additionally, the stereochemical outcome of the condensation of 
D-serine 3.208 onto the ketone 3.205 is instructive for the synthesis of the citreamicins. 
Although Hosokawa’s and Tatsuta’s synthesis of TMC-66 is not directly related to the study of 
polycyclic xanthone natural products, several aspects of the synthesis and structure are 
informative. Of particular interest is the construction of the G ring using an amino acid and the 
use of the Migata procedure to synthesize the homo phthalate ester onto which the amino acid 
cyclizes.  
3.3.9: SYNTHETIC STUDIES TOWARD LYSOLIPIN I, DUTHALER 
Duthaler published three synthetic studies directed toward the core of lysolipin (3.19) in 
1984329-331 and a final account of his synthesis of the BCD ring core in 1985.332 The pyrolidine 
enamine of ketone 3.219 was bis-alkylated methyl bromoacetate to form ketone 3.220 as a 
 192 
mixture (55:45) of C3 epimers (Scheme 3.36). Exposure of 3.220 to MeSO3H in MeOH removed 
the C3 acetate and, after epimerization at C21, enabled the lactonization between the C3 alcohol 
and the C19 ester. Protection of the ketone as the dithiolane provided 3.221. Reductive 
desulfurization with Raney-nickel followed by trans-esterification and oxidation of the C3 
alcohol gave 3.222. Formation of the morpholine-enamine of 3.222, followed by the addition of 
the quinone 3.223 resulted in the selective conjugate addition at the C5 carbon of the quinone to 
form the N,O-acetal 3.224. Oxidation of 3.224 with FeCl3 regenerated both the quinone and the 
ketone, and subsequent regioselective reductive methylation of the C17 phenol with P(OMe)3 
furnished hydroquinone 3.225. The selectivity of the reduction may be due to the C16 methoxy 
group, which donates electron density into the C6 carbonyl and hence deactivates it toward 
nucleophilic attack by P(OMe)3. Selective deprotection of the phosphate with TMSBr, followed 














Scheme 3.36: Synthesis of the BD ring fragment 3.226 
 
Heating 3.226 in neat MeSO3H promoted hydrolysis of both esters, epimerization at C4, 
and an intramolecular Friedel-Crafts reaction to form an intermediate that was re-esterified with 
diazomethane to give 3.227 (Scheme 3.37). Protection of the C3 ketone as the dioxolane, 
followed by reduction of the C9 ketone gave benzyl alcohol 3.228. Dehydration of the C9 
alcohol, followed by protection of the C17 phenol gave 3.229. Osmium-mediated 
dihydroxylation from the convex face, followed by acid catalyzed trans-acetalization with the 
MOM group gave the BCD ring core 3.230 in 21 steps and 2.5% yield.  
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Scheme 3.37: Duthaler’s completion of synthetic studies toward BCD ring fragment 3.230 










































































































Although 21 steps approaches the step count characteristic of the total syntheses 
described earlier, Duthaler did develop some interesting methodology. The enamine mediated 
addition of ketones to quinones to trap out the N,O-acetal is an interesting way to prevent further 
side-reactions. Additionally, the regioselective reductive methylation with P(OMe)3 
methodology  to provide the mono-methyl hydroquinones may prove useful for the synthesis of 
other polycyclic xanthones such as the kibdelones. The use of the proximal MOM group to form 
the methylenedioxy ring in the lysolipin core is an intriguing alternative to the method developed 
by Ready in the synthesis of simoamicin α (3.22) (see Scheme 3.26). 
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3.3.10: SYNTHETIC STUDIES TOWARD SCH-56036, BARRETT 
In 2005, Barrett synthesized the AB rings of Sch-56036.333 The synthesis of the amine 
fragment began with the Boc protection of isoleucine 3.231, followed by EDCI mediated 
coupling with N,O-dimethylhydroxylamine and N-methylation of the Boc-protected amine gave 
3.232 (Scheme 3.38). Reduction of the amide with LiAlH4, followed by protection of the 
aldehyde as the acetal gave 3.233. The aromatic fragment began with the selective tosylation of 
the benzoic acid 3.234 at the C4 position, followed by bis-methylation of both the phenol and the 
carboxylic acid. Saponification of the ester provided 3.235, which was transformed into the acid 
chloride with SOCl2 and coupled with the amine fragment 3.233 to provide 3.236. Deprotection 
of the tosyl group in 3.236 with KOH and treatment with camphorsulfonic acid (CSA) promoted 
the cyclization with concomitant O-demethylation to furnish isoquinolone 3.237 in eight steps 
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At eight steps and 35% yield, Barrett’s synthesis of the GA ring fragment 3.237 is 
competitive with the methods developed by Ready (eight steps, 41% yield for kibdelone and 
seven steps, 56% yield for simaomicin α (3.22)), Porco (seven steps, 13% yield for kibdelone), 
Suzuki (12 steps, 34% yield), and Kelly (seven steps, 35% yield). Barett’s synthesis also 
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demonstrates the utility of the Pomeranz-Fritsch cyclization for the synthesis of the AB rings 
with chiral centers. 
 
3.5: Prior art in the Martin group towards polycyclic xanthone natural 
products 
3.5.1: THE MOORE REARRANGEMENT 
The rearrangement of 4-alkynylcyclobutenones to quinones was discovered by Moore in 
1985.334-339,438 It is part of a fascinating class of reactions involving enediynes 3.238 or eneyne-
allenes 3.241 known as the cycloaromatization reactions (Figure 2.7).436,440 Enediynes 3.238 can 
undergo a Bergman cyclization (6-endo) to produce a p-benzyne diradical 3.239 or a Schreiner-
Pascal cyclization (5-exo) to produce the fulvene diradical 3.240. Like enediynes 3.238, eneyne-
allenes 3.241 can also undergo a Myers-Saito cyclization (6-endo) to produce a toluene diradical 
3.242 or a Schmittel cyclization (5-exo) to produce the fulvene diradical 3.243. The Moore 












Figure 3.7: Parent cycloaromatization reactions  
 
The mechanism of the Moore rearrangement begins with the electrocyclic ring opening of 
the cyclobutanol 3.244 to the ene-yne-ketene (Scheme 3.39).338 The ketene can cyclize in a 6-
endo radical fashion to produce the diradical intermediate 3.246, which can then undergo an 
intramolecular radical transfer with the R2 group on oxygen to produce the quinone 3.247. The 
alternate 5-exo cyclization can also occur to produce the fulvene diradical 3.248, which also 
undergoes an intramolecular group transfer to form the cyclopentadione 3.249. The preference 
for 5-exo vs 6-endo cyclization is dependant primarily on the substitution of the alkyne (R1) and 
secondarily on the substitution of the alcohol group (R2).
338 Groups that stabilize radicals such as 
alkoxy, phenyl or carbonyls favor the 5-exo mode of cyclization over 6-endo. To a lesser extent, 
TMS substituted alcohols favor the 6-endo mode of cyclization, but if the group at R1 is too 












Evidence for the radical mechanism in the Moore rearrangement can be seen in the 
byproducts of several examples (Figure 3.8).338 Heating either cyclobutanone 3.250 or 3.252 
resulted in the major product arising from the O→C group migration to provide quinones 3.251 
and 3.253 (Figure 3.8, A, B). A minor product isolated from heating the OTBS protected 
cyclobutanol 3.252, however, was 3.254 7%, which arises from an intramolecular C-H 
abstraction of the putative diradical intermediate (Figure 3.8, B).338 Heating the deuterium 
enriched O-alkyl compound 3.255 resulted in the epoxide 3.256 with exclusive deuterium 
incorporation. (Figure 3.8, C).338 This result indicates that the C-H abstraction by the radical 
intermediate is most likely intramolecular. Further evidence for the intramolecular rather than 
intermolecular O→C group migration comes from a radical crossover experiment in which 
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heating 3.257 and 3.258 produced the products 3.259 and 3.260 with deuterium scrambling 
(Figure 3.8, D).338  
Figure 3.8: Evidence for radical mechanism in Moore rearrangement 
 
A) Example of allyl group migration during Moore rearrangement. B) Example of C-H abstraction of an adjacent 
group, followed by recombination. C) Example of preferred C-D abstraction over C-H abstraction. D) Radical 
crossover experiment indicating that intramolecular and not intermolecular radical transfer occurs.  
3.5.2: MARTIN GROUP TOTAL SYNTHESIS OF IB-00208 AGLYCONE  
3.5.2.1: First generation approach toward IB-00208 
The first generation approach of the Martin group toward the polycyclic xanthone IB-
00208 (3.14) was developed by Dr. Mans in 2006.340 The A ring was thought to come from a 
late-stage functionalization of 3.261 at C2 (citreamicin numbering) via Friedel-Crafts acylation 
or an bromination/alkoxycarbonylation sequence (Scheme 3.40). A Claisen rearrangement of the 
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phenolic allyl group moiety at C22 to C23 followed by a Wacker oxidation and an 
enantioselective reduction of the resulting ketone will provide access to either enantiomer of the 
IB-00208 (3.14) aglycone, (absolute stereochemistry unknown). A late-stage glycosylation of the 
less hindered C22 phenol would then provide IB-00208 (3.14). The D and E rings of 3.261 were 
thought to come from a Moore-like rearrangement from alkyne 3.262 (see Figure 3.9). The 
alkyne 3.262 was thought to come from the union of alkyne 3.264 and naphtho-cyclobutanone 









































































































































































The key Moore-like rearrangement, was inspired by a benzannulation reaction reported 
by Fuganti in 2003 (Figure 3.9, A).341,342 Heating 3.267 in a mixture of Ac2O and NaOAc 
initiated a cascade in which the neighboring methoxy ether attacks the incipient carbocation to 
form the oxonium 3.269, which is subsequently de-methylated to provide the benzofuran 3.270. 
In an analogous fashion, heating the benzocyclobutanone 3.271 will lead to a Moore 
rearrangement to produce the diradical intermediate 3.273 (Figure 3.9, B). Oxidation of the 
radical intermediate would generate the quinone cation 3.274, which would capture the 
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neighboring aryl ether to produce a similar oxonium intermediate 3.275, subsequent 
demethylation of which should produce 3.276  
Figure 3.9: Fuganti’s benzannulation cascade and proposed oxidative Moore rearrangement 
 
 
a) Fuganti’s benzannulation. b) Proposed oxidative Moore rearrangement. 
3.5.2.2: Strategies toward the synthesis of the naphthocyclobutanone fragment 
   
Formation of the naphthyne via metal-halogen exchange with substrates such as 3.277 
and subsequent 2+2 cycloaddition with a variety of enol ethers 3.278 did provide some of 
naphthocyclobutanone 3.279, but only if the enol ether lacked substitution at R6 and/or R5 
(Equation 3. 1). When substitution was present at both R6 and R5, no desired product was formed 
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and thus the aryne cycloaddition strategy toward the naphthocyclobutanone fragment was 
deemed non-productive. 
Equation 3.1: Unsuccessful Aryne route to naphthocyclobutanone fragment 3.263 
 
To overcome the limitations of the aryne chemistry, Dr. Mans developed a novel route 
towards the naphthocyclobutanone fragment 3.291, which involved forming the arene via ring 
closing metathesis (RCM) (Scheme 3.41). Metal halogen exchange of the bromo-styrene 3.281 
with tert-BuLi followed by reaction with the known vinyl squarate 3.282 furnished the squarate 
adduct 3.283 in 66% yield. Attempts to improve the yield with additives such as CeCl3 or 
tetramethylethylenediamine (TMEDA) or varying the temperature did not improve the yield of 











Scheme 3.41: Successful naphthocyclobutanone route via squarate addition and RCM 
 
 
The moderate yields of the squarate addition prompted Dr. Mans and later Dr. Knueppel 
to investigate other methods of coupling the styrenes and vinyl squarate 3.282. Hypothesizing 
that having substitution at C21 and C3 made the aryllithium too hindered to react with 3.282, Dr. 
Mans investigated less substituted styrenes in the squarate addition. Metal-halogen exchange of 
either the bromostyrene 3.286 or 3.289, and subsequent addition of the vinyl squarate 3.282 did 
provided only 12% of the desired adduct 3.287 (Figure 3.10, A, B). The major products were 
3.288 and 3.290, the result of an 8-π and subsequent 6-π electrocyclic ring closure (Figure 3.10, 
A,B). The reason why the electrocyclic ring-closed products are seen when bromostyrenes 3.286 
and 3.289 are used and not when 3.294 or 3.280 were used is attributed to the A1,3 strain 
associated with bringing the squarate moiety into the same plane as the arene ring in the former 
example and not in the latter. Later, Dr. Knueppel also attempted to improve the squarate 
addition by adapting a three-component coupling developed by Barett in his total synthesis of 
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ent-clavilactone B (Figure 3.10, C).343 The methodology added Grignard reagents into arynes, 
generated from the ortholithiation of the arylfluoride, to generate a new aryl Grignard reagent. 
Although the vinyl arene 3.292 was furnished from the reaction of the aryne generated from 
3.291 and lithium divinyl cuprate in 19-57% yield, the addition of squarate 3.282 provided no 
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a) Attempted coupling of vinyl squarate 3.282 with bromostyrene 3.291. b) Attempted coupling of vinyl squarate 
3.282 with bromostyrene 3.289. c) Attempted use of Barett’s methodology by Dr. Knueppel toward the 
naphthocyclobutanone fragment.343 
 
3.5.2.3: Evaluation of oxidative Moore rearrangement 
With a reliable route to the naphthocyclobutanone 3.284 established, synthesis of the F 
ring coupling fragment commenced. MOM protection and subsequent ortho-lithiation of arene 
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3.294, followed by reaction with DMF furnished the aldehyde 3.295 (Scheme 3.42). Hydrolysis 
of the MOM ether and addition of ethynylmagnesium bromide provided a propargyl alcohol, 
which was protected as the cyclic silyl ether 3.296. Deprotonation of 3.296 and addition into the 
naphthocyclobutanone 3.284 provided the propargyl alcohol 3.297 as a mixture (1:1) of 
diastereomers. Before embarking on the oxidative cascade to form the xanthone, the Moore 
rearrangement was investigated as a benchmark. Hydrolysis of the acetal with p-toluenesulfonic 
acid (PTSA) in acetone, followed by heating at 80 °C in degassed benzene provided a mixture 
(10:1) of the 6-endo product 3.298 and the 5-exo product 3.299. Care was needed during 
purification after the hydrolysis of 3.297 as the Moore rearrangement initiated at surprisingly low 
temperatures. Interestingly, heating the hydrolyzed 3.297 in methanol provided a mixture (1:0) 



















With 3.297 established as a substrate for the Moore rearrangement, the oxidative cascade 
was investigated. Hydrolysis of the acetal moiety in 3.297 and subsequent heating in methanol 
with copper acetate did not produce the desired cyclization product 3.300, but instead gave 3.301 
(tentative assignment), the result of methanol intercepting the putative quinone cation 
intermediate (Figure 3.11, A). A variety of protic (H2O, tert-BuOH, i-PrOH, F3CCH2OH, 
AcOH), polar aprotic (acetone, DMF, MeCN) and organic (THF, hexanes, glyme) solvents were 
screened with copper-based and quinone based oxidants but most reactions produced 
 210 
unidentified side-products. Interestingly, Dr. Mans reported that when benzoquinone was used as 
an additive, the main product detected was an adduct between benzoquinone and the desired 
product 3.300. In the hopes that the cyclic silyl ether moiety was interfering with the capture of 
the phenol oxygen atom, 3.297 was deprotected with HF•pyr, and the derived phenol was 
subjected to the same reaction conditions used previously, but no desired product was identified 
(Figure 3.11, B). The failure of the Fuganti-inspired oxidative Moore concluded Dr. Mans 
contributions toward the synthesis of IB-00208 (3.14)   
Figure 3.11: Attempted oxidative Moore rearrangement 
 
 
3.5.2.4: Second generation synthetic strategy toward IB-00208 
Dr. Knueppel re-imagined the route to the pentacyclic core 3.303.344 Instead of the 
Fuganti-like Moore rearrangement, he envisioned a cyclization cascade from ynone 3.306 
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(Scheme 3.43). Removal of the TBS group on the C14 phenol would result in an intramolecular 
conjugate addition of the phenol moiety to form the xanthone, which upon heating should open 
up to the ketene intermediate 3.305 prior to a 6-π electrocyclic ring closure to form the 
hydroquinone 3.304. Oxidation of the hydroquinone and subsequent functionalization at C2 
would provide the pentacyclic core 3.303 which would follow a similar sequence toward IB-
00208 (3.14). The ynone 3.306 was thought to come from the addition of 3.307 to the 
























3.5.2.5: Model study 
Model studies were initiated to investigate the chemistry involved in the addition of 
ynones to cyclobutanones and to evaluate the conjugate addition/electrocyclization cascade. 
Unfortunately, attempted coupling between the ynone 3.307 and the benzocyclobutadione 3.309 
provided no desirable product 3.310, even in the presence of CeCl3 or 12-c-4 (Scheme 3.44). 
Deprotonation of 3.307 and quenching with MeI of benzaldehyde revealed that although the 
ynone was being deprotonated, the anion was not reacting with 3.309. 
Scheme 3.44: Attempted acetylide coupling between 3.307 and 3.309 
 
 
The failure to add the ynone 3.307 into 3.309 prompted the investigation of adding the 
propargyl alcohol into the benzocyclobutadione 3.309 first, then oxidize to the ynone 3.310. 
Addition of ethynylmagnesium bromide to aldehyde 3.328 (prepared in three steps from 3.311 in 
40% yield) formed the MOM-deprotected propargyl alcohol, which was protected as the cyclic 
silyl ether 3.312 (Scheme 3.45). Deprotonation of 3.312 and addition to the benzocyclobutadione 
3.309 provided the adduct 3.313 in 65% yield. Deprotection of the cyclic silyl acetal with HF•Py 
provided the propargyl alcohol 3.314. Several conditions were screened in order to oxidize the 
propargyl alcohol 3.314 to the ynone 3.310, but only complex mixtures were obtained so this 









Gratifyingly, the Moore rearrangement of 3.314 proceeded upon heating in THF, and 
subsequent oxidation of the benzyl alcohol with IBX delivered the quinone, which upon 
treatment with silica, unexpectedly resulted in the spontaneous cyclization to the spirocycle 
3.315 in 68% yield from 3.314 (Scheme 3.46). Microwave heating the spirocycle in toluene gave 
mixtures of the desired quinone 3.317 and the hydroquinone 3.316. Air and Ag2O were evaluated 
to convert the hydroquinone 3.316 to 3.317 but it was found that a basic KOH workup after the 








3.5.2.6: Synthesis of the pentacyclic core 
Once the groundwork had been established in the model system, work began on the 
pentacyclic core. Bromination of the commercially available aldehyde 3.280 occurred selectively 
at C4 (Scheme 3.47). Protection of both phenols as the MOM ethers and Wittig olefination 
provided the bromostyrene 3.318 in 92% yield. Metal-halogen exchange of the bromostyrene 
3.318 with tert-BuLi, followed by the addition of vinyl squarate 3.282 provided 3.319 in 57% 
yield. Ring closing metathesis (RCM) and addition of ethynylmagnesium bromide provided 
3.320. Double deprotonation of the propargyl alcohol 3.320 followed by quenching with the 
aldehyde 3.307 (see Scheme 3.51) provided the coupled product 3.321 in 79% yield. Initial 
experiments with adding acetylide 3.312 into the napthocyclobutanone provided none of 3.321. 
Hydrolysis of the C6 acetal, followed by Moore rearrangement under the conditions used in the 
model system provided only trace amounts of the quinone 3.322. A solvent screen found that 
PhMe, THF, PhCl, MeCN and DMF were all poor solvents for the Moore cyclization. Only 
degassed DMSO, which had been stored over 4Å molecular sieves provided the product 3.322 in 
42% yield. Oxidation of 3.322 with IBX and subsequent deprotection provided the spirocycle 
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3.323, but attempts to use the conditions developed in the model system to generate the 
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Attempts to deprotect both of the MOM ethers in 3.324 with TFA/H2O resulted in 
complex mixtures. Fortunately, selective deprotection of the C3 MOM group of the spirocycle 
3.323 was accomplished with TFA/H2O, but attempted removal of the second MOM group gave 
complex mixtures (Scheme 3.48). Numerous bromination conditions were tried (NBS/i-Pr2NH, 
PyHBr3, NBS, Br2, CuBr2 and Br2•1,4-dioxane) but only a slow addition of Br2 to a mixture of 
3.325 in pyridine/CH2Cl2 provided 3.326 in 19% yield, the major byproduct being the C22 
MOM-deprotected product. Unfortunately, attempts to affect the alkoxy carbonylation, 
formylation or the Rosenmund-von Braun reaction of 3.326 to provide either the carbomethoxy-, 
formyl- or cyano- groups at C2 all led to complex mixtures.   
Scheme 3.48: Attempted functionalization of the B ring 
 
3.5.2.7: 
Successful strategy towards IB-00208 aglycone 
The inability to functionalize the B ring in 3.325 led to a redesign of the synthesis. Dr. 
Knueppel envisaged that the A ring moiety could be appended to the quinone 3.328, which 
would be prepared from the alkyne 3.329 via the Moore rearrangement (Scheme 3.49). The 
alkyne 3.329 would be formed from the union of the aldehyde 3.307 and propargyl alcohol 
3.330, which ultimately would come from the coupling of the bromostyrene 3.331 and the vinyl 
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squarate 3.282. The utilization of this strategy culminated in the total synthesis of IB-00208 
(3.14) aglycone 3.14 in 2015 through the combined efforts of Dr. Knueppel, Dr. Cheng and Dr. 
Yang.345, 346 













































































































































































Lithium-halogen exchange of the bromo arene 3.332, followed by alkylation with 
propylene oxide provided alcohol 3.333 (Scheme 3.50). Bromination of 3.333 under Tanemura 
conditions (NBS, cat. NH4NO3) proceeded regioselectively at C4, and protection of the alcohol 
as the MOM ether furnished 3.334.347 Oxidative-demethylation of the arene to the quinone with 
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CAN, followed by a reductive workup with sodium dithionite (Na2S2O4) provided the 
hydroquinone, which was subsequently cyclized to isochroman 3.335 via a TMSOTf catalyzed 
oxy-Pictet-Spengler cyclization with the MOM group. Attempts to initiate the oxy-Pictet-
Spengler from the hydroquinone dimethyl ether 3.334 led to lower yields and competitive 
oxidation at C1 during the CAN oxidation. Duff formylation of 3.335 with 
hexamethylenetetramine (HMTA) in neat trifluoroacetic acid, followed by bis-MOM protection 
and Wittig olefination provided the key bromostyrene 3.331.348 
Scheme 3.50: Synthesis of AB ring fragment 3.331 
 
Synthesis of the F ring coupling partner began with protection of the phenol 3.336 as the 
MOM ether (Scheme 3.51). MOM-directed ortho-lithiation at C9, followed by quenching with 
paraformaldehyde furnished benzyl alcohol 3.337. Oxidation of the benzyl alcohol with 
PCC/celite, followed by hydrolysis of the MOM ether and protection of the phenol as the TBS 






Scheme 3.51: Synthesis of F ring fragment 3.307 
 
Lithium-halogen exchange of the bromo-styrene 3.331 and addition into the vinyl 
squarate 3.282 provided 3.338 (Scheme 3.52). RCM with Grubbs II catalyst, followed by 
addition of ethynylmagnesium bromide to the C17 ketone furnished 3.330. Attempts to add 
ethynylmagnesium bromide into aldehyde 3.307, followed by double-deprotonation and addition 
into the benzocyclobutanone were unsuccessful, perhaps because of the steric bulk of both the 
nucleophile and the electrophile.  Double-deprotonation the propargyl alcohol 3.330 with 
EtMgBr afforded the desired compound 3.329 in 83% yield, but these results were not 
reproducible, owing perhaps to adventitious proton sources. Adding super-stoichiometric 
quantities of base to consume the proton sources led to addition products of the aldehyde. 
Fortunately, tetramethylpiperidine magnesiumbromide (TMPMgBr) was sufficiently sterically 
hindered that it did not add into the aldehyde. Hence, adding TMPMgBr to a solution of 3.330 
and 3.307 gave the bis-propargyl alcohol 3.329 in 80% yield. Deprotection of the acetal to the 
ketone and heating in dilute DMSO initiated the Moore rearrangement to give quinone 3.328. 
Oxidation of the C1 carbon atom was very sensitive to the electronics of the aromatic core. 
Formation of the xanthone moiety or the C8 carbonyl group prior to oxidation with DDQ 
resulted in no reaction, while deprotection of the C14 TBS ether to the phenol and oxidation with 
DDQ led to complex mixtures. Benzylic oxidation proceeded from intermediate 3.328 with DDQ 
in CH2Cl2/H2O to provide the C1 hemiacetal, but attempts to oxidize the C8 alcohol resulted 
complex mixtures. Modifying the DDQ oxidation by adding MeOH and BaCO3 allowed for the 
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isolation of the C1 methoxy acetal, which enabled the oxidation of the C8 alcohol with IBX in 
DMSO to provide 3.339.   
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i) Grubbs II, PhMe, 110 C
ii) ethynyl magnesiumbromide,
THF, 0 C r.t.
i) DDQ, BaCO3,
MeOH,DCM, r.t.




































































Deprotection of the TBS moiety in 3.339 with Et3N•3HF and cyclization at C7 formed 
the spirocycle 3.340 (Scheme 3.53). Deprotection of the acetal moiety at C1, followed by 
oxidation with pyridinium dichromate (PDC) provided the lactone 3.341. Heating 3.341 in 
MeCN in a microwave under an atmosphere of oxygen led to the bis-MOM protected core of IB-
00208 (3.14). Deprotection of the MOM groups with TMSBr led to an equilibrating mixture 
(2:1) of redox tautomers 3.14 and 3.342 in 22 steps from 3.332 and in 1.3% overall yield. Both 
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the Ready group and the Porco group also noted similar redox tautomerization in the kibdelones 
when one of the hydroquinones was not protected. 
Scheme 3.53: Martin’s completion of IB-00208 (3.14) aglycon  
 
The synthesis of IB-00208 (3.14) provided valuable lessons for the application of the 
Martin group strategy toward other polycyclic xanthone natural products. Although the synthesis 
of the napthocyclobutanone fragment was accomplished by the addition of the lithiostyrene into 
the vinyl squarate 3.282, the reaction was sensitive to the substituents on the arene ring, and the 
yields only ranged from 50-60%. The coupling of the napthocyclobutanone fragment and the F 
ring fragment was also temperamental, perhaps because of adventitious proton sources and/or 
sterics effects. The outcomes of the Moore rearrangement of the adducts 3.319, 3.314 and 3.297 
were dependant on the solvent, providing the 6-endo and 5-exo cyclization products in varying 
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amounts (Scheme 3.47, 3.45 and 3.42). The late stage oxidation at C1 proved also proved to be 
dependent on the electronics of the aromatic ring, with even the remote C8 carbonyl affecting the 
outcome of the reaction. Future applications of this strategy toward other polycyclic xanthone 
natural products would need to investigate different strategies towards the synthesis of the G or 
A rings. Currently, the A ring is synthesized in the beginning, appended to styrene 3.331 and 
oxidation of the benzylic carbon furnishes the lactone moiety in IB-00208 (3.14). Though this 
strategy was successful for IB-00208 (3.14), other polycyclic xanthone natural products such as 
cervinomycin (3.17), kigamicins (3.20) and citreamicin have an additional G ring and the A ring 
are more densely functionalized and thus would make it difficult to build a suitable A and G ring 
precursor in the beginning, which would be stable to the strong base chemistry encountered 
during the synthesis. 
3.5.3: WORK BY DR. NICHOLS TOWARD TRICYCLIC XANTHONES 
The utilization of the Moore rearrangement toward the synthesis of xanthone natural 
products was more broadly explored by Dr. Alex Nichols who developed a general approach to 
1,4-diogygenated xanthones that was applied to a synthesis of dulcisxanthone C.349,350 The first 
approach xanthones utilized the coupling of the cyclic silyl ether protected propargyl alcohol 
derivative 3.345, first reported by Dr. Mans (see Scheme 3.42), and the squarate 3.346 or 3.347.  
Addition of ethynyl magnesiumbromide to salicylaldehyde (3.343) furnished propargyl 
alcohol 3.344 (Scheme 3.54), and protection of both the alcohol and the phenol moieties 
provided the cyclic silyl ether 3.345. Deprotonation of the acetylene moiety and addition of the 
subsequent anion to either the squarate 3.346 or 3.347, gave the cyclobutanols 3.348 or 3.349, 
which provided the quinones 3.350 and/or 3.351 upon heating in toluene. Removal of the cyclic 





Scheme 3.54: Dr. Alex Nichols’s first generation approach 
  
 
Several oxidants were screened to oxidize the benzylic alcohol in 3.352 or 3.353 to the 
ketone, which was thought to cyclize to the xanthone 3.354 or 3.355 under the reaction 
conditions (Equation 3.2). Though Dr. Nichols was able to isolate the desired products, the yields 
varied from 10% to 70% along with the byproducts 3.358 or 3.359 and the quinones 3.356 or 
3.357. Dr. Knueppel also had difficulty in oxidizing compounds such as 3.352 or 3.353 (see 
Scheme 3.45).344 Subjection of the xanthone 3.354 or 3.355 to Jones oxidation conditions only 
returned 10% of the xanthone along with a substantial amount of degradation products, 








Equation 3.2: Dr. Alex Nichols’s attempted cyclization of 3.352 or 3.353 to the xanthone 
3.354 or 3.355 
 
The byproducts 3.358 and/or 3.359 were proposed to be formed by first cyclizing to the 
spirocycle 3.360 or 3.361 (Scheme 3.55). Coordination of the oxidant to the alcohol forms 
complex 3.362 or 3.363, which upon enolization to 3.364 or 3.365 facilitates an oxidative 













































3.352: R = Me
3.353: R = OMe
3.358: R = Me
3.359: R = OMe
Mn-2
3.360: R = Me
3.361: R = OMe
3.362: R = Me
3.363: R = OMe
3.364: R = Me
3.365: R = OMe  
 
To overcome this problem, both MOM and PMB protecting were investigated as 
protecting groups for the phenol (Scheme 3.56). Addition of ethynyl magnesium bromide to 
PMB or MOM protected salicylaldehydes 3.366a-j furnished propargyl alcohols 3.367a-j. 
Double-deprotonation of these propargyl alcohols and addition into the squarate 3.347 gave the 
cyclobutanols 3.367a-j, which after heating in toluene provided quinone 3.368a-j. Gratifyingly, 
Jones oxidation cleanly provided the ketones 3.369a-j in 88-99% yield, other oxidants such as 
PCC or PDC required longer reaction times and provided the ketone in lower yields. While the 
MOM protected derivative of 3.369a required harsh conditions to deprotect and produced 
mixtures of products, the PMB group was cleanly removed in the presence of TFA to provide 
either the xanthones 3.370c,d,e and 3.370h or the spirocycles 3.371f,g,i and 3.371j. The 
exclusion of oxygen and light was key for the isolation of the xanthones in high yield, which 
paradoxically resulted in the reduction of the quinone to the hydroquinone. Fortunately, the 
spirocycles 3.371f,g,i and 3.371j can be converted to the xanthones 3.370f,g,i and 3.370j in the 
presence of K2CO3 and acetone. Finally, by alkylation of 3.370c with K2CO3 and Me2SO4, Dr. 
Nichols was able to synthesize dulcisxanthone c (3.372) in seven steps and in 22% overall yield. 
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Scheme 3.56: Dr. Alex Nichols’s second generation synthesis of xanthones 
 
 
The substituents on the aromatic ring determined the product ratios between xanthone or 
spirocycle formation. While substituents at the 3- and 5-positions had little effect, producing 
only the xanthones 3.370c,d,e and 3.370h. Substituents at the 6-position and electron donating 
substituents at the 4-position favored the spirocycles 3.371f,g (Scheme 3.57). The electron-
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donating groups at C4 are thought to deactivate the carbonyl through resonance (Shown in 
structure 3.374), which reduces the electrophilicity of the ketone and hence bias between the α- 
and β-positions of the quinone toward nucleophilic attack. Substituents at C6 are thought to favor 
the spirocycle because of the steric interactions between the substituent and the ketone that are 
encountered when cyclizing on the β-carbon, shown in 3.373. 





CHAPTER 4: SYNTHESIS OF THE CORE OF CITREAMICIN η AND GA-
RING MODEL STUDIES 
4.1 Synthetic strategy towards citreamicin η 
The synthetic strategy developed in the Martin group for the synthesis of citreamicin η 
(4.1) was inspired by the work of Dr. Knueppel in his second-generation investigation towards 
the synthesis of IB-00208 (see Chapter 3, Section 3.5.2).344,345 An additional challenge presented 
by citreamicin η (4.1) is the presence of the GAB-rings, which comprise a dihydro-5H-
oxazolo[3,2-b]isoquinoline-2,5(3H)-dione moiety, the chemistry of which has yet to be explored. 
Strategically, the stereochemistry in the G-ring was planned to come from a late-stage 
condensation of the amino acid derivative α-methyl serine onto the isocoumarin 4.2, which can 
be formed from palladium-catalyzed couplings from the pentacyclic compound 4.3 (Scheme 
4.1). New methodology must be developed for the transformation of 4.3 to citreamicin η (4.1). 
The E-ring in 4.3 can come from the quinone 4.4 in a cyclization cascade than is inspired by the 
work of Dr. Nichols (see Chapter 3, Scheme 3.56).349-351 In a similar sequence seen in the 
synthesis of IB-00208, quinone 4.4 could be formed from a Moore rearrangement of the 
acetylide 4.5 which can be made from the union of acetylene, cyclobutanone 4.6 and the 
aldehyde fragment 4.7. Finally, the benzocyclobutanone 4.6 can be synthesized from the addition 
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4.2: Synthesis of the BC-ring coupling fragment 
4.2.1: ATTEMPTED USE OF COMINS ORTHO-METALATION 
The two common methods used to generate aryllithium reagents are lithium-halogen 
exchange and directed ortho-lithiation (DOM). A variety of directing groups (DG) can be used 
for DOM, with amides and carbamates being among the most effective (Figure 4.1, A).352-354 
Comins discovered that the combination of lithium amide of the N,N,N’-
trimethylethylenediamine (LTMDA) 4.10 and aryl aldehydes produces a tetrahedral intermediate 
4.11 in situ that can function as a powerful DG for ortho-lithiation (Figure 4.1, B).355-359 The use 
of Comins’ methodology could then allow for the direct addition of the arene 4.9 without use of 
















Figure 4.1: Directed ortho-metalation and planned use of Comins LTMDA 4.10 
 
 
a) Directed ortho-metalation (DOM) and relative directing group (DG) efficacies. B) Proposed use of 
Comins’ ortho-lithiation of vanillin derivative 4.9. 
The strongly basic conditions of DOM limits the types of protecting groups available for 
the protection of the C4 and C5 hydroxyl groups on the arene 4.9. An additional problem is that 
the two protecting groups at C4 and C5 must be orthogonal and not affect ortho-lithiation 
selectivity (C2 vs C6). The three orthogonally protected vanillin derivatives were synthesized to 
evaluate compatibility with the DOM conditions: the C4 MOM group can be hydrolyzed 
selectively in 4.14 (Figure 4.2, A), the C4 isopropyl group in 4.16 can be selectively removed 
with Lewis acids (Figure 4.2, B),360 and the C4 ethoxybutyl (EB) group should hydrolyze faster 
than the C5 MOM group in 4.19 (Figure 4.2, C).  The differentially protected vanillin derivative 
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4.18 was synthesized from piperonal (4.17) via a procedure originally developed by Dr. Alex 
Nichols.349   
Figure 4.2: Synthesis of protected vanillin derivatives 
 
 
The C4 phenol protected TIPS-protected vanillin derivative 4.21 was synthesized, but C5 
phenol protected compound 4.22 was also formed.  (Table 4.1). Attempts to favor 4.21 over 4.22 
by changing solvents and bases did not alter the product ratios from ~2:1 of 4.21:4.22. Use of 









Table 4.1: Attempted selective synthesis of TIPS vanillin derivative 
 
Base Solvent Yield 4.21 Yield 4.22 Yield 4.23 
2,6-lutidine THF 61 34 0 
2,6-lutidine CH2Cl2 59 33 0 
2,6-lutidine MeCN 24 18 0 
2,6-lutidine PhMe 64 36 0 
2,6-lutidine DMF 36 20 10 
Et3N DMF 34 20 23 
(i-Pr)2NEt DMF 21 12 25 
imidazole DMF 35 12 10 
 
With the protected vanillin derivatives 4.14, 4.16 and 4.19 in hand, the synthesis of vinyl 
squarate 4.8 commenced with the conversion of squaric acid 4.24 to dimethyl squarate 4.25. The 
literature procedures for the synthesis of dimethyl squarate 4.25 require long reaction times, so 
an alternate procedure using anhydrous HCl in MeOH was investigated (Scheme 4.3, Condition 
A).361,362 Gratifyingly, dimethyl squarate 4.25 was synthesized in 94% yield at room temperature 
in under 2 h using this method (Scheme 4.3, Condition B). Transformation of 4.25 onto 4.8 was 
performed via a one-pot procedure developed by Moore, which required the use of vinyl lithium 
(made in situ from tetravinyltin and n-BuLi) (Scheme 4.3, Condition C).361 Unfortunately, 
synthesis of large amounts of the vinyl squarate 4.8 was hampered by the moderate yields (55 – 
66%) and the requirement of large amounts of tetravinyltin. An alternate procedure was devised 
to circumvent the use of large amounts of tetravinyltin by using vinylmagnesium bromide and a 
catalytic amount of CeCl3•2LiCl (Scheme 4.3, Condition D). The yields were comparable to the 
vinyllithium method, but the vinylmagnesium bromide had to be made fresh and the synthesis of 
anhydrous CeCl3•2LiCl proved tedious. The two step procedure using either of the two methods 
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to produce the adduct 4.26 followed by ionization offered no improvements over the one-pot 
procedure (Scheme 4.3, Condition E,F).337 
Scheme 4.2: Synthesis of vinyl squarate 4.8 
 
An additional complication that was encountered was that the dimethyl squarate 4.25 
hydrolyzed and the vinyl squarate 4.8 would decompose in the freezer after 1 – 2 weeks. This 
prompted the investigation of the diisopropyl squarate 4.27, which was reported by Liebeskind to 
be more stable.363 Subjection of the isopropyl squarate 4.27 to the one-pot procedure for the 
vinyl squarate 4.8, however, provided a mixture of the mixed acetal 4.28 and the vinyl adduct 
4.29 instead of the desired 4.30 (Scheme 4.4, Condition A). The two step procedure exclusively 





Scheme 4.3: Attempted synthesis of isopropyl squarate 4.30  
 
 
 Several attempts were made to effect the ortho-lithiation of 4.16 utilizing Comins’ 
methodology, followed by addition of vinyl squarate 4.8; however, only starting material and 
vinyl squarate 4.8 were recovered (Scheme 4.4). Prolonged stirring after the addition of vinyl 









Scheme 4.4: Attempted Comins ortho-lithiation/squarate addition 
N N
Li





























To assess whether the appropriate aryllithium was being formed, MOM protected vanillin 
derivative 4.14 and piperonal (4.17) were subjected to the reaction conditions used for the ortho-
lithiation of 4.16, followed by quenching with benzaldehyde as a model electrophile. 
Interestingly, the ortho-lithiation of vanillin derivative 4.14 resulted in a mixture of C3 and C6 
benzaldehyde adducts 4.32 and 4.33 (1.2:1) (Figure 4.3, A). It is likely that the MOM group is a 
competitive directing group with the lithium-N,O-acetal generated from the addition of LTMDA  
to the aldehyde moiety. ortho-lithiation of piperonal (4.17), however, did give the desired 
product 4.34 in 67% yield (Figure 4.3, B). This result suggests that the MOM and EB protected 
derivative 4.19 and 4.14 will be poor substrates in the Comins ortho-lithiation due to competitive 
































































a) Attempted Comins ortho-lithiation of 4.14 resulting in a mixture of C6 and C3 alkylated products. b) 
Comins ortho-lithiation of piperonal delivering only the C6 alkylated product 4.10.  
 
Due to the harsh conditions of the ortho-lithiation (excess n-BuLi, THF, –20 °C to 0 °C), 
and the ability of MOM protecting groups to compete with the LTMDA to direct ortho-lithiation, 
metal-halogen exchange was investigated using lithium N,O-dimethyl amine as an in situ 
protecting agent for the aldehyde. Preparation of differentially protected 4,5-
dihydroxybenzaldehyde derivative 4.36 was accomplished in three steps (Scheme 4.5). Selective 
alkylation of 4,5-dihydroxybenzaldehyde with benzyl bromide in the presence of K2CO3 
provided the 4-benzylated compound 4.35. Ortho-selective bromination utilizing Fujisaki’s 





Scheme 4.5: Synthesis of ortho-lithiation probe 4.36 
 
 
Utilizing lithium N,O-dimethylamine as an in situ protecting agent, aldehyde 4.36 was 
subjected to metal-halogen exchange with n-BuLi followed by quenching with benzaldehyde as 
the model electrophile (Figure 4.4, A). Surprisingly, a mixture of butylated products 4.38 and 
4.39 were recovered in varying amounts depending on the solvent, temperature, and number of 
equivalents of n-BuLi. The structure of 4.39 was confirmed by oxidizing the lactol to the lactone 
(see experimental). Use of tert-BuLi in place of n-BuLi only delivered the expected lactol 4.37 in 














Figure 4.4: Attempted in situ protection/ortho-lithiation of aldehyde 4.36 
 
 
a) In situ protection of the aldehyde 4.36 with lithium N,O dimethyl amide and subsequent metal-halogen 
exchange with n-BuLi resulting in butylated products 4.38 and 4.39. b) In situ protection of the aldehyde 4.36 with 
lithium N,O dimethyl amide and subsequent metal-halogen exchange with tert-BuLi resulting in aldehyde adduct 
4.37. 
The putative mechanisms for the formation of 4.38 and 4.39 both involve the 
intermediacy of a benzyl anion (Scheme 4.6). Addition of the N,O-dimethylamide into aldehyde 
4.36 produces the complex 4.40, which after lithium-bromine exchange, gave the aryllithium 
4.41 and butylbromide. A second equivalent of n-BuLi deprotonated the benzyl group to produce 
tri-anion 4.42, which reacts with the butylbromide to give 4.43; addition of benzaldehyde that 




Scheme 4.6: Proposed mechanism for the formation of 4.38 and 4.39 
  
4.2.2: SQUARATE ADDITION VIA LITHIUM-HALOGEN EXCHANGE 
4.2.2.1: Selective bromination 
The failure of the Comins ortho-lithiation strategy for the synthesis of 4.12 was attributed 
to the lack of orthogonal protecting groups that are stable under the strongly basic reaction 
conditions. Thus, the strategy developed for the synthesis of IB-00208 (not shown) was revisited 
(Figure 4.5, A). The orthogonally protected vanillic derivative 4.48 was chosen instead of the 
benzyl protected compound 4.36 due to the diversity of conditions available to remove the PMB 




Figure 4.5: Revised synthetic plan toward benzocyclobutanone 4.6 
 
The first route to 4.48 involved selective alkylation of 4.20 with PMBCl in the presence 
of NaHCO3 and NaI to provide 4.50 in 84% yield on 20 g scales (Scheme 4.7).
377 The undesired 
C5 alkylated product 4.53 and the bis- PMB protected compound 4.57 were only isolated in 2% 
and 7% yield respectively. Unexpectedly, ortho-bromination of 4.50 under the same conditions 
used for the benzyl protected analogue 4.35 (see Scheme 4.5) delivered the C3-brominated 









Scheme 4.7: Unexpected C3-bromination of PMB-protected vanillin derivative 4.52 
 
The fact that bromination at C3 of 4.50, was favored even in the presence of amines that 
promote ortho-bromination, is unusual. In cases where both the substituents in the 4- and 5-
positions are both alkyl or hydroxyl, bromination occurs in the 3-position (Figure 4.6, A).371,372 
Bromination at the 6-position can be favored if the substituent in the 4-position is deactivating or 












Figure 4.6: Selectivity in the bromination of vanillin derivatives  
 
a) Example of bromination in the 3-position when both groups are alkyl from Sarma.371 b) Example of bromination 
in the 6-position when the C4 group is an acyl group from Raiford.374 c) Example of bromination in the 6-position 
when the C5 group is an OH group from Hazlet.376 d) Generalized selectivity preferences for bromination of vanillin 
derivatives. 
There are two known methods to effect the selective ortho-bromination of phenols: The 
method developed by Pearson in 1967 utilizes tert-BuNH2 and bromine, whereas the method 
developed by Fujisaki in 1993 utilizes catalytic 2°-amines with NBS.364,365 The combination of 
amine and bromine source is thought to generate an N-bromoamine intermediate 4.64 that favors 
ortho- rather than para-bromination (Figure 4.7). The fact that bromination of 4.50 under 
Fujisaki’s conditions failed to provide the ortho-brominated product 4.51 presents a unique 
challenge of reversing the selectivity change induced by the PMB group. Two pathways were 
considered to provide insight to this problem. If bromination precedes deprotonation, one would 
expect the selectivity to be lower (Figure 4.7, Pathway B) than if deprotonation precedes 
bromination (Figure 4.7, Pathway A) because one would expect the phenoxide 4.63 to be more 
reactive at the 2- and 6-postions towards electrophilic reactions relative to the 2- and 6-postions 
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in 4.65 The reactivity of the 3-positions in 4.63 and 4.65 would be expected to be similar. Basic 
amines should favor pathway A over pathway B and hence be more selective for the bromination 
in the 6-position.  
Figure 4.7: Hypothetical effect of amine basicity on bromination selectivity  
 
 
Based on the proposed hypothesis, four amines were chosen with increasing pKa values: 
tert-BuNH2 (pKa~10.6), (i-Bu)2NH (pKa~11), 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
(pKa~12) and tetramethylguanidine (TMG) (pKa~14). These were screened with Br2, 2,4,4,6-
tetrabromocyclohexa-2,5-dienone (TBCO) and NBS as sources of [Br+].366 NBS was quickly 
identified as the brominating reagent of choice due to the ease of handling and intermediate 
reactivity relative to Br2 and TBCO. Solvent appeared to have a profound effect on the product 
ratios: the selectivity was the lowest in CH2Cl2 and increased with added toluene. Starting with a 
2:3 ratio of PhMe/CH2Cl2, 4.50 was brominated with NBS with each of the four amines and the 
relative ratios of the 2-, 3- and 6-brominated products 4.52, 4.68 and 4.51 were determined by 
1H-NMR (Table 4.2, entries 1 – 4). As expected, selectivities increased with the increasing pKa 
of the amine, with TMG providing >20:1 selectivity for the 6-brominated product 4.51. Amines 
are known in the literature to catalyze the halogenation of alkenes in the presence of 
halogenating agents,367-371 but this is the first instance of N-bromoTMG being used in the 
selective bromination of an aromatic ring.367 On scale, however, the bromination of 4.50 with 
NBS and TMG delivered the product 4.51 in only 30 – 40% yields, and the reaction rarely went 
to completion. Simply adding more NBS to the reaction caused the formation of polybrominated 
compounds. Increasing the ratio of toluene in the mixed solvent system allowed the reaction to 
go to completion with a slight excess of NBS, but upon warming, polybrominated compounds 
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were formed. To drive the reaction to completion while avoiding over-bromination, reductive 
quenches to neutralize any active brominating agents in the reaction mixture were examined. Of 
the several quenching agents examined [butylated hydroxytoluene (BHT), sodium thiosulfate, 
hydroquinone, and thiourea], BHT proved the most effective. Repeating the selectivity 
experiment with the four amines still showed that TMG offered the highest selectivity. (Table 
4.2, entries 5 – 9). Additional problems were encountered on scale-up: The yields ranged from 
40 – 60%, and the selectivity between the 3- and 6-brominated products varied significantly. 
Interestingly, when stirring the NBS and TMG together at 0 ºC on scale, a white precipitate 
formed. Analysis of the solids with starch-iodine test strips revealed that was an active oxidizing 
agent and addition of these solids to 4.50 produced amounts of 4.51 and 4.52. 
Table 4.2: Effect of amine and solvent on bromination regioselectivity. Ratios determined by 
crude NMR 
 
Amine NBS:amine PhMe:CH2Cl2 quench 4.52 4.68 4.51 4.50 
tert-BuNH2 1:1 2:3 N/A 1  0 3.75  0.87  
(i-Bu)2NH 1:1 2:3 N/A 1  2.5  11.5  0  
DBU 1:1 2:3 N/A 1  3  13.5  0  
TMG 1:1 2:3 N/A 1  2  21.5  0  
tert-BuNH2 1.2:1.3 5:1 BHT 1 1.33 7.33 1.33 
(i-Bu)2NH 1.2:1.3 5:1 BHT 1 1 3.75 6.25 
DBU 1.2:1.3 5:1 BHT 1 1 6 1.17 
TMGa 1.2:1.3 5:1 BHT 1 0 11 0 
a) 40 – 60% yield on scale, 1:1 – 5:1 ratios of 3- and 6-brominated products 4.52 and 4.51 
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The discovery that the white precipitate contained active brominating reagent suggested 
that it may be a mixture of succinimide (4.71) and N-bromo TMG 4.72 (Figure 4.8, A). The salt 
(4.73 + 4.75) may be detrimental to the reaction due to its insolubility under the reaction 
conditions and may not be as selective of a brominating agent as N-bromo TMG 4.72 because it 
would not form any of phenolate. Changing the stoichiometry from 1.2:1.3 NBS:TMG to 1:2 
may shift the equilibrium away from (4.73 + 4.75) towards the N-bromo TMG 4.72, which may 
be beneficial to selectivity and solubility (Figure 4.8, B).   

























































a) Possible incomplete formation of N-bromoTMG 4.72 when NBS/TMG ratio is 1:1. b) Possible complete 
formation of N-bromoTMG 4.72 when NBS/TMG ratio is 1:2.  
Gratifyingly, changing the stoichiometry from 1.2:1.3 to 1:2 gave >20:1 selectivity for 
the 6-brominated derivative 4.51 in a variety of solvents and no reductive quench was necessary 
(Table 4.3, entries 1 – 4). Up to this point, the reactions had been run relatively dilute (0.0125 M) 
and hence large volumes would be required to synthesis significant quantities of 4.51. 
Accordingly, the concentration of the reaction was varied from 0.00625 M to 0.1 M to determine 
the effect of concentration of the yields of 4.51 (Table 4.3, entries 5 – 9). Gratifyingly, the yield 
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increased with higher concentrations and on scale, the selectivities and yields stayed the same, 
and multiple grams of the brominated vanillin derivative 4.51 were synthesized in 83% yield. 
Table 4.3: Bromination of 4.50 using 2:1 TMG:NBS 
 
Solvent Concentration (M) Yield (%) Ratio (4.51:4.52) 
CH2Cl2/PhMe (5:1) 0.0125 39% >20:1 
PhMe 0.0125 44 – 62% >20:1 
CH2Cl2/MeCN (3:2) 0.0125 52% >20:1 
THF 0.0125 26% >20:1 
CH2Cl2 0.00625 18% N/A 
CH2Cl2 0.0125 39% >20:1 
CH2Cl2 0.025 61% N/A 
CH2Cl2 0.05 78% N/A 
CH2Cl2 0.1 84% (83%)
a N/A 
a) Performed on gram scale 
 
4.2.2.2: MOM protection and Wittig olefination 
 
With access to multigram quantities of the bromoarene 4.51, work was initiated toward 
the synthesis of styrene 4.48 (Scheme 4.8). MOM protection with diisopropylethylamine 
(DIPEA) and MOMCl gave the protected aldehyde 4.76 in 92% yield (Scheme 4.8). The initial 
conditions (NaH/Ph3PMeBr) for the Wittig olefination provided styrene 4.48 in variable yields. 
The major byproduct of the reaction was the benzyl alcohol 4.77, presumably arising either from 
reduction of the aldehyde by the base or a competing Cannizzaro reaction. Generation of the 
ylide with n-BuLi or tert-BuOLi did not reduce the amounts of the benzyl alcohol 4.77.  
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Scheme 4.8: MOM protection of 4.51 and Wittig olefination 
 
Curiously, there are few reports of Cannizzaro reactions occurring during Wittig 
olefinations. The only example found was the observation of Gupta in 1968 who found that 
reaction of 2-furaldehyde (4.78) with the ylide generated from butyltriphenylphosphonium 
bromide and n-BuLi in Et2O produced a mixture of Cannizzaro products 4.79 and 4.80.
379 If the 
same reaction was carried out in DMF and the ylide generated from butyltriphenylphosphonium 
bromide and NaOEt, the desired product 4.81 was major product (yield not reported) and only 
7% of the Cannizzaro products 4.79 and 4.80 were detected. 
Scheme 4.9: Gupta’s observation of Cannizzaro side-reactions during Wittig olefination  
 
 The benzyl alcohol 4.77 is most likely formed via the Cannizzaro reaction between 
aldehyde 4.76 and trace amounts of lithium hydroxide present in the reaction mixture. The 
lithium hydroxide adduct 4.83 can then react with another equivalent of aldehyde 4.82 to form 
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4.84, which can undergo a hydride transfer to form the benzyl-alkoxide 4.86 and benzoic acid 
4.85 (Scheme 4.10). The benzoic acid is immediately deprotonated under the basic reaction 
conditions, which drives the reaction forward. The addition of polar aprotic solvents may 
coordinate the lithium counterion that is required to bind the aldehyde and form the highly 
ordered transition state needed for the hydride transfer in 4.84 and disfavor the formation of 
benzyl alcohol 4.77, which is supported by Gupta’s observation because the use of polar aprotic 
solvent DMF and the less Lewis acidic sodium base suppressed Cannizzaro side reaction. 
Scheme 4.10: Putative mechanism for the formation of benzyl alcohol 4.77 
 
Several polar aprotic cosolvents such as DMF, MeCN and DMSO were screened in their 
ability to suppress the formation of 4.77 and increase the yield (Figure 4.9, A). Gratifyingly, 
MeCN and DMSO reduced the amount of 4.77 formed and provided styrene 4.48 in 85% and 
81% yields respectively. Due to the relative cost of MeCN, DMSO was used as the co-solvent on 
scale. Telescoping the sequence from the phenol 4.51 and utilizing the optimized conditions 






Figure 4.9: Solvent screen to reduce benzyl alcohol 4.77 byproduct 
 
  4.2.2.3: Squarate addition 
With a robust and scaleable route for the synthesis of the bromostyrene 4.48 established, 
work began on the lithium-halogen exchange and subsequent coupling with the vinyl squarate 
4.8. Unfortunately, lithium-halogen exchange of the bromostyrene 4.48 and addition of the vinyl 
squarate 4.8 only gave returned squarate and the debrominated styrene 4.89 as the major 
products. Sadly, this result stands in contrast to the work done previously in the Martin group 










Scheme 4.11: Attempted squarate addition between 4.48 and 4.8 
  
  The generation of the organolithium species was analyzed by lithium-halogen exchange 
of 4.90, which was made via Wittig olefination from 4.36, with tert-BuLi and quenching with 
benzaldehyde as a model electrophile. These experiments revealed that along with the expected 
adduct 4.91, the debrominated styrene 4.92 and the bis-adduct 4.93 which was confirmed by 
oxidizing to the bis-ketone, (see experimental), were the primary side-products, and the cause of 
the mass imbalance (Table 4.2). Presumably, 4.92 was formed via the protonation of the 
aryllithium intermediate, but whether the proton source was internal or external was not clear. 
Several proton sponges in which their conjugate acids would not protonate the aryllithium 
intermediate, such as LiH, NaH and mesityllithium were added to the reaction mixture prior to 
metal-halogen exchange with tert-BuLi to rule out external proton sources as the origin of 4.92. 
Sodium hydride provided a small yield improvement of the adduct 4.91 but large amounts of 
debrominated product 4.92 seemed to suggest that the primary source of protons was internal. A 
solvent screen revealed that nonpolar solvents such as toluene produced more of the 
debrominated byproduct 4.92 and less of the bis-adduct 4.93 while the opposite was true in more 
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polar solvents such as THF. Accordingly, it was found that a mixture (3:1) of ether and toluene 
provided 4.91 in 76% yield and minimized the formation of 4.92 and 4.93 (for an explanation of 
these effects, see figure 4.10).  
Table 4.2: Solvent screen optimization for metal-halogen exchange 
 
Solvent T 4.91 4.92 4.93 
Et2O –78 °C 59% N/A 7% 
THF –78 °C 54% N/A 9% 
PhMe –78 °C 67% 32% N/A 
Et2O –100 °C 50% 22% N/A 
THF/Et2O/pentane
a –78 °C 45% N/A 30% 
MTBE –78 °C 32% N/A N/A 
PhMe/Hexaneb –78 °C 48% N/A N/A 
Et2O/PhMe
c –78 °C 76% N/A N/A 
a) 4:4:1 ratio of THF/Et2O/pentane. b) 1:1 ratio of PhMe/Hexane. c) 3:1 ratio of Et2O/PhMe 
Use of the optimized conditions for the metal-halogen exchange of 4.48, followed by 
reaction with the vinyl squarate 4.8 provided the desired adduct 4.49 in 32%, but 26 – 78% of the 







Equation 4.1: Successful squarate addition 
 
 
The presence of large amounts of 4.89, despite using NaH as a “proton sponge” suggests 
that there is another internal proton source besides tert-butyl bromide. The butylated byproducts 
isolated during the lithium-halogen exchange with the in situ protected aldehyde 4.36 suggests 
that the protons in the benzylic position may be the source of the debrominated product 4.89 (see 
Figure 4.4).  To investigate this possibility, the organolithium reagent was generated from 4.90 
with tert-BuLi in Et2O and stirred at room temperature for 2 h and then quenched with 
benzaldehyde (Equation 4.2). The main products were 4.94 and 4.95. The formation of 4.94 and 
4.95 are indicative of benzylic deprotonation during the reaction conditions. The benzylic anion 
must have reacted with oxygen to produce transient hemi-acetals, which collapsed to the 








Equation 4.2: Evidence for benzylic deprotonation during lithium-halogen exchange  
 
The combined observations seen in the solvent screen and the benzylic deprotonation 
experiment reveals a surprising amount of side-reactions occur during the metal-halogen 
exchange of 4.90. Metal-halogen exchange with tert-BuLi produces the aryllithium intermediate 
4.96 and tert-BuBr. In the desired pathway, a second equivalent of tert-BuLi deprotonates the 
tert-BuBr to form isobutylene, and reaction with benzaldehyde produces 4.91 (Figure 4.10, 
pathway A). If the solvent is too non-polar, the aryllithium reagent competes with tert-BuLi in 
the elimination of tert-BuBr to from the de-brominated product 4.92 (Figure 4.10, pathway B). If 
the solvent is too polar, the MOM group directs a second equivalent of tert-BuLi to deprotonate 
the aromatic ring of the benzyl group to form 4.93 after quenching with benzaldehyde (Figure 
4.10, pathway C). The organolithium 4.96 is unstable, and if the reaction temperature increases 
or too much time elapses, it will disproportionate to the benzyl anion 4.98, which will provide 











Figure 4.10: Putative mechanism for the formation of 4.91, 4.92 and 4.93 
 
a) Desired pathway to provide the expected adduct 4.91. b) Reaction of the aryl lithium with tert-BuBr to 
produce the debrominated product 4.92, which is favored when the reaction solvent is non-polar. c) MOM-directed 
ortho-metalation (DOM) of the benzyl group to produce the dianion 4.97, which produced 4.93 upon quenching 
with benzaldehyde. Favored in polar solvents. d) Disproportionation of the aryl lithium 4.96 to form benzyl anion 
4.98, which upon protonation produces the deprotonated byproduct 4.92. 
 
More aggregated organolithium reagents are less basic and should disfavor the benzylic 
deprotonation pathway to form 4.92. The degree of aggregation of the organolithium reagent is 
often a function of the coordinating ability of the solvent: coordinating solvents favor less 
aggregated states, while non-coordinating solvents favor more aggregated states. Accordingly, 
conditions were developed to generate the aryllithium in a non-coordinating solvent such as 
toluene to favor the more highly aggregated species, thus disfavoring the undesirable benzylic 
deprotonation pathway. Using n-BuLi in place of tert-BuLi should suppress any 4.92 formed by 
the reaction of the aryllithium with tert-BuBr. Several solvent mixtures of toluene were screened 
 258 
to optimize the amount of the benzaldehyde adduct 4.91 (Table 4.3).380 Interestingly, toluene 
with no added co-solvent gave the best yield of 4.91 (Table 4.3, Entry 4). The metal-halogen 
exchange was slower in toluene and did not go to completion at –78 ºC, but warming to 0 ºC 
provided complete conversion. Gratifyingly, very little of the debrominated byproduct 4.92 was 
seen, even at 0 ºC (Table 4.3, Entry 5).  
Table 4.3: Solvent screen in toluene 
 
Solvent Temp (ºC) Yield 
PhMe/THF (2:1) –78 50% 
PhMe/THF (9:1) –78 55% 
PhMe/THF (99:1) –78 32% 
PhMe –78 54% 
PhMe –78 → 0 76% 
 
Although application of the optimized conditions in toluene provided the desired product, 
the yields of 4.49 were only 18 – 32% (Equation 4.3). The product was accompanied with the 
debrominated compound 4.89, together with the compounds tentatively assigned to be 4.99 and 
4.100, each as single diastereomers in 11% and 9% yields, respectively. The structures of 4.99 
and 4.100 were assigned after full characterization by both 1D- and 2D-NMR (key HMBC 
correlations shown). Evidence for structure 4.100 was the presence of two carbonyl carbon 
atoms in the 13C-NMR at 192 ppm and 167 ppm indicating ketone and an ester functional 
groups; only four methoxy groups, and the presence of a quartet at 124 ppm (J = 284 Hz), which 
is characteristic of a CF3 carbon atom. Evidence for structure 4.99 was the presence of only one 
carbonyl carbon atom at 192 ppm, the presence of five methoxy groups and the presence of three 
acetal carbons at 99 ppm, 97 ppm and 120 ppm. The resonance at 99 ppm belonged to the carbon 
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atom of the MOM group (determined by HMBC, not shown) while two of the five methoxy 
groups were coupled to the acetal carbon at 120 ppm, and the other acetal was coupled to the 
olefin proton.   
Equation 4.3: Attempted squarate addition in toluene 
 
 
It is unclear if performing the metal-halogen exchange in toluene and subsequent addition 
of the vinyl squarate 4.8 had a role in the formation of 4.99 and 4.100, thus the previously 
optimized conditions were reinvestigated in order to maximize the yields of 4.49. Instead of 
warming the aryllithium to 0 °C before adding the squarate 4.8, the squarate 4.8 was added at –
78 °C, and the cooling bath was replace with an ice/water bath to rapidly warm the reaction 
mixture to 0 °C. Gratifyingly, use of this modification provided, after TFAA quench, the desired 
adduct 4.49 in 41% yield (Figure 4.11, A). Shockingly, the omission of TFAA also provided 
4.49 in 44% yield, indicating that the TFAA quench is not necessary to produce 4.49 (Figure 
4.11, B). In addition to the expected debrominated product 4.89, which was isolated in 20% 
yield, analysis of the reaction mixtures revealed that most of the “missing” mass in the reaction 
was going to a single byproduct, which after full characterization by 1D- and 2D-NMR was 
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tentatively determined to be 4.101 as a mixture (3.7:1) of olefin isomers in 10 – 20% yields. 
Evidence for the structure of 4.101 was presence of two carbonyl carbons at 196/194 ppm and 
171 ppm, indicative of a ketone and an ester; and the presence of two olefinic carbon atoms, (1) 
at 151 ppm, which was coupled to proton at 6.68 ppm (q, J = 7.3 Hz) via HSQC, and (2) at 139 
ppm, which was coupled to no protons via HSQC. Additionally, the proton 6.68 ppm (q, J = 7.3 
Hz) is coupled to the methyl group at 1.96 ppm (d, J = 7.3 Hz). 
Figure 4.11: Squarate addition and isolation of byproduct 4.101 
 
a) Addition of vinyl squarate 4.8 at –78 °C, followed by warming to 0 °C with TFAA quench. b) Addition of vinyl 
squarate 4.8 at –78 °C, followed by warming to 0 °C, no TFAA quench. Discovery of byproduct 4.101. 
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The byproducts 4.99, 4.100 and 4.101 may be related through a common intermediate. 
Addition of the organolithium 4.102 to vinyl squarate 4.8 produces the alkoxide 4.103, which 
upon workup and exposure to silica delivers the desired product 4.49. The alkoxide intermediate 
4.103, however, can undergo an electrocyclic ring opening to produce the vinylogous enolate 
4.104.381 In the presence of TFAA, the extended enolate undergoes a Claisen condensation to 
produce the trifluoro-ketone intermediate 4.105. The electrophilicity of the trifluoro-ketone 
moiety causes both a 5-exo cyclization from C5 to form the 4.100 and a 6-endo cyclization from 


















Scheme 4.12: Putative mechanism for the formation of 4.99, 4.100 and 4.101 
 
Although oxy-anions are known to accelerate the electrocyclic ring opening,381 there may 
be a minimum temperature at which the reaction takes place. Lithium-halogen exchange of the 
styrene 4.48, followed by quenching with the vinyl squarate 4.8 and warming to temperature 
intervals between –78 ºC and 0 ºC revealed that the minimum temperature with which the 
electrocyclic ring opening occurs is – 40 ºC (Table 4.4). Surprisingly, keeping the temperature at 
–78 ºC, lead to a decrease in the yield of 4.49 (Table 4.4, Entry 2). Adding the squarate at –78 ºC 
and replacing the cooling bath with a dry ice/ethanol/glycol bath (1:9) to rapidly raise the 
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temperature to –20 ºC provided the desired product 4.49 in 68% yield (Table 4.4, Entry 3). 
Unfortunately the yield decreased from 68% on a 100 mg scale to 40% on a gram scale, perhaps 
because at larger scales, the rate at which the internal temperature rises is much slower than on 
smaller scales (Table 4.4, Entries 3,5,6).   
Table 4.4: Temperature screen for squarate addition 
 
X ºC Scale (mg) Yield 
0 500  45 – 55% 
–78 100 43% 
–20 100 68% 
–40 500 53% 
–20 500 61% 
–20 1000 40% 
4.2.2.4: Attempted magnesium-halogen exchange 
The difficulty encountered with the addition of the aryllithium into the vinyl squarate 4.8 
prompted the investigation of the use of organomagnesium reagents, which are known to be less 
basic than their lithium counterparts. The magnesium-halogen exchange of 4.90 was attempted 
with i-PrMgBr•LiCl in THF with and without added dioxane, which was known to accelerate the 
reaction.382-386 Even with dioxane, the magnesium-halogen exchange was sluggish, and after 24 h 
and quenching with benzaldehyde, only debrominated material 4.92 was isolated (Scheme 4.13). 
The formation of 4.92 under these conditions is most likely due to the elimination of i-PrBr, 
which is produced after the magnesium-halogen between 4.90 and i-PrMgBr•LiCl. 
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Scheme 4.13: Attempted magnesium-halogen exchange with i-PrMgBr•LiCl 
  
Magnesium ate complexes are known to be more reactive than monoalkyl- and 
dialkylmagnesium compounds, and in 2001, Oshima demonstrated that magnesium ate 
complexes can be used in magnesium halogen exchange of a variety of arenes, even at –78 
ºC.387,389 Generation of [i-PrMgBu2]Li by adding two equivalents of n-BuLi to i-PrMgBr in THF, 
followed by addition of bromostyrene 4.90 presumably generated the ate-complex 4.106 
(Scheme 4.14). Unfortunately, quenching with benzaldehyde produced a mixture of the desired 










Scheme 4.14: Attempted magnesium-ate-halogen exchange with 4.90 
 
It is clear from these results that all three groups in the magnesium ate complex 4.106 can 
be transferred to an electrophile. To overcome this problem, MeLi was used instead of n-BuLi to 
generate the alternate ate complex [i-PrMgMe2]Li (Scheme 4.15). Methyl groups are known to 
have low migratory aptitude with similar organometallics and thus can be thought of as “dummy 
ligands”. 387,389 Gratifyingly, quenching with benzaldehyde furnished the desired adduct 4.91 in 
98% yield.  
Scheme 4.15: Successful magnesium-ate-halogen exchange with 4.90 
  
 
Unfortunately, generation of the magnesium ate complex 4.108 under the same 
conditions used previously and quenching with the vinyl squarate 4.8, produced the methylated 
compound 4.109 in 60% yield and debrominated compound 4.89. The formation of 4.109 can be 
explained by the reaction of [i-PrMgMe2]Li and 4.48 to produce methylbromide rather than the 
expected i-PrBr. The reaction of the arylmagnesium-ate complex with methyl bromide must be 
faster than the reaction with vinyl squarate 4.8. 
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Scheme 4.16: Attempted squarate addition with magnesium-ate complex 
 
Previous work done in the Martin group encountered difficulties with the metal-halogen 
exchange of bromostyrenes and subsequent addition to vinyl squarate 4.8. The bromostyrene 
4.48 turned out to be a uniquely frustrating substrate in this reaction. However, after 
optimization, the yields of 4.49 are now equal to those obtained by Dr. Mans and Dr. Knueppel 
(61 – 68%, Chapter 3, Scheme 3.41, 3.45). Key to this optimization was the discovery that the 
intermediate aryllithium reagent 4.102 is unstable and will disproportionate to the benzyl anion 
4.98 and that the intermediate vinyl squarate adduct 4.103 will undergo an anion-accelerated 
electrocyclic ring opening reaction at temperatures above – 40 °C (Scheme 4.12). 
4.2.3: RING CLOSING METATHESIS (RCM)  
Despite the moderate yields for the squarate addition, enough material was pushed 
through to explore the downstream chemistry. Subjection of 4.49 to the RCM conditions 
developed previously in the group provided the BC-ring fragment 4.110 in 60% yield, while use 
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of dichloroethylene (DCE) as the solvent offered no improvements (Table 4.5, Entry 1,2).390-393 
The presence of baseline material by TLC prompted the addition of BHT to the reaction mixture 
to suppress any possible radical side reactions.394 Although BHT seemed to slow the reaction, the 
yield did not change, and the overall mass balance was improved (Table 4.5, Entry 3). Heating 
slightly longer and quenching with DMSO (to sequester Ru salts) provided the BC-ring fragment 
4.110 in 78% yield (Table 4.5, Entry 4).395 
Table 4.5: RCM of squarate adduct 4.49 
 
 
Solvent T Additive Quench Yield 
PhMe 120 °C N/A N/A 60% 
DCE 90 °C N/A N/A 58% 
DCE 90 °C BHT N/A 57% (77% brsm) 
DCE 90 °C BHT DMSOa 78% (91% brsm) 
 
a) DMSO sequesters Ru salts.  
4.3: Acetylide addition 
Synthesis of the F-ring fragment 4.113 began with demethylation of the aldehyde 4.111 
using freshly distilled BBr3, which was key for clean demethylation with minimal byproducts 









Two sequences are possible for the generation of 4.115, the precursor for the Moore 
rearrangement. Ethynyl magnesium bromide could be added to 4.110 followed by coupling with 
aldehyde 4.113 (Figure 4.13, Pathway A) or ethynyl magnesium bromide could be added to 
aldehyde 4.113 followed by coupling with 4.110 (Figure 4.13, Pathway B).345, 346 Previous 
difficulties with adding 4.114 to 4.110 (Pathway B) prompted the investigation of adding 4.113 
to 4.112 first (Pathway A). Several bases, solvents and additives were screened in an effort to 
prepare 4.115. Bromomagnesium 2,2,6,6-tetramethylpiperidide (TMPMgBr) was shown to be 
highly effective for the similar coupling in the synthesis of IB-00208 (see Chapter 3, Scheme 
3.52), but use of this base only provided 4.115 in 35% yield. Prolonged stirring with TMPMgBr 
or with other bases only produced multiple unidentifiable byproducts and did not increase yield. 
Interestingly, the coupling of 4.114 to 4.110 (Pathway B) using TMPMgBr also provided 4.115 
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A review of the literature for methods to couple aldehydes and alkynes lead to an 
intriguing example in Myers’ synthesis of the core of neocarzinostatin.397 The intramolecular 
coupling of the aldehyde and alkyne moieties in 4.116 proved troublesome due to the sensitivity 
of 4.116 to both basic and acidic conditions (Figure 4.14, A). To address these issues, Myers 
found that adding 4.116 to a pre-mixed solution of LiHMDS and anhydrous CeCl3, formed the 
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cyclized product 4.117 in 87% yield. To replicate this procedure, 4.114 was added to a pre-
mixed solution of LiHMDS and anhydrous CeCl3•2LiCl, followed by 4.110 to provide 4.115 in 
47% yield (Figure 4.14, B). 
Figure 4.14: Myers’s LiHMDS/CeCl3 mediated coupling of acetylides and aldehydes 
 
a) Myers’s LiHMDS/CeCl3 mediated intramolecular coupling of 4.116 toward neocarzinostatin.
397 b) 
Application of LiHMDS/CeCl3 toward the intermolecular coupling of 4.114 and 4.110.  
This result prompted the investigation of organocerates because they are known to have 
enhanced nucleophilicity and reduced basicity. However, the use of anhydrous CeCl3•2LiCl with 
LiHMDS or other amide bases did not offer any improvements.167 The ideal method would be to 
quantitatively generate the cerium acetylide in situ. However, this poses a problem: As seen with 
MnCl2•2LiCl (see Chapter 2, Figure 2.6), salts such as CeCl3•2LiCl will contain adventitious 
proton sources which will consume any base used to generate the acetylide anion. Usually these 
problems can be solved by the addition of excess base, but only if the electrophile is either in 
excess or not a limiting reagent, which is presently the case. Ideally, an internal indicator would 
be used to measure the quantity of n-BuLi needed for acetylide formation, but the indicator must 
maintain a brightly colored endpoint in the presence of Lewis acids such as CeCl3.  
Serendipitously, such an indicator was discovered in 4-(phenylazo)diphenylamine (PDA) 
(4.118), which was originally used for the titration of TMPMgBr.398 PDA was found to turn deep 
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purple once deprotonated even in the presence of CeCl3, and it can form highly colored 
complexes even in the presence of a variety of Lewis acids and solvents (Figure 4.15).  


















a) Color of PDA after deprotonation. b) Color of PDA. c) Color of PDA after protonation or complexation with a 
Lewis acid. 
To utilize PDA as an internal indicator for the quantitative deprotonation of 4.114, the 
relative pKa values of the indicator, the alcohol and the acetylide needed to be determined. The 
addition of n-BuLi to a solution of freshly distilled propargyl alcohol and PDA revealed that the 
colored endpoint appeared after the addition of one equivalent of n-BuLi. This means that the 
pKa of PDA is greater than the alcohol proton, but less than the acetylide proton, thus to use 
PDA as an internal indication to generate the acetylide anion, additional equivalent of n-BuLi 
would be needed after the endpoint was seen. Gratifyingly, adding n-BuLi to a mixture of 4.114, 
CeCl3•2LiCl and PDA until a vivid purple endpoint was seen, followed by adding another 
equivalent of n-BuLi and 4.110 provided the adduct 4.115 in 84% yield (Equation 4.4). 
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Equation 4.4: Successful alkyne addition utilizing CeCl3•2LiCl and PDA as an internal indicator 
 
 
4.4: Use of PDA for the titration of bases, Lewis acids and reducing agents 
4.4.1: TITRATION OF BASES 
The success of the acetylide addition using PDA 4.118 as an internal indicator led to the 
investigation of PDA 4.118 as an general-purpose, indicator to titrate a variety of reagents.399 
While there are numerous techniques for determining the concentrations of strongly basic 
carbanions such as alkyllithium and Grignard reagents, reliable methods for titrating weaker 
bases, such as amide anions, are lacking.400, 409,417 Furthermore, there are few reliable methods 
available for titrating solutions of common Lewis acids.425-427 
The general strategy for using PDA to titrate bases and acids is outlined in Figure 4.16. 
Bases with conjugate acids have a pKa greater than PDA can be titrated with an acid having a 
pKa less than PDA (Figure 4.16, 4.118 → 4.119). Alternatively, acids having a pKa less than that 
of PDA can be titrated using a base that has a conjugate acid with a pKa greater than PDA 
(Figure 4.16, 4.118 → 4.120). By selecting the right standard acids and/or bases, a general 
method to titrate unknown acids and/or bases that have a pKa above and below the pKa of PDA 





Figure 4.16: Use of PDA to titrate a variety of acids and bases 
 
a) 4.118 → 4.120: titration of an unknown weak base. b) 4.120 → 4.118: titration of an unknown strong 
acid. c) 4.118 → 4.119: titration of an unknown weak acid. d) 4.118 → 4.119: titration of an unknown strong base.  
To examine the feasibility and scope of using PDA as an indicator for the titration of 
bases, the concentration of a series of bases commonly encountered in a synthetic laboratory was 
determined using sec-butanol as the standard acid. The results thus obtained were compared to 
the concentrations obtained using other reported methods (Table 4.6). PDA is equally effective 
as known methods in determining the concentrations of n-BuLi, EtMgBr, (i-Pr)2NMgBr, tert-
BuLi, n-BuZnX•MgX2•LiX, and HC≡CMgBr. Endpoints for the various titrations were dramatic 
and ranged from bright red with magnesium bases to deep purple with potassium bases. In the 
case of HC≡CMgBr, it was necessary to add DMPU as a cosolvent to improve the rate of the 





Table 4.6: Titration of bases with PDA 
 
  Standard Methodsg   PDAg Total Basef 
Base (M)  Ind H+ (M)j  H+ (M)j  
EtMgBr 1 1,10-Phend s-BuOH 1.07±0.01  s-BuOHk 1.06 ± 0.04 1.13 
(iPr)2NMgBr
a 0.83 1,10-Phend s-BuOH 0.68±0.03  s-BuOHk 0.64 ± 0.04 0.86 
n-BuLi 2.5 1,10-Phend s-BuOH 2.11±0.11  s-BuOH 2.10 ± 0.10 2.33 
tert-BuLi 2 n-piv-toluidinec N/A 1.61  s-BuOHi,k 1.64 ± 0.10 3.29 
n-BuZnXb 0.5 I2/LiCl
e N/A 0.27±0.01  s-BuOHk 0.25 ± 0.04 0.47 
HC≡CMgBr 0.5 1,10-Phend s-BuOH 0.55±0.03  s-BuOHh,k 0.55 ± 0.02 0.55 
aMade by refluxing (i-Pr)2NH and EtMgBr in THF for 24 h.
 bMade in situ from Mg in THF with fused 
ZnCl2, LiCl and n-BuBr (ref 421).
 cAdded tert-BuLi to a solution of n-pivaloyl toluidine in THF at 0 oC until a 
yellow endpoint was observed (ref 405). d1,10-Phenanthroline was pre-activated with 1 drop n-BuLi, and sec-
butanol was used as the proton source (ref 410, 416). eUsed a solution of I2 in 0.5 M LiCl in anhydrous THF (ref 
418). fCalculations for total base were done by adding to deionized water and titrating with HCl that had been 
standardized with potassium hydrogen phthalate (KHP) using phenolphthalein as the indicator (ref 424). gUnless 
otherwise indicated, all titrations were done in anhydrous THF at 0 oC. hDMPU was added as a cosolvent to make 
color change more distinct. iAnhydrous Et2O was used as the solvent. 
jEach titration was done in triplicate and 
confidence intervals set to 95%. kEndpoint was red. 
In initial experiments to titrate NaHMDS with sec-butanol and PDA, no endpoint was 
observed. Surprisingly, sodium 2-butoxide, which is produced during the titration, was found to 
deprotonate PDA. This finding prompted a brief inquiry of counterion effects with alkoxides. 
The lithium, sodium and potassium conjugate bases of n-BuOH, sec-BuOH and tert-BuOH were 
added to a solution of PDA in THF in order to determine which alkoxides can deprotonate PDA 
(Figure 4.17). These experiments showed that the lithium alkoxides do not deprotonate PDA in 






Figure 4.17: Effect of cation on alkoxides in the presence of PDA 
 
With the knowledge that sodium and potassium alkoxides can deprotonate PDA, a 
different standard weak acid was sought with a pKa which is slightly lower than sec-butanol 
(pKa = 30.3 in DMSO).422 Fortunately butylated hydroxytoluene (BHT) was found to fit this 
need (pKa = 16.8 in DMSO).423 Gratifyingly, use of BHT instead of sec-butanol in the titration 
of NaHMDS gave titers that were comparable to the ones obtained when using 1,10-
phenanthroline as the indicator (Table 4.7, Entry 1). The observation that potassium alkoxides 
can deprotonate PDA suggested that it might be possible to develop a procedure to titrate tert-
BuOK utilizing BHT as the standard acid. As expected, PDA can also be used for the titration of 
tert-BuOK (Table 4.7, Entry 2). However, because there are no standard procedures titrating 
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potassium alkoxides, the question accuracy remains. KOH, the most likely basic contaminant in 
tert-BuOK, was added to a variety of organic solvents in order to determine if KOH can 
deprotonate PDA. KOH was found to not deprotonate PDA in every solvent screened except for 
DMSO. Even adding tert-BuOK to wet THF to generate reactive microcrystalline KOH did not 
deprotonate PDA. These results support that the titer for tert-BuOK with PDA and BHT is 
accurate, so PDA is the first indicator that has been reported to directly titrate solutions of tert-
BuOK. 
Table 4.7: Use of BHT to titrate NaHMDS and tert-BuOK 
 
  Standard Methods   PDAc Total Baseb 
Base (M)  Ind H+ (M)  H+ (M)d  
NaHMDS 2 1,10-Phena s-BuOH 1.87 ± 0.09  BHT 1.83 ± 0.12 2.18 
tert-BuOK 1 N/A N/A N/A  BHT 0.71 ± 0.02 0.92 
a1,10-Phenanthroline was pre-activated with 1 drop n-BuLi, and sec-butanol was used as the proton source. 
bCalculations for total base were done by quenching into deionized water and titrating with HCl that had been 
standardized with potassium hydrogen phthalate (KHP) using phenolphthalein as the indicator (ref 424). cUnless 
otherwise indicated, all titrations were done in anhydrous THF at 0 oC. dEach titration was done in triplicate and 
confidence intervals set to 95%. 
 
 
Although PDA was shown to be an effective indicator for titrating strong bases such as n-
BuLi, weaker bases such as ZnMe2 and n-BuZnCl•LiCl do not deprotonate PDA. However, we 
resoned that it might be possible to titrate these bases by using a standard strong acid. The 
endpoint would occur when the base is consumed and the acid protonates PDA. A solution of 
NaOH was titrated with a standardized solution of HCl, and PDA proved just as effective as 
phenolphthalein as an indicator (Table 4.7, Entry 1). With the proof of principal established, the 
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titration of ZnMe2 and n-BuZnCl•LiCl was attempted using CSA as an anhydrous standard acid 
(Table 4.7, Entries 2, 3). Unfortunately, the values obtained with PDA seemed to be closer to the 
values obtained when ZnMe2 or n-BuZnCl•LiCl were quenched into water and titrated with HCl 
rather than the values obtained with iodometric titration. This suggests that protic strong acids 
may not be the best choice for determining the concentration of active weakly basic 
organometallic reagents.  
Table 4.7: Attempted titration of weak bases 
 
  Standard Methodse   PDAe Total Based 
Base (M)  Ind H+ (M)g  H+ (M)g  
NaOHa 1 Phenolphthalein HCl 0.95 ± 0.06  HClf 0.96 ± 0.02 N/A 
n-BuZnClb 0.5 I2/LiCl
c N/A 0.24 ± 0.02  CSA 0.50 ± 0.02 0.47 
Me2Zn 1.2 I2/LiCl
c N/A 1.20 ± 0.21  CSA 1.31 ± 0.10 1.38 
aStandardized with potassium hydrogen phthalate (KHP). bMade by adding n-BuLi to fused ZnCl2.
 cUsed a solution 
of I2 in 0.5 M LiCl in anhydrous THF. 
dCalculations for total base were done by quenching into deionized water and 
titrating with HCl that had been standardized with potassium hydrogen phthalate (KHP) using phenolphthalein as the 
indicator (ref 424). eUnless otherwise indicated, all titrations were done in anhydrous THF at 0 oC (ref 418). 
fTitration done in MeOH/H2O. 
gEach titration was done in triplicate and confidence intervals set to 95%. 
4.4.2: TITRATION OF LEWIS ACIDS 
Methods for titrating Lewis acids have been surprisingly neglected. Indeed, there are only 
two general procedures that are frequently used to determine the concentration of solutions of 
Lewis acids. The first of these involves titrating the protic acid that is released upon quenching 
the Lewis acid in water using a standard base and phenolphthalein as the indicator. Although this 
method works in some cases, a number of Lewis acids, such as MgBr2•Et2O, do not produce an 
equivalent of acid when they are quenched with water. The second common procedure to 
determine concentrations of Lewis acids involves complexometric titration with ethylenediamine 
tetraacetic acid (EDTA).425 Such titrations are performed by adding a standard solution of EDTA 
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to an aqueous solution of the Lewis acid containing an indicator that forms a colored complex 
with the metal ion. The endpoint is reached when the color disappears. The drawback of this 
method is that the total metal ion concentration may not accurately reflect the amount of active 
Lewis acid in solution owing to adventitious moisture. Hence, there is a need for better methods 
to determine the concentrations of common solutions of Lewis acids. 
As outlined in Figure 4.16, pyridine was chosen as the standard weak base in the titration 
of Lewis acids using PDA as an indicator. The concentrations of AlMe3 and i-Bu2AlH that were 
determined using pyridine and PDA as the indicator gave titers comparable to those obtained 
using standard procedures (Table 4.8, entries 5,6).426,427 The concentration of Me2AlCl 
determined with PDA was in good agreement with the value obtained by quenching into water 
and the titration of the protic acid (Table 4.8, entry 1). The titers that were determined for 9-
borobicyclononane bromide (9-BBN-Br), TiCl4, and MgBr2•Et2O were roughly twice that 
obtained using standard methods (Table 4.8, entries 2 – 4). This may be due to complexes such 
as 4.122, which is in equilibrium with 4.123, that can form upon combination of Lewis acids and 
pyridine (Scheme 4.18).428 The reaction of 4.122 or 4.123 with a second equivalent of Lewis base 
forms 4.124 before the violet endpoint is observed. Similar reactions may be envisioned for 
TiCl4 and MgBr2•Et2O. When this 1:2 stoichiometry is taken into consideration, titration of these 
Lewis acids with pyridine using PDA as an indicator gave titers comparable to those obtained by 
titrating the Brønsted acid released upon reaction of the Lewis acid with water or by 
complexometric titration with EDTA using eriochrome black t as the indicator (Table 4.8, entries 
4 – 6).425 The concentrations of 9-BBN-Br determined by hydrolysis and MgBr2•Et2O 
determined using a EDTA titration were slightly different from the values determined with PDA 
(Table 4.8, entries 5,6). Although the reasons for these discrepancies are currently unknown, 
some possible causes may be postulated. For example, the borinic acid formed upon hydrolysis 
of 9-BBN-Br with water might consume hydroxide ion, thereby resulting in underestimating the 
Lewis acid concentration.429 Supporting this hypothesis, titration of the acid released upon 
reaction of 9-BBN with methanol and triethylamine using PDA as an indicator also gave a titer 
 279 
of 1.18 ± 0.24 M, a result very similar to that obtained with PDA and pyridine.  That the 
concentration of MgBr2•Et2O determined by titration with EDTA was somewhat higher than the 
one determined with PDA might arise because complexometric titration measures the total 
concentration of magnesium ions, not just MgBr2•Et2O. Hence, complexometric titration may 
overestimate the Lewis acid concentration. 
Table 4.8: Use of PDA to titrate Lewis acids 
 
  Standard Methods    PDAa  
Acid (M)  Ind base (M)b  H+ (M)b 
Et2AlCl 1 Phenolphthalein
d NaOH 0.77 ± 0.37  pyridine 0.87 ± 0.06 
9-BBN-Br 1 Phenolphthaleind NaOH 1.01 ± 0.07  pyridine 1.18 ± 0.24f 
TiCl4 1 Phenolphthalein
d NaOH 0.93±0.23g  pyridine 0.96 ± 0.10f 
MgBr2•Et2O
h 0.86 Eriochrome black te EDTA 1.08 ± 0.03  pyridine 0.83 ± 0.11f 
AlMe3 1 Phenazine
c pyridine 0.72 ± 0.07  pyridine 0.79 ± 0.03 
iBu2AlH 1 Phenazine
c pyridine 0.83 ± 0.03  pyridine 0.83 ± 0.03 
aUnless otherwise indicated, all reactions were run at room temperature in anhydrous DCM. bEach titration was done 
in triplicate and confidence intervals set to 95%. cAnhydrous toluene was used as the solvent (ref 426, 427). 
dCalculations were done by quenching into deionized water and titrating with NaOH that had been standardized with 
potassium hydrogen phthalate (ref 424). eEDTA was standardized with Zn(OAc)2•2H2O and Eriochrome black t (ref 
425). fMolarity calculated using 1:2 stoichiometry of Lewis acid to pyridine (see text for discussion). gMolarity 
calculated using 4:1 stoichiometry of  NaOH to Lewis acid. hPrepared from Mg and ethylene dibromide in 
anhydrous Et2O then adding benzene until the biphasic MgBr2•OEt2 mixture becomes homogeneous. 




4.4.3: TITRATION OF REDUCING AGENTS 
Metal hydride reducing reagents are frequently employed in synthesis, and many of the 
indicators that have been used to titrate bases have been also used to titrate LiAlH4 and other 
reducing agents.430-432 Benzophenone was found to be a convenient agent to determine the titer of 
some reducing agents using PDA as an indicator. Benzophenone reacts with the reducing agent 
to form a species that does not induce a change in the color of the indicator. Once all of the 
benzophenone is consumed, the reducing agent will either deprotonate the indicator to form a 
colored complex or form a colored Lewis acid/base pair depending upon the acidic or basic 
character of the reducing agent. The use of this method to determine the concentration of several 
reducing agents was compared to a commonly-used procedure in which reduction of fluorenone, 
which is yellow, leads to a colorless solution (Table 4.9). The titers of LiAlH4 and LiB(sia)3H 
were determined using PDA as an indicator,  and the values thus obtained compare well to those 
found with fluorenone (Table 4.9, entries 2,3). However, the titer of i-Bu2AlH, which is Lewis 
acidic in nature, with PDA differs from that obtained using the fluorenone method (Table 4.9, 
entry 1). Notably, the titer of this solution of i-Bu2AlH using benzophenone and PDA is within 
experimental error to that determined using pyridine and either PDA or phenazine (Table 4.8, 












Table 4.9: Use of PDA to titrate reducing agents 
 
  Fluorenonea  PDA 
 
Red agent (M)  (M)e  Hydride acceptor (M)e 
iBu2AlH 1 1.02± 0.1  benzophenone 0.84 ± 0.06
b 
LiAlH4 1 0.99 ± 0.15
d  benzophenone 1.02 ± 0.18c,d 
LiB(sia)3H 1 1.06
f  benzophenone 1.04 ± 0.09c 
aUnless otherwise indicated, all titrations were done in anhydrous THF at room temperature (ref 430). bTitration was 
done in anhydrous CH2Cl2 at room temperature. 
cTitration was performed in anhydrous Et2O at room temperature.
 
dMolarity calculated using 4:1 stoichiometry of benzophenone to reducing agent. eUnless otherwise indicated, each 
titration was done in triplicate and confidence intervals set to 95%. fTitration was only done once due to unexpected 
color change. 
In summary, PDA is a convenient, colorimetric indicator that can be easily used to 
directly determine the concentrations of a variety of strong carbon- and nitrogen-centered bases 
in the presence of a number of counterions, including Li, Na, K, Mg, and sometimes Zn. 
Additionally, we found that PDA could be used as an indicator to titrate tert-BuOK without 
interference from KOH or other basic impurities. Although the titration of weaker bases such as 
ZnMe2 and n-BuZnCl•LiCl with CSA and PDA give results that reflect the total base content, it 
is possible that by prudent selection of the standard acid or base, it may be possible to determine 
the concentration of many reactive reagents commonly used in synthetic organic chemistry. PDA 
was also shown to be an effective indicator for titrating a number of Lewis acids using pyridine 
as a standard base. Finally, the concentrations of hydride reducing agents can be determined 
using benzophenone and PDA. Currently, however, the limitations of using PDA as an indicator 
include; (1) The titrations of weakly basic organometallic agents; (2) Hydride reducing agents 
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which are neither basic enough to deprotonate PDA nor acidic enough to protonate PDA, and (3) 
Weak Lewis acids which do not complex PDA to produce a colored complex. 
4.5 Hydrolysis of acetal and Moore rearrangement 
4.5.1: HYDROLYSIS OF ACETAL 4.115 
4.5.1.1: Hydrolysis of PMB protected F-ring fragment 
The utilization of PDA as an internal indicator enabled the synthesis of multiple grams of 
the acetal 4.115, and our focus was directed to effecting the hydrolysis of the 4.115 and 
subsequent Moore rearrangement. Hydrolysis of the acetal moiety in 4.115 using the same 
conditions used in the synthesis of IB-00208 (Figure 4.18, B) (see also Chapter 3, Schemes 3.42 
and 3.52) produced only complex mixtures (Figure 4.18, A). 
Figure 4.18: Hydrolysis of 4.115 and hydrolysis of 4.126 in the synthesis of IB-00208 
 
a) Attempted hydrolysis of acetal 4.115. b) Successful hydrolysis of 4.126 using the same conditions 
Both compound 4.115 and compound 4.126 contain several acid sensitive moieties such 
as the MOM and PMB protecting groups as well as the benzyl alcohol groups at C8 and C17. 
However, only 4.115 contains PMB groups, so they were initially thought to be the culprit. A 
survey of the literature for methods that hydrolyze acetals in the presence of benzyl alcohols or 
PMB groups (Table 4.10) revealed that lanthanide triflates (Table 4.10, entries 2,5 and 9) and 
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acid-doped silica (Table 4.10, entries 2,5 and 9) are highly effective Lewis acids for this 
purpose.433-458   
Table 4.10: Lewis acid mediated hydrolysis of Acetal 
 
 
Ref LA Additive Conditions Yield 
Conia433 silica oxalic acid CH2Cl2, rt 77 – 98% 
Yadav436 CeCl3 NaI MeCN, reflux 81 – 92% 
Yadav437 I2  MeCN, rt 90 – 95% 
Fujioka438-447 R3SiOTf R3N CH2Cl2, 0 ºC 74 – 92% 
Fujioka448-452 TESOTf P(o-tol)3 CH2Cl2, 0 ºC 80 – 95% 
Procopio453 Ce(OTf)3  MeNO2, rt 25 – 99% 
Hu454 I2  acetone, rt 93 – 98% 
Gregg455 In(OTf)3  acetone, rt 32 – 94% 
Li456 TFA  HCCl3, rt 90 – 100% 
Procopio457 Er(OTf)3  MeNO2, rt 68 – 99% 
Hou458 Ph3PHBr  CH2Cl2, 50 ºC 61 – 90% 
 
Several Lewis and Brønsted acids were screened to hydrolyze 4.115 to 4.125, but all 
conditions produced complex mixtures except oxalic acid-doped silica, where the desired 
product was detected by LCMS in trace amounts (Equation 4.5). Developed by Conia in 1978,433 
acid-doped hydrated silica is prepared by adding either oxalic acid (0.25 mmol/g silica) or 
sulfuric acid (for harder to hydrolyze acetals) and water (0.1 mL/g silica) to a rapidly stirred 
slurry of silica in CH2Cl2. Conceivably, any acid could be doped onto the silica and in order to 
develop a milder hydrolysis of 4.115. Hence, a series of Brønsted acids were screened according 
to their pKa values. Strong acids such as PTSA and HCl produced multiple products, while 
weaker acids such as acetic acid did not promote any reaction. Fortunately phosphoric acid and 
fumaric acid produced a single product, but the reaction times were considerably longer with 
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fumaric acid. Screening the solvent revealed an interesting trend: The reaction was fastest in 
nonpolar solvents CH2Cl2 and PhMe, while more polar solvents slowed the reaction down 
considerably. This observation is consistent with the need for the substrate to adsorb to the silica 
in order to hydrolyze.  
Equation 4.5: Hydrolysis screen 
 
With the hydrolysis of 4.115 optimized using H3PO4/silica in CH2Cl2, the reaction was 
scaled up. A single product was produced, but the NMR spectra did not match that expected for 
4.124. After analyzing the 1H-NMR, 13C-NMR, HSQC, and HMBC spectra, the product of the 
reaction was assigned as being 4.128, present as a mixture of rotamers (key HMBC correlations 
shown) (Scheme 4.19). Furthermore, the mass of 4.128 is 734, which is the same mass of the 
starting material less water. There were no carbonyl carbon atoms present in the 13C-NMR, and 
the presence of two new Csp2-O carbon atoms with an HMBC correlation to the proton attached 






Scheme 4.19: Unexpected formation of 4.128 during hydrolysis of 4.115  
 
 
Examples of but-2-yne-1,4-diols rearranging to furans are known.459,460 Particularly 
relevant is the work by Chan,460 who found that heating but-2-yne-1,4-diol 4.129 in 
dichloroethane (DCE) with PTSA produced mixtures of the allene 4.131 and furan 4.130 when 
the reaction was stopped after only 30 minutes, but furan 4.130 was formed as the sole product 








Scheme 4.20: Precedence for the rearrangement of but-2-yne-1,4-diols  to furans 
 
The putative mechanism for the formation of 4.128 is shown in Scheme 4.21. The 
rearrangement starts by ionization of the C8 alcohol to the benzyl cation 4.132, followed by a 
semipinacol-like rearrangement that results in the ring-expansion of the cyclobutanone and 
migration of the aryl ring to produce the allene 4.133. Protonation of the allene produces the 
carbocation 4.134 that is intercepted by the carbonyl oxygen atom to form the oxonium ion 











Scheme 4.21: Putative Mechanism for the formation of 4.128 
 
The acid sensitivity of the C8 benzyl alcohol in 4.115 led to the investigation of other 
routes to circumvent the need to hydrolyze the acetal. Suzuki used a Moore-like rearrangement 
of benzocylobutanone acetals to produce hydroquinones in his syntheses of TAN-1085 and other 
natural products.461-468 This strategy is attractive because it would circumvent the need to 
hydrolyze 4.115 to 4.125. Unfortunately, attempts to rearrange 4.115 to the quinone acetal 4.136 
by heating in toluene led to complex mixtures (Figure 4.19, A). Reducing the acetylene to the 
trans alkene with LiAlH4 provided a compound with a mass consistent with 4.137 by LCMS in 
50% yield (Figure 4.19, B).469 Attempts to oxidize the benzyl alcohol to the ketone 4.138 or 






Figure 4.19: Attempted alternate Moore-like rearrangements 
a)  
 
Attempted Moore cyclization from acetal 4.115. b) Reduction of alkyne 4.115 to alkene 4.137 with LiAlH4. 
c) Attempted oxidation of benzylic alcohol to the ketone 4.138. d) Attempted cyclization of alkene 4.137 to 
monomethylhydroquinone 4.139. 
Serendipitously, compound 4.113 was left overnight in an NMR tube during 
characterization, whereupon returning the next day, two products were seen by TLC. Purification 
of the mixture provided 4.113 and 4.140 in 40% and 33% yields, respectively (Equation 4.6). 
Compound 4.140 was clearly formed upon the hydrolysis of 4.113 due to the trace acid in CDCl3 
as evidenced by the fact that there were only two methyl peaks present in the 1H-NMR spectrum. 
This result further implicated the C8-benzyl alcohol as the acid sensitive moiety of 4.115 and not 
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the PMB or acetal groups. The question remained: Why was the hydrolysis of 4.126 successful 
but the hydrolysis of 4.115 unsuccessful? 















4.5.1.2: Design, synthesis and utilization of an acid stable F-ring fragment 
The striking differences between hydrolysis outcomes can be explained by an in-depth 
analysis of mechanism. In order for a benzyl alcohol moiety to ionize, two things must occur: 
First, the alcohol must be activated via protonation. Second, the plane of the aromatic ring must 
rotate until perpendicular to the activated alcohol so that the π-system can donate into the O-C 
σ*-orbital in order to break the bond (Figure 4.20, A). Compound 4.126, because it contains 
substitution in both ortho-positions, will always suffer A1,3 strain if the arene ring is 
perpendicular to the incipient oxonium ion (Figure 4.20, B). Compound 4.115, however, has one 
A1,3 interaction but it can rotate 180º so there is no steric penalty (Figure 4.20, A). In order to 
disfavor the rotation of the arene ring without the aid of A1,3 strain, a new protecting group 
scheme was devised (Figure 4.20, C). Tethering both the propargyl alcohol and the phenol 
together in 4.145 would force the arene to adopt a high energy boat-like orientation in order for 
the arene to be perpendicular to the O-C σ*-orbital (4.146). Additionally if the groups labeled R 
are sufficiently bulky, the boat like conformation would also have significant steric congestion. 
Looking to previous work by Dr. Mans, Dr. Knueppel and Dr. Nichols, the cyclic silyl ether 
4.147 was identified as an ideal candidate for this purpose (see Chapter 3, sections 3.42, 3.45, 
and 3.54).  
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Figure 4.20: Putative hypothesis of the difference between the hydrolysis of 4.115 and 4.126  
 
a) Hydrolysis of 4.115, only one A1,3 interaction in 4.141. b) Hydrolysis of 4.126, two A1,3 interaction are present in 
4.143 and 4.144. c) Cyclic derivative 4.145 would have to adopt the boat-like conformation 4.146 to ionize. 
As a direct comparison to the fragment 4.126, the TBS ether analogue of 4.147 was 
synthesized in two steps from the aldehyde 4.112 (Figure 4.21, A). The synthesis of the cyclic 
silyl ether 4.147, however, was hampered by the extreme sensitivity of the intermediate acetylide 
adduct (not shown), which suffered rapid decomposition with acid, heat, prolonged exposure to 
silica gel and even the trace acid in CDCl3. Initial attempts form 4.147 from the crude material 
without purification resulted in large amounts of the hydrolyzed compound 4.150. Although 
4.150 could be transformed into the desired product 4.147 under Mitsunobu conditions,470,471 the 
yields were only 20%. Fortunately, purification of the crude acetylide with a quick silica plug 
and concentration of the eluent under reduce pressure without heat, sufficiently purified the 
material without decomposition. Thus, the subsequent protection as the cyclic silyl ether 
furnished 4.147 in 82% yield.  
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Figure 4.21: Synthesis of F-ring coupling partner 4.147 and 4.149 
  
 
The three F-ring fragments 4.113, 4.149 and 4.147 were subjected to the hydrolysis 
conditions developed previously (H3PO4/silica) (Figure 4.22). Unsurprisingly, F-ring fragment 
4.113 decomposed under the reaction conditions (Figure 4.22, A). The TBS ether analogue 4.149 
also decomposed when exposed to the H3PO4/silica hydrolysis conditions (Figure 4.22, B). 
Subjection of the cyclic silyl enol ether 4.147 to the reaction conditions produced no noticeable 
decomposition, even after 24 hours, and 4.147 was recovered in quantitative yield (Figure 4.22, 








Figure 4.22: Stability test of F-ring fragments 4.113, 4.147 and 4.149 to acetal hydrolysis 
conditions 
 
The addition of n-BuLi to a mixture of 4.147, CeCl2•2LiCl and PDA until a purple 
endpoint was seen, whereupon another equivalent of n-BuLi and 4.110 were added to provide 
4.151, which was contaminated with the ring-opened compound 4.152 and the dimer 4.152 
(Figure 4.23). Dr. Alex Nichols encountered similar problems with ring opening during the 
coupling of cyclic silyl ethers such as 4.147, but he was able to suppress the hydrolysis products 
by quenching the reaction with acetic acid instead of water or sodium bicarbonate.349 
Presumably, the cyclic silyl ether moiety is susceptible to cleavage by the hydroxide ion that is 
formed when the reaction is quenched with water or aqueous sodium bicarbonate solutions. The 
acetic acid quench allowed for the synthesis of 4.151 in 90% yield on multigram scale which 
after hydrolysis of the acetal moiety with H3PO4/silica provided 4.154 in 70 – 99% yield (Figure 





Figure 4.23: Adaption of alkyne addition toward the coupling of 4.147 and 4.110 and subsequent 
acetal hydrolysis 
 
4.5.2: MOORE REARRANGEMENT 
4.5.2.1: Optimization of Moore rearrangement 
Attempts to initiate the Moore cyclization of 4.154 by heating in DMSO produced only 
trace amounts of desired product 4.154 (Scheme 4.25, A). This observation stands in contrast to 
the result obtained upon heating 4.126 in DMSO to produce 4.155 in 66% yield (Scheme 4.25, 
B).  Changing the concentration, temperature or using other solvents also did not improve yields. 
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The Moore rearrangement has been shown to go through a radical mechanism, and radical side-
reactions may be responsible for the low yield. Unfortunately, use of BHT or Bu3SnH as radical 
inhibitors had little effect on the reaction outcome. 
Figure 4.25: Initial screen for Moore rearrangement 
 
a) Attempted Moore rearrangement of 4.154. b) Moore rearrangement of 4.126 in the synthesis of IB-00208 
aglycone. 
The initial failure of the Moore rearrangement led to the re-investigation of the Cu(OAc)2 
mediated transformation of 4.156 to 4.157 discovered by Dr. Mans (Figure 4.25, A see also 
Chapter 3, Figure 3.11).  An intermediate such as 4.157 could potentially be elaborated to the 
core of citreamicin via displacement of the methoxy group by the neighboring phenoxide. 
Accordingly, subjection of 4.154 to Dr. Mans’s conditions produced a single product in 64% 
yield. After characterization of the compound by 1D- and 2D-NMR spectroscopy, the product of 
the reaction was determined to be 4.159, not the desired 4.158 (key HMBC correlations shown). 
Evidence for the structure of 4.159 came from the fact that the methyl group was only correlated 
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to one carbonyl carbon atom at 170 ppm, and there were two carbon peaks (the alkyne carbon 
atoms) that were correlated to the benzylic proton. 
Figure 4.7: Example of an oxidative Moore rearrangement from Dr. Mans and attempted 
oxidative Moore rearrangement of 4.154 
  
 
a) Example of an oxidative Moore rearrangement from Dr. Mans (see Chapter 3, Scheme 3.11). b) 
Attempted oxidative Moore rearrangement of 4.154 resulting in 4.159. 
Previous work in the Martin group showed that the yield of Moore cyclizations are 
solvent dependent (see Chapter 3, Scheme 3.42 and 3.47). In particular, Dr. Mans demonstrated 
that performing the Moore cyclization in MeOH gave exclusive formation of the quinone. 
Considering that the byproduct 4.159 arises from the interception of the ketene intermediate with 
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methanol, a solvent screen was done with protic solvents of decreasing nucleophilicity. Most of 
the solvents produced complex mixtures of products, but tert-amyl alcohol seemed to produce 
two major products cleanly (Equation 4.7).  
Equation 4.7: Solvent screen for the Moore rearrangement of 4.152 
 
A brief optimization of the reaction parameters found that dry tert-amylOH (482 ppm 
H2O) provided cleaner reactions than wet tert-amylOH (5373 ppm H2O). Heating 4.154 in tert-
amylOH provided the desired quinone 4.154 in 20 – 56% yields, along with the 5-exo-cyclized 
product 4.161 as a mixture (1.5:1) of olefin isomers in nearly equal amounts (20 – 40%) 
(Equation 4.8). Attempts to alter the ratio of 4.154 to 4.161 by varying temperature or by using 
additives, such as radical inhibitors, had little effect on the ratio of 4.154 to 4.161. Further 
analysis of the reaction mixture revealed that besides the 5-exo-cyclized product 4.161, the 
hydroquinone 4.160 and, surprisingly, the C-H insertion product 4.162 as mixture (1.1:1) of 
diastereomers. Evidence for the 5-exo-cyclized product 4.161 was the coupling between the 
benzylic proton (7.05/7.01 ppm, d, J = 9.5/9.4 Hz) and the olefin proton (7.19/7.14 ppm, d, J = 
9.5/9.4 Hz), while the evidence for the hydroquinone 4.161 was the lack of carbonyl carbon 
atoms, the presence two extra Csp2-O carbon atoms at 140 and 150 ppm and the HMBC 
correlation between the benzylic proton and the carbon atom at 150 ppm. The structure of 4.162 
was determined after 1D- and 2D-NMR characterization (key HMBC correlations shown). 
Further evidence for 4.162 can be seen in that the carbonyl carbon atoms are at 206 ppm and 198 
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ppm, which is downfield compared to the carbonyl carbon atoms of 4.161, which appear at 
190/189 ppm and 188/187 ppm.     
Equation 4.8: Successful Moore rearrangement in tert-amylOH 
 
The isolation of 4.162 suggests that the Moore rearrangement may go through an ionic 
mechanism. For example, heating the benzocyclobutanone 4.163 produces the ketene 
intermediate 4.164, which can undergo an ionic 6-endo cyclization to produce 4.165 that has 
carbene-like character at C16 (Scheme 4.22). Protonation at the C16 carbon atom of 4.165 then 
gives 4.168. Alternatively, the 5-exo cyclization of 4.164 would produce 4.169, which also has 
carbene-like character at C7. Protonation of 4.169 would provide the 5-exo product 4.172. The 
carbene intermediate 4.169 may be a major resonance contributor because the C-H insertion onto 
the tert-butyl group of the cyclic silyl ether occurs to form 4.162. In 2002, Engles analyzed the 
Moore rearrangement computationally and found that the carbene 4.169 may be a major 
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resonance contributor in the 5-exo cyclization.472 The isolation of 4.162 represents direct 
evidence that the Moore rearrangement may proceed though a carbene-like mechanism.   
































































































The switch from radical to ionic mechanisms in cycloaromatization reactions has been 
observed previously.473-481 For example in 2015, Harrowven found that heating squarate 4.174 in 
dioxane with trace amounts of D2O produced the deuterated compound 4.175 (Scheme 4.26, 
A).473  O’Connor found that exposure of the ene-diyne 4.176 to lithium-halides and pivalic acid 
in polar aprotic solvent, gave 4.177 via a formal HX insertion across the putative ionic p-
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benzyne intermediate (Scheme 4.26, B).477 Evidence for the electrophilic character of the same 
carbon atom can be seen in another example from  Harrowven, who found that heating the 
squarate 4.178 produced a mixture of 4.179 and 4.180, which upon hydrolysis and oxidation 
produced the quinone 4.181 (Scheme 4.26, C).473 Products 4.179 and 4.180 can come from 
electrophilic attack of the acetate ion onto a carbene intermediate similar to 4.169. Finally, 
Moore observed the incorporation of THF during the rearrangement of the ketene 4.182, 
indicating that the Moore rearrangement may have alternate mechanisms available (Scheme 
























































LiX, PivOH, DMSO, 37 C




























a) Deuterium incorporation during Moore cyclization suggestive of ionic mechanism from Harrowven, 
2015.473 b) Incorporation of “HX” during Bergmann cyclization suggests ionic mechanism example from O’Connor, 
2007.477 c) Intramolecular attack by acetate on ionic intermediate example from Harrowven, 2015.473 d) 
Nucleophilic attack of THF on ionic intermediate in Moore cyclization example from Moore, 1986.478 
Harrowven reported that heating squarates such as 4.174 in dioxanes with 1% H2O, gave 
a mixture (1:1) of the 6-endo and 5-exo products.473 These results seem to be consistent with the 
results of the Moore rearrangement of 4.154 in tert-amylOH. Owing to the radical/zwitterionic 
dichotomy of the Moore rearrangement, it may be possible to favor the desired 4.154 over 4.161 
by changing the solvent. Previous results in the Martin group have also shown a strong 
dependence of the Moore rearrangement on the solvent (see Chapter 3, Scheme 3.42, 3.47). A 
comprehensive solvent and temperature screen was done to see if any other solvent would 
furnish 4.154 cleanly, but initial attempts to initiate the Moore rearrangement of 4.154 in a 
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variety of solvents gave complex mixtures. Degassing the solvent thoroughly, however, was key 
to obtaining the desired product 4.154 in non-protic solvents. The solvent screen in de-gassed 
solvent found that ethereal solvents and methyl-tert-butylether (MTBE) in particular provided 
the product 4.154 cleanly (Figure 4.27). Lower temperatures also seemed to produce less of the 
hydroquinone byproduct 4.160, and the reaction was found to proceed at temperatures as low as 
60 ºC. Scaling up the Moore rearrangement in MTBE did favor the desired product 4.154 over 
the 5-exo product 4.161, but only in a 3:2 ratio in a combined yield of 53%. 



































































  4.5.2.2: Attempts to improve 6-endo/5-exo product ratios 
The low selectivity between the 6-endo and 5-exo cyclization modes in the Moore 
rearrangement is perplexing. Dr. Mans was able to achieve a 10:1 selectivity between the 6-endo 
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and 5-exo products utilizing very similar starting materials (see Chapter 3, Scheme 3.42). 
Likewise, none of the 5-exo product was reported during the Moore cyclization of 4.126 or in 
any of the substrates used by Dr. Nichols (see Chapter 3, Scheme 3.54).  The substitution of the 
alcohol can modulate the selectivity between the 6-endo and 5-exo products (see Chapter 3, 
Scheme 3.39).338 Attempts to substitute the alcohol moiety of 4.152 with TBS, TES or a TMS 
group only led to complex mixtures (Figure 4.28, A). Attempts to use Libeskind’s Bu3SnOMe 
modified Moore rearrangement, which exchanges the proton of the alcohol with a tributyltin 
moiety in situ, led to unidentifiable products (Figure 4.28, B).485,486 Attempts to isomerize the 
propargyl group to the allene, to initiate a 6π-electrocyclization only returned starting material 
















Figure 4.28: Attempts to alter 6-endo to 5-exo product ratio 
  
 
a) Attempted silyl protection of 4.154. b) Attempted isomerization to the allene 4.185 with tert-BuOK.483 
c) Attempted use of Libeskind’s Bu3SnOMe modified Moore rearrangement, to form 4.186.
485,486 
 
Another possible route to affect the ratio of the 6-endo and 5-exo products could be the 
use of transition metal catalysts, which are known to affect outcomes of pericyclic reactions.487-
523 In fact, several examples of chromium-mediated Moore rearrangements are known (Figure 
4.29).492-500 The reaction of chromium Fischer carbenes with alkynes such as 4.187 leads to the 
η-6 chromium ketene complex 4.188, which cyclizes in an analogous manner to the Moore 
rearrangement (Figure 4.29, A).492 The coordination of a metal to an intermediate such as 4.188 
could theoretically “template” the reaction to favor the 6-endo or 5-exo products.488-490 
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Figure 4.29: Examples of Chromium-mediated Moore rearrangement 
 
 
A) Example in 2008 by Herndon and Wang of a Moore-like rearrangement initiated by a chromium Fischer 
carbene which results proximal alkyl C-H abstraction.492 B) Example in 2008 by Herndon and Wang of a Moore-like 
rearrangement initiated by a chromium Fischer carbene which results olefin cyclization.469 C) Wulff’s Moore-like 
rearrangement of Fischer carbine to form indoline in 1996.493 
A review of the literature for catalysts that can catalyze the ring opening of 
cyclobutanones revealed that Fe,501-508 Ni,509-513 Co,514,515 Rh,517-519 Ru516 and even phosphines520-
523 have been used. Accordingly, Fe2(CO)9, Ni(COD)2, [Rh(COD)Cl]2 and tributylphosphine 
were chosen for the initial screen. Previously, the Moore rearrangement of 4.154 was shown to 
occur at only 60 ºC, so the catalyst screen was done at room temperature. All catalysts produced 
complex mixtures except Fe2(CO)9, which furnished two distinct products at room temperature. 
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Scaling up this reaction and isolation of the two products revealed that neither the desired 6- 
endo product 4.154, nor the 5-exo product was formed. After intensive NMR studies, the 
tentative assignments of the two compounds are 4.199 and 4.200 (key HMBC correlations 
shown). Evidence for the structure of 4.200 is the presence of two new Csp2-O carbons atoms at 
159 ppm and 139 ppm, an m/z of 917 (M + Na) indicating that the product has added the mass of 
(Fe(CO)4), two carbonyl carbons atoms in 
13C-NMR spectrum at 171 ppm and 208 ppm and 
three carbonyl IR stretches at 2061 cm-1, 2005 cm-1 and 1784 cm-1. 
Figure 4.30: Attempted metal mediated Moore rearrangement 
 
 
Iron, cobalt and electrophilic Fischer carbene complexes are to produce furans in the 
presence of alkynes (Figure 4.31, A, B, C).524-526 Coordination of the alkyne to the Fischer 
carbene complex 4.201 is thought to form the electrophilic carbene intermediate 4.202 (Figure 
4.31 A). Attack of the carbene by the carbonyl produces an oxonium ion, which aromatizes to 
form the furan 4.203. The formation of 4.199 and 4.200 may proceed though a similar 
intermediate to 4.202, although the exact mechanism the formation of these byproducts is 
unclear. 
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Figure 4.31: Examples of furan formation with Fischer carbenes 
 
a) Example of furan formation with Fe0 Fischer carbene 4.201 from Semmelhack (1986).525 b) Example of 
furan formation with Co1 Fischer carbene 4.205 from O’Connor (1993).515 c) Example of furan formation with Fe0 
Fischer carbene 4.206 from Schnatter (2009).524 
4.5.2.3: Summary 
The Moore rearrangement is a complex reaction. It seems that by using tert-amylOH as 
the solvent, the reaction mechanism may switch from radical to ionic thus, forming 4.154 and 
4.161 in equal amounts. The intermediates of the Moore rearrangement may also have carbene-
like character, as evidenced by the formation of the byproduct 4.162. Using MTBE as the solvent 
improved the ratio between 4.154 and 4.161 from 1:1 to 1.5:1 and eliminated the formation of 
4.162. At this point, it is not clear why such a significant amount of the unwanted 5-exo product 
4.161 was isolated in the reaction. Dr. Mans only observed the 5-exo product in ~10% yield and 
others members in the Martin group did not report any of the 5-exo product (see Chapter 3, 
Schemes 3.42, and 3.54). Both 4.158 and 4.154 (Figure 4.25) have similar substitution on the 
arene ring and differ only in the position of the alkoxy groups and the protecting groups. 
Although the Moore rearrangement of 4.154 provided mixtures of 4.161 and the desired 4.154, 
the procedure in MTBE was scaleable and several grams of 4.154 were obtained.   
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4.6: Formation of the xanthone core 
With ample quantities of 4.154 in hand, we explored the cyclization to the xanthone core 
as outlined in Scheme 4.23. Oxidation of the benzylic alcohol in 4.208 to 4.209 should enable 
cyclization to the hydroquinone 4.210 and, after further oxidation, provide the xanthone core 
4.211. Unfortunately, both Dr. Nichols and Dr. Knueppel attempted similar cyclizations with 
numerous oxidants without success (See Chapter 3, Scheme 3.45 and Equation 3.2). 
Scheme 4.23: Planned cyclization of 4.208 to xanthone 4.211 
 
Removal of the silyl ether from the quinone 4.154 using HF•Pyridine buffered with 
additional pyridine provided the benzyl alcohol 4.208, which was thermally and acid labile. 
Equation 4.9: Deprotection of the cyclic silyl ether 
 
 
Two different types of oxidations are needed to effect the transformation of 4.208 to 
4.211: An oxidation of the benzylic alcohol in 4.208 to the ketone 4.209 and an oxidation of the 
 308 
hydroquinone 4.210 to the quinone 4.211 (see Scheme 4.23). A survey of the literature for 




 tert-BuONO535,536,539), Co,526 Cu,531,533,546 Fe531 and 
V532 salts are known to oxidize hydroquinones to quinones, whereas the nitroxyl oxidants 
(TEMPO, N-hydroxyphthalimide (NHPI), 5-F-AZADO, AcNH-TEMPO)    can oxidize the 
alcohols to ketones. Of the reagents listed in Table 4.12, only DDQ and MnO2 are precedented to 






















Table 4.12: Oxidation of benzylic alcohols 
 
 
Ref Oxidant Additive Conditions Yield 
Karimi526 Co(II) NHPIa O2, MeCN, rt 82 – 95% 
Iwabuchi527,528 5-F-AZADOb NaNO2 AcOH, O2, rt 71 – 99% 
Toofan529 BPCPc N/A PhH, reflux 60 – 95% 
Ishii530 NOx NHPI
a MeCN, 60 ºC 10 – 84% 
Sparfel531 Fe(II), Cu(I) N/A MeOH, O2 34 – 95% 
Bora532 tert-BuOOH V(O)SO4 MeCN/H2O, rt 70 – 96% 
Ji533 Cu(OAc)2 TEMPO
d MeCN/H2O, rt 82 – 96% 
Sekar534 DABCOe-CuCl TEMPOd PhMe, O2, 100 ºC 20 – 98% 
Hu535 tert-BuONO TEMPOd DCE, O2, 80 ºC 93 – 97% 
Hu/Mo536 tert-BuONO DDQf DCE, O2, 80 ºC 95 – 99% 
Stahl537 AcNH-TEMPOd HNO3/HCl MeCN/H2O, O2, 45 ºC 43 – 98% 
Gao538 DDQf NaNO2 DCM/AcOH, O2, rt 17 – 97% 
Jahn539 TEMPOd tert-BuONOg CH2Cl2, reflux 60 – 99% 
Golchoubian540 H2O2 Mn(II) Neat, rt 90 – 97% 
Lou451 MnO2/Alumina N/A CH2Cl2, reflux 87 – 96% 
Gritter542 MnO2 N/A PhH, rt 100% 
Bunce543 MnO2 N/A  74 – 97% 
Trudell544 H5IO6 CrO3 MeCN/CH2Cl2, - 78 ºC 52 – 93% 
Adler545 DDQf N/A Dioxane, rt 14 – 93% 
Maumy546 Me3NO CuCl2 MeCN, 60 ºC 40 – 100% 
a) N-Hydroxyphthalimide (NHPI). b) 2-Azaadamantane-N-oxyl (AZADO). c) 2,2'-Bipyridylchromium 
(BPCP). d) (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl (TEMPO). e) 1,4-Diazabicyclo[2.2.2]octane (DABCO). f) 2,3-
Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). g) BF3•OEt2 also added. 
 
DDQ, MnO2 and BaMnO4 were screened with a variety of bases and solvents to 
transform 4.208 to 4.211. BaMnO4, even on a variety of solid supports, proved too strong an 
oxidant and afforded intractable mixtures. Oxidation of 4.208 with DDQ was fastest in non-polar 
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solvents and slowest in polar aprotic solvents; however, even after identifying CH2Cl2 as the 
optimum solvent and K2CO3 as the optimum base, 4.211 was isolated in only 8 – 18% yield. Co-
oxidants such as AcOH/NaNO2 (to produce NOx) or Ag2O had a detrimental effect on the 
reaction. Oxidations of 4.208 with MnO2 were much cleaner than those with DDQ, so MnO2 was 
chosen for further study. A key observation was that the yields of 4.211 were lower when the 
starting material was incubated with K2CO3 before the addition of MnO2. Stirring 4.208 in DMF 
with K2CO3 resulted in the quantitative conversion to new compound with an identical mass to 
the starting material by LCMS analysis. Based on similar byproducts isolated by Dr. Nichols, the 
identity of this compound is proposed to be 4.212 (Figure 4.31, B See also Chapter 3, Equation 
3.2). Surprisingly, the transformation of 4.208 to 4.211 with MnO2 proceeded without any base 
present. Re-screening the solvents revealed that polar aprotic solvents provided 4.211 in the 
highest yield, with DMF and MeCN providing 4.211 in 40% yield. Curiously, the presence of 
molecular sieves in the reaction caused the yield of 4.211 to drop significantly. The molecular 
sieves could sequester water, which is known to affect the oxidizing potential of MnO2 by 
occupying active sites on the manganese surface.554 This observation suggested that perhaps the 
MnO2 was too active and that by “poisioning” the MnO2, the yields might improve. Accordingly, 
oxidation of 4.208 with MnO2 in CH2Cl2 poisoned with pyridine gave comparable yields (40%) 











Figure 4.31: Cyclization of 4.208 to 4.211 
  
Subjecting the product 4.211 to the reaction conditions (MnO2 in CH2Cl2/pyridine) 
resulted in 80% recovery of the product, suggesting that the product is stable under the reaction 
conditions and that the yield loss is due to side-reactions occurring during the oxidation of the 
intermediates such as 4.208 or 4.210 (Figure 4.32, A). Analysis of the crude reaction mixtures by 
 312 
LCMS shows peaks with m/z of 1189, 1303 and 1827 amu, which are well above the mass of 
4.211  and may indicate that oxidative dimerization is occurring. The mechanism of MnO2 
oxidation of benzylic alcohols is thought to involve benzylic radicals, which may be 
exceptionally stable and facilitate the desorption and oxidative polymerization. Therefore we 
reasoned that cooling the reaction might favor the subsequent oxidation without diffusion into 
the solvent. Accordingly, oxidizing 4.208 with MnO2 in CH2Cl2/pyridine at 0 °C provided the 
desired product 4.211 in 35% yield and the isolation of several other products by TLC (4.214) 
(Figure 4.32, B). Analysis of these products by LCMS indicated that they might be partially 
oxidized intermediates, presumably a mixture of 4.209 and 4.210. Resubjection to the reaction 
conditions provided 4.211 in ~30% yield with another 30% of the recovered intermediates. 
Unfortunately, prolonged stirring at 0 °C for 48 h did not improve conversion. The overall yield 
after “two cycles” of the reaction, though not ideal, is 50%, which is sufficient to explore the 















































Currently, the conversion of 4.208 to 4.211 is not optimized. The tendency of the starting 
material 4.208 to rearrange under basic and acidic conditions continues to make this 
transformation difficult. Additionally, the phenol moiety is electron rich and presumably 
undergoes several unwanted side reactions such as oxidative dimerization and/or radical 
polymerization which results in the low yields. Similar difficulties with this transformation were 
encountered by other members in the Martin group (see Chapter 3, Schemes 3.45 and Equation 
3.2). The discovery that “poisoning” MnO2 with polar aprotic solvents such as DMF or pyridine 
and that the product is stable to these conditions suggests that this reaction can be optimized. In 
order optimize this reaction, it may be useful to explore of MnO2-stable radical inhibitors such as 
TEMPO to suppress radical side-reactions during the oxidation of 4.208, or use catalytic co-
oxidants such as I2 to increase conversion when performing the oxidation at 0 °C. 
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4.7: Selective removal of the PMB group 
4.7.1: ATTEMPTED PMB GROUP REMOVAL BY OXIDATION 
PMB was originally chosen as the protecting group because it can be removed via 
oxidation, hydrogenolysis, or ionization with Lewis acids. Removal of the PMB group by 
oxidation would provide the most orthoganality because the MOM group could be labile to 
Lewis acids, and the quinone moiety would be reduced during hydrogenolysis. A comprehensive 
literature search revealed that DDQ, CAN, and Ph3CBF4 are the most common oxidants used to 
remove the PMB group (Table 4.13).556-565  
Table 4.13: Summary of methods for the oxidative removal of PMB 
 
 
Ref [O] Additive Conditions Yield 
Magnusson556 DDQ KX/18-cr-6 PhMe, 80 ºC 33 – 92% 
Shen/Hu557 DDQ tBuONO O2, PhCl, 100 ºC 81 – 99% 
Chandrasekhar558 FeCl3 DDQ CH2Cl2/H2O, rt 62 – 94% 
Sharma559 Mn(OAc)3 DDQ CH2Cl2, rt 61 – 90% 
Floreancis560 MnO2/PbO2 DDQ MeNO2, 2,6-Cl2-Py 70 – 92% 
Katoh561 PIFA tBuCHO CH2Cl2, rt 30 – 94% 
Cossy562 PCC  CH2Cl2, reflux 35 – 90% 
Barton563 Ph3CBF4  CH2Cl2, rt 70 – 90% 
Yonemitsu564 DDQ  CH2Cl2/H2O, rt 60 – 95% 
Samuelsson565 CAN  MeCN/H2O, rt 8 – 89% 
However, attempts to remove the PMB group in 4.211 with DDQ, Ph3CBF4 or CAN led 
to complex mixtures. Despite screening several solvents and additives to mitigate potential acid-
catalyzed side reactions, the only observable product was p-anisaldehyde 4.216 (Equation 4.11). 
The fact that p-anisaldehyde was detected indicated that the PMB group was removed 
successfully, but the product 4.215 may be unstable to the reaction conditions. Analysis of crude 
 315 
reaction mixtures by LCMS showed several compounds were produced in the reaction with 
masses between 1100 and 1400 amu, indicating oxidative polymerization. 
Equation 4.11: Attempted oxidative PMB deprotection 
 
An intermediate in the oxidation of the PMB group is a benzyl cation, which if 
intercepted by an alcohol, would form an acetal. This tactic was utilized by Dr. Yang who 
oxidized the C1 carbon atom in 4.217 with DDQ in the presence of MeOH and BaCO3 to give 
the methoxy acetal 4.218 (Figure 4.34, A).345,346, 566, 567 Unfortunately, subjection of 4.211 to 
these conditions except using n-BuOH as the alcohol, provided none of the desired product 
4.219; only p-anisaldehyde 4.216 was detected (Figure 4.33, B). The reasons for the failure to 
remove the PMB group via oxidation are not clear. Analysis of the reaction mixtures by LCMS 
showed multiple masses in the range between 1100 and 1400 amu. The fact that p-anisaldehyde 
was detected could mean that there was still sufficient water in the reaction intercept the 
oxonium intermediate after oxidation of the PMB group. The addition of desiccants such as 
molecular sieves to the reaction mixture may assist in forming 4.218, but the removal of the 






Figure 4.33: Attempted oxidation of the PMB group to the acetal 
 
a) Example of successful DDQ benzylic oxidation to acetal from Martin groups’ synthesis of IB-00208.344, 345 b) 
Failure to adapt PMB oxidation to acetal with 4.211. 
4.7.2: PMB GROUP REMOVAL BY LEWIS ACIDS OR REDUCTION 
4.7.2.1: Attempted PMB group removal with Lewis acids  
The instability of 4.215 to the reaction conditions used for the oxidative removal of the 
PMB group in 4.211 led to the investigation of Lewis acids for the deprotection. Unfortunately, 
subjection of 4.211 to conditions developed by Dr. Nichols gave a mixture of products that were 
determined to be the reduced MOM-deprotected compound 4.221 and the reduced bis-
deprotected compound 4.220 by LCMS.349 Compound 4.220 could potentially be elaborated to 
citreamicin after reoxidation to the quinone, but the lack of high yielding methods to oxidize the 
hydroquinones in this system and selectivity required to oxidize the para-hydroquinone over the 
ortho-hydroquinone moieties in 4.220 made this route difficult, and thus not pursued.    
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4.220 4.221  
  The oxonium ion formed from the ionization of the PMB group should be more stable 
than the corresponding oxonium ion formed from ionization of a MOM acetal, so selective 
removal of a PMB group should be possible. Yet, to date, there are no methods that remove the 
PMB group with Lewis acids selectively over the MOM group. A survey of the literature 
revealed numerous Lewis acids that are capable of removing the PMB group that are available to 













Table 4.14: Lewis acid mediated deprotection of PMB 
 
 
Ref LA Additive Conditions Yield 
Jung568 ClO2SNCO  CH2Cl2, –78 ºC 72 – 88% 
Hou569 Ph3PHBr  MeCN, reflux 54 – 97% 
Ilangolvan570 Cl2(CO)2  DCE, rt 46 – 89% 
Iwasaki571 MgBr2•OEt2 DMS CH2Cl2, rt 35 – 90% 
Yadav572 CBr4  MeOH, reflux 70 – 92% 
Sawama/Sajiki573 FeCl3  CH2Cl2, rt 53 – 98% 
Ilangolvan574 POCl3  DCE, rt 65 – 95% 
Srikrishna575 BF3•OEt2 NaCNBH3 THF, reflux 65 – 98% 
Ploypradith576 Amberlyst-15  PhMe, 110 ºC 70 – 95% 
Ozaki577 TMSCl/SnCl2 anisole CH2Cl2, rt 78 – 96% 
Holmes578 BCl3•DMS HNO3/HCl CH2Cl2, rt 16– 100% 
Kahne579 TFA  CH2Cl2, rt 84 – 99% 
Sauve580 SnCl2/AlCl3 EtSH CH2Cl2, rt 76 – 91% 
Tokuyama581 BCl3 (Me)5PhH CH2Cl2, –78 ºC 91 – 94% 
Jung582 TfOH 1,3-(MeO)2Ar CH2Cl2, 0 ºC 79 – 94% 
Codee583 HCl  HFIP, 0 ºC 48 – 90% 
Sharma584 ZnCl4  MeCN, rt 67 – 92% 
Pale/Blanc585 AgPF6 1,3,5-(MeO)3Ar CH2Cl2, 40 ºC 72– 100% 
Marcantoni586 CeCl3 NaI MeCN, reflux 49 – 97% 
Nino587 Ce(OTf)3  MeNO2, 60 ºC 30 – 99% 
A simple model system 4.224 was chosen to evaluate the selective deprotection of PMB 
in the presence of a MOM group. Catechol (4.222) was treated with MOMCl in the presence of 
K2CO3 in acetone to provide 4.223,




Scheme 4.24: Synthesis of selective PMB deprotection model system 
 
Several Lewis acids were added to a solution of the model compound 4.224 in CH2Cl2 at 
–78 ºC and the reactions, were stirred for 30 minutes and quenched. The crude reaction mixtures 
were analyzed by GCMS. The strong Lewis acids SnCl4, BBr3 and BCl3 produced mixtures of 
4.225 (R = H) and unidentified Lewis acid adducts, indicating that the PMB group may indeed 
be selectively removed (Table 4.15, entries 2,3,5). Reaction of 4.224 with TMSI provided 4.225 
(R = TMS) as the major product, but catechol 4.227 was also isolated, indicating that TMSI can 
deprotect MOM groups even at –78 ºC (Table 4.15, entries 4). Et2AlCl, however, produced only 
PMB deprotected product 4.225 and the PMB alkylated product 4.227, with no evidence of 
MOM removal (Table 4.15, entries 1). Screening several additives to capture the PMB cation did 
not satisfactorily reduce the amount of the alkylated product 4.227 (Table 4.15, entries 6, 7, 8). 
Et2AlCl seems to be a Lewis acid which promotes the selective ionization of the PMB group 
over the MOM group and a more thorough screen of cation sponges and/or solvents may reduce 
the amounts of the PMB alkylated products such as 4.227. However, the selective removal of the 










Table 4.15: Selective PMB deprotection Lewis acid screen 
OMOM
OPMB


























LA Additive R A B C D E other 
Et2AlCl N/A H 1.04 1 0 3.3 0 0 
BCl3 N/A H 0 1 0 0 0 1.81 
BBr3 N/A H 0.97 1 0 0 0 2.18 
TMSI N/A TMS 2.30 0 1 0 0 0 
SnCl4 N/A H 0 0 0 0 0 1 
Et2AlCl allylTMS H 1 0 0 4.70 0 0 
Et2AlCl TES-H H 1 0 0 4.08 0 1.63 
Et2AlCl AlMe3 H 1 0 0 7.01 0 2.16 
 
Unfortunately, use of either TMSI or Et2AlCl for the selective removal of the PMB group 
in 4.211 produced mixtures of MOM-deprotected compound 4.230 and bis-deprotected 







Figure 4.35: Unsuccessful use of TMSI or Et2AlCl in PMB deprotection 
 
The only literature example of selective removal of PMB group over a MOM group 
involved a directing effect of adjacent carbonyl group.589 Keith found that selective PMB or 
MOM group deprotection can be governed by the groups proximity to the carbonyl group 
(Figure 4.36).589 This result suggests that the MOM group is selectively removed because of a 
chelation effect of the C6-carbonyl group in 4.211. Hence, selective removal of the PMB group 











Figure 4.36: Keith’s selective removal of MOM or PMB 
 
a) Example of carbonyl-assisted deprotection using a silica resin immobilized sulfonic acid (PTSA-Si) which favors 
MOM over PMB deprotection from Keith.589 b) Example of carbonyl-assisted deprotection which favors PMB over 
MOM deprotection from Keith.589  
 
4.7.2.2: Successful hydrogenolysis of PMB group 
Because our ability to selectively remove the PMB group from 4.211 under both Lewis 
acid and oxidative conditions, the reductive removal of the PMB was investigated. In the event, 
hydrogenolysis of 4.211 with Pd/C in PhMe/MeOH under a balloon of hydrogen gas provided 
4.235 in 53% yield (Equation 4.12). The reduction of the C19-C20 double bond was unexpected, 
but also intriguing as citreamicin ε, Sch-56036 and the kibdelones all lack this double bond (See 
Chapter 3, Figures 3.1, and 3.3).  
Equation 4.12: Successful removal of the PMB group with hydrogenolysis 
 
4.7.2.3: Summary 
The hydrogenolysis of the PMB group is currently unoptimized and thus higher yields of 
4.235 may be achieved by investigating solvents, catalyst loadings and hydrogen pressure. To 
 323 
advance 4.236 to citreamicin, the hydroquinone moiety and the C19-C20 bond need to be 
installed. 
4.8: GA-ring synthesis Model Studies 
4.8.1: PROPOSAL AND MODEL SYNTHESIS 
With the route to the core of citreamicin established, it was necessary to develop the 
methodology for the synthesis of the G- and A-rings. A significant portion of the structural 
variety in the polycyclic xanthone natural products is in the G-ring. Thus, a method that diverges 
from a common core could potentially access all the different members of the family. The 
general plan is outlined in Scheme 4.25. ortho-Bromination of the phenol of 4.236 and 
subsequent triflation would produce 4.237, which would be the key divergent intermediate. 
Alkoxycarbonylation and palladium catalyzed ketone coupling would produce the isocoumarin 
4.238, which can be condensed with amines to form either isoquinolones such as 4.239 or 
dihydrooxazolo-[3,2-b]-isoquinolinones which are found in cervinomycin and citreamicin 
(Figure 4.38). By varying the ketone and the amine components, one could conceivably 
synthesize any member of the polycyclic xanthone natural products.     










Figure 4.38: Plan for the late stage G- and A-ring synthesis 
 
There are no known syntheses of isocoumarins like 4.238 (Scheme 4.25), so we selected 
the model system 4.242 to develop the key reactions. Guaiacol (4.240) was brominated using 
NBS/TMG to provide 4.241 in 84% yield (Scheme 4.26, see also Table 4.3). Triflation of the 
phenol group with triflic anhydride then provided 4.242 in 95% yield.  
Scheme 4.26: Synthesis of model system 
OMe










4.240 4.241 4.242  
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4.8.2: DEVELOPMENT OF THE ALKOXYCARBONYLATION 
The alkoxycarbonylation of 4.242 to produce the ester 4.243 was done under standard 
conditions (Et3N, DMSO/MeOH, Pd(OAc)2) using dppf as the ligand, and the reactions were 
analyzed by GCMS to determine product ratios (Table 4.39, entry 1).590 Unfortunately, the 
standard conditions resulted in poor conversion of 4.242. Prolonged stirring or the use of K2CO3 
under higher pressure (50 psi), only served to marginally improve conversions and produced the 
hydrolyzed product 4.241 (Table 4.39, entries 2, 3). The initial experiments revealed two major 
problems in the alkoxycarbonylation of 4.242; (1) Poor conversion of the starting material 4.242 
to 4.243 and (2) the hydrolysis of 4.242. To solve these problems, several ligands were screened 
to improve conversion along with bases with pKa’s less than Et3N to produce less hydroxide 
(Table 4.39, entries 4 – 8). The ligand screen revealed that dppp was superior to other ligands 
and all bases tested provided none of the hydrolyzed material 4.241. Most of the reaction showed 
poor conversion of 4.242 to 4.243 with the exception of sodium acetate, which dramatically 
increased the yield (Table 4.39, entries 6). However, this result was not reproducable so other 





















Table 4.16: Initial attempt to alkoxycarbonylate 4.242: product ratios by GCMS 
Ligand CO Base A B C 
dppf Balloon Et3N 1 3.1 0 
dppfa Balloon Et3N 1 1.9 2.6 
dppf 50psi K2CO3 0 1 1.4 
dppp 50psi Na2HPO4 0 1 0 
dppp 50psi NMM 1 2.5 0 
dppp 50psi NaOAc 4.5 1 0 
dppp 50psi DTBP 1 4.2 0 
dppp 50psi NaH2PO4 0 1 0 
a) reaction stirred for 24 h 
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A review of the literature on alkoxycarbonylations of aryl sulfonate esters revealed many 
conditions,590-593 but few insights into the problems of conversion or suppression of hydrolysis. 
One intriguing example from Buchwald in the alkoxycarbonylation of aryl-mesylate and 
tosylates mentions hydrolysis of the reactants as a problem.594 Buchwald found that the 
hydrolysis of aryl mesylates and tosylates was minimized in non-polar solvents such as toluene 
and that the inclusion of molecular sieves improved conversion and increased yields. 
Equation 4.13: Buchwald’s alkoxycarbonylation of aryl-mesylate and tosylates  
 
Adapting Buchwald’s conditions to the alkoxy carbonylation of 4.242 suppressed 
hydrolysis, but poor conversion remained and the phthalate 4.244 and the reduced compound 
4.243 were detected by GCMS: (Table 4.17). Several bases and temperatures were screened, but 
little improvement in conversion was seen (Table 4.17, entries 1 – 4). Recalling the interesting 
effect of acetate in the previous example, a soluble source of acetate was added to the reaction 












Table 4.17: Alkoxycarbonylation of 4.242 using modified Buchwald conditions: Product ratios 
by GCMS 
 








dppp K2CO3 70 ºC N/A 2.7 33.2 1.4 1 
dppp Cs2CO3 70 ºC N/A 1.2 1.1 0.5 1 
dppp K3PO4 70 ºC N/A 2.8 22.3 1.5 1 
dppp K2CO3 100 ºC N/A 1.6 21.0 1.8 1 
dppp K2CO3 70 ºC (n-Bu)4NOAc 3.0 4.6 0.2 1 
a) Ratios of 4.252, 4.242, 4.253 and 4.254 were determined by GCMS 
Scaling up the reaction allowed for the isolation of the desired product 4.252 in 76% 
yield, but the phthalate compound 4.244 was also formed in 19% yield (Table 4.18, entry 1). 
Evidence that acetate ion is critical for the success of the reaction was found in two experiments. 
Omission of n-Bu4NOAc provided 4.252 in only 9% yield, and using n-Bu4NCl instead of n-
Bu4NOAc gave no 4.252 (Table 4.18, entries 3,4). Stronger bases such as K3PO3 provided lower 
yields of 4.252 (Table 4.18, entry 2). Use of only 0.2 equivalents of n-Bu4NOAc still provided 
the desired product 4.252, but in only 67% yield, and the reaction took 24 h to go to completion 








Table 4.18: Alkoxycarbonylation of 4.242 500 mg to 1 g scale, isolated yields 
 
Ligand Base T  Additive A B C D 
dppp K2CO3 70 ºC (n-Bu)4NOAc 76% ~5% 0% 19% 
dppp K3PO4 70 ºC (n-Bu)4NOAc 45% 35% 0% 0% 
dppp K2CO3 70 ºC N/A 9% 57% 0% 0% 
dppp K2CO3 70 ºC (n-Bu)4NCl 0% 0% 0% 0% 
dppp K2CO3 70 ºC (n-Bu)4NOAc
a 67% ~5% 0% 11% 
a) 0.2 equivalents used 
Based on the work of Amatore on the mechanisms of Pd catalysis, and others on the 
mechanism of mechanism of alkoxycarbonylation,595-579 the putative role of n-Bu4NOAc is 
depicted in Scheme 4.27.598 The Pd0 species 4.255 reacts with n-Bu4NOAc to form the anionic 
species 4.256. Anionic species 4.256 oxidatively inserts with the aryl triflate to form 4.257. 
Ligand association of carbon monoxide and de-complexation of n-Bu4NX provides neutral 
complex 4.258. α-Migratory insertion of carbon monoxide followed by coordination of the 
alcohol gives complex 4.259. Mechanistic studies on alkoxy carbonylation of arenes have shown 
that the rate limiting step is attack of the alkoxide on the palladium species 4.259.595-579 The 
significant rate enhancement seen in the presence of n-Bu4NOAc may be due to an general base-
assisted deprotonation of the alcohol in 4.260 to form 4.261, which after coordination of acetate 
to form the anionic complex 4.262 can then facilitate reductive elimination to give 4.256 and the 









The palladium-ate complex 4.256 may favor oxidative insertion into the more polarized 
Csp2-OTf bond over the less polarized Csp2-Br bond, and hence may disfavor the formation of 
phthalate 4.244. However, the proportion of the ionic ate-complex 4.256 in the reaction mixture 
would be expected to be smaller in non-polar solvents and larger in polar aprotic solvents. Thus, 
the reaction would also be expected to be more selective for the desired product 4.252 in polar 
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aprotic solvents. To test this hypothesis, several solvents with differing polarity were screened in 
the alkoxycarbonylation of 4.242 and the ratios of the desired product 4.252 and the phthalate 
4.244 were measured by GCMS (Equation 4.14). The selectivity for 4.252 was highest in polar 
aprotic solvents and lowest in non-polar solvents, the highest selectivity being in DMSO and 
MeCN, supporting the hypothesis that the ate-complex favors oxidative insertion at the triflate 
rather than the bromide. 
Equation 4.14: Effect of solvent on the ratios of 4.252 and 4.244 during alkoxycarbonylation 
 
 
Using DMSO as a solvent, however, reintroduced the hydrolysis issues seen earlier. 
Several bases were screened in addition to n-Bu4NOAc in order to suppress hydrolysis, but no 
improvement was observed. Minimization of 4.241 came from increasing the amount of 
molecular sieves (1.5 mg/mg vs. 0.5 mg/mg in toluene) and using n-Bu4NOAc (2 eq) as the sole 
base. Interestingly, there was a significant difference between 4 Å molecular sieves and 3 Å 
molecular sieves, with 3 Å molecular sieves providing higher conversions and fewer byproducts 
than 4 Å molecular sieves. The reaction was scaled up, and the desired product 4.252 was 
isolated in 69% yield, which is comparable to the conditions using toluene; however the 
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hydrolysis product 4.241 was still seen in 10% yield. Although the yields for the 
alkoxycarbonylation of 4.242 to 4.252 were about the same in toluene or DMSO, the conditions 
in toluene were chosen to move forward due to the ease of purification.  
 





4.8.3: DEVELOPMENT OF A PALLADIUM-CATALYZED KETONE COUPLING TOWARDS 
ISOCOUMARINS 
With the conditions for the alkoxycarbonylation developed, the coupling to form the 
isocoumarin 4.265 was investigated next. Based on the work of Hosokawa/Tatsuta in the 
synthesis of TMC-66, the Migita procedure seemed ideal due to the mild conditions (see Chapter 
3, Scheme 3.32).499 Unfortunately, this procedure produced mixtures of the butylated product 







Equation 4.16: Attempted Migita coupling with 4.252 
 
The low yield and presence of the butylated byproduct 4.264 led to the abandonment of 
the Migata procedure in favor of a method that utilizes acetone directly. A literature search 
revealed that the coupling of arenes to acetone suffers from two problems: (1) Polyarylation 
because the product is more acidic than the starting material, and (2) the proclivity of acetone to 
polymerize under the basic reaction conditions.600-602 Several methods exist that can accomplish 
this transformation, but the ligands required were complicated and not commercially available 
and thus undesirable. Fortunately Buchwald developed a procedure for coupling acetone with of 
ortho-nitro arenes in his synthesis of substituted indoles. Inclusion of 4-methoxyphenol as a 
putative proton shuttle was key for the success of the reaction (Equation 4.17).603   
Equation 4.17: Buchwald’s acetone coupling of ortho-nitro arenes 
 
Several ligands and palladium sources were screened in an attempt to adapt Buchwald’s 
coupling conditions for the synthesis of isocoumarin 4.265, and the results were analyzed by 
GCMS. The screen identified johnphos 4.271 as the ligand that provided the highest conversion 
of 4.243 to 4.265 and Pd2(dba)3•HCCl3 as the optimal palladium source (Figure 4.40). Initial 
attempts to scale up the reaction, however, only provided 4.265 in low yields. The dramatic 
effects seen in the alkoxycarbonylation reaction of 4.242 in the presence of n-Bu4NOAc was 
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attributed to an assisted deprotonation of the alcohol by acetate. Accordingly, n-Bu4NOAc was 
added to the reaction mixture with the expectation that it would facilitate formation of the 
acetone enolate. Gratifyingly, the addition of n-Bu4NOAc to the reaction mixture produced the 
isocoumarin 4.265 in 65% yield (Figure 4.40). Inspection of the reaction mixture by GCMS also 
revealed compounds having masses consistent with 4.273 and 4.274, which may be 
intermediates in the reaction. Currently, this reaction is unoptimized and future work to convert 
the intermediates 4.273 and/or 4.274 to the desired product 4.265 or whether 4-methoxyphenol is 
necessary in addition to n-Bu4NOAc. 
 
 








































4.273 4.274  
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4.8.4: Development of the amine condensation 
With the methodology established for both the alkoxycarbonylation and the acetone 
arylation, the coupling of amines with the isocoumarin 4.265 to form dihydrooxazolo-[3,2-b]-
isoquinolinones was investigated. A literature search for reagents capable of transforming esters 
directly into amides revealed a number of Lewis acids (Table 4.19).604-621 However, citreamicin 
requires the condensation of an amino acid, and in order to develop methods that can 
accommodate any of the polycyclic xanthone natural products the method would need to work 
for amino acids as well as aliphatic amines. There are few methods that are applicable to 
condensing amino acids with esters, and these include use of CpTaCl4 and AlMe3, the latter of 
which was reported previously in the Martin group.616 (Table 4.19, entries 2,11). 
Table 4.19: Summary of methods to transform esters to amides 
 
Reference LA conditions  Yield 
Roskamp604-606 Sn(HMDS)2 –40 ºC→ rt 30 – 94% 
Goldman/Kohn607 CpTaCl4 –14 ºC→ rt 60 – 98% 
Lasne608 PrMgBr 70 ºC 30 – 70% 
Helquist609 Ti(OiPr)4 DCE, reflux 35 – 93% 
Gellman/Stahl610 Sc(OTf)3, Ti(NMe2)4 PhMe, 90 ºC 2 – 99% 
Proco Jr.611 Ti(OiPr)4, Zr(OtBu)4
a PhMe, 100 ºC 50 – 98% 
Morimoto/Ohshima612 La(OTf)3 Rt → 70 ºC 80 – 99% 
Guarna613 LiNTf2 HCCl3, 70 ºC 12 – 99% 
Ranu614 InI3 110 ºC 83 – 93% 
Huang615 DIBAL-H THF, rt 28 – 95% 
Martin616 AlMe3 DCE, reflux 31 – 77% 
Weinreb617,618 AlMe3 PhH, 50 ºC → reflux 31 – 100% 
Roussi619,620 MAOb Rt-100 ºC 10 – 97% 
Yoon621 NaAlEt2H2 PhMe, reflux 88 – 96% 
a) HOBt is an additive. b). MAO = methyl aluminum oxide 
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Several Lewis acids were screened for their ability to promote the coupling of α-methyl 
serine622-626 4.275 with the isocoumarin 4.265, but only AlMe3 and Ti(OiPr)4 produced any 
products (Scheme 4.27). The reaction with AlMe3 produced 4.277, which resulted from AlMe3 
coordinating the carbonyl group, delivering a methyl group and subsequent ionization of the 






Scheme 4.28: Attempted coupling of α-Methyl serine 4.275 with the isocoumarin 4.265 
 
The isolation of 4.278 indicated that free AlMe3 may methylate ionizable carbonyls 
during the reaction. To analyze these reactions in more detail without the burden of synthesizing 
large amounts of α-methyl serine (4.275), L-phenylalanine was used as a model amino acid. 
Accordingly, Ti(OiPr)4 and AlMe3 were re-tested in their capacity to couple amino acids to 
isocoumarins (Scheme 4.29). While Ti(OiPr)4 only produced the ring opened product 4.279 and 
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the isopropyl ester 4.280, AlMe3 produced the desired product 4.281, along with the 
isoquinolone 4.282, in 10% and 30% yields, respectively.  
Scheme 4.29: Coupling of L-phenylalanine and isocoumarin 4.265 
 
Review of the relevant literature revealed the work of Yoon (see Table 4.19, entry 14), 
who used aluminum ate complexes to effect the transformation of esters to amides (Figure 
4.41).621 A particularly attractive feature of the aluminum-ate complexes 4.284, 4.287 or 4.290 
was their ability to form amides with sterically hindered amines (Figure 4.41, C) and esters 










Yoon made his aluminum-ate complexes in situ by heating Li[Et2AlH2] and the amine 
under reflux. Because Li[Et2AlH2] is no longer commercially available, we hypothesized that the 
combination of AlMe3 and MeLi, which are readily available, would produce LiAlMe4 which 
may be used to affect similar transformations. The combination of LiAlMe4 and phenylalanine 
4.278 would aluminum-ate complex 4.291, which is similar to those in Yoon’s chemistry (Figure 
4.42). The amido-aluminum ate complex 4.291 should also be more nucleophilic than the 






Figure 4.42: Formation of aluminum-ate complex with amino acid 
 
Refluxing L-phenylalanine 4.278 with LiAlMe4, which was generated in situ from AlMe3 
and MeLi, in a mixture of THF and toluene, followed by the addition of the isocoumarin 4.265 
provided the isoquinolone 4.282 in 85% yield; though none of the desired cyclized product 4.281 
was observed. 
Equation 4.18: Successful coupling of phenylalanine and isocoumarin 4.265 
 
The fact that some of the tri-cyclic product 4.281 was formed from the coupling of 
phenylalanine 4.278 with isocoumarin 4.265 in the presence of AlMe3 and not LiAlMe4 may 
suggest that the cyclization of 4.282 to 4.281 may proceed in the presence of Lewis acids. 
Accordingly, several Brønsted and Lewis acids were screened in order to affect this 
transformation (Equation 4.19). Although traces of the tricyclic compound 4.281 were seen in 




Equation 4.19: Attempted conversion of 4.282 to 4.281 with Brønsted and Lewis acids 
 
Since the cyclization of 4.282 to 4.281 was unsuccessful with Lewis or Brønsted acids, 
halolactonization or oxy-mercuration followed by reduction was evaluated as a strategy (Table 
4.20). Several halolactonization conditions were tried using Ph3P=S as a promoter, but the 
halogenated isoquinolone 4.296 (B) was the major product in each case.632 Oxy-mercuration of 
4.282, followed by reduction with NaBH4 only gave returned starting material (Table 4.20, 
entries 4,5). Examination of the reaction mixture before the reduction revealed that the 
isoquinolone B (X = HgX) was being formed exclusively. However, addition of NaBH4 provided 
only starting material 4.282. The only reaction to produce the desired product 4.295 was the 
iodolactonization conditions, but observation of the reaction mixture showed that the 
iodoisoquinolone 4.296 was produced rapidly, followed by a slower conversion to 4.295 in 29% 










Oxidant Conditions Additive A B RSM 
Br NBS CH2Cl2, –78 ºC→ r.t. TMG N/A N/A 0% 
Br NBS CH2Cl2, r.t. Ph3P=S 0% ~100% 0% 
Br NBS CH2Cl2, r.t. Ph3P=S 0% 90% 0% 
Hg Hg(TFA)2 MeOH, r.t.; NaBH4 N/A 0% 0% ~100% 
Hg Hg(TFA)2 MeOH, r.t.; NaBH4 N/A 0% 0% ~100% 
I NIS CH2Cl2, r.t. Ph3P=S 22% 0% 0% 
I NIS CH2Cl2, –78 ºC→r.t. Ph3P=S 0% 17% 0% 
a) K2CO3was added to the reaction mixture 
Serendipitously, the ring closure was realized by leaving a sample of isoquinolone 4.282 
on the bench top for several days. Isoquinolone 4.282, which is normally a viscous oil, seemed to 
solidify over time. Examination of the solid material showed that it contained some of the 
desired product 4.281. Purification of the mixture provided 4.281 in 20% yield as a single 


























Aside from the syntheses of cervinomycin (see Chapter 3, Sections 3.3.1, 3.3.2 and 
3.3.3), there is little precedence for the formation of tetrahydro-5H-oxazolo[3,2-b]isoquinolin-5-
one and dihydro-5H-oxazolo[3,2-b]isoquinoline-2,5(3H)-dione ring systems. Kelly, Mehta and 
Rao found that the cyclization of the isoquinolone to the tetrahydro-5H-oxazolo[3,2-
b]isoquinolin-5-one ring system was unproductive for the formation of the G-ring, so the success 
of the transformation of 4.282 to 4.281 is unique. A result from Toda suggests that the 
substitution on the chain may favor the closed form via a Thorpe-Ingold effect (Figure 4.43).629 
The bis-methylated derivative 4.297 was cyclized to 4.298 upon standing, but the unsubstituted 
derivative 4.299 did not. Fortunately, this has beneficial implications for the synthesis of 
citreamicin because the bulky nature of the α-methyl serine 4.275 should favor the closed form. 
Figure 4.43: Toda’s example of Thorpe-Ingold assisted cyclization onto a quinolone 
 
a) Potential example of Thorpe-Ingold assisted cyclization from Tohda.629 b) Lack of cyclization without gem 





In summary, a short 12-step route to the pentacyclic core of citreamicin was developed. 
During the course of these efforts, new methodology for the regioselective bromination of PMB 
protected vanillins utilizing TMG and NBS was developed. Other technical advances include: (1) 
suppression of Cannizzaro side-reactions during the Wittig olefination of 4.76 by using DMSO 
as a cosolvent (Scheme 4.30); (2) metal-halogen exchange of styrene 4.48 and the subsequent 
squarate addition was optimized to avoid competitive ortho-lithiation, benzylic deprotonation 
and electrocyclic ring-opening side reactions (Scheme 4.30); and (3) the acetylide addition of 















Scheme 4.30: Summary of the synthesis of acetylide intermediate 4.151 
 
Use of the cyclic silyl protecting group 4.147 as the F-ring coupling partner was critical 
for the success of acetal hydrolysis and subsequent Moore rearrangement (Scheme 4.31). The 
Moore rearrangement was found to be a complicated reaction. In tert-amyl alcohol, the reaction 
produced a mixture (1:1) of 4.154 to 4.161, while use of MTBE as the solvent provided at a 
mixture (1.5:1) of 4.154 to 4.161. MnO2 was found to be the best oxidant for the transformation 
of 4.208 to 4.211 where the use of polar aprotic solvents or bases provided the best yield of 
4.211. The PMB group was removed via hydrogenolysis as opposed to oxidative removal or 
Ionization via Lewis Acids.   
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Scheme 4.31: Summary of the synthesis of 4.235 
 
The downstream chemistry or the synthesis of the GA-rings in citreamicin was developed 
model system (Scheme 4.32). The addition of n-Bu4NOAc was found to be critical for high 
conversions of both the alkoxycarbonylation of 4.242 and the subsequent coupling with acetone. 
A new procedure for the direct coupling of amino acids to isocoumarins to provide isoquinolines 
was developed using an in situ ate-complex generated from LiAlMe4 and the isoquinolone was 




Scheme 4.32: Synthetic summary of the GA-ring fragment 
 
4-(Phenylazo)diphenylamine (PDA) (4.118) was found to be a convenient, colorimetric 
indicator that can be easily used to directly determine the concentrations of a variety of strong 
carbon- and nitrogen-centered bases in the presence of a number of counterions, including Li, 
Na, K, Mg, and sometimes Zn (Figure 4.44).394 PDA can also be used as an indicator to titrate 
tert-BuOK without interference from KOH or other basic impurities. PDA was also shown to be 
an effective indicator for titrating a number of Lewis acids using pyridine as a standard base as 























































Chapter 5: Experimental Section 
5.1: GENERAL EXPERIMENTAL 
Unless otherwise noted, solvents and reagents were used without purification. 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were dried by passage through two columns of 
activated neutral alumina. Methanol (CH3OH), acetonitrile (CH3CN), and N,N-
dimethylformamide (DMF) were dried by passage through two columns of activated molecular 
sieves. Toluene was dried by sequential passage through a column of activated neutral alumina 
followed by a column of Q5 reactant.635 Methylene chloride (CH2Cl2), benzene, triethylamine 
(Et3N), diisopropylethylamine (DIPEA) and 1,3-dimethyl-3,4,5,6-tetrahydro-2-pyrimidinone 
(DMPU) were distilled from calcium hydride prior to use. Dimethyl sulfoxide (DMSO), and tert-
amyl alcohol were stored over 4Å molecular sieves for 48 h prior to use. All solvents were 
determined to contain less than 50 ppm H2O by Karl Fischer coulometric moisture analysis. All 
reactions were performed in flame-dried glassware under argon or nitrogen unless otherwise 
indicated. Volatile solvents were removed under reduced pressure using a Buchi rotary 
evaporator. Reaction mixtures were degassed by putting the reaction vessel under vacuum until 
the solvent effervesced, and backfilling with nitrogen (3 x). Infrared (IR) spectra were obtained 
using a FT IR 1600 spectrophotometer using sodium chloride plates and reported as wave 
numbers. Low resolution chemical ionization mass spectra were obtained with a TSQ-70 
instrument. High resolution measurements were made with a VG Analytical ZAB2-E instrument. 
Thin layer chromatography (TLC) was performed on glass-backed precoated silica gel plates 
(0.25 mm thick with 60 F254) and were visualized using one or both of the following manners: 
UV light (254 nm) and staining with basic aqueous KMnO4 or Cerium ammonium molybdate 
(CAM). Flash flash chromatography was performed according to Still’s procedure using ICN 
Silitech 32-67 D 60A silica gel.636 1H nuclear magnetic resonance (NMR) spectra were obtained 
at either 600, 500, or 400 MHz as indicated as solutions in CDCl3 with 0.05% v/v 
tetramethylsilane (TMS) unless indicated otherwise. 13C-NMR were obtained at either 125, 100 
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or 75 MHz as shown in the indicated deuterated solvent. Chemical shifts are reported in parts per 
million (ppm, δ), and referenced to TMS, and coupling constants are reported in Hertz (Hz). 
Spectral splitting patterns are designated as s, singlet; d, doublet; t, triplet; q, quartet; quint, 
quintuplet; sex, sextet; sept, septuplet; m, multiplet; comp, overlapping multiplets of 
magnetically nonequivalent protons; br, broad; and app, apparent. 
  




epoxybenzo[c][1,2]oxathiin-7-yl)-2-methyl-2-(2-oxopropyl)cyclopentan-1-one  (2.13). (SB-II-
86). A sample of AJS-252Fr2 was crystallized via vapor diffusion from EtOAc and pentanes. 




1-one  (2.14). (SB-II-243B). Isolated after purification of 2.10 by flash chromatography (20% 
IPA/hexanes) to provide 4 mg of 2.14. Crystals were grown by slow evaporation from ethyl 
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acetate, pentane, and chloroform (see section 5.2 for crystal structure); 1H-NMR (400 MHz) δ 
6.57 (d, J = 5.6 Hz, 1 H), 6.06 (d, J = 5.6 Hz, 1 H), 4.94 (dddd, J = 2.0, 2.8, 4.4, 12.4 Hz, 1 H), 
4.00 (bd, J = 12.8 Hz, 1 H), 3.79 (bd, J = 12.8 Hz, 1 H), 3.22 (dd, J = 3.2, 8.0 Hz, 1 H), 3.14 (dd, 
J = 6.4, 13.2 Hz, 1H), 2.65 (dd, J = 2.4, 16.4 Hz, 1 H), 2.62 (dd, J = 3.2, 12.4 Hz, 1 H), 2.48 (m, 
1 H), 2.44 (m, 1 H), 2.33-2.15 (comp, 4 H), 2.01 (dd, J = 8.0, 12.4 Hz, 1 H), 2.00 (t, J = 2.8 Hz, 
1 H), 1.92 (ddd, J = 7.6, 11.6, 23.2 Hz, 1 H), 1.64 (bs, 1 H), 1.02 (s, 3 H) 
NMR assignments: 1H-NMR (400 MHz) δ 6.57 (d, J = 5.6 Hz, 1 H, C6-H), 6.06 (d, J = 
5.6 Hz, 1 H, C5-H), 4.94 (dddd, J = 2.0, 2.8, 4.4, 12.4 Hz, 1 H, C2-H), 4.00 (bd, J = 12.8 Hz, 1 
H, C1-H), 3.79 (bd, J = 12.8 Hz, 1 H, C1-H), 3.22 (dd, J = 3.2, 8.0 Hz, 1 H, C18-H), 3.14 (dd, J 
= 6.4, 13.2 Hz, 1H, C8-H), 2.65 (dd, J = 2.4, 16.4 Hz, 1 H, C10-H), 2.62 (dd, J = 3.2, 12.4 Hz, 1 
H, C3-H), 2.48 (m, 1 H, C10-H), 2.44 (m, 1 H, C19-H), 2.33-2.15 (comp, 4 H, C3-H, C9-H, 
C14-H), 2.01 (dd, J = 8.0, 12.4 Hz, 1 H, C19-H), 2.00 (t, J = 2.8 Hz, 1 H, C16-H), 1.92 (ddd, J = 




2-Allylfuran (2.32). (SB-IV-175). Furan 2.1 (freshly distilled from KOH, 10.4 mL, 144 
mmol) was dissolved in anhydrous THF (100 mL), cooled to –78 °C, and degassed. A solution of 
n-BuLi (2.18 M, 72.5 mL, 158.0 mmol) in hexanes was added via a pressure equalizing addition 
funnel, and the reaction mixture was warmed to 0 °C and stirred for 2 h. The mixture was 
transferred via cannula to a flask containing freshly fused ZnCl2 (21.5 g, 158.1 mmol) and CuCN 
(643 mg, 7.2 mmol) in anhydrous THF (140 mL) at 0 °C, and the mixture was stirred for 10 min. 
Freshly distilled allylbromide (21.2 g, 15.2 mL, 176 mmol) was then added over 15 min, and the 
mixture was stirred for an additional 15 min. Cold aqueous 1 M HCl (100 mL) was added and 
the mixture was extracted with Et2O (2 x 100 mL). The organic layer was washed with cold 
 351 
aqueous 1 M HCl (1 x 100 mL), concentrated NH4OH (1 x 100 mL), and H2O (1 x 100 mL). The 
organic layer was dried (Na2SO4), and purified by fractional distillation using a heated jacketed 
column (7.5 mm x 13 mm) packed with glass helices. The temperature of both the heating bath 
and column jacket was slowly increased (bath: 40 °C → 100 °C, jacket: 40 °C → 80 °C) and the 
pressure was slowly decreaced (760 torr → 40 torr) to isolate two fractions of 2.32 as a solution 
in THF/hexanes; Fraction 1: (bath temperature: 100 °C, jacket temperature: 80 °C, pressure: 450 
torr → 300 torr), Fraction 2: (bath temperature: 100 °C, jacket temperature: 80 °C, 300 torr → 40 
torr). The concentration of 2.32 in both fractions was determined by 1H-NMR using a known 
amount of mesitylene as an internal standard; Fraction 1: (2.53 M, 12.0 mL, 30.36 mmol, 21%), 
Fraction 2: (7.06 M, 13.7 mL, 96.72 mmol, 67%) (88% combined yield); 1H-NMR (500 MHz) δ 
7.31 (m, 1 H), 6.28 (ddd, J = 0.5, 2.5, 4 Hz, 1 H) 6.02 (m, 1 H) 5.98-5.88 (m, 1 H) 5.17-5.09 
(comp, 2 H) 3.39 (dd, J = 1.5, 8.5 Hz, 2 H); 13C-NMR (500 MHz) δ 153.8, 141.2, 133.9, 116.8, 
110.2, 105.4, 32.6; HRMS (CI) m/z calc for C7H7O
+ (M–H), 107.0497; found, 107.0496. 
 
NMR assignments: 1H-NMR (500 MHz) δ 7.31 (m, 1 H, C-7H), 6.28 (ddd, J = 0.5, 2.5, 
4 Hz, 1 H, C6-H) 6.02 (m, 1 H, C5-H) 5.98-5.88 (m, 1 H, C2-H) 5.17-5.09 (comp, 2 H, C1-H) 
3.39 (dd, J = 1.5, 8.5 Hz, 2 H, C3-H); 13C-NMR (500 MHz) δ 153.8 (C4), 141.2 (C7), 133.9 




I-237B). A solution of anhydrous 2-allylfuran (2.32) in THF (1.8 M, 1.80 mL, 3.24 mmol) was 
added to a solution of n-BuLi in hexanes (1.86 M, 1.74 mL, 3.24 mmol) in THF (10 mL) at –78 
°C. The mixture was stirred for 30 min, whereupon it was transferred via cannula to a flask 
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containing a solution of freshly fused ZnCl2 (0.54 g, 4.05 mmol) in THF (20 mL) at –78 °C. The 
mixture was stirred for an additional 30 min before transferring via cannula to a flask containing 
a solution of cyclopentenone (0.13 g, 0.13 mL, 1.62 mmol) and TESCl (0.36 g, 0.41 mL, 2.43 
mmol) in THF (10 mL) at –78 °C. The mixture was stirred for 5 h at –78 °C and warmed to room 
temperature over 16 h, whereupon H2O (1 x 10 mL) was added. The reaction mixture was 
extracted with Et2O (2 x 10 mL), and the combined organic extracts were dried (Na2SO4), 
filtered, concentrated under reduced pressure. The crude material was purified by flash 
chromatography eluting with a gradient of Et2O/hexanes (1:20 → 3:20) to provide 119 mg (30%) 
of 2.37 as a clear oil: 1H-NMR (500 MHz) δ 6.51 (d, J = 4.2 Hz, 1H), 6.50 (d, J = 4.1 Hz, 1 H), 
5.93 (ddd, J = 2.3, 2.3, 5.6 Hz, 1 H), 5.90 (ddd, J = 2.3, 2.3, 5.7 Hz, 1 H), 5.83 (ddd, J = 5.8, 5.8, 
10.1 Hz, 1 H), 5.79 (ddd, J = 7.0, 7.0, 12.7 Hz, 1 H), 5.75-5.73 (comp, 2 H), 5.44 (dt, J = 1.6, 
17.0 Hz, 1 H), 5.35 (dt, J = 1.5, 17.0 Hz, 1 H), 5.17 (dt, J = 1.6, 9.9 Hz, 1 H), 5.15 (dt, J = 1.6, 
9.3 Hz, 1 H), 4.63 (dd, J = 1.8, 5.9 Hz, 1 H), 4.62 (dd, J = 1.9, 5.9 Hz, 1 H), 3.45 (dd, J = 1.4, 6.0 
Hz, 1 H), 3.41 (dd, J = 1.0, 7.1 Hz, 1 H), 2.51-2.44 (comp, 2H), 2.29-2.22 (comp, 2 H), 2.21-
2.12 (comp, 2H), 1.86 (ddd, J = 4.6, 8.5, 13.4 Hz, 1 H), 1.80 (ddd, J = 4.4, 8.8, 13.5 Hz, 1H), 
0.97 (t, J = 8.0 Hz, 9H), 0.94 (t, J = 7.9 Hz, 9 H), 0.67 (q, J = 8.0 Hz, 6 H), 0.56 (q, J = 8.0 Hz, 6 
H); 13C-NMR (125 MHz) δ 149.7, 135.1, 134.7, 134.2, 134.1, 133.9, 133.8, 117.85, 117.80, 90.5, 
90.2, 89.9, 87.10, 87.07, 80.2, 80.0, 47.8, 47.5, 35.5, 34.8, 31.7, 31.5, 6.5, 6.3, 5.8, 4.4;  IR (film) 
3400 (O-H), 2957 (C-H), 2914 (C-H), 2879 (C-H), 1621, 1262, 1098, 1006; LCMS (ESI+APCI); 
found, 287.4 (M–H2O). 
NMR assignments: 1H-NMR (500 MHz) δ 6.51 (d, J = 4.2 Hz, 1H, C7-H), 6.50 (d, J = 
4.1 Hz, 1 H, C7-H), 5.93 (ddd, J = 2.3, 2.3, 5.6 Hz, 1 H, C11-H), 5.90 (ddd, J = 2.3, 2.3, 5.7 Hz, 
1 H, C11-H), 5.83 (ddd, J = 5.8, 5.8, 10.1 Hz, 1 H, C2-H), 5.79 (ddd, J = 7.0, 7.0, 12.7 Hz, 1 H, 
C2-H), 5.75-5.73 (comp, 2 H, C12-H), 5.44 (dt, J = 1.6, 17.0 Hz, 1 H, C1-H), 5.35 (dt, J = 1.5, 
17.0 Hz, 1 H, C1-H), 5.17 (dt, J = 1.6, 9.9 Hz, 1 H, C1-H), 5.15 (dt, J = 1.6, 9.3 Hz, 1 H, C1-H), 
4.63 (dd, J = 1.8, 5.9 Hz, 1 H, C6-H), 4.62 (dd, J = 1.9, 5.9 Hz, 1 H, C6-H), 3.45 (dd, J = 1.4, 6.0 
Hz, 1 H, C3-H), 3.41 (dd, J = 1.0, 7.1 Hz, 1 H, C3-H), 2.51-2.44 (comp, 2H, C13-H), 2.29-2.22 
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(comp, 2 H, C13-H), 2.21-2.12 (comp, 2H, C14-H), 1.86 (ddd, J = 4.6, 8.5, 13.4 Hz, 1 H, C14-
H), 1.80 (ddd, J = 4.4, 8.8, 13.5 Hz, 1H, C14-H), 0.97 (t, J = 8.0 Hz, 9H, C9-H), 0.94 (t, J = 7.9 
Hz, 9 H, C9-H), 0.67 (q, J = 8.0 Hz, 6 H, C8-H), 0.56 (q, J = 8.0 Hz, 6 H, C8-H); 13C-NMR (125 
MHz) δ 149.7 (C7), 135.1 (C11), 134.7 (C11), 134.2 (C2), 134.1 (C2), 133.9 (C12), 133.8 (C12), 
117.85 (C1), 117.80 (C1), 90.5 (C4), 90.2 (C4), 89.9 (C6), 87.10 (C10), 87.07 (C10), 80.2 (C5), 
80.0 (C5), 47.8 (C3), 47.5 (C3), 35.5 (C14), 34.8 (C14), 31.7 (C13), 31.5 (C13), 6.5 (C9), 6.3 






3-(5-Allylfuran-2-yl)-2-methylcyclopentanone (2.6). From TMSI: (SB-III-98). 2-
Methyl-2-cyclopenten-1-one (2.2) (1.02 mL, 10.4 mmol) was dissolved in anhydrous CH2Cl2 (20 
mL) and cooled to –78 °C. Freshly distilled TMSI (2.28 g, 1.62 mL, 11.4 mmol) was added and 
the mixture was stirred for 45 min. A solution of 2-allylfuran (2.32) in THF (9.35 M, 1.67 mL, 
15.6 mmol) and 2-methyl-2-butene (1.47 g, 2.2 mL, 20.8 mmol) was added, and the reaction was 
stirred for 6 h at –78 °C. Triethylamine (Et3N) (2.9 mL, 20.8 mmol) was added, followed by 
MeOH (20 mL), and the reaction mixture was warmed to room temperature and stirred for an 
additional 16 h before concentrating under reduced pressure. The crude residue was purified by 
flash chromatography eluting with a gradient of Et2O/ hexanes (1:20 → 1:5) to provide 1.98 g 
(93%) of 2.6 as a mixture (7.5:1 Trans:Cis) of diastereomers (clear oil). 
From TMSOTf and NaI: (SB-V-52). Neat TMSOTf (1.03 mL, 5.72 mmol) was added 
to a solution of NaI (935 mg, 6.24 mmol) in MeCN (10 mL) at room temperature. The mixture 
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was stirred for 5 min before CH2Cl2 (15 mL) was added and the mixture was cooled to –78 °C. 
Methyl-2-cyclopenten-1-one (2.2) (500 mg, 511 µL, 10.4 mmol) was added and the mixture was 
stirred for 30 min before adding a solution of 2-allylfuran (2.32) in THF (7.1 M, 1.1 mL, 7.8 
mmol) and 2-methyl-2-butene (0.73 g, 1.1 mL, 10.4 mmol). The reaction was stirred for 2 h at –
78 °C before adding Et3N (1.05 g, 1.45 mL, 10.4 mmol) and MeOH (2.1 mL) and warming to 
room temperature. The reaction was concentrated under reduced pressure and the crude oil was 
purified by flash chromatography eluting with a gradient of Et2O/ hexanes (1:20 → 1:5) to 
provide 887 mg (83%) of 2.6 as a mixture (7.5:1 Trans:Cis) of diastereomers (clear oil). 
Trans isomer; 1H-NMR (400 MHz) δ 6.00 (d, J = 3.2 Hz, 1 H), 5.95 (d, J = 2.8 Hz, 1 H), 
5.93 (dddd, J = 6.4, 6.4, 10.0, 16.8 Hz, 1H), 5.13 (dddd, J = 1.6, 1.6, 1.6, 16.8 Hz, 1 H), 5.11 (dq, 
J = 1.6, 9.9 Hz, 1 H), 3.37 (dd, J = 1.2, 6.4 Hz, 2 H), 2.88 (td, J = 6.0, 11.6 Hz, 1 H), 2.49 (m, 
1H), 2.35-2.17 (comp, 3 H), 2.00 (dddd, J = 7.2, 9.6, 10.8, 10.8 Hz, 1 H), 1.13 (d, J = 7.2 Hz, 3 
H); 13C-NMR (100 MHz) δ 219.4, 154.8, 152.8, 133.9, 116.8, 105.9, 105.5, 49.4, 43.6, 37.2, 
32.6, 26.6, 12.8. 
NMR assignments: 1H-NMR (400 MHz) δ 6.00 (d, J = 3.2 Hz, 1 H, C6-H), 5.95 (d, J = 
2.8 Hz, 1 H, C5-H), 5.93 (dddd, J = 6.4, 6.4, 10.0, 16.8 Hz, 1H, C2-H), 5.13 (dddd, J = 1.6, 1.6, 
1.6, 16.8 Hz, 1 H, C1-H), 5.11 (dq, J = 1.6, 9.9 Hz, 1 H, C1-H), 3.37 (dd, J = 1.2, 6.4 Hz, 2 H, 
C3-H), 2.88 (td, J = 6.0, 11.6 Hz, 1 H, C8-H), 2.49 (m, 1H, C10-H), 2.35-2.17 (comp, 3 H, C9-
H, C10-H), 2.00 (dddd, J = 7.2, 9.6, 10.8, 10.8 Hz, 1 H, C12-H), 1.13 (d, J = 7.2 Hz, 3 H, C13-
H); 13C-NMR (100 MHz) δ 219.4 (C11), 154.2 (C7), 152.9 (C4), 133.9 (C2), 116.7 (C1), 106.8 
(C6), 105.7 (C5), 47.6 (C12), 39.8 (C8), 36.1 (C10), 32.5 (C3), 25.5 (C9), 10.7 (C13). 
Cis isomer: (SB-II-250B); 1H-NMR (400 MHz) δ 6.00 (d, J = 3.2 Hz, 1 H), 5.95 (d, J = 
2.8 Hz, 1 H), 5.89 (dddd, J = 6.4, 6.4, 10.4, 16.8 Hz, 1H), 5.13-5.07 (comp, 2 H), 3.31 (dd, J = 
1.2, 6.8 Hz, 2 H), 2.52-1.95 (comp, 6 H), 0.86 (d, J = 7.2 Hz, 3 H); 13C-NMR (100 MHz) δ 
220.2, 154.2, 152.9, 133.9, 116.7, 106.8, 105.7, 47.6, 39.8, 36.1, 32.5, 25.5, 10.7. 
NMR assignments: 1H-NMR (400 MHz) δ 6.00 (d, J = 3.2 Hz, 1 H, C6-H), 5.95 (d, J = 
2.8 Hz, 1 H, C5-H), 5.89 (dddd, J = 6.4, 6.4, 10.4, 16.8 Hz, 1H, C2-H), 5.13-5.07 (comp, 2 H, 
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C1-H), 3.31 (dd, J = 1.2, 6.8 Hz, 2 H, C3-H), 2.52-1.95 (comp, 6 H, C8-H, C9-H, C10-H, C12-
H), 0.86 (d, J = 7.2 Hz, 3 H, C13-H); 13C-NMR (100 MHz) δ 220.2 (C11), 154.8 (C7), 152.8 
(C4), 133.9 (C2), 116.8 (C1), 105.9 (C6), 105.5 (C5), 49.4 (C12), 43.8 (C8), 37.2 (C10), 32.6 






(SB-III-131). Triphenylmethane (30 mg, 12 mmol) and HMDS (376 mg, 488 µL, 2.32 mmol) 
were dissolved in anhydrous THF (7.5 mL) and cooled to 0 °C. n-BuLi was added until the 
solution turned a red color that persisted for at least one minute. Ketone 2.6 (500 mg, 2.44 mmol) 
was added, followed by DMPU (freshly distilled from CaH2, 7.5 mL) and the solution was 
stirred for 4 h at 0 °C. 3-Bromoprop-1-ynyl)trimethylsilane (1.7 g, 7.32 mmol)630 was added at 0 
°C and stirred for an additional 1 h before adding a 25% (w/v) aqueous sodium bisulfate solution 
(10 mL). The mixture was extracted with EtOAc (3 x 20 mL), and the combined organic extracts 
were washed with 13% (w/v) aqueous brine solution (4 x 10 mL), dried (Na2SO4), filtered and 
concentrated under reduced pressure. The crude oil was purified by flash chromatography eluting 
with a gradient of Et2O/ hexanes (1:20 → 1:5) to provide 603 mg (79%) of 2.7 as a pale yellow 
oil: 1H-NMR (400 MHz) δ 6.02 (d, J = 3.2 Hz, 1 H), 5.94 (d, J = 3.2 Hz, 1 H), 5.90 (dddd, J = 
6.8, 6.8, 10.4, 16.8 Hz, 1 H), 5.11 (dddd, J = 1.6, 1.6, 1.6, 17.2 Hz, 1 H), 5.09 (dddd, J = 1.2, 1.2, 
1.2, 9.2 Hz, 1 H) 3.71 (dd, J = 6.0, 11.2 Hz, 1 H) 3.35 (d, J = 7.2, Hz, 2 H) 2.56 (d, J = 16.4 Hz, 
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1 H) 2.52 (m, 1 H), 2.36 (d, J = 16.8 Hz, 1 H), 2.41-2.18 (comp, 3 H), 0.70 (s, 3 H), 0.12 (s, 9 
H); 13C-NMR (100 MHz) δ 219.8, 153.43, 153.12, 134.1, 116.8, 107.3, 106.0, 103.7, 87.4, 52.4, 
42.4, 37.8, 32.7, 27.6, 22.9, 18.5, 0.2. 
NMR assignments: 1H-NMR (400 MHz) δ 6.02 (d, J = 3.2 Hz, 1 H, C6-H), 5.94 (d, J = 
3.2 Hz, 1 H, C5-H), 5.90 (dddd, J = 6.8, 6.8, 10.4, 16.8 Hz, 1 H, C2-H), 5.11 (dddd, J = 1.6, 1.6, 
1.6, 17.2 Hz, 1 H, C1-H), 5.09 (dddd, J = 1.2, 1.2, 1.2, 9.2 Hz, 1 H, C1-H) 3.71 (dd, J = 6.0, 11.2 
Hz, 1 H, C8-H) 3.35 (d, J = 7.2, Hz, 2 H, C3-H) 2.56 (d, J = 16.4 Hz, 1 H, C14-H) 2.52 (m, 1 H, 
C10-H), 2.36 (d, J = 16.8 Hz, 1 H, C14-H), 2.41-2.18 (comp, 3 H, C9-H, C10-H), 0.70 (s, 3 H, 
C13-H), 0.12 (s, 9 H, C17-H); 13C-NMR (100 MHz) δ 219.8 (C11), 153.43 (C7), 153.12 (C4), 
134.1 (C2), 116.8 (C1), 107.3 (C6), 106.0 (C5), 103.7 (C16), 87.4 (C15), 52.4 (C12), 42.4 (C8), 






yl)cyclopentan-1-one. (SB-III-93D). Isolated from the reaction of ketone 2.6 with (3-
bromoprop-1-ynyl)trimethylsilane. Isolated as a mixture as an 0.8:1 ratio of inseparable isomers 
via flash chromatography, eluting with a gradient of PhMe/hexanes (2:5 → 4:5) to provide 39 
mg (4%) of the named compounds as a clear oil: 1H-NMR (400 MHz) δ 6.06 (d, J = 3.2 Hz, 0.8 
H), 6.03 (d, J = 2.8 Hz, 1 H), 5.99-5.85 (comp, 3.6 H), 5.15-5.09 (comp, 3.6 H), 3.70 (m, 1 H), 
3.36 (m, 3.6 H), 3.16 (m, 0.8H), 2.63-2.16 (comp, 12.6 H), 1.11 (d, J = 6.8 Hz, 2.4 H), 0.67 (s, 3 
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H), 0.15 (s, 9 H), 0.14 (s, 9 H), 0.13 (s, 7.2 H), 0.12 (s, 7.2 H); 13C-NMR (100 MHz) δ 219.7, 
219.4, 218.2, 154.7, 153.9, 153.22, 153.18, 153.14, 134.10, 134.06, 116.95, 116.87, 107.5, 107.4, 
106.13, 106.06, 106.0, 104.3, 104.1, 103.72, 103.67, 103.0, 102.7, 88.1, 87.7, 87.5, 87.4, 86.7, 
86.3, 53.3, 52.4, 51.6, 50.4, 48.4, 45.3, 40.8, 40.3, 36.1, 32.83, 32.27, 28.45, 28.38, 28.1, 27.9, 
27.6, 20.5, 19.9, 18.8, 18.1, 12.2, 0.3, 0.1, 0.2, 0.14, 0.09; HRMS (CI) m/z found for 
C25H37O2Si2
+ (M+H), 425. 
NMR assignments: 1H-NMR (400 MHz) (10,10 dialkylated) δ 6.03 (d, J = 2.8 Hz, 1 H, 
C6-H), 5.99-5.85 (comp, 3.6 H, C2-H, C5-H), 5.15-5.09 (comp, 3.6 H, C1-H), 3.70 (m, 1 H, C8-
H), 3.36 (m, 3.6 H, C3-H), 2.63-2.16 (comp, 12.6 H, C9-H, C10-H, C14-H, C18-H), 0.67 (s, 3 H, 
C13-H), 0.15 (s, 9 H, C17-H or C21-H), 0.14 (s, 9 H, C17-H or C21-H); (10,12 dialkylated) 6.06 
(d, J = 3.2 Hz, 0.8 H, C6-H), 5.99-5.85 (comp, 3.6 H, C2-H, C5-H), 5.15-5.09 (comp, 3.6 H, C1-
H), 3.36 (m, 3.6 H, C3-H), 3.16 (m, 0.8H, C8-H), 2.63-2.16 (comp, 12.6 H, C9-H, C10-H, C14-
H, C18-H), 1.11 (d, J = 6.8 Hz, 2.4 H, C13-H), 0.13 (s, 7.2 H, C17-H or C21-H), 0.12 (s, 7.2 H, 
C17-H or C21-H); 13C-NMR (100 MHz) (10,10 dialkylated, major diastereomer) δ 219.4 (C11), 
153.9 (C7), 153.22 (C4), 134.10 (C2), 116.95 (C1), 107.4 (C6), 106.06 (C5), 103.72 (C16), 
103.0 (C20), 87.7 (C19), 87.5 (C15), 51.6 (C12), 50.4 (C10), 48.4 (C8), 32.27 (C3), 27.6 (C18), 
19.9 (C9), 18.1 (C13), 0.3 (C17), 0.2 (C21), (10,10 dialkylated, minor diastereomer)  δ 219.7 
(C11), 153.9 (C7), 153.18 (C4), 134.10 (C2), 116.95 (C1), 107.5 (C6), 106.13 (C5), 104.3 (C20), 
103.67 (C16), 87.4 (C15), 86.3 (C19), 53.3 (C12), 45.3 (C10), 40.3 (C8), 32.27 (C3), 28.38 
(C14), 19.9 (C9), 18.8 (C13), 0.3 (C17), 0.2 (C21), (10,12 dialkylated) δ 218.2 (C11), 154.7 
(C7), 153.14 (C4), 134.06 (C2), 116.87 (C1), 107.4 (C6),106.0 (C5), 104.1 (C16), 102.7 (C20), 
88.1 (C15), 86.7 (C19), 52.4 (C10), 48.4 (C12), 36.1 (C8), 32.83 (C3), 28.1 (C14), 27.9 (C18), 





yl)cyclopentan-1-one. (SB-III-93C). By-product isolated from the reaction of ketone 2.6 with 
(3-bromoprop-1-ynyl)trimethylsilane. Purified via flash chromatography, eluting with a gradient 
of  PhMe/hexanes (2:5 → 4:5) to provide 41 mg (3%) of the named compound as a clear oil: 1H-
NMR  (400 MHz) δ 6.09 (d, J = 3.2 Hz, 1 H), 5.97 (d, J = 2.8 Hz, 1 H), 5.93 (dddd, J = 6.8, 6.8, 
10.4, 16.8 Hz, 1 H), 5.13 (dddd, J = 1.6, 1.6, 1.6, 16.4 Hz, 1 H), 5.109 (dddd, J = 1.2, 1.2, 1.2, 
10.0 Hz, 1 H), 3.77 (dd, J = 6.4, 12.8 Hz, 1H), 3.37 (d, J = 7.2, Hz, 2 H), 2.71 (d, J = 16.8 Hz, 1 
H), 2.70 (d, J = 17.2 Hz, 1 H), 2.64 (d, J = 16.8 Hz, 1 H), 2.61 (t, J = 13.2 Hz, 1 H), 2.61 (d, J = 
16.8 Hz, 1 H), 2.40 (d, J = 16.8 Hz, 1 H), 2.34 (dd, J = 6.4, 13.2 Hz, 1 H), 2.05 (d, J = 17.6 Hz, 1 
H), 0.74 (s, 3 H), 0.15 (s, 9 H), 0.13 (s, 9 H), 0.11 (s, 9 H); 13C-NMR (100 MHz) δ 219.9, 153.3, 
153.0, 134.1, 116.9, 107.5, 106.1, 104.5, 104.2, 101.5, 88.4, 87.6, 87.4, 53.4, 51.8, 38.6, 32.8, 
30.6, 27.7, 26.0, 25.1, 18.2, 0.2, 0.11, 0.06; HRMS (CI) m/z found for C31H47O2Si3
+ (M+H), 534. 
NMR assignments: 1H-NMR (400 MHz) δ 6.09 (d, J = 3.2 Hz, 1 H, C6-H), 5.97 (d, J = 
2.8 Hz, 1 H, C5-H), 5.93 (dddd, J = 6.8, 6.8, 10.4, 16.8 Hz, 1 H, C2-H), 5.13 (dddd, J = 1.6, 1.6, 
1.6, 16.4 Hz, 1 H, C1-H), 5.109 (dddd, J = 1.2, 1.2, 1.2, 10.0 Hz, 1 H, C1-H), 3.77 (dd, J = 6.4, 
12.8 Hz, 1H, C8-H), 3.37 (d, J = 7.2, Hz, 2 H, C3-H), 2.71 (d, J = 16.8 Hz, 1 H, C18-H), 2.70 (d, 
J = 17.2 Hz, 1 H, C22-H), 2.64 (d, J = 16.8 Hz, 1 H, C18-H), 2.61 (t, J = 13.2 Hz, 1 H, C9-H), 
2.61 (d, J = 16.8 Hz, 1 H, C14-H), 2.40 (d, J = 16.8 Hz, 1 H, C14-H), 2.34 (dd, J = 6.4, 13.2 Hz, 
1 H, C9-H), 2.05 (d, J = 17.6 Hz, 1 H, C22-H), 0.74 (s, 3 H, C13-H), 0.15 (s, 9 H, C17-H, C21-H 
or C25-H), 0.13 (s, 9 H, C17-H, C21-H or C25-H), 0.11 (s, 9 H, C17-H, C21-H or C25-H); 13C-
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NMR (100 MHz) δ 219.9 (C11), 153.3 (C7), 153.0 (C4), 134.1 (C2), 116.9 (C1), 107.5 (C6), 
106.1 (C5), 104.5 (C16), 104.2 (C24), 101.5 (C20), 88.4 (C15), 87.6 (C23), 87.4 (C19), 53.4 
(C12), 51.8 (C10), 38.6 (C8), 32.8 (C3), 30.6 (C14), 27.7 (C22), 26.0 (C18), 25.1 (C9), 18.2 
(C13), 0.2 (C17), 0.11 (C25), 0.06 (C21). 
 
Procedure to assay water content in MnCl2•2LiCl solution using camphor (2.73): 
(SB-IV-71,72); Triphenylmethane (2 mg, 0.008 mmol) and HMDS (28 µL, 21 mg, 0.131 mmol) 
were dissolved in anhydrous THF (0.25 mL) and cooled to 0 °C. n-BuLi (1.56 M) was added 
until the solution turned a red color that persisted for at least one minute. A solution of camphor 
2.73 (20 mg, 0.131 mmol) in anhydrous THF (0.25 mL) was added and the solution was stirred 
for 30 min, followed by adding a solution of MnCl2•2LiCl (0.32 mL, 0.408 M, 0.131 mmol). The 
solution was stirred for 5 min before adding TESCl (freshly distilled from CaH2, 44 mg, 66 µL, 
0.293 mmol). The mixture was stirred for an additional 30 min, whereupon the solvent was 
removed reduced pressure. The residue was re-dissolved in pentanes, filtered through Celite, 
concentrated under reduced pressure, and the residue was analyzed by 1H-NMR (400 MHz). 
Ratio of the C3 proton in camphor 2.73 2.08 (t, J = 4.4 Hz, 1 H) to the C3 proton in the silyl enol 
ether 2.74 2.17 (t, J = 3.6 Hz, 0.25 H) was 1:0.25, indicating a proton content of 25 mol %. 
 
4-(5-Allylfuran-2-yl)-5-methylcyclopent-1-en-1-yl)oxy)triethylsilane (2.76). (SB-III-
295). Triphenylmethane (3 mg, 0.007 mmol) was dissolved in anhydrous THF (0.5 mL) and 
cooled to 0 °C. Hexamethyldisilazide (HMDS) (24 mg, 31 µL, 0.146 mmol) was added, followed 
by n-BuLi (ca. 1.56 M, 93 µL, 0.146 mmol) until the reaction mixture turned red. Ketone 2.6 (30 
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mg, 0.146 mmol) was added and the reaction mixture was stirred for 30 min before adding 
TESCl (freshly distilled from CaH2, 26 mg, 29 µL, 0.175 mmol) and stirring for an additional 30 
min. The reaction mixture was diluted with pentanes and filtered through Celite. The organic was 
concentrated to an oil to get 2.76: 1H-NMR (400 MHz)  δ 5.93-5.84 (comp, 3 H), 5.10-5.02 
(comp, 2 H), 4.51 (dd, J = 2.0, 4.0 Hz, 1 H), 3.30 (d, J = 6.4 Hz, 2 H), 2.86 (q, J = 8.4 Hz, 1 H), 
2.47 (ddt, J = 2.0, 8.8, 14.8 Hz, 1 H), 2.31 (ddt, J = 2.0, 8.0, 14.8 Hz, 1 H), 1.07 (d, J = 6.8 Hz, 3 
H), 0.93 (t, J = 8.0 Hz, 9 H), 0.64 (q, J = 7.6 Hz, 6 H). 
NMR assignments: 1H-NMR (400 MHz) δ 5.93-5.84 (comp, 3 H, C2-H, C5-H, C6-H), 
5.10-5.02 (comp, 2 H, C1-H), 4.51 (dd, J = 2.0, 4.0 Hz, 1 H, C10-H), 3.30 (d, J = 6.4 Hz, 2 H, 
C3-H), 2.86 (q, J = 8.4 Hz, 1 H, C12-H), 2.47 (ddt, J = 2.0, 8.8, 14.8 Hz, 1 H, C9-H), 2.31 (ddt, J 
= 2.0, 8.0, 14.8 Hz, 1 H, C9-H), 1.07 (d, J = 6.8 Hz, 3 H, C13-H), 0.93 (t, J = 8.0 Hz, 9 H, C15-





(2.78). (SB-IV-178). A slurry of KH (139 mg, 0.976 mmol) in THF (0.5 mL) was cooled to –78 
°C. A solution of ketone 2.6 (50 mg, 0.244 mmol) and TBSCl (96 mg, 0.634 mmol) in THF (0.5 
mL) were added to the reaction at –78 °C. The reaction mixture was stirred for 1 h and then 
warmed to room temperature. The reaction was diluted with hexanes and the mixture was filtered 
through Celite. The filtrate was concentrated under reduced pressure and the crude oil was 
redissolved in hexanes and purified via silica plug eluting with 1% Et3N in hexanes to provide 66 
mg (85%) of 2.78 as a clear oil: 1H-NMR (400 MHz)  δ 5.93 (dddd, J = 6.4, 6.4, 10.0, 16.8 Hz, 1 
H), 5.89 (d, J = 3.6 Hz, 1 H), 5.86 (d, J = 3.2 Hz, 1 H), 5.11 (dq, J = 1.6, 15.6 Hz, 1 H), 5.08 (dq, 
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J = 1.2, 8.0 Hz, 1 H), 3.62 (m, 1H), 3.34 (app dd, J = 1.2, 6.8 Hz, 2 H), 2.42 (m, 1 H), 2.27 (m, 1 
H), 2.17 (dddd, J = 5.6, 8.8, 8.8 12.4 Hz, 1 H), 1.87 (dddd, J = 4.0, 4.0, 8.8, 12.4 Hz, 1H), 1.47 
(td, J = 0.8, 2.0 Hz, 3 H), 0.95 (s, 9 H), 0.14 (s, 6 H). 
NMR assignments: 1H-NMR (400 MHz) δ 5.93 (dddd, J = 6.4, 6.4, 10.0, 16.8 Hz, 1 H, 
C2-H), 5.89 (d, J = 3.6 Hz, 1 H, C6-H), 5.86 (d, J = 3.2 Hz, 1 H, C5-H), 5.11 (dq, J = 1.6, 15.6 
Hz, 1 H, C1-H), 5.08 (dq, J = 1.2, 8.0 Hz, 1 H, C1-H), 3.62 (m, 1H, C8-H), 3.34 (app dd, J = 1.2, 
6.8 Hz, 2 H, C3-H), 2.42 (m, 1 H, C9-H or C10-H), 2.27 (m, 1 H, C9-H or C10-H), 2.17 (dddd, J 
= 5.6, 8.8, 8.8 12.4 Hz, 1 H, C9-H or C10-H), 1.87 (dddd, J = 4.0, 4.0, 8.8, 12.4 Hz, 1H, C9-H or 




((3-(5-Allylfuran-2-yl)-2-methylcyclopent-1-en-1-yl)oxy)trimethylsilane (2.77). From 
ketone 2.6: (SB-IV-235). Neat TMSOTf (325 mg, 265 µL, 1.46 mmol) was added to a solution 
of NaI (265 mg, 1.51 mmol) in MeCN (2 mL) at room temperature. The mixture was stirred for 5 
min, and CH2Cl2 (3 mL), HMDS (317 mg, 412 µL, 1.95 mmol), and ketone 2.6 (100 mg, 0.49 
mmol) were added sequentially. The mixture was stirred at room temperature for 24 h and then 
diluted with hexanes (50 mL). The reaction mixture was filtered through a silica plug 
(deactivated with Et3N), and the plug was washed once with hexanes (10 mL). The combined 
organic filtrates were concentrated under reduced pressure to provide 113 mg (84%) 2.77 as a 
clear oil. 
From Methyl-2-cyclopenten-1-one (2.2): (SB-IV-255); Neat TMSOTf (254 mg, 207 
µL, 1.14 mmol) was added to a solution of NaI (187 mg, 1.25 mmol) in MeCN (2 mL) at room 
temperature. The mixture was stirred for 5 min before CH2Cl2 (3 mL) was added and the mixture 
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was cooled to –78 °C. Methyl-2-cyclopenten-1-one (2.2) (100 mg, 102 µL, 1.04 mmol) was 
added, and the mixture was stirred for 30 min before adding a solution of 2-allylfuran (2.32) in 
THF (7.1 M, 221 µL, 1.56 mmol) and 2-methyl-2-butene (180 mg, 270 µL, 2.08 mmol). The 
reaction was stirred for 2 h at –78 °C, whereupon HMDS (507 mg, 658 µL, 3.12 mmol) was 
added, and the reaction was warmed to room temperature. A second aliquot of TMSOTf (115 
mg, 94 µL, 0.52 mmol) was added, and the reaction was stirred for an additional 2 h before 
adding MeOH (67 mg, 85 µL, 2.08 mmol). The mixture was diluted with hexanes (50 mL) and 
filtered through a silica plug (deactivated with Et3N) and eluted with hexanes with 1% Et3N. The 
combined organic layers were concentrated under reduced pressure to provide 235 mg (82%) 

















3-(5-Allylfuran-2-yl)-2-methyl-2-(prop-2-ynyl)cyclopentanone (2.33). (SB-III-100). A 
solution of 2.7 (270 mg, 0.86 mmol), AcOH (98 µL, 1.72mmol), and TBAF (450 mg, 1.72 
mmol) in anhydrous THF (2.7 mL) and the reaction was refluxed for 2 h. The solution was 
cooled to room temperature before the solvent was removed under reduced pressure and the 
crude material was purified by flash chromatography eluting with a gradient of Et2O/hexanes 
(1:20 → 1:5) to yield 189 mg (91%) of 2.33 as a pale yellow oil: 1H-NMR  (500 MHz) δ 6.04 (d, 
J = 3.0 Hz, 1 H), 5.95 (d, J = 3.0 Hz, 1 H), 5.91 (dddd, J = 6.5, 6.5, 10.1, 16.2 Hz, 1H),  5.13-
5.09 (comp, 2 H), 3.71 (dd, J = 5.8, 12.1 Hz, 1 H), 3.35 (d, J = 6.4 Hz, 2 H) 2.59-2.50 (comp, 2 
H) 2.37-2.24 (comp, 3 H) 2.17-2.08 (m, 1 H) 2.0 (t, J = 2.6 Hz, 1 H), 0.72 (s, 3 H); 13C-NMR 
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(125 MHz) δ 219.5, 153.0, 133.9, 116.7, 107.2, 105.8, 80.9, 70.6, 52.1, 42.2, 37.2, 32.5, 25.7, 
22.5, 18.2. 
NMR assignments: 1H-NMR (500 MHz) δ 6.04 (d, J = 3.0 Hz, 1 H, C6-H), 5.95 (d, J = 
3.0 Hz, 1 H, C5-H), 5.91 (dddd, J = 6.5, 6.5, 10.1, 16.2 Hz, 1H, C2-H),  5.13-5.09 (comp, 2 H, 
C1-H), 3.71 (dd, J = 5.8, 12.1 Hz, 1 H, C8-H), 3.35 (d, J = 6.4 Hz, 2 H, C3-H) 2.59-2.50 (comp, 
2 H, C10-H, C14-H) 2.37-2.24 (comp, 3 H, C9-H, C10-H, C14-H) 2.17-2.08 (m, 1 H, C9-H) 2.0 
(t, J = 2.6 Hz, 1 H, C16-H), 0.72 (s, 3 H, C13-H); 13C-NMR (125 MHz) δ 219.5 (C11), 153.0 
(C4, C7), 133.9 (C2), 116.7 (C1), 107.2 (C6), 105.8 (C5), 80.9 (C15), 70.6 (C16), 52.1 (C12), 





(2.81). (SB-III-117). K2CO3, (250 mg, 1.81 mmol), K3Fe(CN)6 (20 mg, 0.06 mmol), 
K2OsO2(OH)4•2H2O (11 mg, 0.03 mmol) and K2S2O8 (243 mg, 0.9 mmol) were added to a flask, 
followed by H2O (3 mL). A solution of 2.33 (146 mg, 0.6 mmol) in tert-BuOH (3 mL) was 
added to the vigorously stirred mixture, and stirring at room temperature was continued for 24 h, 
whereupon a solution of saturated aqueous Na2S2O3 (1 mL) was added. The mixture was 
extracted with EtOAc (3 x 10 mL), and the the combined organic extracts were washed with 
13% aqueous brine solution (4 x 5 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude oil was purified by flash chromatography eluting with a gradient of  
EtOAc/hexanes (1:2 → 1:0) to provide 126 mg (76%) of 2.81 as a mixture (1:1) of diastereomers 
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(clear oil). δ 6.08 (app s, 2 H), 4.01 (m, 1 H), 3.74-3.70 (comp, 2 H), 3.62 (m, 1 H), 2.82 (app d, 
J = 6.4 Hz, 2 H), 2.59 (app dt, J = 2.4, 16.4 Hz, 1 H), 2.54 (m, 1 H), 2.37-2.24 (comp, 3 H), 2.18-
2.06 (m, 1 H), 2.01 (app t, J = 2.8 Hz, 1 H), 0.73 (s, 3 H). 
NMR assignments: δ 6.08 (app s, 2 H, C5-H, C6-H), 4.01 (m, 1 H, C2-H), 3.74-3.70 
(comp, 2 H, C1-H), 3.62 (m, 1 H, C8-H), 2.82 (app d, J = 6.4 Hz, 2 H, C3-H), 2.59 (app dt, J = 
2.4, 16.4 Hz, 1 H, C9-H), 2.54 (m, 1 H, C14-H), 2.37-2.24 (comp, 3 H, C9-H, C10-H, C14-H), 




2-ynyl)cyclopentanone (2.82). (SB-III-124). Diol 2.81 (126 mg, 0.46 mmol) and imidazole (37 
mg, 0.55 mmol) were dissolved in anhydrous DMF (2 mL) and CH2Cl2 (0.7 mL), and the 
solution was cooled to –50 °C. TBDPSCl (137 mg, 130 µL, 0.5 mmol) was added, and the 
reaction was stirred for 6 h at –50 °C, whereupon a saturated aqueous NaHCO3 solution (2 mL) 
was added. The mixture was extracted with EtOAc (3 x 5 mL), and the combined organic 
extracts were then washed with 13% aqueous brine solution (4 x 3 mL), dried (Na2SO4), filtered, 
concentrated under reduced pressure. The crude oil was purified by flash chromatography eluting 
with a gradient of  Et2O/hexanes (1:5 → 1:2) to provide 175 mg (75%) of 2.82 as a mixture (1:1) 
of diastereomers (clear oil): 1H-NMR  (500 MHz) δ 7.66-7.63 (comp, 4 H), 7.45-7.36 (comp, 6 
H), 6.02-6.01 (app m, 1 H), 5.98 (app t, 1 H), 4.02-3.97 (app m, 1 H), 3.71-3.64 (app m, 2 H), 
3.60-3.56 (app m, 1 H), 2.84-2.76 (app m, 2 H), 2.54-2.47 (app m, 2 H), 2.30-2.18 (app m, 3 H), 
2.11-2.04 (app m, 1 H), 1.96 (app q, 1 H), 1.07 (bs, 9 H), 0.63 (app d, 3 H); 13C-NMR (125 
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MHz) δ 219.4, 153.1, 151.4, 151.4, 135.5, 135.5, 133.1, 133.0, 129.9, 127.8, 107.4, 107.3, 80.9, 
70.7, 67.1, 52.1, 42.2, 37.2, 32.1, 32.1, 26.9, 25.7, 22.5, 19.3, 18.3. 
NMR assignments: δ 7.66-7.63 (comp, 4 H, C19-H, C23-H), 7.45-7.36 (comp, 6 H, 
C17-H, C18-H, C21-H, C22-H), 6.02-6.01 (app m, 1 H, C6-H), 5.98 (app t, 1 H, C5-H), 4.02-
3.97 (app m, 1 H, C2-H), 3.71-3.64 (app m, 2 H, C1-H), 3.60-3.56 (app m, 1 H, C1-H), 2.84-2.76 
(app m, 2 H, C3-H), 2.54-2.47 (app m, 2 H, C9-H, C14-H), 2.30-2.18 (app m, 3 H, C9-H, C10-
H, C14-H), 2.11-2.04 (app m, 1 H, C10-H), 1.96 (app q, 1 H, C16-H), 1.07 (bs, 9 H, C26-H), 
0.63 (app d, 3 H, C13-H); 13C-NMR (125 MHz) δ 219.4 (C11), 153.1 (C7), 151.4 (C4), 151.4 
(C4), 135.5 (C19, C23), 135.5 (C19, C23), 133.1 (C20, C24), 133.0 (C20, C24), 129.9 (C17, 
C21), 127.8 (C18, C22), 107.4 (C6), 107.3 (C5), 80.9 (C15), 70.7 (C16), 67.1 (C1), 52.1 (C12), 





III-137). Alcohol 2.34 (96 mg, 0.19 mmol) and Et3N (45 mg, 62 µL, 0.47 mmol) was dissolved 
in anhydrous THF (2 mL) and cooled to 0 °C. Vinylsulfonyl chloride (28 mg, 20 µL, 0.22 
mmol)631 was added and the mixture was stirred for 8 h. The mixture was cooled to 0 °C and 
Et3N (42µL, 0.32 mmol) followed by vinylsulfonyl chloride (18 mg, 13µL, 0.14 mmol). The 
mixture was stirred for 16 h, whereupon 1 M HCl (1 mL) was added. The mixture was extracted 
with Et2O (3 x 5 mL), and the combined organic extracts were washed with 1 M HCl (1 x 5 mL), 
dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude oil was re-
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dissolved in toluene (3 mL), filtered, and the filtrate was heated to 75 °C for 16 h. Silica gel (3 g) 
was added at 75 °C, and the reaction was cooled to room temperature before removing the 
solvent under reduced pressure. The crude material was purified by flash chromatography eluting 
with EtOAc/hexanes (1:4) to provide 48 mg (43%) of 2.34 and 49 mg (44%) of 2.89 as an off 
white solid: 1H-NMR (500 MHz) δ 7.69-7.66 (comp, 4 H), 7.47-7.39 (comp, 6 H), 6.55 (d, J = 
5.5 Hz, 1 H), 6.04 (d, J = 5.5 Hz, 1 H), 4.90 (dddd, J = 2.0, 4.0, 4.0, 12.0 Hz, 1 H), 3.92 (dd, J = 
4.0, 12.0 Hz, 1 H), 3.84 (dd, J = 4.5, 11.5 Hz, 1H), 3.20 (dd, J = 3.5, 8.0 Hz, 1H), 3.13 (dd, J = 
6.5, 12.5 Hz, 1 H), 2.65 (dd, J = 2.5, 17.0 Hz, 1H), 2.531 (dd, J = 12.0, 15.5 Hz, 1 H), 2.526 (dd, 
J = 8.0, 17.5 Hz, 1 H), 2.47 (dd, J = 2.5, 14.5 Hz, 1 H), 2.44 (dd, J = 3.5, 12.0 Hz, 1 H), 2.31 (dd, 
J = 1.5, 15.5 Hz, 1 H), 2.26 (dd, J = 7.0, 19.0 Hz, 1 H), 2.12 (ddd, J = 6.5, 9.0, 12.0 Hz, 1 H), 
1.99 (dd, J = 8.0, 12.5 Hz, 1 H), 1.99 (m, 1 H), 1.92 (dddd, J = 9.0, 12.5, 12.5, 12.5 Hz, 1 H), 
1.09 (s, 9 H), 1.02 (s, 3 H); 13C-NMR (125 MHz) δ219.5, 141.7, 135.6, 135.6, 134.5, 132.7, 
132.6, 129.9, 127.8, 91.2, 88.1, 80.9, 80.3, 71.2, 64.8, 58.9, 51.0, 44.3, 37.0, 33.8, 29.4, 27.0, 
26.8, 21.9, 19.3, 18.8;  IR (film) 2960 (C-H), 2932 (C-H), 2858 (C-H), 1741 (C=O), 1365 (S=O), 
1172 (S=O), 1112 (S=O)cm-1; HRMS (ESI) m/z calc for NaC34H40O6SSi
+ (M+Na), 627.2207; 
found, 627.2211. 
 NMR assignments: 1H-NMR (500 MHz) δ 7.69-7.66 (comp, 4 H, C19-H, C23-H), 7.47-
7.39 (comp, 6 H, C17-H, C18-H, C21-H, C22-H), 6.55 (d, J = 5.5 Hz, 1 H, C6-H), 6.04 (d, J = 
5.5 Hz, 1 H, C5-H), 4.90 (dddd, J = 2.0, 4.0, 4.0, 12.0 Hz, 1 H, C2-H), 3.92 (dd, J = 4.0, 12.0 Hz, 
1 H, C1-H), 3.84 (dd, J = 4.5, 11.5 Hz, 1H, C1-H), 3.20 (dd, J = 3.5, 8.0 Hz, 1H, C27-H), 3.13 
(dd, J = 6.5, 12.5 Hz, 1 H, C8-H), 2.65 (dd, J = 2.5, 17.0 Hz, 1H, C10-H), 2.531 (dd, J = 12.0, 
15.5 Hz, 1 H, C3-H), 2.526 (dd, J = 8.0, 17.5 Hz, 1 H, C14-H), 2.47 (dd, J = 2.5, 14.5 Hz, 1 H, 
C10-H), 2.44 (dd, J = 3.5, 12.0 Hz, 1 H, C28-H), 2.31 (dd, J = 1.5, 15.5 Hz, 1 H, C3-H), 2.26 
(dd, J = 7.0, 19.0 Hz, 1 H, C14-H), 2.12 (ddd, J = 6.5, 9.0, 12.0 Hz, 1 H, C9-H), 1.99 (dd, J = 
8.0, 12.5 Hz, 1 H, C28-H), 1.99 (m, 1 H, C16-H), 1.92 (dddd, J = 9.0, 12.5, 12.5, 12.5 Hz, 1 H, 
C9-H), 1.09 (s, 9 H, C26-H), 1.02 (s, 3 H, C13-H); 13C-NMR (125 MHz) δ219.5 (C11), 141.7 
(C6), 135.6 (C19), 135.6 (C23), 134.5 (C5), 132.7 (C20), 132.6 (C24), 129.9 (C18, C22), 127.8 
 367 
(C17, C21), 91.2 (C7), 88.1 (C4), 80.9 (C15), 80.3 (C2), 71.2 (C16), 64.8 (C1), 58.9 (C27), 51.0 
(C12), 44.3 (C8), 37.0 (C14), 33.8 (C28), 29.4 (C3), 27.0 (C10), 26.8 (C26), 21.9 (C9), 19.3 
(C25), 18.8 (C13). 
 
 (((tert-Butyldiphenylsilyl)oxy)methyl)-1,1-dioxido-3,4,8,8a-tetrahydro-7H-4a,7-
epoxybenzo[c][1,2]oxathiin-7-yl)-2-methyl-2-(prop-2-yn-1-yl)cyclopentan-1-one  (2.89). 
(SB-III-137): 1H-NMR (500 MHz) δ7.68-7.65 (comp, 4 H), 7.46-7.39 (comp, 6 H), 6.57 (d, J = 
5.5 Hz, 1H), 6.09 (d, J = 5.5 Hz, 1H), 4.93 (dddd, J = 2.0, 4.0, 4.0, 12.0 Hz, 1 H), 3.91 (dd, J = 
3.5, 11.5 Hz, 1 H), 3.84 (dd, J = 4.5, 11.5 Hz, 1 H), 3.18 (dd, J = 3.5, 8.0 Hz, 1 H), 3.15 (dd, J = 
6.0, 11.5 Hz, 1 H), 2.76 (dd, J = 2.5, 17.0 Hz, 1 H), 2.59 (dd, J = 3.0, 12.0 Hz, 1 H), 2.53 (dd, J = 
9.5, 12.5 Hz, 1 H), 2.50 (m, 1 H), 2.32-2.28 (comp, 3H), 2.21 (dd, J = 9.0, 19.0 Hz, 1 H), 2.08 
(m, 1 H), 2.06 (t, J = 2.5 Hz, 1 H), 1.85 (dd, J = 8.0, 12.5 Hz, 1H), 1.08 (s, 9H), 0.98 (s, 3 H); 
13C-NMR (125 MHz) δ219.5, 141.6, 135.9, 135.6, 135.5, 132.7, 132.6, 129.9, 127.8, 90.6, 87.7, 
80.5, 80.5, 71.9, 64.8, 58.5, 51.7, 43.1, 36.3, 32.6, 29.3, 26.8, 26.6, 20.3, 19.6, 19.3. 
NMR assignments: 1H-NMR (500 MHz) δ 7.68-7.65 (comp, 4 H, C19-H, C23-H), 7.46-
7.39 (comp, 6 H, C17-H, C18-H, C21-H, C22-H), 6.57 (d, J = 5.5 Hz, 1H, C6-H), 6.09 (d, J = 
5.5 Hz, 1H, C5-H), 4.93 (dddd, J = 2.0, 4.0, 4.0, 12.0 Hz, 1 H, C2-H), 3.91 (dd, J = 3.5, 11.5 Hz, 
1 H, C1-H), 3.84 (dd, J = 4.5, 11.5 Hz, 1 H, C1-H), 3.18 (dd, J = 3.5, 8.0 Hz, 1 H, C27-H), 3.15 
(dd, J = 6.0, 11.5 Hz, 1 H, C8-H), 2.76 (dd, J = 2.5, 17.0 Hz, 1 H, C10-H), 2.59 (dd, J = 3.0, 12.0 
Hz, 1 H, C28-H), 2.53 (dd, J = 9.5, 12.5 Hz, 1 H, C3-H), 2.50 (m, 1 H, C14-H), 2.32-2.28 
(comp, 3H, C9-H, C3-H), 2.21 (dd, J = 9.0, 19.0 Hz, 1 H, C14-H), 2.08 (m, 1 H, C10-H), 2.06 (t, 
J = 2.5 Hz, 1 H, C16-H), 1.85 (dd, J = 8.0, 12.5 Hz, 1H, C28-H), 1.08 (s, 9H, C26-H), 0.98 (s, 3 
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H, C13-H); 13C-NMR (125 MHz) δ219.5 (C11), 141.6 (C6), 135.9 (C5), 135.6 (C19), 135.5 
(C23), 132.7 (C20), 132.6 (C24), 129.9 (C18, C22), 127.8 (C17, C21), 90.6 (C7), 87.7 (C4), 80.5 
(C15), 80.5 (C2), 71.9 (C16), 64.8 (C1), 58.5 (C27), 51.7 (C12), 43.1 (C8), 36.3 (C14), 32.6 


























271C). Isolated after leaving a sample of 2.34 on the bench-top. The material was purified by 
flash chromatography eluting with EtOAc/hexanes (1:4) to provide 13 mg of the named 
compound: 1H-NMR  (400 MHz) δ 6.55 (d, J = 5.6 Hz, 1 H), 6.06 (d, J = 5.6 Hz, 1 H), 4.94 (m, 
1 H), 4.00 (m, 1 H), 3.78 (m, 1 H), 3.21 (dd, J = 3.2, 8.0 Hz, 1 H), 3.15 (dd, J = 5.6, 12.4 Hz, 1 
H), 2.67 (d, J = 16.8 Hz, 1 H), 2.60 (dd, J = 12.4, 15.2 Hz, 1 H), 2.59-2.44 (comp, 2 H), 2.47 (d, 
J = 17.2 Hz, 1 H), 2.30 (dd, J = 1.6, 15.2 Hz, 1 H), 2.27-2.15 (comp, 2 H), 2.00 (dd, J = 8.0, 12.4 
Hz, 1 H), 1.89 (m, 1 H), 1.01 (s, 3 H), 0.12 (s, 9 H). 
NMR assignments: 1H-NMR (400 MHz) δ 6.55 (d, J = 5.6 Hz, 1 H, C6-H), 6.06 (d, J = 
5.6 Hz, 1 H, C5-H), 4.94 (m, 1 H, C2-H), 4.00 (m, 1 H, C1-H), 3.78 (m, 1 H, C1-H), 3.21 (dd, J 
= 3.2, 8.0 Hz, 1 H, C18-H), 3.15 (dd, J = 5.6, 12.4 Hz, 1 H, C8-H), 2.67 (d, J = 16.8 Hz, 1 H, 
C14-H), 2.60 (dd, J = 12.4, 15.2 Hz, 1 H, C3-H), 2.59-2.44 (comp, 2 H, C10-H, C19-H), 2.47 (d, 
J = 17.2 Hz, 1 H, C14-H), 2.30 (dd, J = 1.6, 15.2 Hz, 1 H, C3-H), 2.27-2.15 (comp, 2 H, C9-H, 
C10-H), 2.00 (dd, J = 8.0, 12.4 Hz, 1 H, C19-H), 1.89 (m, 1 H, C9-H), 1.01 (s, 3 H, C13-H), 0.12 
(s, 9 H, C20-H). 
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Ozone Titration procedure:   
A 0.1 M stock solution of styrene in acetone with Sudan III indicator was prepared by 
dissolving styrene (575 µL, 5 mmol) and Sudan III (5 mg, 0.014 mmol) in 50 mL acetone. 
Acetone (80 mL) in a 100 mL round-bottom flask fitted with a stir-bar, was cooled to –78 °C and 
ozone was bubbled through for 5-6 min until the solution was a deep blue color. Aliquots (1 mL) 
were then removed from the ozone solution with a disposable polypropylene syringe and were 
added to the 0.1 M styrene stock solution (2 mL) at room temperature until the red color of the 
Sudan III disappeared and the solution turned colorless. The molarity of the ozone solution was 












































yl)cyclopentan-1-one  (2.125). (SB-III–203). 2.34 (15 mg, 0.025 mmol), pyridine (2 mg, 2 µL, 
0.025 mmol) and 2,6-lutidine (13 mg, 14 µL, 0.124 mmol) was dissolved in acetone/H2O (9:1, 2 
mL). The mixture was cooled to –78 °C, and a solution of ozone in acetone (0.28 M, 0.89 mL, 
0.025mmol) was added to a jacketed pressure equalizing addition funnel that was pre-cooled to –
78 °C. The ozone solution was added over 1 min, and the reaction mixture was warmed to room 
temperature. The solvent was removed under reduced pressure, and the aqueous layer was 
extracted with EtOAc (3 x 1 mL). The combined organic extracts were washed with cold 1 M 
HCl (2 x 1 mL), dried (Na2SO4), filtered and concentrated under reduced pressure to provide 15 
mg (92%) of 2.135. HRMS (ESI) m/z calc for C34H39O8SiS
+ (M–H2O), 635.2135; found, 
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635.2141; (SB-III-130): When a sample of 2.125 was reduced with NaBH4 in MeOH, a product 
was isolated with M+3H2 which is indicative of the reduction of three carbonyl groups. HRMS 




4a,7-epoxybenzo[c][1,2]oxathiin-7-yl)-2-methylcyclopentan-1-one  (2.144). (SB-III-189). 
Lindlar’s catalyst (26 mg), quinoline (57 mg, 52 µL, 0.44 mmol) was added to a solution of 2.89 
(27 mg, 0.45 mmol) in a mixture of EtOAc/1-octene (1:1, 0.6 ml). The mixture was purged with 
N2 then H2 (30 psi) was introduced and the reaction was shaken in a par-hydrogenator at room 
temperature for 6 h. The mixture was filtered through Celite, the solvent was removed under 
reduced pressure to provide 11 mg (62%) of 2.144: 1H-NMR (400 MHz) δ 7.69-7.66 (comp, 4 
H), 7.45-7.38 (comp, 6 H), 6.54 (d, J = 5.6 Hz, 1 H), 6.08 (d, J = 5.6 Hz, 1 H), 5.60 (dddd, J = 
6.0, 9.2, 10.4, 16.4 Hz, 1 H), 5.15-5.08 (comp, 2 H), 4.92 (dtd, J = 2.0, 4.0, 8.0 Hz, 1 H), 3.92 
(dd, J = 3.6, 11.6 Hz, 1 H), 3.18 (dd, J = 2.8, 7.6 Hz, 1 H), 2.76 (dd, J = 6.0, 10.4 Hz, 1 H), 2.62 
(ddt, J = 1.2, 6.0, 14.4 Hz, 1 H), 2.55-2.44 (comp, 2 H), 2.53 (d, J = 12.4 Hz, 1 H), 2.50 (d, J = 
12.0 Hz, 1 H), 2.30 (dd, J = 2.0, 15.2 Hz, 1 H), 2.22-2.08 (comp, 3 H), 1.83 (dd, J = 8.0, 12.4 Hz, 
1 H), 1.08 (s, 9 H), 1.01 (s, 3 H). 
 NMR assignments: 1H-NMR (400 MHz) δ 7.69-7.66 (comp, 4 H, C19-H, C23-H), 7.45-
7.38 (comp, 6 H, C17-H, C18-H, C21-H, C22-H), 6.54 (d, J = 5.6 Hz, 1 H), 6.08 (d, J = 5.6 Hz, 
1 H, C5-H), 5.60 (dddd, J = 6.0, 9.2, 10.4, 16.4 Hz, 1 H, C15-H), 5.15-5.08 (comp, 2 H, C16-H), 
4.92 (dtd, J = 2.0, 4.0, 8.0 Hz, 1 H, C2-H), 3.92 (dd, J = 3.6, 11.6 Hz, 1 H, C1-H), 3.18 (dd, J = 
2.8, 7.6 Hz, 1 H, C1-H), 2.76 (dd, J = 6.0, 10.4 Hz, 1 H, C27-H), 2.62 (ddt, J = 1.2, 6.0, 14.4 Hz, 
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1 H, C8-H), 2.55-2.44 (comp, 2 H, C3-H, C10-H), 2.53 (d, J = 12.4 Hz, 1 H, C14-H), 2.50 (d, J 
= 12.0 Hz, 1 H, C14-H), 2.30 (dd, J = 2.0, 15.2 Hz, 1 H, C3-H), 2.22-2.08 (comp, 3 H, C9-H, 





epoxybenzo[c][1,2]oxathiin-7-yl)-2-methyl-2-(2-oxopropyl)cyclopentan-1-one  (2.155). (SB-
III-279). Magnesium turnings (4.6 mg, 0.189 mmol) and HgCl2 (1.7 mg, 0.006 mmol) were 
added to a round-bottom flask. EtOH (0.5 mL) was added, and the mixture was cooled to 0 °C 
and stirred for 10 min before adding H3PO4 (10 µL, 0.172 mmol).  The mixture was stirred for 5 
min before adding a solution of 2.34 (5 mg, 0.0063 mmol) in EtOH (0.5 mL). The mixture was 
stirred for 1 h, whereupon a saturated aqueous NH4Cl solution (0.5 mL) was added. The mixture 
was filtered through Celite, washed with EtOAc (3 x 1 mL), and the layers were separated. The 
aqueous layers were extracted with EtOAc (3 x 1 mL), and the combined organic extracts were 
dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude residue was 
purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:4 → 1:2) to 
provide 4 mg (78%) of 2.155: 1H-NMR (400 MHz) δ 7.69-7.65 (comp, 4 H), 7.48-7.39 (comp, 6 
H), 6.54 (d, J = 5.6 Hz, 1 H), 6.00 (d, J = 5.6 Hz, 1H), 4.86 (dtd, J = 2.0, 4.4, 8.0 Hz, 1 H), 3.94 
(dd, J = 4.0, 11.6 Hz, 1 H), 3.84 (dd, J = 4.4, 12.0 Hz, 1 H), 3.17 (dd, J = 3.2, 7.6 Hz, 1 H), 3.08 
(d, J = 18.4 Hz, 1 H), 2.97 (dd, J = 6.8, 12.8 Hz, 1 H), 2.85 (d, J = 18.4 Hz, 1 H), 2.71 (ddd, J = 
9.6, 12.0, 18.8 Hz, 1 H), 2.55 (dd, J = 12.0, 15.6 Hz, 1 H), 2.47 (dd, J = 8.0, 18.4 Hz, 1 H), 2.33 
(dd, J = 2.0, 14.8 Hz, 1 H), 2.30 (dd, J = 3.2, 11.2 Hz, 1 H), 2.15 (m, 1 H), 2.06 (s, 3 H), 1.96 
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(dd, J = 7.6, 12.0 Hz, 1 H), 1.86 (qd, J = 8.4, 12.4 Hz, 1 H), 1.09 (s, 9 H), 0.96 (s, 3H);  IR (film) 
3291 (O-H), 2961 (C-H), 2932 (C-H), 2859 (C-H), 1741 (C=O), 1365, 1173, 1140, 1113 cm-1; 
HRMS (ESI); found, 645.2 (M+Na); HRMS (CI); found, 623.5 (M+H). 
 NMR assignments: 1H-NMR (400 MHz) δ 7.69-7.65 (comp, 4 H, C19-H, C23-H), 7.48-
7.39 (comp, 6 H, C17-H, C18-H, C21-H, C22-H), 6.54 (d, J = 5.6 Hz, 1 H, C6-H), 6.00 (d, J = 
5.6 Hz, 1H, C5-H), 4.86 (dtd, J = 2.0, 4.4, 8.0 Hz, 1 H, C2-H), 3.94 (dd, J = 4.0, 11.6 Hz, 1 H, 
C1-H), 3.84 (dd, J = 4.4, 12.0 Hz, 1 H, C1-H), 3.17 (dd, J = 3.2, 7.6 Hz, 1 H, C27-H), 3.08 (d, J 
= 18.4 Hz, 1 H, C14-H), 2.97 (dd, J = 6.8, 12.8 Hz, 1 H, C8-H), 2.85 (d, J = 18.4 Hz, 1 H, C14-
H), 2.71 (ddd, J = 9.6, 12.0, 18.8 Hz, 1 H, C10-H), 2.55 (dd, J = 12.0, 15.6 Hz, 1 H, C3-H), 2.47 
(dd, J = 8.0, 18.4 Hz, 1 H, C10-H), 2.33 (dd, J = 2.0, 14.8 Hz, 1 H, C3-H), 2.30 (dd, J = 3.2, 11.2 
Hz, 1 H, C28-H), 2.15 (m, 1 H, C9-H), 2.06 (s, 3 H, C16-H), 1.96 (dd, J = 7.6, 12.0 Hz, 1 H, 




(2.161). (SB-IV-49C). n-BuLi (1.56 M, 0.31 mL, 0.49 mmol) was added to a solution of 
bromobenzene (80 mg, 53 µL, 0.51 mmol) in THF (1 mL) at –78 °C. The mixture was stirred for 
45 min before adding a solution of CeCl3•2LiCl (0.19 M, 1.9 mL, 0.36 mmol).
167 The mixture 
was stirred for an additional 30 min before adding 2.89 (11 mg, 0.018 mmol) as a solution in 
THF (1 mL). The mixture was stirred for 1 h at –78 °C before adding a saturated aqueous NH4Cl 
solution (1 mL) and extracting with EtOAc. The combined organic extracts were dried (Na2SO4), 
filtered, concentrated under reduced pressure and the crude residue was purified by flash 
chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:2) to provide 3 mg (27%) 
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of 2.161 and 3 mg (24%) of 2.161: 1H-NMR (400 MHz) δ 7.68-7.64 (comp, 4 H), 7.49-7.36 
(comp, 6 H), 6.18 (d, J = 10.0 Hz, 1 H), 5.91 (d, J = 10.0 Hz, 1H), 4.99 (dq, J = 4.4, 8.3 Hz, 1H), 
3.88 (app t, J = 2.4 Hz, 1 H), 3.87 (dd, J = 2.8, 4.4 Hz, 1 H), 3.04 (dd, J = 2.4, 16.8 Hz, 1 H), 
2.94 (dd, J = 6.0, 12.8 Hz, 1 H), 2.86 (dt, J = 2.8,16.8 Hz, 1 H), 2.83 (dt, J = 3.2, 18.8 Hz, 1 H), 
2.73 (ddd, J = 2.2, 3.4, 16.8 Hz, 1 H), 2.66 (dd, J = 2.8, 16.8 Hz, 1 H), 2.48 (dd, J = 6.0, 12.8 Hz, 
1 H), 2.35 (dd, J = 2.8, 16.8 Hz, 1 H), 2.24-2.16 (comp, 2 H), 1.91 (t, J = 4.0 Hz, 1 H), 1.87 (ddd, 
J = 2.4, 6.4, 14.6 Hz, 1 H), 1.08 (s, 3 H), 1.07 (s, 9 H); 13C-NMR (150 MHz) δ 219.6, 138.6, 
135.6, 135.5, 134.9, 132.5, 132.4, 130.04, 130.03, 128.1, 127.0, 125.1, 81.0, 80.6, 71.6, 64.5, 
51.2, 46.8, 36.6, 32.8, 28.9, 28.2, 26.7, 21.0, 19.6, 19.5;  IR (film) 3389 (O-H), 2925 (C-H), 2854 
(C-H), 1734 (C=O), 1493, 1448 (S=O), 1343, 1261, 1176, 1112, 1053, 973 cm-1; LRMS (APCI); 
found, 587.2 (M–H2O)
+.  
 NMR assignments: 1H-NMR (400 MHz) δ 7.68-7.64 (comp, 4 H, C19-H, C23-H), 7.49-
7.36 (comp, 6 H, C17-H, C18-H, C21-H, C22-H), 6.18 (d, J = 10.0 Hz, 1 H, C6-H), 5.91 (d, J = 
10.0 Hz, 1H, C5-H), 4.99 (dq, J = 4.4, 8.3 Hz, 1H, C2-H), 3.88 (app t, J = 2.4 Hz, 1 H, C1-H), 
3.87 (dd, J = 2.8, 4.4 Hz, 1 H, C1-H), 3.04 (dd, J = 2.4, 16.8 Hz, 1 H, C28-H), 2.94 (dd, J = 6.0, 
12.8 Hz, 1 H, C10-H), 2.86 (dt, J = 2.8,16.8 Hz, 1 H, C3-H), 2.83 (dt, J = 3.2, 18.8 Hz, 1 H, C3-
H), 2.73 (ddd, J = 2.2, 3.4, 16.8 Hz, 1 H, C8-H), 2.66 (dd, J = 2.8, 16.8 Hz, 1 H, C28-H), 2.48 
(dd, J = 6.0, 12.8 Hz, 1 H, C14-H), 2.35 (dd, J = 2.8, 16.8 Hz, 1 H, C14-H), 2.24-2.16 (comp, 2 
H, C9-H), 1.91 (t, J = 4.0 Hz, 1 H, C16-H), 1.87 (ddd, J = 2.4, 6.4, 14.6 Hz, 1 H, C10-H), 1.08 
(s, 3 H, C13-H), 1.07 (s, 9 H, C26-H); 13C-NMR (150 MHz) δ 219.6 (C11), 138.6 (C6), 135.6 
(C19 or C23), 135.5 (C19 or C23), 134.9 (C4), 132.5 (C20 or C24), 132.4 (C20 or C24), 130.04 
(C18 or C22), 130.03 (C18 or C22), 128.1 (C17, C21), 127.0 (C27), 125.1 (C5), 81.0 (C15), 80.6 
(C2), 71.6 (C16), 64.5 (C1), 51.2 (C12), 46.8 (C12), 36.6 (C8), 32.8 (C14), 28.9 (C10), 28.2 




1,1-Diphenylbutane-1,4-diol. (SB-IV-49C). Isolated from the reaction of with 2.89 with 
phenylcerium. Purified via flash chromatography, eluting with a gradient of EtOAc/hexanes 
(1:10 → 1:2): 1H-NMR (500 MHz) δ 7.43 (dd, J = 1.3, 8.5 Hz, 4 H), 7.31 (t, J = 7.4 Hz, 4  H), 
7.22 (tt, J = 1.2, 6.8 Hz, 2 H), 3.68 (t, J = 6.0 Hz, 2 H), 2.43 (app. t, J = 7.3 Hz, 2 H), 1.66 (bs, 2 
H), 1.60 (m, 2 H); 13C-NMR (125 MHz) δ 147.1, 128.2, 126.8, 126.1, 77.9, 63.2, 38.9, 27.2.  
NMR assignments: 1H-NMR (500 MHz) δ 7.43 (dd, J = 1.3, 8.5 Hz, 4 H, C8-H), 7.31 (t, 
J = 7.4 Hz, 4  H, C9-H), 7.22 (tt, J = 1.2, 6.8 Hz, 2 H, C10-H), 3.68 (t, J = 6.0 Hz, 2 H, C2-H), 
2.43 (app. t, J = 7.3 Hz, 2 H, C4-H), 1.66 (bs, 2 H, O1-H, O6-H), 1.60 (m, 2 H, C3-H); 13C-NMR 





Dec-9-enal (2.117). (SB-VIII–104). Pyridinium chlorochromate (PCC) (830 mg, 3.84 
mmol) was added to a slurry of basic alumina (3.84 g) in CH2Cl2 (6 mL) and stirred at room 
temperature for 2 h. Dec-9-en-1-ol (300 mg, 363 µL, 1.92 mmol) was added, and the mixture 
was stirred at room temperature for 3 h. The reaction mixture was filtered through a silica plug 
and eluted with a mixture of EtOAc/hexanes (1:3, 50 mL). The solvent was removed under 





(R)-9,10-Dihydroxydecanal (2.118). (SB-VIII–106). Water (3.1 mL) was added to a 
solid mixture of K2S2O8 (252 mg, 0.932 mmol), Na2HPO4 (264 mg, 1.863 mmol), NaIO4 (26 mg, 
0.124 mmol) and K2OsO2(OH)4•2H2O (11 mg, 0.031 mmol) at room temperature and stirred for 
5 min. (DHQD)2Phal (36 mg, 0.046 mmol) was added, followed by tert-BuOH (3.1 mL) and 
2.117 (96 mg, 0.621 mmol) and the reaction was stirred at room temperature for 4 h whereupon a 
saturated aqueous Na2S2O3 solution (1 mL) was added. The mixture was salted with NaCl and 
extracted with acetone (3 x 5 mL) and the combined organic extracts were then dried (Na2SO4), 
filtered, concentrated under reduced pressure. The crude residue was purified by flash 
chromatography eluting with a gradient of acetone/hexanes (3:10 → 1:2) to provide 83 mg 
(71%) of 2.118 as a white solid (stereochemistry assigned based on generalized model). 
 
(R)-Decane-1,2,10-triol. (SB-VIII-107). NaBH4 (78 mg, 2.07 mmol) was added to a 
solution of 2.118 (78 mg, 0.413 mmol) in MeOH (5 mL) at room temperature. The reaction was 
stirred for 4 h before adding AcOH (~0.1 mL) and concentrating the reaction mixture under 
reduced pressure. The crude residue was purified by flash chromatography eluting with a 
gradient of acetone/hexanes (1:2 → 3:4) to provide 54 mg (69%) of the named compound as a 
white solid: mp 53-55 °C; 1H-NMR (CD3OD, 500 MHz) δ 3.58-3.54 (m, 1 H), 3.54 (t, J = 6.5 
Hz, 2 H), 3.54 (dd, J = 4.5, 11.0 Hz, 1 H), 4.41 (dd, J = 6.5, 11.0 Hz, 1 H), 1.56-1.46 (comp, 4 
H), 1.39-1.30 (comp, 10 H); 13C-NMR (CD3OD, 125 MHz) δ 73.3, 67.4, 63.0, 34.4, 33.7, 30.8, 
30.7, 30.5, 36.9, 26.7;  IR (film) 3373 (O-H), 2924 (C-H), 2851 (C-H), 1644, 1466, 1073 cm-1; 
HRMS (ESI) m/z calc for NaC10H22O3
+ (M+Na), 213.1461; found, 213.1471. 
 NMR assignments: 1H-NMR (CD3OD, 500 MHz) δ 3.58-3.54 (m, 1 H, C9-H), 3.54 (t, J 
= 6.5 Hz, 2 H, C1-H), 3.54 (dd, J = 4.5, 11.0 Hz, 1 H, C10-H), 4.41 (dd, J = 6.5, 11.0 Hz, 1 H, 
C10-H), 1.56-1.46 (comp, 4 H, C2-H, C8-H), 1.39-1.30 (comp, 10 H, C3-H, C4 C7-H-H, C5-H, 
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C6-H); 13C-NMR (CD3OD, 125 MHz) δ 73.3 (C9), 67.4 (C10), 63.0 (C1), 34.4 (C8), 33.7 (C2), 
30.8 (C7), 30.7 (C3), 30.5 (C6), 36.9 (C4), 26.7 (C5). 
 
Dihydroxylation procedure A.  
Water (5 mL/mmol substrate) was added to a solid mixture of K2S2O8 (1.5 eq), Na2HPO4 
(3 eq), NaIO4 (0.2 eq), MeSO2NH2 (1 eq) and K2OsO2(OH)4•2H2O (0.05 eq) at room 
temperature and stirred for 5 min. Quinuclidine (0.3 eq) was added, followed by tert-BuOH (5 
mL/mmol substrate) and the olefin (1 eq) and the reaction was stirred at room temperature until 
olefin was consumed (as judged by TLC) whereupon a solution of saturated aqueous Na2S2O3 
was added. The mixture was extracted with CH2Cl2 (3 x 5 mL/mmol substrate) and the combined 
organic extracts were dried (Na2SO4), filtered, concentrated under reduced pressure. The crude 
residue was purified by flash chromatography to provide the pure diol. 
 
Dihydroxylation procedure B.  
Water (5 mL/mmol substrate) was added to a solid mixture of K2S2O8 (1.5 eq), Na2HPO4 
(3 eq or 4 eq), K3Fe(CN)6 (0.2 eq), MeSO2NH2 (1 eq) and K2OsO2(OH)4•2H2O (0.05 eq) at room 
temperature and stirred for 5 min. Quinuclidine (0.3 eq) is then added, followed by tert-BuOH (5 
mL/mmol substrate) and the olefin (1 eq) and the reaction was stirred at room temperature until 
olefin was consumed (as judged by TLC) whereupon a solution of saturated aqueous Na2S2O3 
was added. The mixture was extracted with CH2Cl2 (3 x 5 mL/mmol substrate) and the combined 
organic extracts were dried (Na2SO4), filtered, concentrated under reduced pressure. The crude 
residue was purified by flash chromatography to provide the pure diol. 
Dihydroxylation procedure C.  
Water (5 mL/mmol substrate) was added to a solid mixture of K2S2O8 (1.5 eq), Na2HPO4 
(3 eq or 4 eq), NaIO4 (0.2 eq) or K3Fe(CN)6 (0.2 eq), MeSO2NH2 (1 eq) and 
K2OsO2(OH)4•2H2O (0.05 eq) at room temperature and stirred for 5 min. (DHQD)2Phal (0.075 
eq) was added, followed by tert-BuOH (5 mL/mmol substrate) and the olefin (1 eq) and the 
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reaction was stirred at room temperature until olefin was consumed (as judged by TLC) 
whereupon a solution of saturated aqueous Na2S2O3 was added. The mixture was extracted with 
CH2Cl2 (3 x 5 mL/mmol substrate) and the combined organic extracts were dried (Na2SO4), 
filtered, concentrated under reduced pressure. The crude residue was purified by flash 




(R)-1-phenylethane-1,2-diol. (SB-V-178/189).   
Compound 2.112 was prepared according to the general procedure B. The crude residue 
was purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:3 → 1:0) to 
provide 16 mg (99%) of 2.112 as a white solid.  
Compound 2.112 was prepared according to the general procedure C. The crude residue 
was purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:3 → 1:0) to 
provide 11 mg (80%) of 2.112 as a white solid.Enantiomeric excess was determined to be 97% 
via chiral HPLC using a chiralcel OD-H column and eluting with a mixture of IPA/hexanes (2%) 




Compound 2.113 was prepared according to the general procedure B. The crude residue 
was purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:3 → 1:0) to 
provide 52 mg (89%) of 2.113 as a white solid.  
Compound 2.113 was prepared according to the general procedure C. The crude residue 
was purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:3 → 1:0) to 
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provide 11 mg (72%) of 2.113 as a white solid. Enantiomeric excess was determined to be 90% 
via chiral HPLC using a chiralcel OJ-H column and eluting with a mixture of IPA/hexanes 




Compound 2.114 was prepared according to the general procedure B. The crude residue 
was purified by flash chromatography eluting with a gradient of acetone/hexanes (1:9 → 1:3) to 
provide 41 mg (67%) of 2.114 as a white solid.  
Compound 2.114 was prepared according to the general procedure B. The crude residue 
was purified by flash chromatography eluting with a gradient of acetone/hexanes (1:9 → 1:3) to 
provide 11 mg (57%) of 2.114 as a white solid. Enantiomeric excess was determined to be 94% 
via chiral HPLC using a chiralcel OJ-H column and eluting with a mixture of IPA/hexanes (8%) 
at a rate of 1 mL/min. Enantiomer A: rt = 11 min, Enantiomer B: rt = 13 min. 
 
 
methyl (2R,3R)-2,3-dihydroxy-3-phenylpropanoate. (SB-V-197/202).  
Compound 2.116 was prepared according to the general procedure B. The crude residue 
was purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:3 → 1:0) to 
provide 89 mg (91%) 2.116 as a white solid.  
Compound 2.116 was prepared according to the general procedure C. The crude residue 
was purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:3 → 1:0) to 
provide 67 mg (68%) 2.116 as a white solid. Enantiomeric excess was determined to be 96% via 
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chiral HPLC using a chiralcel OD-H column and eluting with a mixture of IPA/hexanes (5%) at 






4-(n-Butoxyethoxy)-3-(methoxymethoxy)benzaldehyde  (4.19). (SB-IV-301). n-Butyl 
vinyl ether (41 mg, 53 µL, 0.411 mmol) was added to a solution of 4.18 (50 mg, 0.274 mmol) 
and pyridinium para-toluenesulfonate (PPTS) (7 mg, 0.027) in CH2Cl2 (0.5 mL) at room 
temperature. The mixture was stirred for 16 h before adding a solution of saturated aqueous 
NaHCO3 (1 mL). The mixture was extracted with CH2Cl2 (3 x 1 mL) and the combined organic 
extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. The crude oil 
was purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:4) to 
provide 3 mg (72%) of 4.19: 1H-NMR (400 MHz) δ 9.87 (s, 1 H), 7.66 (d, J = 2.0 Hz, 1 H), 7.51 
(dd, J = 2.0, 8.4 Hz, 1 H), 7.24 (d, J = 8.4 Hz, 1 H), 5.53 (q, J = 5.2 Hz, 1 H), 5.28 (d, J = 6.8 Hz, 
1 H), 5.25 (d, J = 6.8 Hz, 1 H), 3.75 (dt, J = 6.4, 9.6 Hz, 1 H), 3.53 (s, 3 H), 3.50 (dt, J = 6.8, 9.8 
Hz, 1 H), 1.57 (d, J = 5.2 Hz, 31 H), 1.56 (m, 2 H), 1.35 (sex, J = 7.6 Hz, 2 H), 0.89 (t, J = 7.6 
Hz, 1 H). 
NMR assignments: 1H-NMR (400 MHz) δ 9.87 (s, 1 H, C1-H), 7.66 (d, J = 2.0 Hz, 1 H, 
C7-H), 7.51 (dd, J = 2.0, 8.4 Hz, 1 H, C3-H), 7.24 (d, J = 8.4 Hz, 1 H, C4-H), 5.53 (q, J = 5.2 
Hz, 1 H, C8-H), 5.28 (d, J = 6.8 Hz, 1 H, C14-H), 5.25 (d, J = 6.8 Hz, 1 H, C14-H), 3.75 (dt, J = 
6.4, 9.6 Hz, 1 H, C9-H), 3.53 (s, 3 H, C15-H), 3.50 (dt, J = 6.8, 9.8 Hz, 1 H, C9-H), 1.57 (d, J = 
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5.2 Hz, 31 H, C16-H), 1.56 (m, 2 H, C10-H), 1.35 (sex, J = 7.6 Hz, 2 H, C11-H), 0.89 (t, J = 7.6 
Hz, 1 H, C12-H). 
 
3,4-Diisopropoxy-4-methoxy-2-vinylcyclobut-2-en-1-one  (4.28). (SB-VI-99). A 
solution of diisopropyl squarate 4.27   (580 mg, 2.93 mmol) in THF (20 mL) was cooled to – 78 
°C, then degassed. In a separate flask, a solution of tetravinyl stannane (200 mg, 160 µL, 0.88 
mmol) in Et2O (3 mL) was cooled to – 78 °C, then degassed. A solution of n-BuLi (1.56 M, 2.06 
mL, 3.22 mmol) was added to the tetravinyl stannane solution at – 78 °C. The reaction mixture 
was warmed to 0 °C and stirred for 20 min before adding to the solution of diisopropyl squarate 
4.27 at – 78 °C. The reaction mixture was stirred for 2 h at – 78 °C, whereupon a solution of 
saturated aqueous NaHCO3 (10 mL) was added.  The mixture was extracted with EtOAc (3 x 10 
mL), and the combined organic extracts were dried (Na2SO4), filtered, and concentrated under 
reduced pressure. The crude oil was purified by flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:10 → 1:2) to provide 501 mg (76%) of 4.29. 
A solution of 4.29 (250 mg, 1.1 mmol) and MeOH (0.70 g, 0.89 mL, 22.0 mmol) in THF 
(11 mL) was cooled to 0 °C. BF3.OEt2 (184 mg, 0.16 mL, 1.32 mmol) was added and the 
reaction mixture was stirred at 0 °C for 2 h whereupon a solution of saturated aqueous NaHCO3 
solution (5 mL) was added.  The mixture was extracted with EtOAc (3 x 10 mL) and the 
combined organic extracts were dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude oil was purified by flash chromatography eluting with a gradient of  
EtOAc/hexanes (1:10 → 1:2) to provide 140 mg (53%) of 4.28: 1H-NMR  (600 MHz) δ 6.14 (dd, 
J = 11.1, 17.6 Hz, 1 H), 6.00 (dd, J = 1.9, 17.6 Hz, 1 H), 5.41 (dd, J = 1.9, 11.1 Hz, 1 H), 4.96 
(sep, J = 6.2, 1 H), 4.22 (sep, J = 6.2, 1 H), 3.50 (s, 3 H), 1.45 (d, J = 6.2 Hz, 3 H), 1.43 (d, J = 
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6.2 Hz, 3 H), 1.24 (d, J = 6.2 Hz, 3 H), 1.20 (d, J = 6.2 Hz, 3 H); 13C-NMR (150 MHz) δ 189.9, 
179.8, 126.7, 121.95, 121.87, 113.4, 78.0, 68.9, 53.3, 23.3, 23.5, 22.56, 22.52;  IR (film) 2979 
(C-H), 2937 (C-H), 2877, 2836, 1759 (C=O), 1643, 1605, 1584, 1425, 1374, 1324, 1256, 1181, 
1078, 994 cm-1; HRMS (ESI) m/z calc for NaC13H20O4
+ (M+Na), 263.1254; found, 263.1252. 
NMR assignments: 1H-NMR (600 MHz) δ 6.14 (dd, J = 11.1, 17.6 Hz, 1 H, C2-H), 6.00 
(dd, J = 1.9, 17.6 Hz, 1 H, C1-H), 5.41 (dd, J = 1.9, 11.1 Hz, 1 H, C1-H), 4.96 (sep, J = 6.2, 1 H, 
C7-H), 4.22 (sep, J = 6.2, 1 H, C11-H), 3.50 (s, 3 H, C10-H), 1.45 (d, J = 6.2 Hz, 3 H, C12-H or 
C13-H), 1.43 (d, J = 6.2 Hz, 3 H, C12-H or C13-H), 1.24 (d, J = 6.2 Hz, 3 H, C8-H or C9-H), 
1.20 (d, J = 6.2 Hz, 3 H, C8-H or C9-H); 13C-NMR (150 MHz) δ 189.9 (C4), 179.8 (C6), 126.7 
(C3), 121.9 (C1), 121.9 (C2), 113.4 (C5), 78.0 (C7), 68.9 (C11), 53.3 (C10), 23.3 (C8 or C9), 
23.5 (C8 or C9), 22.6 (C12 or C13), 22.5 (C12 or C13). 
 
4-(Benzyloxy)-3-hydroxy benzaldehyde (4.35). (SB-IV-267). A mixture of 4,5-
dihydroxybenzaldehyde (4.20) (5.0 g, 36.2 mmol) and K2CO3 (5.0 g, 36.2 mmol) in DMF (20 
mL) was heated at 60 °C for 4 h. The mixture was cooled to room temperature and benzyl 
bromide (7.7 g, 5.4 mL, 45.2 mmol) was added, and the mixture was stirred 16 h whereupon a 
solution of saturated aqueous NH4Cl (10 mL) and H2O (10 mL) was added. The mixture was 
extracted with toluene (3 x 20 mL), and the combined organic extracts were washed with 13% 
aqueous brine solution (4 x 3 mL), dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude oil was crystallized by dissolving in hot toluene (20 mL) to provide 3.4 g 
(35%) of 4.35 as a tan solid: mp 115-120 °C. Hexanes (20 mL) were added to the mother liquors 
and the mixture was heated until the solids were dissolved. Upon cooling to room temperature, 
another 0.9 g (11%) of 4.35 (46% total) was isolated as a tan solid: 1H-NMR (400 MHz) δ 9.84 
(s, 1 H), 7.46 (d, J = 2.0 Hz, 1 H), 7.44-7.40 (comp, 6 H), 7.04 (d, J = 8.0 Hz, 1 H), 5.82 (s, 1 H), 
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5.21 (s, 2 H); 13C-NMR (100 MHz) δ 191.0, 150.9, 146.3, 135.2, 130.8, 128.9, 128.8, 127.9, 
124.3, 114.4, 111.5, 71.3;  IR (film) 3217 (OH), 2871 (CH), 1675 (C=O), 1606, 1582, 1512, 
1455, 1345, 1281, 1117, 1016 cm-1; HRMS (ESI) m/z calc for C14H11O3
–, 227.0714; found, 
227.0716. 
NMR assignments: 1H-NMR (400 MHz) δ 9.84 (s, 1 H, C1-H), 7.46 (d, J = 2.0 Hz, 1 H, 
C7-H), 7.44-7.40 (comp, 6 H, C3-H, C10-H, C11-H, C12-H), 7.04 (d, J = 8.0 Hz, 1 H, C4-H), 
5.82 (s, 1 H, C13-H), 5.21 (s, 2 H, C8-H); 13C-NMR (100 MHz) 191.0 (C1), 150.9 (C5), 146.3 
(C6), 135.2 (C9), 130.8 (C2), 128.9 (C11), 128.8 (C12), 127.9 (C10), 124.3 (C3), 114.4 (C7), 
111.5 (C4), 71.3 (C8). 
 
 
4-(Benzyloxy)-2-bromo-3-hydroxy benzaldehyde. (SB-VI-34). A solution of aldehyde 
4.35 (2.93 g, 12.84 mmol) in CH2Cl2 (108 mL) and toluene (667 mL) was cooled to –78 °C. A 
separate flask containing a slurry of NBS (2.74g, 15.41 mmol) in CH2Cl2 (25 mL) was cooled to 
0 °C and tetramethylguanidine (TMG) (1.92 g, 2.09 mL, 16.69 mmol) was added dropwise. The 
slurry was stirred for 5 min (or until homogeneous) before being added to the solution of 4.35 at 
–78 °C. The reaction mixture was stirred at –78 °C for 2 h whereupon butylatedhydroxytoluene 
(BHT) (0.85g, 3.85 mmol) was added, the bath was removed, and the reaction was warmed to 
room temperature over 2 h. The mixture was washed with saturated aqueous NH4Cl (1 x 100 
mL), deionized H2O (1 x 100 mL), dried (Na2SO4). The combined organic extracts were then 
filtered through a silica plug (500 mL). The combined organic extracts were discarded, and the 
plug was eluted with 1:1 EtOAc/hexanes (1 x 1 L) and the eluent was concentrated under 
reduced pressure to provide 2.56 g (65%) of the crude named compound as an orange to brown 
solid. The crude was recrystallized in IPA (49 mL) to provide 2.46 g (62%) of the pure titled 
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compound as an off-white solid: mp 118-120 °C; 1H-NMR (400 MHz) δ 10.25 (s, 1 H), 7.53 (d, 
J = 8.6 Hz, 1 H), 7.43-7.40 (comp, 5 H), 6.98 (d, J = 8.6 Hz, 1 H), 6.21 (s, 1 H), 5.22 (s, 2 H); 
13C-NMR (100 MHz) 190.9, 150.8, 143.4, 134.9, 128.9, 128.9, 127.8, 127.4, 122.5, 113.1, 110.6, 
71.6; HRMS (ESI) m/z calc for C14H10BrO3
–, 304.9819; found, 304.982; m/z calc for 
C14H10BrO3
–, 306.9800; found, 306.9802. 
NMR assignments: 1H-NMR (400 MHz) δ 10.25 (s, C1-H), 7.53 (d, J = 8.6 Hz, C3-H), 
7.43-7.40 (comp, C10-H, C11-H, C12-H), 6.98 (d, J = 8.6, C4-H), 6.21 (s, C13-H), 5.22 (s, C8-
H); 13C-NMR (100 MHz) 190.9 (C1), 150.8 (C5), 143.4 (C6), 134.9 (C9), 128.9 (C2), 128.9 
(C11), 127.8 (C12), 127.4 (C10), 122.5 (C3), 113.1 (C7), 110.6 (C4), 71.6 (C8). 
 
 
4-(Benzyloxy)-2-bromo-3-(methoxymethoxy)benzaldehyde  (4.36). (SB-V-194). A 
solution of 4-(benzyloxy)-2-bromo-3-hydroxybenzaldehyde (1.36 g, 4.43 mmol) and 
diisopropylethylamine (DIPEA) (0.69 g, 0.93 mL, 5.32 mmol) in CH2Cl2 (27 mL) was cooled to 
0 °C. Chloromethylmethylether (MOMCl)633 (0.53 g, 0.50 mL, 6.64 mmol) was added, and the 
reaction mixture was warmed to room temperature and stirred for 2 h whereupon a solution of 
saturated aqueous NaHCO3 (10 mL) was added. The mixture was extracted with EtOAc (3 x 5 
mL), and the combined organic layers were dried (Na2SO4), filtered, and concentrated under 
reduced pressure. The crude oil solidified slowly upon standing to provide 4.36 as a waxy white 
solid: mp 54-56 °C; 1H-NMR  (400 MHz) δ 10.26 (s, 1 H), 7.70 (d, J = 8.8 Hz, 1 H), 7.43-7.33 
(comp, 5 H), 7.01 (d, J = 8.8 Hz, 1 H), 5.21 (s, 2 H), 5.17 (s, 2 H), 3.59 (s, 3 H); 13C-NMR (100 
MHz) 190.0, 157.3, 143.7, 135.3, 128.8, 128.5, 127.7, 127.5, 126.4, 123.3, 112.2, 98.9, 71.2, 
58.2;  IR (film) 2935 (CH), 1682 (C=O), 1579, 1482, 1378, 1298, 1275, 1254, 1214, 1158 cm-1; 
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HRMS (ESI) m/z calc for NaC16H15BrO4
+ (M+Na), 373.0046; found, 373.0054; m/z calc for 
NaC17H17BrO3
+ (M+Na), 375.0027; found, 375.0037. 
NMR assignments: 1H-NMR (400 MHz) δ 10.26 (s, 1 H, C1-H), 7.70 (d, J = 8.8 Hz, 1 
H, C3-H), 7.43-7.33 (comp, 5 H, C10-H, C11-H, C12-H), 7.01 (d, J = 8.8 Hz, 1 H, C4-H), 5.21 
(s, 2 H, C8-H), 5.17 (s, 2 H, C13-H), 3.59 (s, 3 H, C14-H); 13C-NMR (100 MHz) 190.0 (C1), 
157.3 (C5), 143.7 (C6), 135.3 (C9), 128.8 (C2), 128.5 (C11), 127.7 (C12), 127.5 (C10), 126.4 




3-(Methoxymethoxy)-4-((1-phenylpentyl)oxy)benzaldehyde  (4.38). (SB-IV-282). A 
solution of n-BuLi (2.5 M, ca. 0.35 mL, 0.880 mmol) was added to a slurry of triphenylmethane 
(Ph3C-H) (2 mg, 0.007 mmol), and N,O-dimethylhydroxylamine hydrochloride (42 mg, 0.426 
mmol) in THF (1 mL) at 0 °C until the solution turned a persistent red color (5 min). The 
solution was added to a slurry of 4.36 (50 mg, 0.142 mmol) and NaH (60 % dispersion in 
mineral oil, ca. 4 mg, 0.071 mmol) in THF (1 mL) at 0 °C, and the mixture was stirred for 30 
min. In a separate flask, a solution of n-BuLi (2.5 M, 0.14 mL, 0.312 mmol) in hexanes was 
added to THF (0.5 mL) at –78 °C. The reaction mixture containing 4.36 was added to the n-BuLi 
and stirred for 1 h before adding benzyl bromide (49 mg, 34 µL, 0.286 mmol) and warming to 0 
°C. The reaction was stirred for 10 min, whereupon a solution of saturated aqueous NaHCO3 (1 
mL) was added. The mixture was extracted with EtOAc (3 x 1 mL) and the combined organic 
extracts were dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude oil 
was purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:5) to 
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provide 11 mg (24%) of 4.38 as an oil and 19 mg (49%) of 4.92: 1H-NMR (400 MHz) δ 9.77 (s, 
1 H), 7.59 (d, J = 2.0 Hz, 1 H), 7.34-7.32 (comp, 6 H), 6.81 (d, J = 8.4 Hz, 1 H), 5.30 (app dd, J 
= 1.2, 6.4 Hz, 2 H), 5.19 (dd, J = 5.2, 7.2 Hz, 1 H), 3.57 (s, 3 H), 2.11 (dddd, J = 4.8, 8.0, 10.0, 
18.8 Hz, 1 H), 1.89 (ddt, J = 5.2, 5.2, 10.4, 14.0 Hz, 1 H), 1.52 (dtdd, J = 3.2, 5.6, 11.2, 11.2, 
12.4 Hz, 1 H), 1.43-1.32 (comp, 3 H), 0.90 (t, J = 7.6 Hz, 3 H); 13C-NMR (100 MHz) δ 190.7, 
154.4, 147.3, 141.3, 129.9, 128.7, 127.8, 126.2, 125.8, 116.8, 114.7, 95.5, 81.6, 56.4, 38.3, 27.9, 
22.5, 14.0;  IR (film) 2954 (C-H), 2930 (C-H), 2858 (C-H), 1687 (C=O), 1595, 1504, 1263, 
1155, 1127, 1078, 997 cm-1; HRMS (ESI) m/z calc for NaC20H24O4
+ (M+Na), 351.1567; found, 
351.1571.  
NMR assignments: 1H-NMR (400 MHz) δ 9.77 (s, 1 H, C1-H), 7.59 (d, J = 2.0 Hz, 1 H, 
C7-H), 7.34-7.32 (comp, 6 H, C3-H, C10-H, C11-H, C12-H), 6.81 (d, J = 8.4 Hz, 1 H, C4-H), 
5.30 (app dd, J = 1.2, 6.4 Hz, 2 H, C13-H), 5.19 (dd, J = 5.2, 7.2 Hz, 1 H, C8-H), 3.57 (s, 3 H, 
C14-H), 2.11 (dddd, J = 4.8, 8.0, 10.0, 18.8 Hz, 1 H, C15-H), 1.89 (ddt, J = 5.2, 5.2, 10.4, 14.0 
Hz, 1 H, C15-H), 1.52 (dtdd, J = 3.2, 5.6, 11.2, 11.2, 12.4 Hz, 1 H, C16-H), 1.43-1.32 (comp, 3 
H, C16-H, C17-H), 0.90 (t, J = 7.6 Hz, 3 H, C18-H); 13C-NMR (100 MHz) δ 190.7 (C1), 154.4 
(C5), 147.3 (C6), 141.3 (C9), 129.9 (C2), 128.7 (C11), 127.8 (C12), 126.2 (C3), 125.8 (C10), 










ol  (4.39). (SB-IV-278). A solution of n-BuLi (2.5 M, ca. 0.35 mL, 0.880 mmol) was added to a 
slurry of triphenylmethane (Ph3C-H) (2 mg, 0.007 mmol) and N,O-dimethylhydroxylamine 
hydrochloride (17 mg, 0.170 mmol) in THF (1 mL) at 0 °C  until the solution turned a persistent  
red color (5 min). The solution was added to a slurry of 4.36 (50 mg, 0.142 mmol) and NaH (60 
% dispersion in mineral oil, ca. 4 mg, 0.071 mmol) in THF (1 mL) at 0 °C and the mixture was 
stirred for 30 min. In a separate flask, a solution of n-BuLi (2.5 M, 0.14 mL, 0.312 mmol) in 
hexanes was added to THF (0.5 mL) cooled to –78 °C. The reaction mixture containing 4.36 was 
added to the n-BuLi and stirred for 1 h before adding benzaldehyde (21 µL, 23 mg, 0.213 mmol) 
and warming to 0 °C. The reaction was stirred for 10 min whereupon a solution of saturated 
aqueous NaHCO3 (1 mL) was added. The mixture was extracted with EtOAc (3 x 1 mL) and the 
combined organic extracts were dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude oil was purified by flash chromatography eluting with a gradient of 









(SB-IV-280B). Pyridinium chlorochromate (PCC) (44 mg, 0.200 mmol) was added to a solution 
of 4.39 (33 mg, 0.076 mmol) in CH2Cl2 (0.5 mL) at room temperature. The reaction mixture was 
stirred for 1 h before adding silica (~ 200 mg), and removing the solvent under reduced pressure 
and the crude material was purified by flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:10 → 1:4) to provide 26 mg (79%) of the titled compound as a mixture (1:1) 
of diastereomers: 1H-NMR (400 MHz) δ 7.50 (d, J = 8.4 Hz, 1 H), 7.49 (d, J = 8.4 Hz, 1 H), 
7.37-7.25 (comp, 20 H), 6.92 (d, J = 8.4 Hz, 1 H), 6.91 (d, J = 8.4 Hz, 1 H), 6.41 (s, 1 H), 6.39 
(s, 1 H), 5.20 (app q, J = 7.2 Hz, 2 H), 5.11 (d, J = 5.6 Hz, 1 H), 5.00 (d, J = 5.6 Hz, 1 H), 4.85 
(d, J = 5.6 Hz, 1 H), 4.83 (d, J = 5.6 Hz, 1 H), 3.33 (s, 3 H), 3.29 (s, 3 H), 2.09-2.00 (comp, 2 H), 
1.98-1.82 (comp, 2 H), 1.49-1.39 (comp, 2 H), 1.38-1.29 (comp, 6 H), 0.88 (t, J = 6.8 Hz, 3 H) 
0.87 (t, J = 7.2 Hz, 3 H); 13C-NMR (100 MHz) δ 169.8, 155.8, 155.6, 142.52, 142.49, 140.6, 
140.5, 140.4, 136.1, 129.3, 128.8, 128.7, 128.1, 128.0, 127.9, 127.8, 125.90, 125.88, 121.95. 
121.86, 119.23, 119.21, 117.0, 116.8, 98.3, 98.1, 82.0, 81.8, 81.3, 57.22, 57.16, 38.2, 38.1, 27.7, 
27.6, 22.5, 22.4, 13.9;  IR (film) 2932 (C-H), 1764 (C=O), 1491, 1458, 1338, 1251, 1271, 1159, 
1076, 1049, 1002, 954 cm-1; HRMS (ESI) m/z calc for NaC27H28O5
+ (M+Na), 455.1829; found, 
455.1835. 
NMR assignments: 1H-NMR (400 MHz) δ 7.50 (d, J = 8.4 Hz, 1 H, C3-H), 7.49 (d, J = 
8.4 Hz, 1 H, C3-H), 7.37-7.25 (comp, 20 H, C10-H, C11-H, C12-H, C21-H, C22-H, C23-H), 
6.92 (d, J = 8.4 Hz, 1 H, C4-H), 6.91 (d, J = 8.4 Hz, 1 H, C4-H), 6.41 (s, 1 H, C19-H), 6.39 (s, 1 
H, C19-H), 5.20 (app q, J = 7.2 Hz, 2 H, C8-H), 5.11 (d, J = 5.6 Hz, 1 H, C13-H), 5.00 (d, J = 
5.6 Hz, 1 H, C13-H), 4.85 (d, J = 5.6 Hz, 1 H, C13-H), 4.83 (d, J = 5.6 Hz, 1 H, C13-H), 3.33 (s, 
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3 H, C14-H), 3.29 (s, 3 H, C14-H), 2.09-2.00 (comp, 2 H, C15-H), 1.98-1.82 (comp, 2 H, C15-
H), 1.49-1.39 (comp, 2 H, C16- H), 1.38-1.29 (comp, 6 H, C16-H, C17-H), 0.88 (t, J = 6.8 Hz, 3 
H, C18-H) 0.87 (t, J = 7.2 Hz, 3 H, C18-H); 13C-NMR (100 MHz) δ 169.8 (C1), 155.8 (C5), 
155.6 (C5), 142.52 (C6), 142.49 (C6), 140.6 (C9), 140.5 (C7), 140.4 (C7), 136.1 (C9), 129.3 
(C20), 128.8 (C22), 128.7 (C22), 128.1 (C11), 128.0 (C11), 127.9 (C12 or C23), 127.8 (C12 or 
C23), 125.90 (C10 or C21), 125.88 (C10 or C21), 121.95 (C2). 121.86 (C2), 119.23 (C3), 119.21 
(C3), 117.0 (C4), 116.8 (C4), 98.3 (C13), 98.1 (C13), 82.0 (C19), 81.8 (C19), 81.3 (C8), 57.22 
(C14), 57.16 (C14), 38.2 (C15), 38.1 (C15), 27.7 (C16), 27.6 (C16), 22.5 (C17), 22.4 (C17), 13.9 
(C18). 
 
5-(Benzyloxy)-4-(methoxymethoxy)-3-phenyl-1,3-dihydroisobenzofuran-1-ol  (4.37). 
(SB-V-21). A solution of n-BuLi (2.5 M, ca. 0.14 mL, 0.341 mmol) was added to a slurry of 
triphenylmethane (Ph3C-H) (2 mg, 0.007 mmol) and N,O-dimethylhydroxylamine hydrochloride 
(17 mg, 0.170 mmol) in THF (1 mL) at 0 °C  until the solution turns a persistent (5 min) red 
color. The solution was added to a slurry of 4.36 (50 mg, 0.142 mmol) and NaH (60 % 
dispersion in mineral oil, ca. 4 mg, 0.071 mmol) in THF (1 mL) at 0 °C and the mixture was 
stirred for 30 min before cooling to –78 °C. A solution of tert-BuLi (1.41 M, 0.22 mL, 0.312 
mmol) in pentanes was added, and the mixture stirred for five min before adding benzaldehyde 
(21 µL, 23 mg, 0.213 mmol) and warming to 0 °C. The reaction was stirred for 10 min 
whereupon a solution of saturated aqueous NaHCO3 (1 mL) was added. The mixture was 
extracted with EtOAc (3 x 1 mL) and the combined organic extracts were dried (Na2SO4), 
filtered, and concentrated under reduced pressure. The crude oil was purified by flash 
chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:2) to provide 34 mg (63%) 
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of 4.37 as a mixture of diastereomers: 1H-NMR  (400 MHz) δ 7.43-7.27 (comp, 20 H), 7.15 (d, J 
= 8.0 Hz, 1 H), 7.148 (d, J = 8.4 Hz, 1 H), 7.03 (d, J = 8.4 Hz, 1 H), 7.02 (d, J = 8.0 Hz, 1 H), 
6.60 (s, 1 H), 6.45 (s, 1 H), 6.42 (d, J = 2.0, 1 H), 6.20 (s, 1 H), 5.08 (app s, 4 H), 4.94 (d, J = 4.0 
Hz, 1 H), 4.93 (d, J = 4.0 Hz, 1 H ), 4.68 (d, J = 4.0 Hz, 1 H ), 4.67 (d, J = 4.0 Hz, 1 H ), 3.23 (s, 
3 H), 3.22 (s, 3 H). 
NMR assignments: 1H-NMR (400 MHz) δ 7.43-7.27 (comp, 20 H, C10-H, C11-H, C12-
H, C17-H, C18-H, C19-H), 7.15 (d, J = 8.0 Hz, 1 H, C3-H), 7.148 (d, J = 8.4 Hz, 1 H, C3-H), 
7.03 (d, J = 8.4 Hz, 1 H, C4-H), 7.02 (d, J = 8.0 Hz, 1 H, C4-H), 6.60 (s, 1 H, C15-H), 6.45 (s, 1 
H, C1- H), 6.42 (d, J = 2.0, 1 H, C1-H), 6.20 (s, 1 H, C15-H), 5.08 (app s, 4 H, C8-H), 4.94 (d, J 
= 4.0 Hz, 1 H, C13-H), 4.93 (d, J = 4.0 Hz, 1 H, C13-H), 4.68 (d, J = 4.0 Hz, 1 H, C13-H), 4.67 




Pyridinium chlorochromate (PCC) (44 mg, 0.691 mmol) was added to a solution of 4.37 (34 mg, 
0.090 mmol) in CH2Cl2 (0.5 mL) at room temperature. The reaction mixture was stirred for 2 h 
whereupon silica was added and the residual solvent was removed under reduced pressure. The 
crude material was purified by flash chromatography eluting with a gradient of EtOAc/hexanes 
(1:10 → 1:2) to provide 22 mg (65%) of the titled compound as a clear oil: 1H-NMR  (500 MHz) 
δ 7.69 (d, J = 8.4 Hz, 1 H), 7.41-7.38 (comp, 4 H), 7.36-7.35 (comp, 4 H), 7.29-7.26 (comp, 2 
H), 7.19 (d, J = 8.4, 1 H), 6.42 (s, 1 H), 5.17 (s, 2 H), 4.96 (d, J = 5.7 Hz, 1 H), 4.78 (d, J = 5.7 
Hz, 1 H), 3.20 (s, 3 H); 13C-NMR (125 MHz) δ 169.8, 156.2, 142.3, 140.5, 136.0, 135.5, 129.3, 
128.76, 128.75, 128.5, 127.8, 127.5, 122.1, 119.8, 115.7, 98.1, 81.4, 71.4, 57.2;  IR (film) 3034 
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(C-H), 2936 (C-H),  1765 (C=O), 1613, 1495, 1456, 1385, 1339, 1279, 1200, 1160, 1076, 1002, 
949 cm-1; HRMS (ESI) m/z calc for NaC23H20O5 (M+Na), 399.1203; found, 399.1207.  
NMR assignments: 1H-NMR (500 MHz) δ 7.69 (d, J = 8.4 Hz, 1 H, C3-H), 7.41-7.38 
(comp, 4 H, C11-H, C18-H), 7.36-7.35 (comp, 4 H, C10-H, C17-H), 7.29-7.26 (comp, 2 H, C12-
H, C19-H), 7.19 (d, J = 8.4, 1 H, C4-H), 6.42 (s, 1 H, C15-H), 5.17 (s, 2 H, C8-H), 4.96 (d, J = 
5.7 Hz, 1 H, C13-H), 4.78 (d, J = 5.7 Hz, 1 H, C13-H), 3.20 (s, 3 H, C14-H); 13C-NMR (125 
MHz) δ 169.8 (C1), 156.2 (C5), 142.3 (C6), 140.5 (C16), 136.0 (C9), 135.5 (C7), 129.3 (C19), 
128.76 (C11 or C18), 128.75 (C11 or C18), 128.5 (C12), 127.8 (C17), 127.5 (C10), 122.1 (C2), 
119.8 (C3), 115.7 (C4), 98.1 (C13), 81.4 (C15), 71.4 (C8), 57.2 (C14). 
 
3-Hydroxy-4-((4-methoxybenzyl)oxy) benzaldehyde  (4.50). (SB-V-297). A mixture of 
4,5-dihydroxybenzaldehyde 4.20 (10.0 g, 65.6 mmol), NaHCO3 (8.2 g, 98.4 mmol) and sodium 
iodide (NaI) (3.0 g, 19.6 mmol) in anhydrous DMF (40 mL) was heated at 40 °C for 2 h. Para 
methoxybenzyl chloride (PMBCl)634 (20.6 g, 17.8 mL, 131.2 mmol) was added and then stirred 
at 40 °C for an additional 24 h whereupon the reaction was cooled to room temperature and H2O 
(80 mL) was added. The mixture was extracted with EtOAc (3 x 30 mL) and the combined 
organic extracts were then washed with 13% aqueous brine solution (4 x 10 mL), and the 
combined organic extracts were dried (Na2SO4). Hexanes (50 mL) was added and the combined 
organic extracts were filtered through a silica plug and eleted with 2:1 EtOAc/Hexanes (1 x 300 
mL) and the combined organic layers were concentrated under reduced pressure. The crude 
material was crystallized from toluene (40 mL) to yield 13.4g (79%) pure 4.50 as a white solid: 
mp 117-120 °C. 
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The mother liquors were washed with a 5% NaOH solution (3 x 60 mL) and the 
combined organic extracts were discarded. The aqueous layer was neutralized with saturated 
aqueous NH4Cl and extracted with EtOAc (3 x 20 mL). The combined organic extracts were 
washed with a saturated aqueous NaHCO3 solution (5 mL), dried (Na2SO4), filtered, and 
concentrated under reduced pressure. The solids were purified by flash chromatography eluting 
with a gradient of EtOAc/hexanes (1:4 → 1:2) to provide 3.4 g (20%) more 4.50 as an off-white 
solid (99% total): 1H-NMR  (400 MHz) δ 9.83 (s, 1 H), 7.52 (d, J = 2.0 Hz, 1 H), 7.44 (dd, J = 
2.0, 8.0 Hz, 1 H), 7.36 (d, J = 8.8, 2 H), 7.05 (d, J = 8.0 Hz, 1 H), 6.95 (d, J = 8.8 Hz, 2 H), 5.10 
(s, 2 H), 3.84 (s, 3 H); 13C-NMR (100 MHz) δ 191.0, 160.0, 151.1, 146.3, 130.7, 129.8, 127.2, 
124.3, 114.3, 114.2, 111.5, 71.1, 55.3;  IR (film) 3213 (OH), 1668 (C=O), 1612, 1504, 1274, 
1128 cm-1; HRMS (ESI) m/z calc for C15H14O4
–, 257.0819; found, 257.0826. 
NMR assignments: 1H-NMR (400 MHz) δ 9.83 (s, 1 H, C1-H), 7.52 (d, J = 2.0 Hz, 1 H, 
C7- H), 7.44 (dd, J = 2.0, 8.0 Hz, 1 H, C3- H), 7.36 (d, J = 8.8, 2 H, C10- H), 7.05 (d, J = 8.0 Hz, 
1 H, C4- H), 6.95 (d, J = 8.8 Hz, 2 H, C11- H), 5.10 (s, 2 H, C8- H), 3.84 (s, 3 H, C13- H); 13C-
NMR (100 MHz) δ 191.0 (C1), 160.0 (C12), 151.1 (C5), 146.3 (C6), 130.7 (C2), 129.8 (C10), 









4-Hydroxy-3-((4-methoxybenzyl)oxy) benzaldehyde (4.53) (SB-V-83/94/95). The 
mother liquors from the PMB protection of 4.50 were purified by flash chromatography eluting 
with a gradient of EtOAc/hexanes (1:5 → 1:2) to provide 3.0 g of crude oily solid. The solid was 
dissolved in toluene (10 mL) and extracted with 2 M NaOH solution (3 x 5 mL). The aqueous 
layer was neutralized with 1 M HCl solution and extracted with toluene (3 x 10 mL). The 
combined organic extracts were washed with a saturated aqueous NaHCO3 solution (5 mL), 
dried (Na2SO4), filtered, and concentrated under reduced pressure and the crude was purified by 
flash chromatography eluting with EtOAc/hexanes (2:5) buffered with 1% Et3N to provide 175 
mg 4.53 (2%) as a white solid: mp 125-127 °C; 1H-NMR (400 MHz) δ 9.85 (s, 1 H), 7.45 (d, J = 
2.0 Hz, 1 H), 7.42 (dd, J = 2.0, 8.0 Hz, 1 H), 7.36 (d, J = 8.8 Hz, 2 H), 7.06 (d, J = 8.0 Hz, 1 H), 
6.95 (d, J = 8.8 Hz, 2 H), 5.77 (bs, 1 H), 5.13 (s, 2 H), 3.84 (s, 3 H); 13C-NMR (100 MHz) δ 
191.0, 160.0, 151.0, 146.3, 130.7, 129.8, 127.2, 124.3, 114.3, 114.2, 111.4, 71.1, 55.3; HRMS 
(ESI) m/z calc for NaC15H14O4
+ (M+Na), 281.0784; found, 281.0783. 
NMR assignments: 1H-NMR (400 MHz) δ 9.85 (s, 1 H, C1- H), 7.45 (d, J = 2.0 Hz, 1 H, 
C7- H), 7.42 (dd, J = 2.0, 8.0 Hz, 1 H, C3- H), 7.36 (d, J = 8.8 Hz, 2 H, C10-H), 7.06 (d, J = 8.0 
Hz, 1 H, C4-H), 6.95 (d, J = 8.8 Hz, 2 H, C11-H), 5.77 (bs, 1 H, OH), 5.13 (s, 2 H, C8-H), 3.84 
(s, 3 H, C13-H); 13C-NMR (100 MHz) δ 191.0 (C1), 160.0 (C12), 151.0 (C5), 146.3 (C6), 130.7 





3,4-Bis((4-methoxybenzyl)oxy)benzaldehyde (4.54) (SB-V-83/94/95). The combined 
organic extracts from the PMB protection of 4.50 were dried (Na2SO4), filtered, and concentrated 
under reduced pressure and the crude was purified by flash chromatography eluting with 
EtOAc/hexanes (2:5) buffered with 1%Et3N to provide 840 mg (7%) of 4.54 as a waxy solid: mp 
57-60 °C; 1H-NMR  (400 MHz) δ 9.81 (s, 1 H), 7.48 (m, 1 H), 7.42-7.34 (comp, 5 H), 7.02 (dd, J 
= 2.8, 8.0 Hz, 1 H), 6.91-6.81 (comp, 4 H), 5.17 (d, J = 2.0 Hz, 2 H), 5.13 (d, J = 2.0 Hz, 2 H), 
3.82 (comp, 6 H); 13C-NMR (100 MHz) δ 190.9, 159.5, 159.4, 154.4, 149.2, 136.2, 129.1, 128.8, 
128.6, 128.2, 126.6, 114.0, 113.9, 113.2, 112.6, 70.8, 70.7, 55.3;  IR (film) 3206 (OH), 1669 
(C=O), 1612, 1517, 1505, 1274, 1250, 1206, 1178, 1128 cm-1; HRMS (ESI) m/z calc for 
NaC23H22O5
+ (M+Na), 401.1359; found, 401.1359. 
NMR assignments: 1H-NMR (400 MHz) δ 9.81 (s, 1 H, C1-H), 7.48 (m, 1 H, C7-H), 
7.42-7.34 (comp, 5 H, C4-H, C10-H, C16-H), 7.02 (dd, J = 2.8, 8.0 Hz, 1 H, C3-H), 6.91-6.81 
(comp, 4 H, C11-H, C17-H), 5.17 (d, J = 2.0 Hz, 2 H, C8-H), 5.13 (d, J = 2.0 Hz, 2 H, C14-H), 
3.82 (comp, 6 H, C13-H, C19-H); 13C-NMR (100 MHz) δ 190.9 (C1), 159.5 (C12), 159.4 C18), 
154.4 (C5), 149.2 (C6), 136.2 (C2), 129.1 (C10), 128.8 (C16), 128.6 (C9), 128.2 (C10), 126.6 






3-Bromo-5-hydroxy-4-((4-methoxybenzyl)oxy)benzaldehyde (4.52) (SB-V-87). A 
solution of NBS in CH2Cl2 (0.1 M, 14.4 mL, 1.45 mmol) was added over 1.5 h to a slurry of 
aldehyde 4.50 (248 mg, 0.96 mmol) and diisobutylamine (24 mg, 33 µL, 0.19 mmol) in CH2Cl2 
(4 mL) at – 78 °C. The reaction was stirred for 30 min, whereupon a solution of saturated 
aqueous Na2S2O3 (2 mL) was added, and the reaction was warmed to room temperature over 2 h. 
The mixture was extracted with CH2Cl2 (1 x 2 mL), and the combined organic extracts were 
dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude oil was purified by 
flash chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:4) to provide 167 mg 
(55%) of 4.52 as a yellow solid: mp 147-149 °C; 1H-NMR  (400 MHz) δ 9.77 (s, 1 H), 7.65 (d, J 
= 1.5 Hz, 1 H), 7.45 (d, J = 1.5 Hz, 1 H), 7.35 (d, J = 8.8 Hz, 2 H), 6.94 (d, J = 8.8 Hz, 2 H), 6.60 
(bs, 1 H), 5.12 (s, 2 H), 3.83 (s, 3 H); 13C-NMR (100 MHz) δ 189.6, 160.1, 149.1, 146.8, 130.2, 
130.0, 129.9, 126.9, 114.3, 109.4, 108.2, 71.6, 55.3;  IR (film) 3223 (OH), 1673 (C=O), 1515, 
1426, 1290, 1254, 1150 cm-1; HRMS (ESI) m/z calc for C15H12BrO4
–, 334.9924; found, 
334.9934. 
NMR assignments: 1H-NMR (400 MHz) δ 9.77 (s, 1 H, C1-H), 7.65 (d, J = 1.5 Hz, 1 H, 
C7-H), 7.45 (d, J = 1.5 Hz, 1 H, C3-H), 7.35 (d, J = 8.8 Hz, 2 H, C10-H), 6.94 (d, J = 8.8 Hz, 2 
H, C11-H), 6.60 (bs, 1 H, O-H), 5.12 (s, 2 H, C8-H), 3.83 (s, 3 H, C13-H); 13C-NMR (100 MHz) 
δ 189.6 (C1), 160.1 (C12), 149.1 (C5), 146.8 (C6), 130.2 (C2), 130.0 (C10), 129.9 (C3), 126.9 






2-Bromo-3-hydroxy-4-((4-methoxybenzyl)oxy) benzaldehyde  (4.51). (SB-VII-68). 
Aldehyde 4.50 (3.73 g, 14.44 mmol) was slurried in CH2Cl2 (144 mL) and cooled to – 78 °C. In 
a separate flask, TMG (3.32 g, 3.62 mL, 28.88 mmol) was added to a slurry of NBS (2.57 g, 
14.44 mmol) in CH2Cl2 (43 mL) at 0 °C. The mixture was stirred until it became homogenous (~ 
5 min), whereupon it was added in one portion to the aldehyde slurry at – 78 °C. The reaction 
mixture was stirred for 30 min at – 78 °C, whereupon AcOH (0.87 g, 0.83 mL, 28.88 mmol) was 
added and the reaction was warmed to room temperature.  The mixture was filtered through a 
silica plug (300 mL) eluting with EtOAc/Hexane (1:1, 1 x 1.5 L). The eluent was concentrated 
under reduced pressure to provide 4.05 g (83%) 4.51 as a white to light yellow solid: mp 154-
156 °C (IPA). The crude material can be purified by flash chromatography eluting with a 
gradient of acetone/hexanes with 1% Et3N (7:13 → 7:3) but in most cases the material was 
sufficiently pure for the next step;  1H-NMR (400 MHz) δ 10.26 (s, 1 H), 7.55 (d, J = 8.2 Hz, 1 
H), 7.35 (d, J = 8.8 Hz, 2 H), 6.99 (d, J = 8.2 Hz, 1 H), 6.95 (d, J = 8.8 Hz, 2 H), 6.13 (s, 1 H), 
5.17 (s, 2 H), 3.84 (s, 3 H); 13C-NMR (100 MHz) δ 190.9, 160.1, 150.8, 143.5, 129.8, 127.3, 
126.8, 122.5, 114.3, 113.0, 110.6, 71.5, 55.4;  IR (film) 3388 (OH), 2927 (C-H) 1680 (C=O), 
1588, 1516, 1487, 1464, 1282, 1251, 1176, 1130 cm-1; HRMS (ESI) m/z calc for NaC15H13BrO4
+ 
(M+Na), 358.9889; found, 358.9010. 
NMR assignments: 1H-NMR (400 MHz) δ 10.26 (s, 1 H, C1-H), 7.55 (d, J = 8.2 Hz, 1 
H, C3-H), 7.35 (d, J = 8.8 Hz, 2 H, C10-2), 6.99 (d, J = 8.2 Hz, 1 H, C4-H), 6.95 (d, J = 8.8 Hz, 
2 H, C11-H), 6.13 (s, 1 H, O-H), 5.17 (s, 2 H, C8-H), 3.84 (s, 3 H, C13-H); 13C-NMR (100 
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MHz) δ 190.9 (C1), 160.1 (C12), 150.8 (C5), 143.5 (C6), 129.8 (C2), 127.3 (C10), 126.8 (C9), 




By-product isolated from the crystallization of 4.51 in IPA. Purified via flash chromatography 
eluting with a gradient of acetone/hexanes (1:5 → 2:5) buffered with 1% Et3N to isolate 105 mg 
of the named compound as a clear oil;  1H-NMR (400 MHz) δ 7.33 (d, J = 8.8 Hz, 2 H), 7.21 (d, 
J = 8.8 Hz, 1 H), 6.92 (d, J = 8.8 Hz, 2 H), 6.91 (d, J = 8.8 Hz, 1 H), 5.75 (s, 1 H), 5.06 (s, 2 H), 
3.88 (sept, J = 6.4 Hz, 2 H), 3.83 (s, 3H), 1.21 (d, J = 6.0 Hz, 6 H), 1.18 (d, J = 6.0 Hz, 6 H); 
13C-NMR (100 MHz) δ 159.8, 156.1, 143.0, 132.6, 129.6, 127.9, 119.1, 114.1, 111.1, 109.3, 
98.4, 71.4, 68.7, 55.3, 22.9, 22.5; LCMS (APCI): 381 (M–C3H8O).  
NMR assignments: 1H-NMR (400 MHz) δ 7.33 (d, J = 8.8 Hz, 2 H, C10-H), 7.21 (d, J = 
8.8 Hz, 1 H, C3-H), 6.92 (d, J = 8.8 Hz, 2 H, C11-H), 6.91 (d, J = 8.8 Hz, 1 H, C4-H), 5.75 (s, 1 
H, C1-H), 5.06 (s, 2 H, C8-H), 3.88 (sept, J = 6.4 Hz, 2 H, C15-H, C16-H), 3.83 (s, 3H, C13-H), 
1.21 (d, J = 6.0 Hz, 6 H, C17-H or C18-H), 1.18 (d, J = 6.0 Hz, 6 H, C17-H or C18-H); 13C-
NMR (100 MHz) δ 159.8 (C12), 156.1 (C5), 143.0 (C6), 132.6 (C10), 129.6 (C2), 127.9 (C9), 
119.1 (C3), 114.1 (C7), 111.1 (C11), 109.3 (C4), 98.4 (C1), 71.4 (C8), 68.7 (C15, C16), 55.3 







2-Bromo-4-((4-methoxybenzyl)oxy)-3-(methoxymethoxy) benzaldehyde  (4.76). (SB-
VII-70). A solution of the crude aldehyde 4.51 (6.76 g, 20.05 mmol) and diisopropylethylamine 
(DIPEA) (3.89 g, 5.25 mL, 30.07 mmol) in CH2Cl2 (140 mL) was cooled to 0 °C. Chloromethyl 
methyl ether (MOMCl)633 (1.18 M, 25.5 mL, 30.07 mmol) was added, and the cooling bath was 
removed. The solution was stirred at room temperature for 3 h, whereupon a solution of saturated 
aqueous NaHCO3 (20 mL) was added. The mixture was extracted with CH2Cl2 (3 x 20 mL), and 
the combined organic extracts were dried (Na2SO4), filtered, and concentrated under reduced 
pressure to provide crude 4.76 as a white solid: mp 88-90 °C. The crude material can be purified 
by flash chromatography eluting with a gradient of EtOAc/hexanes (1:20 → 1:3) but in most 
cases the material was sufficiently pure for the next step; 1H-NMR (400 MHz) δ 10.27 (s, 1 H), 
7.72 (d, J = 8.6 Hz, 1 H), 7.34 (d, J = 8.6 Hz, 2 H), 7.02 (d, J = 8.6 Hz, 1 H), 6.92 (d, J = 8.6 Hz, 
2 H), 5.19 (s, 2 H), 5.11 (s, 2 H), 3.82 (s, 3 H), 3.58 (s, 3 H); 13C-NMR (100 MHz) δ 191.0, 
159.8, 157.4, 143.6, 129.4, 127.5, 127.2, 126.4, 123.2, 114.1, 112.2, 98.8, 71.0, 58.1, 55.3;  IR 
(film) 2968 (C-H), 1674 (C=O), 1515, 1382, 1250, 931 cm-1; HRMS (ESI) m/z calc for 
NaC17H17BrO5
+ (M+Na), 403.0152; found, 403.0147. 
NMR assignments: 1H-NMR (400 MHz) δ 10.27 (s, 1 H, C1-H), 7.72 (d, J = 8.6 Hz, 1 
H, C3-H), 7.34 (d, J = 8.6 Hz, 2 H, C10-H), 7.02 (d, J = 8.6 Hz, 1 H, C4-H), 6.92 (d, J = 8.6 Hz, 
2 H, C11-H), 5.19 (s, 2 H, C8-H), 5.11 (s, 2 H, C14-H), 3.82 (s, 3 H, C13-H), 3.58 (s, 3 H, C15-
H); 13C-NMR (100 MHz) δ 191.0 (C1), 159.8 (C12), 157.4 (C5), 143.6 (C6), 129.4 (C10), 127.5 
(C2), 127.2 (C9), 126.4 (C3), 123.2 (C7), 114.1 (C11), 112.2 (C4), 98.8 (C14), 71.0 (C8), 58.1 




2-Bromo-4-((4-methoxybenzyl)oxy)-3-(methoxymethoxy)-1-vinylbenzene  (4.48). 
Procedure using tert-BuOLi: (SB-V-196): A slurry of methyltriphenylphosphonium bromide 
(Ph3PMeBr) (2.86 g, 8.01 mmol) and crude 4.76 in a mixture of anhydrous THF (18 mL) and 
DMSO (ppm H2O ≤ 600, 18 mL) was cooled to 0 °C and degassed. In a separate flask, a solution 
of tert-BuOLi in THF (9 mL) was prepared by adding n-BuLi (ca. 1.44 M, 7.4 mL, 10.7 mmol) 
to a solution of tert-BuOH (freshly distilled over CaH2, 0.79 g, 1.02 mL, 10.68 mmol) and 
triphenylmethane (Ph3C-H) (66 mg, 0.27 mmol) in THF (9 mL) until a red endpoint was 
observed. The solution of tert-BuOLi was added to the flask containing Ph3PMeBr and 4.76 at 0 
°C, and the stirring was continued for 30 min, whereupon a solution of saturated aqueous 
NaHCO3 (10 mL) was added. The mixture was extracted with EtOAc (3 x 10 mL), and the 
combined organic extracts were dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude oil was purified by flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:20 → 1:4) to provide 1.72 g (85%) of 4.48 as a waxy white solid.  
Procedure using n-BuLi: (SB-VI-70): THF (35 mL) was added to a round bottom flask 
containing. A slurry of methyltriphenylphosphonium bromide (Ph3PMeBr) (14.12 g, 40.10 
mmol) was cooled to 0 °C, and degassed. A solution of n-BuLi in hexanes (1.61 M, 25 mL, 
40.10 mmol) was slowly added over 10 min. The mixture was stirred for an additional 5 min 
whereupon DMSO (70 mL) was added followed by a solution of the crude 4.76 in THF (35 mL). 
The reaction was stirred for 10 min before a solution of saturated aqueous NaHCO3 (50 mL) and 
water (100 mL) was added. The mixture was extracted with EtOAc (3 x 100 mL), dried 
(Na2SO4), filtered and concentrated under reduced pressure. The crude oil was purified by flash 
chromatography eluting with a gradient of EtOAc/hexanes (1:20 → 1:4) to provide 6.51 g (86% 
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from 4.51) of 4.48 as a white waxy solid: mp 41-43 °C; 1H-NMR  (400 MHz) δ 7.34 (d, J = 8.8 
Hz, 2 H), 7.26 (d, J = 8.8 Hz, 1 H), 7.02 (dd, J = 11.2, 17.2 Hz, 1 H), 6.90 (comp, 3 H), 5.56 (dd, 
J = 1.2, 17.2 Hz, 1 H), 5.25 (dd, J = 1.2, 11.2 Hz, 1 H), 5.17 (s, 2 H), 5.03 (s, 2 H) 3.82 (s, 3 H), 
3.59 (s, 3 H); 13C-NMR (100 MHz) δ 159.8, 151.8, 143.7, 135.7, 131.7, 129.3, 128.3, 121.9, 
119.6, 115.2, 114.0, 113.2, 98.7, 71.0, 58.1, 55.3;  IR (film) 2934 (C-H) 2835, 1614, 1587, 1515, 
1484, 1465, 1382, 1287, 1251, 1214, 1174, 1159, 1033, 985 cm-1; HRMS (CI) m/z calc for 
C18H19BrO4
+, 377.0388; found, 377.0391. 
NMR assignments: 1H-NMR (400 MHz) δ 7.34 (d, J = 8.8 Hz, 2 H, C10-H), 7.26 (d, J = 
8.8 Hz, 1 H, C3-H), 7.02 (dd, J = 11.2, 17.2 Hz, 1 H, C1-H), 6.90 (comp, 3 H, C4-H, C11-H), 
5.56 (dd, J = 1.2, 17.2 Hz, 1 H, C16-H), 5.25 (dd, J = 1.2, 11.2 Hz, 1 H, C16-H), 5.17 (s, 2 H, 
C8-H), 5.03 (s, 2 H, C14-H) 3.82 (s, 3 H, C13-H), 3.59 (s, 3 H, C15-H); 13C-NMR (100 MHz) δ 
159.8 (C12), 151.8 (C5), 143.7 (C6), 135.7 (C1), 131.7 (C2), 129.3 (C10), 128.3 (C9), 121.9 




(2-Bromo-4-((4-methoxybenzyl)oxy)-3-(methoxymethoxy)phenyl) methanol (4.77) 
(SB-V-138). Isolated from the Wittig olefination of 4.76. Purified via flash chromatography 
eluting with a gradient of EtOAc/hexanes (1:10 → 3:4) to provide 142 mg (17%) of 4.77 as a 
clear oil: 1H-NMR  (400 MHz) δ 7.33 (d, J = 8.8 Hz, 2 H), 7. 15 (d, J = 8.4 Hz, 1 H), 6.93 (d, J = 
8.4 Hz, 1 H), 6.90 (d, J = 8.8 Hz, 2 H), 5.18 (s, 2 H), 5.02 (s, 2 H), 4.70 (d, J = 6.4 Hz, 2 H), 3.80 
(s, 3 H), 3.57 (s, 3 H), 1.98 (t, J = 6.4 Hz, 1 H); 13C-NMR (100 MHz) δ 159.5, 151.7, 143.7, 
133.3, 129.3, 128.3, 124.1, 118.5, 114.0, 113.0, 98.7, 70.9, 65.0, 58.0, 55.3;  IR (neat) 3431 
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(OH), 2935 (C-H), 1613, 1592, 1516, 1485, 1466, 1382, 1252, 1213, 1175, 1159, 1003 cm-1; 
HRMS (ESI) m/z calc for NaC17H19BrO5
+ (M+Na), 405.0308; found, 405.0310. 
NMR assignments: 1H-NMR (400 MHz) δ 7.33 (d, J = 8.8 Hz, 2 H, C10-H), 7. 15 (d, J 
= 8.4 Hz, 1 H, C3- H), 6.93 (d, J = 8.4 Hz, 1 H, C4-H), 6.90 (d, J = 8.8 Hz, 2 H, C11-H), 5.18 (s, 
2 H, C8-H), 5.02 (s, 2 H, C14-H), 4.70 (d, J = 6.4 Hz, 2 H, C1-H), 3.80 (s, 3 H, C13-H), 3.57 (s, 
3 H, C15-H), 1.98 (t, J = 6.4 Hz, 1 H, OH); 13C-NMR (100 MHz) δ 159.5 (C12), 151.7 (C5), 
143.7 (C6), 133.3 (C9), 129.3 (C10), 128.3 (C7), 124.1 (C3), 118.5 (C2), 114.0 (C11), 113.0 




1-(Benzyloxy)-3-bromo-2-(methoxymethoxy)-4-vinylbenzene (4.90). (SB-V-194). A 
slurry of methyltriphenylphosphonium bromide (Ph3PMeBr) (2.40 g, 6.64 mmol) and crude 4.36 
in anhydrous THF (14 mL) and DMSO (ppm H2O ≤ 600, 14 ML) was cooled to 0 °C and 
degassed. In a separate flask, a solution of tert-BuOLi in THF was prepared by adding n-BuLi 
(ca. 1.90 M, 4.66 mL, 8.86 mmol) to a solution of tert-BuOH (freshly distilled over CaH2, 0.66 
g, 0.85 mL, 8.86 mmol) and triphenylmethane (Ph3C-H) (54 mg, 0.22 mmol) in THF (14 mL) 
until a red endpoint was observed. The solution of tert-BuOLi was added to the flask containing 
methyltriphenylphosphonium bromide and crude 4.36 at 0 °C, and the mixture was stirred for 30 
min. A solution of saturated aqueous NaHCO3 solution (10 mL) was then added, and the mixture 
was extracted with EtOAc (3 x 10 mL). The combined organic extracts were then dried 
(Na2SO4), filtered, concentrated under reduced pressure, and the crude oil was purified by flash 
chromatography eluting with a gradient of EtOAc/hexanes (1:20 → 1:4) to provide 1.45 g (94%) 
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of 4.90 as a clear oil: 1H-NMR  (400 MHz) δ 7.43-7.33 (comp, 5 H), 7.26 (d, J = 8.6 Hz, 1 H), 
7.02 (dd, J = 11.0, 17.4 Hz, 1 H), 6.90 (d, J = 8.6 Hz, 1 H), 5.56 (d, J = 17.4 Hz, 1 H), 5.25 (d, J 
= 11.0 Hz, 1 H), 5.20 (s, 2 H), 5.11 (s, 2 H), 3.60 (s, 3 H); 13C-NMR (100 MHz) δ 151.7, 143.7, 
136.3, 135.7, 131.8, 128.6, 128.2, 127.4, 121.9, 119.7, 115.2, 113.2, 98.8, 71.1, 58.1;  IR (film) 
2924 (CH), 1588, 1484, 1382, 1289, 1262, 1160 cm-1; HRMS (ESI) m/z calc for NaC17H17BrO3
+ 
(M+Na), 371.0253; found, 371.0260; m/z calc for NaC17H17BrO3
+ (M+Na), 373.0235; found, 
373.0241. 
NMR assignments: 1H-NMR (400 MHz) δ 7.43-7.33 (comp, 5 H, C12-H, C11-H, C10-
H), 7.26 (d, J = 8.6 Hz, 1 H, C3-H), 7.02 (dd, J = 11.0, 17.4 Hz, 1 H, C1-H), 6.90 (d, J = 8.6 Hz, 
1 H, C4-H), 5.56 (d, J = 17.4 Hz, 1 H, C15-H), 5.25 (d, J = 11.0 Hz, 1 H, C15-H), 5.20 (s, 2 H, 
C8-H), 5.11 (s, 2 H, C13-H), 3.60 (s, 3 H, C14-H); 13C-NMR (100 MHz) δ 151.7 (C5), 143.7 
(C6), 136.3 (C9), 135.7 (C1), 131.8 (C2), 128.6 (C11), 128.2 (C12), 127.4 (C10), 121.9 (C15), 













(3-(Benzyloxy)-2-(methoxymethoxy)-6-vinylphenyl)(phenyl)methanol  (4.91). (SB-
VI-48).  
Using tert-BuLi: Styrene 4.90 (100 mg, 0.29 mmol) was dissolved in toluene (2 mL), 
concentrated under reduced pressure (3 x) and put under vacuum for  2 h. Toluene (2 mL) and 
Et2O (9 mL) was added, followed by NaH (60 % dispersion in mineral oil, ca. 2 mg, 0.06 mmol), 
and the slurry was stirred for 15 min. The reaction mixture was cooled to – 78 °C, and degassed. 
A solution of tert-BuLi in pentanes (1.60 M, 0.39 mL, 0.63 mmol) was added dropwise over the 
course of 1 min and then stirred for an additional 1 min before adding benzaldehyde (freshly 
distilled from CaH2, 125 mg, 120 µL, 1.14 mmol). The reaction was stirred for 10 min 
whereupon a solution of saturated aqueous NaHCO3 (1 mL) was added, and the reaction was 
warmed to room temperature. The mixture was extracted with EtOAc (3 x 2 mL), and the 
combined organic extracts were dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude oil was purified by flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:10 → 1:4) to provide 36 mg (85%) of 4.91 as a clear oil.  
Using n-BuLi: (SB-V-212): Styrene 4.90 (50 mg, 0.143 mmol) was dissolved in toluene 
(2 mL), concentrated under reduced pressure (3 x) and put under vacuum for  2 h. Toluene (2 
mL) was added and the reaction mixture was cooled to – 78 °C and degassed. A solution of n-
BuLi in hexanes (1.87 M, 0.10 mL, 0.186 mmol) was added at – 78 °C, and stiring continued for 
30 min before warming to 0 °C and stirring for an additional 1 h. Benzaldehyde (freshly distilled 
from CaH2, 29 mg, 28 µL, 0.286 mmol) was then added, and the reaction was stirred for 10 min 
before adding a solution of saturated aqueous NaHCO3 (1 mL) and warming to room 
temperature. The mixture was extracted with EtOAc (3 x 2 mL) and the combined organic 
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extracts were dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude oil 
was purified by flash chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:4) to 
provide 36 mg (69%) of 4.91 as a clear oil.  
Using Li[i-PrMgMe2] (SB-VI-216): Styrene 4.90 (50 mg, 0.143 mmol) was dissolved in 
toluene (2 mL), concentrated under reduced pressure (3 x) and put under vacuum for  2 h. THF 
(1 mL) was added, followed by NaH (60 % dispersion in mineral oil, ca. 1 mg, 0.03 mmol) and 
the slurry was stirred for 15 min. In a separate flask, THF (2 mL) was added and the solvent was 
cooled to – 78 °C and degassed. The solvent was warmed to 0 °C and a solution of i-
PrMgBr•LiCl in THF (1.36 M, 0.13 mL, 0.172 mmol) was added, followed by a solution of 
MeLi in Et2O (1.56 M, 0.22 mL, 0.343 mmol) and the reaction mixture was stirred for 10 min at 
0 °C. The solution of styrene 4.90 in THF was added to the flask containing Li[i-PrMgMe2], and 
the mixture was stirred for 30 min before adding benzaldehyde (freshly distilled from CaH2, 60 
mg, 58 µL, 0.573 mmol) and stirring for an additional 10 min. A solution of saturated aqueous 
NaHCO3 (1 mL) was then added, and the mixture was warmed to room temperature. The mixture 
was extracted with EtOAc (3 x 2 mL), and the combined organic extracts were dried (Na2SO4), 
filtered, and concentrated under reduced pressure. The crude oil was purified by flash 
chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:4) to provide 36 mg (98%) 
of 4.91 as a clear oil.  1H-NMR (400 MHz) δ 7.41-7.18 (comp, 11 H), 6.94 (d, J = 8.4 Hz, 1 H), 
6.90 (dd, J = 10.8, 17.2 Hz, 1 H), 6.30 (d, J = 9.2 Hz, 1 H), 5.47 (dd, J = 1.2, 17.2 Hz, 1 H), 5.14 
(dd, J = 1.6, 11.2 Hz, 1 H), 5.07 (d, J = 1.6 Hz, 2 H), 5.03 (d, J = 5.4 Hz, 1 H), 4.78 (d, J = 5.4 
Hz, 1 H), 4.02 (d, J = 9.2 Hz, 1 H), 3.31 (s, 3 H); 13C-NMR (100 MHz) δ 150.8, 144.5, 144.3, 
136.5, 135.1, 134.5, 131.4, 128.6, 128.1, 128.0, 127.5, 126.6, 125.5, 123.1, 115.9, 113.5, 99.2, 
70.8, 69.7, 57.6;  IR (film) 3459 (OH), 3085, 3062, 3030, 2938 (CH), 1597, 1487, 1452, 1382, 
1283, 1189, 1157, 1062, 995 cm-1; HRMS (ESI) m/z calc for NaC24H24O4
+ (M+Na), 399.1567; 
found, 399.1576.  
NMR assignments: 1H-NMR (400 MHz) δ 7.41-7.18 (comp, 11 H, C3-H, C10-H, C11-
H, C12-H,C18-H, C19-H, C20-H), 6.94 (d, J = 8.4 Hz, 1 H, C4-H), 6.90 (dd, J = 10.8, 17.2 Hz, 1 
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H, C1-H), 6.30 (d, J = 9.2 Hz, 1 H, C16-H), 5.47 (dd, J = 1.2, 17.2 Hz, 1 H, C15- H), 5.14 (dd, J 
= 1.6, 11.2 Hz, 1 H, C15- H), 5.07 (d, J = 1.6 Hz, 2 H, C8-H), 5.03 (d, J = 5.4 Hz, 1 H, C13-H), 
4.78 (d, J = 5.4 Hz, 1 H, C13-H), 4.02 (d, J = 9.2 Hz, 1 H, O-H), 3.31 (s, 3 H, C14- H); 13C-
NMR (100 MHz) δ 150.8 (C5), 144.5 (C6), 144.3 (C1), 136.5 (C17), 135.1 (C9), 134.5 (C2), 
131.4 (C15), 128.6 (C11), 128.1 (C12), 128.0 (C4), 127.5 (C19), 126.6 (C20), 125.5 (C18), 




1-(Benzyloxy)-2-(methoxymethoxy)-4-vinylbenzene (4.92). (SB-V-28A). By-product 
isolated as a result of the metal-halogen exchange of 4.90. Purified via flash chromatography 
eluting with a gradient of EtOAc/hexanes (1:20 → 1:10) to provide 15 mg (14%) of 4.92 as a 
clear oil 1H-NMR (400 MHz) δ 7.43-7.30 (comp, 5 H), 7.23 (d, J = 2.0 Hz, 1 H), 6.97 (dd, J = 
2.0, 8.4 Hz, 1 H), 6.86 (d, J = 8.4 Hz, 1 H), 6.61 (dd, J = 11.2, 17.6 Hz, 1 H), 5.60 (d, J = 17.6 
Hz, 1 H), 5.24 (s, 2 H), 5.16 (s, 2 H), 5.14 (d, J = 11.2 Hz, 1 H), 3.53 (s, 3 H); 13C-NMR (125 
MHz) δ 149.0, 147.1, 137.1, 132.2, 131.4, 128.5, 127.9, 127.2, 120.9, 115.0, 114.3, 112.3, 95.8, 
71.0, 56.3;  IR (film) 3034 (C-H), 2931 (C-H), 1603, 1579, 1511, 1455, 1430, 1391, 1262, 1226, 
1155, 1131, 1078 cm-1; HRMS (ESI) m/z calc for NaC17H18O3
+ (M+Na), 293.1148; found, 
293.1152.  
NMR assignments: 1H-NMR (400 MHz) δ 7.43-7.30 (comp, 5 H, C10-H, C11-H, C12-
H), 7.23 (d, J = 2.0 Hz, 1 H, C7-H), 6.97 (dd, J = 2.0, 8.4 Hz, 1 H, C3-H), 6.86 (d, J = 8.4 Hz, 1 
H, C4-H), 6.61 (dd, J = 11.2, 17.6 Hz, 1 H, C1-H), 5.60 (d, J = 17.6 Hz, 1 H, C15-H), 5.24 (s, 2 
H, C8-H), 5.16 (s, 2 H, C13-H), 5.14 (d, J = 11.2 Hz, 1 H, C15-H), 3.53 (s, 3 H, C14-H); 13C-
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NMR (125 MHz) δ 149.0 (C5), 147.1 (C6), 137.1 (C9), 132.2 (C1), 131.4 (C2), 128.5 (C10), 
127.9 (C12), 127.2 (C11), 120.9 (C3), 115.0 (C7), 114.3 (C4), 112.3 (C15), 95.8 (C13), 71.0 





3-(Benzyloxy)-2-(methoxymethoxy)-6-vinylphenol. (SB-VII-82). Styrene 4.90 (50 mg, 
0.143 mmol) was dissolved in toluene (2 mL), concentrated under reduced pressure (3 x) and put 
under vacuum for  2 h. THF (1 mL) was added, followed by NaH (60 % dispersion in mineral 
oil) (ca. 1 mg, 0.03 mmol) and the slurry was stirred for 15 min. In a separate flask, THF (1 mL) 
was added and the solvent was cooled to – 78 °C and degassed. The solvent was warmed to 0 °C 
and a solution of i-PrMgBr•LiCl in THF (1.43 M, 0.11 mL, 0.157 mmol) was added, followed 
by a solution of MeLi in Et2O (1.47 M , 0.21 mL, 0.315 mmol) and the mixture was stirred for 
10 min at 0 °C. The solution of styrene 4.90 in THF was added to the flask containing Li[i-
PrMgMe2], and the reaction mixture was stirred for 30 min before the solution was aerated with 
a balloon of oxygen for 10 min. A solution of saturated aqueous NaHCO3 (1 mL) was then 
added, and the mixture was warmed to room temperature and extracted with EtOAc (3 x 5 mL). 
The combined organic extracts were dried (Na2SO4), filtered, concentrated under reduced 
pressure, and the crude oil was purified by flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:10 → 1:4) to provide 20 mg (49%) of the named compound: 1H-NMR (400 
MHz) δ 7.42-7.31 (comp, 5 H), 7.12 (d, J = 8.8 Hz, 1 H), 6.91 (dd, J = 11.2, 17.6 Hz, 1 H), 6.73 
(s, 1 H), 6.51 (d, J = 8.8 Hz, 1 H), 5.70 (dd, J = 1.2, 17.6 Hz, 1 H), 5.20 (dd, J = 1.2, 11.2 Hz, 1 
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H), 5.13 (s, 2 H), 5.10 (s, 2 H), 3.54 (s, 3 H); 13C-NMR (125 MHz) δ 150.7, 147.8, 136.8, 134.0, 
131.1, 128.6, 128.1, 127.4, 122.1, 119.0, 113.1, 105.4, 99.6, 70.8, 57.6;  IR (film) 3373 (O-H), 
2910 (C-H), 1612, 1509, 1455, 1317, 1291, 1239, 1223, 1154, 1093, 1073, 999 cm-1; HRMS 
(ESI) m/z calc for NaC17H18O4
+ (M+Na), 309.1097; found, 309.1098.  
NMR assignments: 1H-NMR (400 MHz) δ 7.42-7.31 (comp, 5 H, C10-H, C11-H, C12-
H), 7.12 (d, J = 8.8 Hz, 1 H, C3-H), 6.91 (dd, J = 11.2, 17.6 Hz, 1 H, C1-H), 6.73 (s, 1 H, O-H), 
6.51 (d, J = 8.8 Hz, 1 H, C4-H), 5.70 (dd, J = 1.2, 17.6 Hz, 1 H, C15-H), 5.20 (dd, J = 1.2, 11.2 
Hz, 1 H, C15-H), 5.13 (s, 2 H, C8-H), 5.10 (s, 2 H, C13-H), 3.54 (s, 3 H, C15-H); 13C-NMR (125 
MHz) δ 150.7 (C5), 147.8 (C7), 136.8 (C9), 134.0 (C6), 131.1 (C1), 128.6 (C11), 128.1 (C12), 




Pyridinium chlorochromate (PCC) (149 mg, 0.691 mmol) was added to a solution of 4.91 (130 
mg, 0.345 mmol) in CH2Cl2 (2 mL) at room temperature. The mixture was stirred for 2 h, 
whereupon silica was added and the residual solvent was removed under reduced pressure. The 
crude material was purified by flash chromatography eluting with EtOAc/hexanes (1:10) to 
provide 81 mg (67%) of the named compound as a clear oil: 1H-NMR  (500 MHz) δ 7.84 (app. d, 
J = 8.5, 2 H), 7.56 (app. t, J = 7.3, 1 H), 7.45-7.32 (comp, 8 H), 7.04 (d, J = 8.5, 1 H), 6.41 (dd, J 
= 11.0, 17.3, 1 H), 5.56 (dd, J = 0.8, 17.3, 1 H), 5.14 (s, 2 H), 5.07 (dd, J = 0.8, 11.0, 1 H), 5.03 
(s, 2 H), 3.16 (s, 3 H); 13C-NMR (125 MHz) δ 196.7, 150.7, 142.7, 137.5, 136.4, 134.2, 133.6, 
132.8, 129.7, 129.2, 128.64, 128.59, 128.2, 127.5, 121.6, 115.2, 115.0, 98.8, 71.0, 57.3;  IR 
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(film) 2926 (C-H), 1673 (C=O), 1596, 1483, 1451, 1315, 1273, 1213, 1160, 1059, 994 cm-1; 
HRMS (ESI) m/z calc for NaC24H22O4
+ (M+Na), 397.1410; found, 397.1416.  
NMR assignments: 1H-NMR (500 MHz) δ 7.84 (app. d, J = 8.5, 2 H, C18-H), 7.56 (app. 
t, J = 7.3, 1 H, C20-H), 7.45-7.32 (comp, 8 H, C3-H, C10-H, C11-H, C12-H, C19-H), 7.04 (d, J 
= 8.5, 1 H, C4-H), 6.41 (dd, J = 11.0, 17.3, 1 H, C1-H), 5.56 (dd, J = 0.8, 17.3, 1 H, C15-H), 
5.14 (s, 2 H, C8-H), 5.07 (dd, J = 0.8, 11.0, 1 H, C15-H), 5.03 (s, 2 H, C13-H), 3.16 (s, 3 H, 
C14-H); 13C-NMR (125 MHz) δ 196.7 (C16), 150.7 (C5), 142.7 (C6), 137.5 (C17), 136.4 (C1), 
134.2 (C9), 133.6 (C2), 132.8 (C20), 129.7 (C18), 129.2 (C15), 128.64 (C19), 128.59 (C11), 
128.2 (C12), 127.5 (C10), 121.6 (C7) 115.2 (C3), 115.0 (C4), 98.8 (C13), 71.0 (C8), 57.3 (C14). 
 
(2-((3-(Hydroxy(phenyl)methyl)-2-(methoxymethoxy)-4-
vinylphenoxy)methyl)phenyl)(phenyl)methanol  (4.93). (SB-V-88B). By-product isolated as a 
consequence of DOM on the benzyl group during metal-halogen exchange of 4.90. Purified via 
flash chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:4) to provide 22 mg 




vinylphenoxy)methyl)phenyl)(phenyl)methanone. (SB-V-88). Pyridinium chlorochromate 
(PCC) (40 mg, 0.185 mmol) was added to a solution of 4.93 (22 mg, 0.046 mmol) in CH2Cl2 (1 
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mL) at room temperature. The mixture was stirred for 2 h, whereupon silica was added and the 
solvent was removed under reduced pressure. The crude material was purified by flash 
chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:4) to provide 7 mg (32%) 
of the named compound as a clear yellow oil: 1H-NMR  (400 MHz) δ 7.81 (app. d, J = 8.0 Hz, 4 
H), 7.74 (d, J = 7.6 Hz, 1 H), 7.61-7.52 (comp, 3 H), 7.48-7.38 (comp, 6 H), 7.29 (d, J = 8.4 Hz, 
1 H), 6.96 (d, J = 8.4 Hz, 1 H), 6.38 (dd, J = 10.8, 17.2 Hz, 1 H), 5.53 (d, J = 17.2 Hz, 1 H), 5.32 
(s, 2 H), 5.05 (d, J = 10.8 Hz, 1 H), 4.94 (s, 2 H), 3.13 (s, 3 H); LCMS (APCI) found 497.  
NMR assignments: 1H-NMR (400 MHz) δ 7.81 (app. d, J = 8.0 Hz, 4 H, C20-H, C25-
H), 7.74 (d, J = 7.6 Hz, 1 H, C11-H), 7.61-7.52 (comp, 3 H, C12-H, C22-H, C27-H), 7.48-7.38 
(comp, 6 H, C13-H, C14-H, C21-H, C26-H), 7.29 (d, J = 8.4 Hz, 1 H, C4-H), 6.96 (d, J = 8.4 
Hz, 1 H, C3-H), 6.38 (dd, J = 10.8, 17.2 Hz, 1 H, C1-H), 5.53 (d, J = 17.2 Hz, 1 H, C17-H), 5.32 






vinylcyclobut-2-en-1-one  (4.49). (SB-VI-173). A round bottom flask containing 4.90   (500 mg, 
1.32 mmol) was dissolved in toluene (2 mL) and concentrated under reduced pressure (2 x) and 
put under vacuum for 2 h. Separately, 3,4,4-trimethoxy-2-vinylcyclobut-2-en-1-one (4.8) was 
freshly purified via flash chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 
1:2) and put under vacuum for 2 h. Toluene (9 mL), Et2O (44 mL) and NaH (60 % dispersion in 
mineral oil, 16 mg, 0.26 mmol) was added to the flask containing 4.90, and the mixture was 
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stirred for 10 min before cooling to – 78 °C. The reaction vessel was put under vacuum until the 
solvent effervesced, and backfilled with nitrogen (4 x). A solution of tert-BuLi in pentanes (1.85 
M, 1.64 mL, 3.03 mmol) was added dropwise to the mixture at – 78 °C and stirring was 
continued for an additional 5 min before adding a solution of 4.8 in Et2O (2 mL) that had been 
slurried over NaH (60 % dispersion in mineral oil, 8 mg, 0.13 mmol) for at least 5 min. The 
reaction mixture was warmed to –20 °C and stirred for an additional 15 min, whereupon a 
solution of saturated aqueous NaHCO3 (10 mL) was added. The mixture was extracted with 
EtOAc (3 x 10 mL), and the combined organic extracts were dried (Na2SO4), filtered, and 
concentrated under reduced pressure. The crude oil was purified by flash chromatography eluting 
with a gradient of EtOAc/hexanes (1:10 → 1:4) to provide 364 mg (61%) of 4.90 as a yellow oil 
that slowly turns into a solid upon standing: mp 75-77 °C;  1H-NMR (600 MHz) δ 7.37 (d, J = 
8.6 Hz, 1 H), 7.34 (d, J = 8.8 Hz, 2 H), 7.02 (d, J = 8.6 Hz, 1 H), 6.90 (d, J = 8.8 Hz, 2 H), 6.77 
(dd, J = 10.8, 17.6 Hz, 1 H), 6.16 (dd, J = 2.8, 17.6 Hz, 1 H), 6.08 (dd, J = 10.4, 18.0 Hz, 1 H) 
5.60 (dd, J = 1.2, 17.6 Hz, 1 H), 5.56 (dd, J = 2.8, 10.4 Hz, 1 H), 5.18 (dd, J = 1.2, 10.8 Hz, 1 H), 
5.06 (s, 2 H), 5.04 (s, 2 H) 3.81 (s, 3 H), 3.47 (s, 6 H), 3.38 (s, 3 H); 13C-NMR (150 MHz) δ 
191.1, 170.9, 159.6, 152.8, 151.1, 142.5, 134.2, 129.3, 129.3, 128.4, 126.0, 125.8, 124.1, 121.3, 
116.7, 115.1, 114.5, 114.0, 99.0, 70.7, 57.3, 55.3, 52.7; IR (film) 2945 (C-H), 1765 (C=O), 1515, 
1465, 1251, 1028, 992 cm-1; HRMS (CI) m/z calc for C26H28O7
+ (M+), 452.1835; found, 
452.1837. 
NMR assignments: 1H-NMR (600 MHz) δ 7.37 (d, J = 8.6 Hz, 1 H, C3-H), 7.34 (d, J = 
8.8 Hz, 2 H, C10-H), 7.02 (d, J = 8.6 Hz, 1 H, C4-H), 6.90 (d, J = 8.8 Hz, 2 H, C11-H), 6.77 (dd, 
J = 10.8, 17.6 Hz, 1 H, C1-H), 6.16 (dd, J = 2.8, 17.6 Hz, 1 H, C22-H), 6.08 (dd, J = 10.4, 18.0 
Hz, 1 H, C21-H) 5.60 (dd, J = 1.2, 17.6 Hz, 1 H, C16-H), 5.56 (dd, J = 2.8, 10.4 Hz, 1 H, C22-
H), 5.18 (dd, J = 1.2, 10.8 Hz, 1 H, C16-H), 5.06 (s, 2 H, C8-H), 5.04 (s, 2 H, C14-H) 3.81 (s, 3 
H, C13-H), 3.47 (s, 6 H, C23-H, C24-H), 3.38 (s, 3 H, C15-H); 13C-NMR (150 MHz) δ 191.1 
(C19), 170.9 (C17), 159.6 (C12), 152.8 (C20), 151.1 (C5), 142.5 (C6), 134.2 (C1), 129.3 (C11), 
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129.3 (C2), 128.4 (C9), 126.0 (C22), 125.8 (C7), 124.1 (C21), 121.3 (C3), 116.7 (C18), 115.1 




3-Butyl-4,4-dimethoxy-2-vinylcyclobut-2-en-1-one. (SB-IV-270A). By-product 
isolated from the reaction of 4.90 with 4.8. Purified via flash chromatography eluting with a 
gradient of EtOAc/hexanes (1:10 → 1:5) to provide 4 mg (10%) of the named compound.  1H-
NMR (400 MHz) δ 6.17 (dd, J = 11.2, 17.6 Hz, 1 H), 6.00 (dd, J = 2.0, 17.6 Hz, 1 H), 5.43 (dd, J 
= 2.0, 11.2 Hz, 1 H), 4.41 (t, J = 6.4 Hz, 2 H), 3.53 (s, 6 H), 1.79 (quint, J = 6.4 Hz, 2 H), 1.48 
(sex, J = 7.6 Hz, 2 H) 0.98 (t, J = 7.6 Hz, 3 H). 
NMR assignments: 1H-NMR (400 MHz) δ 6.17 (dd, J = 11.2, 17.6 Hz, 1 H, C9-H), 6.00 
(dd, J = 2.0, 17.6 Hz, 1 H, C10-H), 5.43 (dd, J = 2.0, 11.2 Hz, 1 H, C10-H), 4.41 (t, J = 6.4 Hz, 2 
H, C4-H), 3.53 (s, 6 H, C11-H, C12-H), 1.79 (quint, J = 6.4 Hz, 2 H, C3-H), 1.48 (sex, J = 7.6 
Hz, 2 H, C2-H) 0.98 (t, J = 7.6 Hz, 3 H, C1-H). 
 
 
1-((4-Methoxybenzyl)oxy)-2-(methoxymethoxy)-4-vinylbenzene  (4.89). (SB-V-184). 
By-product isolated from the reaction of 4.90 with 4.8. Purified via flash chromatography eluting 
with a gradient of EtOAc/hexanes (1:10 → 1:4) to provide 51 mg of 4.89 as a white waxy solid: 
mp 55-58 °C; 1H-NMR (400 MHz) δ 7.34 (d, J = 8.8 Hz, 2 H), 7.22 (d, J = 2.2 Hz, 1 H), 6.97 
 411 
(dd, J = 2.2, 8.4 Hz, 1 H), 6.89 (d, J = 8.8 Hz, 2 H), 6.86 (d, J = 8.4 Hz, 1 H), 6.61 (dd, J = 10.8, 
17.6 Hz, 1 H), 5.59 (dd, J = 0.8, 17.6 Hz, 1 H), 5.22 (s, 2 H), 5.13 (dd, J = 0.8, 10.8 Hz, 1 H), 
5.01 (s, 2 H), 3.79 (s, 3 H), 3.51 (s, 3 H); 13C-NMR (100 MHz) δ 159.3, 149.0, 147.1, 136.2, 
131.3, 129.0, 129.0, 120.9, 115.0, 114.4, 113.9, 112.2, 95.7, 70.8, 56.3, 55.3;  IR (film) 2916 (C-
H), 1514, 1251, 1223, 1177, 1156, 1127, 1084, 1029 cm-1; HRMS (ESI) m/z calc for 
NaC18H20O4
+ (M+Na), 323.1254; found, 323.1261. 
NMR assignments: 1H-NMR (400 MHz) δ 7.34 (d, J = 8.8 Hz, 2 H, C10-H), 7.22 (d, J = 
2.2 Hz, 1 H, C7-H), 6.97 (dd, J = 2.2, 8.4 Hz, 1 H, C3-H), 6.89 (d, J = 8.8 Hz, 2 H, C11-H), 6.86 
(d, J = 8.4 Hz, 1 H, C4-H), 6.61 (dd, J = 10.8, 17.6 Hz, 1 H, C1-H), 5.59 (dd, J = 0.8, 17.6 Hz, 1 
H, C16-H), 5.22 (s, 2 H, C8-H), 5.13 (dd, J = 0.8, 10.8 Hz, 1 H, C16-H), 5.01 (s, 2 H, C14-H), 
3.79 (s, 3 H, C13-H), 3.51 (s, 3 H, C15-H); 13C-NMR (100 MHz) δ 159.3 (C12), 149.0 (C5), 
147.1 (C6), 136.2 (C1), 131.3 (C16), 129.0 (C9), 129.0 (C10), 120.9 (C2), 115.0 (C3), 114.4 




product isolated from the reaction of 4.90 with 4.8. Isolated via flash chromatography eluting 
with a gradient of EtOAc/hexanes (1:10 → 1:4)  to provide 5 mg (12%) of the named compound 
as a white solid;  1H-NMR (400 MHz) δ 7.34 (d, J = 8.8 Hz, 2 H), 7.13 (d, J = 8.4 Hz, 1 H), 6.91 
(d, J = 8.8 Hz, 2 H), 6.91 (dd, J = 11.2, 18.0 Hz, 1 H), 6.69 (s, 1 H), 6.52 (d, J = 8.8 Hz, 1 H), 
5.70 (dd, J = 1.6, 18.0 Hz, 1 H), 5.20 (dd, J = 1.6, 11.2 Hz, 1 H), 5.11 (s, 2 H), 5.02 (s, 2 H), 3.82 
(s, 3 H), 3.53 (s, 3 H); LCMS (APCI); found, 285 (M–CH3O)
+. 
NMR assignments: 1H-NMR (400 MHz) δ 7.34 (d, J = 8.8 Hz, 2 H, C10-H), 7.13 (d, J = 
8.4 Hz, 1 H, C3-H), 6.91 (d, J = 8.8 Hz, 2 H, C11-H), 6.91 (dd, J = 11.2, 18.0 Hz, 1 H, C1-H), 
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6.69 (s, 1 H, O17-H), 6.52 (d, J = 8.8 Hz, 1 H, C4-H), 5.70 (dd, J = 1.6, 18.0 Hz, 1 H, C16-H), 
5.20 (dd, J = 1.6, 11.2 Hz, 1 H, C16-H), 5.11 (s, 2 H, C8-H), 5.02 (s, 2 H, C14-H), 3.82 (s, 3 H, 







VII-252C). By-product isolated from the reaction of 4.90 with 4.8. Purified via flash 
chromatography eluting with a gradient of EtOAc/hexanes (1:10 → 1:4)  to provide 523 mg 
(8%) of the named compound as a yellow oil which crystallizes in the freezer;  1H-NMR (500 
MHz) δ 7.57 (d, J = 9.0 Hz, 1 H), 7.35 (d, J = 8.5 Hz, 1 H), 7.11 (d, J = 3.0 Hz, 1 H), 7.00 (dd, J 
= 3.0, 9.0 Hz, 1 H), 6.95 (d, J = 8.5 Hz, 1 H), 6.75 (dd, J = 11.0, 17.5 Hz, 1 H), 6.35-6.24 (comp, 
2 H), 6.15-6.02 (comp, 2 H), 5.63-5.52 (comp, 3 H), 5.15 (dd, J = 1.0, 11.0 Hz, 1 H), 5.08 (s, 2 
H), 5.00 (s, 2 H), 3.83 (s, 3 H), 3.441 (s, 6 H), 3.438 (s, 6 H), 3.34 (s, 3 H); 13C-NMR (125 MHz) 
δ 191.5, 190.9, 170.8, 170.1, 159.4, 152.7, 151.0, 150.2, 142.3, 134.1, 131.37, 131.36, 129.3, 
127.4, 126.5, 125.9, 125.7, 124.0, 123.5, 121.3, 116.8, 116.7, 116.3, 114.9, 114.5, 113.6, 98.9, 
68.3, 57.2, 55.4, 53.3, 52.5;  IR (film) 2944 (C-H), 2838 (C-H), 1768 (C=O), 1605, 1505, 1470, 
1335, 1256, 993 cm-1; HRMS (ESI) m/z calc for NaC34H36O10
+ (M+Na), 627.2201; found, 
627.2201. 
NMR assignments: 1H-NMR (500 MHz) δ 7.57 (d, J = 9.0 Hz, 1 H, C14-H), 7.35 (d, J = 
8.5 Hz, 1 H, C3-H), 7.11 (d, J = 3.0 Hz, 1 H, C11-H), 7.00 (dd, J = 3.0, 9.0 Hz, 1 H, C13-H), 
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6.95 (d, J = 8.5 Hz, 1 H, C4-H), 6.75 (dd, J = 11.0, 17.5 Hz, 1 H, C1-H), 6.35-6.24 (comp, 2 H, 
C31-H, C32-H), 6.15-6.02 (comp, 2 H, C23-H, C24-H), 5.63-5.52 (comp, 3 H, C18-H, C24-H, 
C32-H), 5.15 (dd, J = 1.0, 11.0 Hz, 1 H, C18-H), 5.08 (s, 2 H, C8-H), 5.00 (s, 2 H, C16-H), 3.83 
(s, 3 H, C17-H), 3.441 (s, 6 H, C25-H, C26-H or C33-H, C34-H), 3.438 (s, 6 H, C25-H, C26-H 
or C33-H, C34-H), 3.34 (s, 3 H, C15-H); 13C-NMR (125 MHz) δ 191.5 (C29), 190.9 (C21), 
170.8 (C27), 170.1 (C19), 159.4 (C12), 152.7 (C5), 151.0 (C30), 150.2 (C22), 142.3 (C6), 134.1 
(C1), 131.37 (C10), 131.36 (C14), 129.3 (C9), 127.4 (C32), 126.5 (C2), 125.9 (C24), 125.7 (C7), 
124.0 (C23), 123.5 (C31), 121.3 (C3), 116.8 (C28), 116.7 (C20), 116.3 (C13), 114.9 (C4), 114.5 
(C18), 113.6 (C11), 98.9 (C16), 68.3 (C8), 57.2 (C15), 55.4 (C17), 53.3 (C25, C26 or C33, C34), 
52.5 (C25, C26 or C33, C34). 
 
Methyl 5-hydroxy-1-methoxy-2-(3-((4-methoxybenzyl)oxy)-2-(methoxymethoxy)-6-
vinylbenzoyl)-5-(trifluoromethyl)cyclopent-2-ene-1-carboxylate  (4.100). (SB-V-216E). By-
product isolated from the reaction of 4.90 with 4.8 when TFAA was included. Purified via flash 
chromatography eluting with acetone/hexanes (1:4) to provide 54 mg (9%) of 4.100: 1H-NMR  
(500 MHz) δ 7.34 (d, J = 8.6 Hz, 2 H), 7.31 (d, J = 8.6 Hz, 1 H), 7.03 (d, J = 8.6 Hz, 1 H), 6.90 
(d, J = 8.6 Hz, 2 H), 6.67 (t, J = 2.7, 1 H), 6.51 (dd, J = 11.0, 17.3 Hz, 1 H), 5.59 (d, J = 17.3, 1 
H), 5.18 (d, J = 11.0, 1 H), 5.07 (d, J = 5.1, 1 H), 5.04 (s, 2 H), 5.04 (d, J = 5.1, 1 H), 4.46 (s, 1 
H),  3.81 (s, 3 H), 3.80 (s, 3 H), 3.68 (s, 3 H), 3.36 (s, 3 H), 3.00 (dd, J = 3.2, 19.5 Hz, 1 H), 2.75 
(dd, J = 2.2, 19.5 Hz, 1 H); 13C-NMR (125 MHz) δ 192.8, 167.5, 159.7, 153.0, 150.6, 144.1, 
142.3, 133.0, 132.4, 129.4, 129.3, 129.1, 128.2, 124.2 (q, J = 284 Hz ), 121.2, 115.2, 115.2, 
114.0, 99.2, 86.8, 84.9 (q, J = 29 Hz), 70.9, 57.8, 56.2, 55.3, 52.7, 40.6;  IR (film) 3462 (O-H), 
2954 (C-H), 2840 (C-H), 1756 (C=O), 1668 (C=O), 1614, 1596, 1516, 1484, 1467, 1380, 1250, 
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1173, 1113, 1033, 993 cm-1; HRMS (ESI) m/z calc for NaC28H29O9
+ (M+Na), 589.1656; found, 
589.1658. 
NMR assignments: 1H-NMR (500 MHz) δ 7.34 (d, J = 8.6 Hz, 2 H, C10-H), 7.31 (d, J = 
8.6 Hz, 1 H, C3-H), 7.03 (d, J = 8.6 Hz, 1 H, C4-H), 6.90 (d, J = 8.6 Hz, 2 H, C11-H), 6.67 (t, J 
= 2.7, 1 H, C21-H), 6.51 (dd, J = 11.0, 17.3 Hz, 1 H, C1-H), 5.59 (d, J = 17.3, 1 H, C16-H), 5.18 
(d, J = 11.0, 1 H, C16-H), 5.07 (d, J = 5.1, 1 H, C14-H), 5.04 (s, 2 H, C8-H), 5.04 (d, J = 5.1, 1 
H, C14-H), 4.46 (s, 1 H, O-H),  3.81 (s, 3 H, C24-H), 3.80 (s, 3 H, C13-H), 3.68 (s, 3 H, C23-H), 
3.36 (s, 3 H, C15-H), 3.00 (dd, J = 3.2, 19.5 Hz, 1 H, C22-H), 2.75 (dd, J = 2.2, 19.5 Hz, 1 H, 
C22-H); 13C-NMR (125 MHz) δ 192.8 (C17), 167.5 (C18), 159.7 (C12), 153.0 (C12), 150.6 
(C21), 144.1 (C5), 142.3 (C20), 133.0 (C6), 132.4 (C2), 129.4 (C1), 129.3 (C10), 129.1 (C7), 
128.2 (C9), 124.2 (C26), 121.2 (C3), 115.2 (C4), 115.2 (C16), 114.0 (C11), 99.2 (C14), 86.8 
(C19), 84.9 (C25), 70.9 (C8), 57.8 (C15), 56.2 (C23) 55.3 (C24), 52.7 (C13), 40.6 (C22). 
 
(3-((4-Methoxybenzyl)oxy)-2-(methoxymethoxy)-6-vinylphenyl)((1R,5S)-1,7,7-
trimethoxy-5-(trifluoromethyl)-6-oxabicyclo[3.1.1]hept-2-en-2-yl)methanone  (4.99). (SB-V-
216D). By-product isolated from the reaction of 4.90 with 4.8 when TFAA was included. 
Purified via flash chromatography eluting with acetone/hexanes (1:4) to provide 67 mg (11%) of 
4.99. Further purified via prep TLC eluting with a gradient of Et2O/CH2Cl2/hexanes   (1:3:40 → 
1:3:10) to provide 12 mg (40%) of 4.99: 1H-NMR  (500 MHz) δ 7.35 (d, J = 8.8 Hz, 3 H), 7.03 
(d, J = 8.5 Hz, 1 H), 6.91 (d, J = 8.8 Hz, 2 H), 6.62 (m, 1 H) 6.59 (bs, 1 H), 5.63 (d, J = 17.3 Hz, 
1 H), 5.17 (d, J = 11.7 Hz, 1 H), 5.11 (bd, J = 4.4 Hz, 1 H), 5.05 (s, 1 H), 5.01 (bd, J = 4.4 Hz, 1 
H), 3.82 (s, 3 H), 3.59 (s, 3 H), 3.41 (s, 3 H), 3.37 (s, 3 H), 3.35 (s, 3 H), 2.95 (dd, J = 2.4, 20.5 
Hz, 1 H), 2.22 (dd, J = 2.9, 20.2 Hz, 1 H); 13C-NMR (125 MHz) δ 192.3, 159.7, 152.0, 150.6, 
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142.0, 141.5, 134.0, 132.6, 129.4, 128.8, 128.2, 123.4 (q, J = 279 Hz), 120.9, 119.8, 114.8, 
114.0, 99.3, 96.6, 84.0 (bm), 70.9, 58.0, 55.3, 54.3, 51.7, 50.2;  IR (film) 2952 (C-H), 2850 (C-
H), 1671 (C=O), 1614, 1516, 1484, 1467, 1283, 1251, 1172, 1083, 1033, 993 cm-1; HRMS (ESI) 
m/z found, 581. 
NMR assignments: 1H-NMR (500 MHz) δ 7.35 (d, J = 8.8 Hz, 3 H, C3-H, C10-H), 7.03 
(d, J = 8.5 Hz, 1 H, C4-H), 6.91 (d, J = 8.8 Hz, 2 H, C11-H), 6.62 (m, 1 H, C1-H) 6.59 (bs, 1 H, 
C21-H), 5.63 (d, J = 17.3 Hz, 1 H, C16-H), 5.17 (d, J = 11.7 Hz, 1 H, C16-H), 5.11 (bd, J = 4.4 
Hz, 1 H, C14-H), 5.05 (s, 1 H, C8-H), 5.01 (bd, J = 4.4 Hz, 1 H, C14-H), 3.82 (s, 3 H, C13-H), 
3.59 (s, 3 H, C27-H), 3.41 (s, 3 H, C23-H), 3.37 (s, 3 H, C15-H), 3.35 (s, 3 H, C24-H), 2.95 (dd, 
J = 2.4, 20.5 Hz, 1 H, C22-H), 2.22 (dd, J = 2.9, 20.2 Hz, 1 H, C22-H); 13C-NMR (125 MHz) δ 
192.3 (C17), 159.7 (C12), 152.0 (C21), 150.6 (C5), 142.0 (C6), 141.5 (C7), 134.0 (C20), 132.6 
(C1), 129.4 (C10), 128.8 (C2), 128.2 (C9), 123.4 (C26), 120.9 (C3), 119.8 (C18), 114.8 (C4, 
C16), 114.0 (C11), 99.3 (C14), 96.6 (C19), 84.0 (C25), 70.9 (C8), 58.0 (C15), 55.3 (C13), 54.3 





vinylbenzoyl)pent-3-enoate  (4.101). (SB-VI-107C). Isolated from the reaction of 4.90 with 4.8 
when TFAA was not included. Purified via flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:4 → 2:5) to provide 59 mg (10%) of  4.101 as a yellow oil; 1H-NMR  (600 
MHz) δ (Major isomer) 7.34 (d, J = 8.8 Hz, 2 H), 7.29 (d, J = 8.6 Hz, 1 H), 6.99 (d, J = 8.6 Hz, 1 
H), 6.90 (d, J = 8.8 Hz, 2 H), 6.68 (q, J = 7.3, 1 H), 6.42 (dd, J = 11.0, 17.4 Hz, 1 H), 5.56 (d, J = 
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17.4 Hz, 1 H), 5.23 (bs, 1 H), 5.13 (d, J = 11.0 Hz, 1 H), 5.05-5.02 (comp, 4 H), 3.81 (s, 3 H), 
3.77 (s, 3 H), 3.47 (s, 3 H), 3.37 (s, 3 H), 1.96 (d, J = 2.3 Hz, 3 H); (Minor isomer) 7.34 (d, J = 
8.8 Hz, 2 H), 7.29 (d, J = 8.6 Hz, 1 H), 7.00 (d, J = 8.6 Hz, 1 H), 6.90 (d, J = 8.8 Hz, 2 H), 6.68 
(q, J = 9.6, 1 H), 6.52 (dd, J = 11.0, 17.4 Hz, 1 H), 5.56 (d, J = 17.4 Hz, 1 H), 5.23 (bs, 1 H), 
5.15 (d, J = 11.0 Hz, 1 H), 5.05-5.02 (comp, 4 H), 3.81 (s, 3 H), 3.75 (s, 3 H), 3.39 (s, 3 H), 3.38 
(s, 3 H), 1.59 (d, J = 7.3 Hz, 3 H); 13C-NMR (150 MHz) δ (Major isomer) 196.1, 171.1, 159.6, 
151.3, 150.8, 142.3, 139.2, 133.4, 132.7, 129.3, 129.3, 128.3, 121.2, 114.7, 114.6, 114.0, 99.1, 
73.4, 70.8, 57.6, 57.6, 55.3, 52.1, 15.4; (Minor isomer) 194.9, 171.2, 159.6, 151.0, 143.8, 142.2, 
139.2, 137.2, 136.1, 129.3, 129.0 128.3, 121.8, 115.3, 115.0, 114.0, 99.0, 79.1, 70.9, 57.8, 57.6, 
55.3, 52.1, 15.0;  IR (neat) 2951 (C-H), 2836 (C-H), 1754 (C=O), 1661 (C=O), 1642, 1614, 
1595, 1516, 1483, 1467, 1382, 1292, 1252, 1214, 1195, 1176, 1115, 1033, 992 cm-1; HRMS 
(ESI) m/z calc for NaC26H30O8
+ (M+Na), 493.1833; found, 493.1831. 
NMR assignments: 1H-NMR (600 MHz) δ (Major isomer) 7.34 (d, J = 8.8 Hz, 2 H, 
C10-H), 7.29 (d, J = 8.6 Hz, 1 H, C3-H), 6.99 (d, J = 8.6 Hz, 1 H, C4-H), 6.90 (d, J = 8.8 Hz, 2 
H, C11-H), 6.68 (q, J = 7.3, 1 H, C21-H), 6.42 (dd, J = 11.0, 17.4 Hz, 1 H, C1-H), 5.56 (d, J = 
17.4 Hz, 1 H, C16-H), 5.23 (bs, 1 H, C19-H), 5.13 (d, J = 11.0 Hz, 1 H, C16-H), 5.05-5.02 
(comp, 4 H, C8-H, C14-H), 3.81 (s, 3 H, C23-H), 3.77 (s, 3 H, C13-H), 3.47 (s, 3 H, C24-H), 
3.37 (s, 3 H, C15-H), 1.96 (d, J = 2.3 Hz, 3 H, C22-H); (Minor isomer) 7.34 (d, J = 8.8 Hz, 2 H, 
C10-H), 7.29 (d, J = 8.6 Hz, 1 H, C3-H), 7.00 (d, J = 8.6 Hz, 1 H, C4-H), 6.90 (d, J = 8.8 Hz, 2 
H, C11-H), 6.68 (q, J = 9.6, 1 H, C21-H), 6.52 (dd, J = 11.0, 17.4 Hz, 1 H, C1-H), 5.56 (d, J = 
17.4 Hz, 1 H, C16-H), 5.23 (bs, 1 H, C19-H), 5.15 (d, J = 11.0 Hz, 1 H, C16-H), 5.05-5.02 
(comp, 4 H, C8-H, C14-H), 3.81 (s, 3 H, C23-H), 3.75 (s, 3 H, C13-H), 3.39 (s, 3 H, C24-H), 
3.38 (s, 3 H, C15-H), 1.59 (d, J = 7.3 Hz, 3 H, C22-H); 13C-NMR (150 MHz) δ (Major isomer) 
196.1 (C17), 171.1 (C18), 159.6 (C12), 151.3 (C5), 150.8 (C21), 142.3 (C6), 139.2 (C20), 133.4 
(C2), 132.7 (C1), 129.3 (C10), 129.3 (C7), 128.3 (C9), 121.2 (C3), 114.7 (C4), 114.6 (C16), 
114.0 (C11), 99.1 (C14), 73.4 (C19), 70.8 (C8), 57.6 (C24), 57.6 (C15), 55.3 , 52.1 (C13), 15.4 
(C22); (Minor isomer) 194.9 (C17), 171.2 (C18), 159.6 (C12), 151.0 (C5), 143.8 (C21), 142.2 
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(C6), 139.2 (C20), 137.2 (C2), 136.1 (C1), 129.3 (C10), 129.0 (C7), 128.3(C9), 121.8 (C3), 
115.3 (C16), 115.0 (C4), 114.0 (C11), 99.0 (C14), 79.1 (C19), 70.9 (C8), 57.8 (C15), 57.6 (C24), 
55.3 (C23), 52.1 (C13), 15.0 (C22). 
 
1-((4-Methoxybenzyl)oxy)-2-(methoxymethoxy)-3-methyl-4-vinylbenzene  (4.109). 
(SB-VI-226). Styrene 4.90 (161 mg, 0.425 mmol) was dissolved in toluene (2 mL), concentrated 
under reduced pressure (3 x) and put under vacuum for  2 h. THF (2 mL) was added, followed by 
NaH (60 % dispersion in mineral oil) (~1 mg, 0.03 mmol) and the slurry was stirred for 15min. 
In a separate flask, THF (6 mL) was added and the solvent was cooled to – 78 °C and the 
reaction vessel was degassed. The solvent was warmed to 0 °C and a solution of i-PrMgBr•LiCl 
in THF (1.36 M, 0.34 mL, 0.467 mmol) was added, followed by a solution of MeLi in Et2O (1.56 
M, 0.60 mL, 0.935 mmol) at 0 °C and the mixture was stirred for 10 min. The solution of 
Styrene 4.90 in THF was added to the flask containing Li[i-PrMgMe2], and the reaction mixture 
was stirred for 30 min before adding squarate 4.8 (120 mg, 0.637 mmol) and the reaction was 
stirred for an additional 15 min whereupon a solution of saturated aqueous NaHCO3 (1 mL) was 
added, and the mixture was warmed to room temperature. The mixture was extracted with 
EtOAc (3 x 5 mL), and the combined organic extracts were dried (Na2SO4), filtered, and 
concentrated under reduced pressure. The crude oil was purified by flash chromatography eluting 
with a gradient of EtOAc/hexanes (1:10 → 1:2) to provide 95 mg (71%) of 4.109 as a white 
solid: mp 48-50 °C; 1H-NMR (600 MHz) δ 7.34 (d, J = 8.8 Hz, 2 H), 7.19 (d, J = 8.5 Hz, 1 H), 
6.90 (d, J = 8.8 Hz, 2 H), 6.87 (dd, J = 10.9, 17.4 Hz, 1 H), 6.81 (d, J = 8.5 Hz, 1 H), 5.51 (dd, J 
= 1.5, 17.4 Hz, 1 H), 5.20 (dd, J = 1.5, 10.9 Hz, 1 H), 5.08 (s, 2 H), 5.01 (s, 2 H), 3.81 (s, 3 H), 
3.53 (s, 3 H), 2.32 (s, 3 H); 13C-NMR (150 MHz) δ 159.4, 150.9, 144.6, 134.7, 131.2, 130.2, 
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129.1, 129.0, 121.4, 114.1, 113.9, 111.5, 98.9, 70.5, 57.5, 55.3, 12.6;   IR (film) 2937 (C-H), 
1614, 1517, 1488, 1462, 1380, 1293, 1250, 1159, 1044, 977 cm-1; HRMS (ESI) m/z calc for 
NaC19H22O4
+ (M+Na), 337.1410; found, 337.1407. 
NMR assignments: 1H-NMR (600 MHz) δ 7.34 (d, J = 8.8 Hz, 2 H, C10-H), 7.19 (d, J = 
8.5 Hz, 1 H, C3-H), 6.90 (d, J = 8.8 Hz, 2 H, C11-H), 6.87 (dd, J = 10.9, 17.4 Hz, 1 H, C1-H), 
6.81 (d, J = 8.5 Hz, 1 H, C4-H), 5.51 (dd, J = 1.5, 17.4 Hz, 1 H, C16-H), 5.20 (dd, J = 1.5, 10.9 
Hz, 1 H, C16-H), 5.08 (s, 2 H, C8-H), 5.01 (s, 2 H, C14-H), 3.81 (s, 3 H, C13-H), 3.53 (s, 3 H, 
C15-H), 2.32 (s, 3 H, C17-H); 13C-NMR (150 MHz) δ 159.4 (C12), 150.9 (C5), 144.6 (C6), 
134.7 (C1), 131.2 (C2), 130.2 (C7), 129.1 (C10), 129.0 (C16), 121.4 (C9), 114.1 (C3), 113.9 






(methoxymethoxy)cyclobuta[a]naphthalen-2(1H)-one  (4.110). (SB-VI-177). A solution of 
4.49 (1.14 g, 2.513 mmol), Grubbs II (149 mg, 0.176 mmol) and BHT (111 mg, 0.502 mmol) in 
dichloroethylene (DCE) was put under vacuum until the solvent effervesced, and the flask was 
backfilled with nitrogen (3 x). The reaction was then heated under reflux for 8 h. The reaction 
mixture was cooled to room temperature, DMSO (0.564 g, 0.62 mL, 8.795 mmol) was added, 
and the mixture was stirred for 16 h at room temperature. The solvent was removed under 
reduced pressure, and the crude material was purified by flash chromatography eluting with a 
gradient of EtOAc/hexanes (1:10 → 1:2) to provide 836 mg (78%) of 4.110 as a brown to green 
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solid: mp 83-85 °C and 214 mg (13%) 4.49 (91% brsm); 1H-NMR  (500 MHz) δ 7.90 (d, J = 8.4 
Hz, 1 H), 7.70 (d, J = 8.8 Hz, 1 H), 7.51 (d, J = 8.8 Hz, 1 H), 7.41 (d, J = 8.8 Hz, 2 H), 7.36 (d, J 
= 8.4 Hz, 1 H), 6.92 (d, J = 8.8 Hz, 2 H), 5.35 (s, 2 H), 5.20 (s, 2 H), 3.82 (s, 3 H), 3.57 (comp, 9 
H); 13C-NMR (125 MHz) δ 193.2, 160.3, 159.6, 150.4, 147.5, 140.6, 133.8, 132.7, 129.4, 128.4, 
125.8, 125.2, 120.1, 118.2, 114.7, 114.0, 99.6, 71.7, 57.7, 55.3, 53.7;  IR (film) 2942 (C-H), 
2836, 1760 (C=O), 1614, 1584, 1515, 1462, 1334, 1251, 1174, 1108, 1033, 937 cm-1; HRMS 
(CI) m/z calc for C24H25O7
+ (M+), 425.1600; found, 425.1596. 
NMR assignments: 1H-NMR (500 MHz) δ 7.90 (d, J = 8.4 Hz, 1 H, C3-H), 7.70 (d, J = 
8.8 Hz, 1 H, C20-H), 7.51 (d, J = 8.8 Hz, 1 H, C1-H), 7.41 (d, J = 8.8 Hz, 2 H, C10-H), 7.36 (d, 
J = 8.4 Hz, 1 H, C4-H), 6.92 (d, J = 8.8 Hz, 2 H, C11-H), 5.35 (s, 2 H, C8-H), 5.20 (s, 2 H, C14-
H), 3.82 (s, 3 H, C13-H), 3.57 (comp, 9 H, C15, C21, C22-H); 13C-NMR (125 MHz) δ 193.2 
(C18), 160.3 (C16), 159.6 (C12), 150.4 (C19), 147.5 (C5), 140.6 (C6), 133.8 (C20), 132.7 (C2), 
129.4 (C11), 128.4 (C9), 125.8 (C1), 125.2 (C7), 120.1 (C3), 118.2 (C4), 114.7 (C17), 114.0 

















2-Hydroxy-4,5-dimethoxy benzaldehyde  (4.112). (SB-VI–200). A solution of 2,4,5-
trimethoxybenzaldehyde 4.111 (3.3 g, 16.78 mmol) in CH2Cl2 (84 mL) was cooled to 0 °C. BBr3 
(freshly distilled from CaH2, 4.59 g, 1.74 mL, 18.45 mmol) was added, and the mixture was 
warmed to room temperature and stirred for 24 h. H2O (20 mL) was added, and stirring was 
continued for an additional 10 min. The mixture was extracted with CH2Cl2 (2 x 20 mL), and the 
combined organic extracts were dried (Na2SO4), filtered, and concentrated under reduced 
pressure to provide 2.60 g (85%) crude 4.112 as a dark green solid: mp 104-106 °C (MeOH). 
The crude material can be purified by flash chromatography eluting with a gradient of 
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acetone/hexanes (1:3 → 1:1), but in most cases the material is sufficiently pure for the next step; 
1H-NMR  (400 MHz) δ 11.41 (s, 1 H), 9.71 (s, 1 H), 6.91 (s, 1 H), 6.48 (s, 1 H), 3.94 (s, 3 H), 
3.89 (s, 3 H); 13C-NMR (100 MHz) δ 194.0, 159.3, 152.2, 142.9, 113.1, 112.8, 100.1, 56.4, 56.3;  
IR (film) 2838 (C-H), 1625 (C=O), 1506, 1475, 1443, 1369, 1339, 1280, 1251, 1198, 1147, 998 
cm-1; LRMS (CI) m/z found, 183. 
NMR assignments: 1H-NMR (400 MHz) δ 11.41 (s, 1 H, C1-H), 9.71 (s, 1 H, O-H), 
6.91 (s, 1 H, C3-H), 6.48 (s, 1 H, C6-H), 3.94 (s, 3 H, C10-H), 3.89 (s, 3 H, C9-H); 13C-NMR 
(100 MHz) δ 194.0 (C1), 159.3 (C7), 152.2 (C5), 142.9 (C4), 113.1 (C3), 112.8 (C2), 100.1 
(C6), 56.4 (C10), 56.3 (C9). 
 
 
4,5-Dimethoxy-2-((4-methoxybenzyl)oxy)benzaldehyde  (4.113). (SB-VI-75). A 
mixture of crude aldehyde 4.112 (0.50 g, 2.74 mmol), K2CO3 (0.76 g, 5.48 mmol) and NaI (0.12 
g, 0.82 mmol) in DMF (1.7 mL) was heated at 40 °C for 2 h. Paramethoxybenzyl chloride 
(PMBCl)634 (0.64 g, 0.56 mL, 4.12 mmol) was then added, and stirring continued at 40 °C for 24 
h. H2O (10 mL) was then added, and the reaction was cooled to room temperature. The mixture 
was extracted with CH2Cl2 (3 x 5 mL), and the combined organic extracts were washed with 5% 
NaOH solution (1 x 10 mL), 13% aqueous brine solution (4 x 3 mL), dried (Na2SO4) and 
concentrated under reduced pressure. The crude material was purified by flash chromatography 
eluting with a gradient of EtOAc/hexanes (1:4 → 1:2) to provide 820 mg (99%) 4.113 as a white 
solid: mp (IPA) 98-99 °C; 1H-NMR  (500 MHz) δ 10.34 (s, 1 H), 7.35 (d, J = 8.8 Hz, 2 H), 7.32 
(s, 1 H), 6.93 (d, J = 8.8 Hz, 2 H), 6.56 (s, 1 H), 5.10 (s, 2 H), 3.93 (s, 3 H), 3.88 (s, 3 H), 3.83 (s, 
3 H); 13C-NMR (125 MHz) δ 188.1, 159.8, 157.8, 155.6, 144.0, 129.2, 128.1, 118.2, 114.2, 
108.8, 98.1, 71.7, 56.2, 55.3;  IR (film) 2958 (C-H), 2937 (C-H), 2837, 1655 (C=O), 1606, 1468, 
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1454, 1276, 1216, 1127, 1037, 1021, 915 cm-1; HRMS (CI) m/z calc for C17H18O5
+ (M+), 
302.1154; found, 302.1159. 
 
NMR assignments: 1H-NMR (500 MHz) δ 10.34 (s, 1 H, C1-H), 7.35 (d, J = 8.8 Hz, 2 
H, C12-H), 7.32 (s, 1 H, C3-H), 6.93 (d, J = 8.8 Hz, 2 H, C13-H), 6.56 (s, 1 H, C6-H), 5.10 (s, 2 
H, C8-H), 3.93 (s, 3 H, C10-H), 3.88 (s, 3 H, C9-H), 3.83 (s, 3 H, C15-H); 13C-NMR (125 MHz) 
δ 188.1 (C1), 159.8 (C7), 157.8 (C5), 155.6 (C14), 144.0 (C4), 129.2 (C12), 128.1 (C11), 118.2 
(C2), 114.2 (C13), 108.8 (C3), 98.1 (C6), 71.7 (C8), 56.2 (C10, C15), 55.3 (C9). 
 
 
1-(4,5-Dimethoxy-2-((4-methoxybenzyl)oxy)phenyl)prop-2-yn-1-ol  (4.114). (SB-VI-
70). A solution of aldehyde 4.113 (354 mg, 1.17 mmol) in THF (7 mL) was degassed. A solution 
of ethynyl magnesium bromide (0.5 M, 5.8 mL, 2.93 mmol) in THF was added and the reaction 
mixture was stirred for 2 h at 5 °C, whereupon a solution of saturated aqueous NaHCO3 (1 mL) 
was added.  The mixture was extracted with EtOAc (3 x 2 mL), and the combined organic 
extracts were dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude oil 
was purified by flash chromatography eluting with EtOAc/hexanes (1:2) to provide 375 mg 
(98%) of 4.114 as a waxy solid: 1H-NMR  (600 MHz) δ 7.36 (d, J = 8.8 Hz, 2 H), 7.13 (s, 1 H), 
6.92 (d, J = 8.8 Hz, 2 H), 6.60 (s, 1 H), 5.68 (dd, J = 2.4, 6 Hz, 1 H), 5.05 (dd, J = 4, 10.6 Hz, 2 
H), 3.87 (s, 3 H), 3.86 (s, 3 H), 3.82 (s, 3 H), 2.79 (d, J = 6 Hz, 1 H), 2.62 (d, J = 2.4 Hz, 1 H); 
13C-NMR (150 MHz) δ 159.6, 150.1, 149.7, 143.5, 129.1, 128.7, 120.8, 114.1, 111.5, 99.5, 83.6, 
73.9, 71.7, 66.3, 56.5, 56.2, 55.3;  IR (film) 3469 (O-H), 3282, 3001, 2936 (C-H), 2836 (C-H), 
1612, 1515, 1464, 1405, 1383, 1304, 1249, 1209, 1175, 1114, 1019, 941 cm-1; HRMS (ESI) m/z 
calc for NaC19H20O5
+ (M+Na), 351.1203; found, 351.1200. 
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NMR assignments: 1H-NMR (600 MHz) δ 7.36 (d, J = 8.8 Hz, 2 H, C12-H), 7.13 (s, 1 
H, C3-H), 6.92 (d, J = 8.8 Hz, 2 H, C13-H), 6.60 (s, 1 H, C6-H), 5.68 (dd, J = 2.4, 6 Hz, 1 H, 
C1-H), 5.05 (dd, J = 4, 10.6 Hz, 2 H, C8-H), 3.87 (s, 3 H, C10-H), 3.86 (s, 3 H, C9-H), 3.82 (s, 3 
H, C15-H), 2.79 (d, J = 6 Hz, 1 H, O-H), 2.62 (d, J = 2.4 Hz, 1 H, C17-H); 13C-NMR (150 MHz) 
δ 159.6 (C14), 150.1 (C7), 149.7 (C5), 143.5 (C4), 129.1 (C12), 128.7 , 120.8 (C3), 114.1 (C13), 
111.5 (C2), 99.5 (C6), 83.6 (C16), 73.9 (C17), 71.7 (C8), 66.3 (C1), 56.5 (C15 or C10), 56.2 




dihydrocyclobuta[a]naphthalen-2-ol  (4.112). (SB-VI-76). A round bottom flask containing 
4.110   (162 mg, 0.381 mmol) was put under vacuum for 2 h. THF (1.6 mL) was added, and the 
reaction mixture was degassed. The mixture was warmed to 0 °C, and a solution of ethynyl 
magnesium bromide (0.5 M, 4.3 mL, 2.14 mmol) in THF was added. The reaction mixture was 
stirred for 2 h at 5 °C, whereupon a solution of saturated aqueous NaHCO3 (1 mL) was added.  
The mixture was extracted with EtOAc (3 x 2 mL), and the combined organic extracts were dried 
(Na2SO4), filtered, and concentrated under reduced pressure. The crude oil was purified by flash 
chromatography eluting with EtOAc/hexanes (1:4) to provide 149 mg (87%) of 4.112 as a brown 
to orange solid: mp 95-100 °C; 1H-NMR (500 MHz) δ 7.84 (d, J = 8.2 Hz, 1 H), 7.61 (d, J = 9.2 
Hz, 1 H), 7.40 (d, J = 8.2 Hz, 1 H), 7.39 (d, J = 8.6 Hz, 2 H), 7.32 (d, J = 9.2 Hz, 1 H), 6.90 (d, J 
= 8.6 Hz, 2 H) 5.33 (d, J = 5.4 Hz, 1 H), 5.20 (d, J = 11.6 Hz, 1 H), 5.16 (d, J = 11.6 Hz, 1 H), 
5.13 (d, J = 5.4 Hz, 1 H) 3.81 (s, 3 H), 3.67 (s, 3 H), 3.66 (s, 3 H), 3.55 (s, 3 H), 2.70 (s, 1 H); 
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13C-NMR (150 MHz) δ 159.5, 150.1, 146.0, 138.7, 136.8, 132.7, 131.1, 129.4, 128.8, 126.3, 
126.2, 116.9, 116.7, 113.9, 107.4, 99.9, 81.8, 77.4, 75.5, 71.6, 57.6, 55.27, 53.2, 52.0;  IR (film) 
3494 (O-H), 3286 (O-H), 2942 (C-H), 2838 (C-H), 1614, 1594, 1515, 1463, 1336, 1251, 1176, 
1154, 1118, 1078, 1031, 948 cm-1; HRMS (ESI) m/z calc for NaC26H26O7
+ (M+Na), 473.1571; 
found, 473.1562. 
NMR assignments: 1H-NMR (500 MHz) δ 7.84 (d, J = 8.2 Hz, 1 H, C20-H), 7.61 (d, J = 
9.2 Hz, 1 H, C3-H), 7.40 (d, J = 8.2 Hz, 1 H, C1-H), 7.39 (d, J = 8.6 Hz, 2 H, C10-H), 7.32 (d, J 
= 9.2 Hz, 1 H, C4-H), 6.90 (d, J = 8.6 Hz, 2 H, C11-H) 5.33 (d, J = 5.4 Hz, 1 H, C8-H), 5.20 (d, 
J = 11.6 Hz, 1 H, C14-H), 5.16 (d, J = 11.6 Hz, 1 H, C14-H), 5.13 (d, J = 5.4 Hz, 1 H, C8-H) 
3.81 (s, 3 H, C13-H), 3.67 (s, 3 H, C21-H), 3.66 (s, 3 H, C22-H), 3.55 (s, 3 H, C15-H), 2.70 (s, 1 
H, C25-H); 13C-NMR (150 MHz) δ 159.5 (C12), 150.1 (C6), 146.0 (C5), 138.7 (C16), 136.8 
(C19), 132.7 (C20), 131.1 (C2), 129.4 (C10), 128.8 (C9), 126.3 (C1), 126.2 (C7), 116.9 (C7), 
116.7 (C3), 113.9 (C11), 107.4 (C17), 99.9 (C14), 81.8 (C24), 77.4 (C18), 75.5 (C25), 71.6 (C8), 













dihydrocyclobuta[a]naphthalen-2-ol  (4.115). (SB-VI-150). A solution of 4.112   (143 mg, 
0.337 mmol) in toluene (2 mL) was concentrated under reduced pressure (3 x), put under 
vacuum for 2 h and dissolved in THF (2.7 mL). A separate roundbottomed flask containing 
4.114 (221 mg, 0.674 mmol) was dissolved in toluene (2 mL), concentrated under reduced 
pressure (3 x) and put under vacuum for 2 h. 4-(Phenylazo)diphenylamine (PDA) (4.118) (5 mg, 
0.017 mmol) was added to the flask containing 4.114, followed by a solution of CeCl3•2LiCl in 
THF (0.33 M, 4.1 mL, 1.35 mmol)167, and the reaction mixture was cooled to – 78 °C and 
degassed. The cooling bath was removed, and the mixture was warmed to 0 °C, whereupon a 
solution of n-BuLi in hexanes was added until the reaction mixture turned a persistent purple 
color (1.21 M, ca. 1.5 mL, 1.81 mmol). After the purple endpoint had been seen, an additional 
ammount of n-BuLi in hexanes (1.21 M, 0.56 mL, 0.67 mmol) was added, and the reaction 
mixture was stirred for 10 min at 0 °C. The solution of 4.112 in THF (1 mL) was slurried over 
NaH (60 % dispersion in mineral oil, ca. 6 mg, 0.150 mmol) before adding to the reaction 
mixture containing 4.114, and stirring was continued for 1 h at 0 °C. A solution of saturated 
aqueous NaHCO3 (5 mL) was then added and the mixture was extracted with EtOAc (3 x 10 
mL). The combined organic extracts were dried (Na2SO4), filtered, and concentrated under 
reduced pressure. The crude oil was purified by flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:2 → 3:4) to provide 212 mg (84%) of 4.115 and 10 mg (7%) of 4.112 (91% 
brsm): 1H-NMR  (600 MHz) δ 7.81 (d, J = 8.6 Hz, 1 H), 7.78 (d, J = 8.6 Hz, 1 H), 7.60 (d, J = 
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6.9 Hz, 1 H), 7.58 (d, J = 6.9 Hz, 1 H), 7.40-7.35 (Comp, 6 H), 7.30 (d, J = 9.0 Hz, 2 H), 7.27 (d, 
J = 8.8 Hz, 2 H), 7.24 (d, J = 8.8 Hz, 2 H), 7.084 (s, 1 H), 7.07 (s, 1 H), 6.55 (s, 1 H), 6.53 (s, 1 
H) 5.74 (app. d, 2 H), 5.29 (d, J = 5.3 Hz, 1 H), 5.25 (d, J = 5.3 Hz, 1 H), 5.16 (app qd, 4 H), 
5.09 (d, J = 5.3 Hz, 1 H), 5.04 (d, J = 5.3 Hz, 1 H), 4.96 (app qd, 4 H), 3.82 (s, 3 H), 3.81 (s, 3 
H), 3.80 (s, 6 H), 3.74 (s, 3 H), 3.73 (s, 3 H), 3.72 (s, 3 H), 3.67 (s, 3 H), 3.64 (s, 3 H), 3.63 (s, 3 
H), 3.58 (s, 3 H), 3.53 (s, 3 H), 3.52 (app. d, 6 H); 13C-NMR (150 MHz) δ 159.5, 159.4, 150.3, 
150.1, 150.0, 149.5, 149.4, 146.3, 143.4, 138.7, 136.7, 132.6, 131.0, 129.4, 129.2, 128.8, 128.7, 
126.3, 126.2, 121.4, 117.2, 117.1, 116.6, 114.0, 113.9, 111.8, 111.6, 107.6, 99.8, 99.7, 87.1, 83.9, 
83.7, 77.6, 71.8, 71.6, 60.9, 60.6, 57.6, 56.3, 56.2, 56.1, 55.3, 55.2, 53.2, 51.9, 51.8;  IR (film) 
3466 (O-H), 2939 (C-H), 2838 (C-H), 2251 (C≡C), 1728, 1613, 1515, 1463, 1405, 1382, 1303, 
1251, 1209, 1113, 1032, 912 cm-1; HRMS (ESI) m/z calc for NaC43H44O12
+ (M+Na), 775.2725; 
found, 775.2722. 
NMR assignments: 1H-NMR (600 MHz) δ 7.81 (d, J = 8.6 Hz, 1 H, C20-H), 7.78 (d, J = 
8.6 Hz, 1 H, C20-H), 7.60 (d, J = 6.9 Hz, 1 H, C3-H), 7.58 (d, J = 6.9 Hz, 1 H, C3-H), 7.40-7.35 
(Comp, 6 H, C10-H,C1-H), 7.30 (d, J = 9.0 Hz, 2 H, C4-H), 7.27 (d, J = 8.8 Hz, 2 H, C36-H), 
7.24 (d, J = 8.8 Hz, 2 H, C36-H), 7.08 (s, 1 H, C29-H), 7.07 (s, 1 H, C29-H), 6.55 (s, 1 H, C32-
H), 6.53 (s, 1 H, C32-H) 5.74 (app. d, 2 H, C26-H), 5.29 (d, J = 5.3 Hz, 1 H, C8-H), 5.25 (d, J = 
5.3 Hz, 1 H, C8-H), 5.16 (app qd, 4 H, C14-H), 5.09 (d, J = 5.3 Hz, 1 H, C8-H), 5.04 (d, J = 5.3 
Hz, 1 H, C8-H), 4.96 (app qd, 4 H, C34-H), 3.82 (s, 3 H, C40-H), 3.81 (s, 3 H, C41-H), 3.80 (s, 6 
H, C13-H), 3.74 (s, 3 H, C40-H), 3.73 (s, 3 H, C41-H), 3.72 (s, 3 H, C39-H), 3.67 (s, 3 H, C39-
H), 3.64 (s, 3 H, C21-H or C22-H), 3.63 (s, 3 H, C21-H or C22-H), 3.58 (s, 3 H, C21-H or C22-
H), 3.53 (s, 3 H, C21-H or C22-H), 3.52 (app. d, 6 H, C15-H); 13C-NMR (150 MHz) δ 159.5 
(C12), 159.4 (C38), 150.3 (C33), 150.1 (C33, C6), 150.0 (C6), 149.5 (C31), 149.4 (C31), 146.3 
(C5), 143.4 (C30), 138.7 (C16), 136.7 (C19), 132.6 (C20), 131.0 (C2), 129.4 (C10), 129.2 (C36), 
128.8 (C9, C35), 128.7 (C35), 126.3 (C1), 126.2 (C7), 121.4 (C29), 117.2 (C4), 117.1 (C4), 
116.6 (C3), 114.0 (C11), 113.9 (C11, C37), 111.8 (C28), 111.6 (C28), 107.6 (C17), 99.8 (C14), 
99.7 (C32), 87.1 (C24), 83.9 (C25), 83.7 (C25), 77.6 (C18), 71.8 (C8), 71.6 (C34), 60.9 (C26), 
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60.6 (C26), 57.6 (C15), 56.3 (C39 or C11), 56.2 (C39 or C11), 56.1 (C39 or C11), 55.3 (C13), 





methoxybenzyl)oxy)-1-(methoxymethoxy)-10H-benzo[4,5]indeno[2,1-b]furan  (4.128). (SB-
VI-170). A batch of Phosphoric acid-doped SiO2 was prepared by the addition of neat 85% 
Phosphoric acid (29 µL, 49 mg, 0.5 mmol) to a slurry of silica (2.0 g) in CH2Cl2 (5 mL). Water 
(50 µL) was added and the slurry was stirred vigorously for 1 h. The solvent was removed under 
reduced pressure until the silica became a free-flowing powder. A portion of the Phosphoric 
acid-doped SiO2 (111 mg) was added to a solution of 4.115 (169 mg, 0.222 mmol) in CH2Cl2 
(2.7 mL) at room temperature. The reaction mixture was stirred for 30 min whereupon 
triethylamine (Et3N) (72 mg, 0.1 mL, 0.7165 mmol) was added and the mixture was filtered 
through Celite and washed with CH2Cl2 (1 x 5 mL). The combined organic extracts were 
concentrated under reduced pressure and the crude oil was purified by flash chromatography 
eluting with a gradient of EtOAc/hexanes (1:4 → 3:4) to provide 46 mg (29%) of 4.128 and 72 
mg (43%) of 4.115. 
1H-NMR (600 MHz) δ 7.79 (d, J = 8.5 Hz, 0.5 H), 7.77 (d, J = 8.5 Hz, 0.5 H), 7.58 (d, J 
= 8.8 Hz, 1 H), 7.42-7.40 (comp, 4.5 H), 7.38-7.35 (comp, 4.5 H), 7.34 (d, J = 8.8 Hz, 0.5 H), 
7.33 (d, J = 8.8 Hz, 0.5 H), 7.22 (s, 0.5 H), 7.20 (s, 0.5 H), 6.94 (d, J = 8.5 Hz, 1 H), 6.91-6.90 
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(comp, 3 H), 6.68 (s, 0.5 H) 6.62 (s, 0.5 H), 6.55 (s, 0.5 H), 6.54 (s, 0.5 H), 5.25 (app d, 2 H), 
5.17 (s, 2 H), 5.02 (app d., 2 H), 4.00 (s, 1.5 H), 3.94 (s, 1.5 H), 3.87 (s, 1.5 H), 3.86 (s, 1.5 H), 
3.83 (s, 1.5 H), 3.81 (s, 4.5 H), 3.57 (s, 1.5 H), 3.56 (s, 1.5 H), 3.44 (s, 3 H), 3.43 (s, 3 H); 13C-
NMR 159.5, 153.2, 153.0, 150.6, 150.6, 150.5, 150.1, 149.4, 144.2, 144.2, 140.5, 140.5, 135.8, 
135.5, 134.4, 133.9, 132.2, 132.1, 131.1, 131.0, 129.4, 129.3, 129.2, 129.1, 129.0, 129.0, 128.8, 
128.8, 128.3, 127.6, 127.4, 127.4, 127.3, 125.6, 125.5, 125.3, 125.3, 118.6, 118.6, 117.1, 117.0, 
117.0, 114.0, 113.9, 116.6, 110.4, 109.9, 100.1, 99.6, 99.1, 94.1, 93.6, 72.2, 71.7, 71.6, 71.6, 
60.4, 57.6, 56.5, 56.2, 56.1, 55.3, 55.3, 51.8, 51.8;  IR (film) 2938 (C-H), 2836 (C-H), 2252, 
2044, 1612, 1586, 1516, 1462, 1404, 1288, 1251, 1211, 1175, 1127, 1101, 1032, 919 cm-1; 
HRMS (ESI) m/z calc for NaC43H42O11
+ (M+Na), 757.2619; found, 757.2615. 
NMR assignments: 1H-NMR (600 MHz) δ 7.79 (d, J = 8.5 Hz, 0.5 H, C1-H), 7.77 (d, J 
= 8.5 Hz, 0.5 H, C1-H), 7.58 (d, J = 8.8 Hz, 1 H, C4-H), 7.42-7.40 (comp, 4.5 H, C10-H, C34-H, 
C21-H), 7.38-7.35 (comp, 4.5 H, C10-H, C34-H, C21-H), 7.34 (d, J = 8.8 Hz, 0.5 H, C3-H), 7.33 
(d, J = 8.8 Hz, 0.5 H, C3-H), 7.22 (s, 0.5 H, C27-H), 7.20 (s, 0.5 H, C27-H), 6.94 (d, J = 8.5 Hz, 
1 H, C11-H, C35-H), 6.91-6.90 (comp, 3 H, C11-H, C35-H), 6.68 (s, 0.5 H, C24-H) 6.62 (s, 0.5 
H, C24-H), 6.55 (s, 0.5 H, C30-H), 6.54 (s, 0.5 H, C30-H), 5.25 (app d, 2 H, C14-H), 5.17 (s, 2 
H, C8-H), 5.02 (app d., 2 H, C32-H), 4.00 (s, 1.5 H, C39-H), 3.94 (s, 1.5 H, C39-H), 3.87 (s, 1.5 
H, C38-H), 3.86 (s, 1.5 H, C38-H), 3.83 (s, 1.5 H, C13-H, C37-H), 3.81 (s, 4.5 H, C13-H, C37-
H), 3.57 (s, 1.5 H, C15-H), 3.56 (s, 1.5 H, C15-H), 3.44 (s, 3 H, C22-H, C23-H), 3.43 (s, 3 H, 
C22-H, C23-H); 13C-NMR 159.5 (C12, C36), 153.2 (C25), 153.0 (C25), 150.6 (C5), 150.6 
(C31), 150.5 (C5), 150.1 (C31), 149.4 (C28), 144.2 (C29), 144.2 (C29), 140.5 (C6), 140.5 (C6), 
135.8 (C20), 135.5 (C20), 134.4 (C16), 133.9 (C16), 132.2 (C1), 132.1 (C1), 131.1 (C2), 131.0 
(C2), 129.4 (C9), 129.3 (C33), 129.2 (C33), 129.1 (C34), 129.0 (C34), 129.0 (C21), 128.8 (C21), 
128.8 (C10), 128.3 (C10), 127.6 (C18), 127.4 (C17), 127.4 (C18), 127.3 (C17), 125.6 (C7), 
125.5 (C7), 125.3 (C4), 125.3 (C4), 118.6 (C26), 118.6 (C26), 117.1 (C3), 117.0 (C3), 117.0 
(C19), 114.0 (C11, C35), 113.9 (C11, C35), 116.6 (C19), 110.4 (C27), 109.9 (C27), 100.1 (C30), 
99.6 (C30), 99.1 (C14), 94.1 (C24), 93.6 (C24), 72.2 (C32), 71.7 (C32), 71.6 (C8), 71.6 (C8), 
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60.4 (C38), 57.6 (C15), 56.5 (C39), 56.2 (C39), 56.1 (C38), 55.3 (C13, C37), 55.3 (C13, C37), 




2-((tert-Butyldimethylsilyl)oxy)-4,5-dimethoxybenzaldehyde  (4.148). (SB-VI-181). 
TBSCl (166 mg, 1.098 mmol) was added to a solution of 4.112 (100 mg, 0.549 mmol) and 
imidazole (75 mg, 1.098 mmol) in DMF (0.5 mL) at room temperature. The mixture was stirred 
for 1 h, whereupon a solution of saturated aqueous NaHCO3 (1 mL) was added. The mixture was 
extracted with EtOAc (3 x 2 mL) and the combined organic extracts were dried (Na2SO4), 
filtered, and concentrated under reduced pressure. The crude oil was purified by flash 
chromatography eluting with acetone/hexanes (1:10) to provide 112 mg (69%) of 4.148 as a 
waxy white solid: mp 64-65 °C; 1H-NMR (500 MHz) δ 10.25 (s, 1 H), 7.25 (s, 1 H), 6.33 (s, 1 
H), 3.88 (s, 3 H), 3.86 (s, 3 H), 1.01 (s, 9 H), 0.24 (s, 6 H); 13C-NMR (125 MHz) δ 188.3, 155.5, 
155.2, 144.3, 119.7, 108.2, 103.5, 56.1, 56.0, 25.6, 18.3, -4.4;  IR (film) 2951 (C-H), 2836 (C-H), 
1754 (C=O), 1661 (C=O), 1642, 1614, 1595, 1516, 1483, 1467, 1382, 1292, 1252, 1214, 1195, 
1176, 1115, 1033, 992 cm-1; HRMS (CI) m/z calc for C15H25O4Si
+ (M+), 297.1522; found, 
297.1527. 
NMR assignments: 1H-NMR (500 MHz) δ 10.25 (s, 1 H, C1-H), 7.25 (s, 1 H, C3-H), 
6.33 (s, 1 H, C6-H), 3.88 (s, 3 H, C12-H), 3.86 (s, 3 H, C11-H), 1.01 (s, 9 H, C10-H), 0.24 (s, 6 
H, C8-H); 13C-NMR (125 MHz) δ 188.3 (C1), 155.5 (C7) 155.2 (C5), 144.3 (C4), 119.7 (C2), 





1-(2-((tert-Butyldimethylsilyl)oxy)-4,5-dimethoxyphenyl)prop-2-yn-1-ol  (4.149). 
(SB-VI-189). A solution of aldehyde 4.148 (110 mg, 0.371 mmol) in THF (1.1 mL) was cooled 
to – 78 °C and reaction vessel was degassed. A solution of ethynyl magnesiumbromide (0.5 M, 
0.9 mL, 0.445 mmol) was then added at – 78 °C, and the mixture was warmed to room 
temperature, and stirred for an additional 30 min. A solution of saturated aqueous NaHCO3 (2 
mL) was then added, and the mixture was extracted with EtOAc (3 x 5 mL). The combined 
organic extracts were dried (Na2SO4), filtered, concentrated under reduced pressure, and the 
crude oil was purified by flash chromatography eluting with acetone/hexanes (1:4) to provide 
103 mg (86%) of 4.149: 1H-NMR  (500 MHz) δ 7.12 (s, 1 H), 6.38 (s, 1 H), 5.67 (d, J = 2.0 Hz, 
1 H), 3.84 (s, 3 H), 3.80 (s, 3 H), 2.62 (bs, 1 H), 2.57 (d, J = 2.0 Hz, 1 H), 1.01 (s, 9 H), 0.25 (s, 3 
H), 0.24 (s, 3 H); 13C-NMR (125 MHz) δ 149.6, 146.6, 143.7, 121.9, 111.1, 103.8, 83.7, 73.8, 
59.6, 56.3, 55.9, 25.7, 18.1, -4.1, -4.2;  IR (neat) 3493 (O-H), 3288 (O-H), 2932 (C-H), 2858 (C-
H), 2253 (C≡C), 2114 (C≡C), 1611, 1514, 1469, 1404, 1322, 1204, 1117, 1012, 945, 1252, 1214, 
1195, 1176, 1115, 1033, 992 cm-1; HRMS (ESI) m/z calc for NaC17H26O4Si
+ (M+Na), 345.1493; 
found, 345.1494. 
NMR assignments: 1H-NMR (500 MHz) δ 7.12 (s, 1 H, C3-H), 6.38 (s, 1 H, C6-H), 5.67 
(d, J = 2.0 Hz, 1 H, C1-H), 3.84 (s, 3 H, C12-H), 3.80 (s, 3 H, C11-H), 2.62 (bs, 1 H, O-H), 2.57 
(d, J = 2.0 Hz, 1 H, C14-H), 1.01 (s, 9 H, C10-H), 0.25 (s, 3 H, C8-H), 0.24 (s, 3 H, C8-H); 13C-
NMR (125 MHz) δ 149.6 (C5), 146.6 (C7), 143.7 (C4), 121.9 (C3), 111.1 (C2), 103.8 (C6), 83.7 






2,2-Di-tert-butyl-4-ethynyl-6,7-dimethoxy-4H-benzo[d][1,3,2]dioxasiline  (4.147). 
(SB-VI-277). A solution of aldehyde 4.122 (1.56 mg, 8.57 mmol) in THF (16 mL) was cooled to 
– 78 °C, the reaction vessel was degassed, and a solution of ethynyl magnesium bromide (0.5 M, 
42.8 mL, 21.41 mmol) was added at – 78 °C. The cooling bath was removed, and the reaction 
mixture was warmed to room temperature and stirred for 1 h, whereupon a solution of dilute 
NH4Cl (10 mL) was added. The mixture was extracted with EtOAc (3 x 10 mL), and the 
combined organic extracts were dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude oil was purified by silica plug eluting with 1:1 mixture acetone/hexanes (500 
mL) to provide 1.44 g of the acetylide adduct as a brown solid which used directly in the next 
step.  
A solution the acetylide adduct (1.44 g, 6.92 mmol) and 2,6-lutidine (1.85 g, 2.0 mL, 17.3 
mmol) in CH2Cl2 (18 mL) was cooled to – 40 °C, (tert-Bu)2Si(OTf)2  (3.65 g, 2.7 mL, 8.30 
mmol) was added, and the reaction mixture was warmed to 0 °C and stirred for 4 h. Saturated 
aqueous NaHCO3 (5 mL) was added, and the mixture was extracted with EtOAc (3 x 10 mL). 
The combined organic extracts were dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude oil was purified by flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:20 → 1:10) to provide 1.98 mg (82%) of 4.147 as a waxy white solid: mp 78-
80 °C; 1H-NMR (500 MHz) δ 6.82 (s, 1 H), 6.49 (s, 1 H), 5.84 (dd, J = 0.7, 2.3 Hz, 1 H), 3.85 (s, 
1 H), 3.83 (s, 3 H), 2.66 (d, J = 2.3 Hz, 1 H), 1.06 (s, 9 H), 1.03 (s, 9 H); 13C-NMR (125 MHz) δ 
149.8, 147.1, 143.2, 116.5, 109.8, 103.6, 83.1, 74.1, 64.5, 56.4, 55.9, 26.9, 26.9, 21.5, 20.9;  IR 
(film) 3287 2936 (C-H), 2896 (C-H), 2860, 2120, 1616, 1512, 1471, 1471, 1450, 1405, 1364, 
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1326, 1291, 1264, 1218, 1200, 1195, 1175, 1126, 1084, 1012, 940 cm-1; HRMS (ESI) m/z calc 
for NaC19H28O4Si
+ (M+Na), 371.1649; found, 371.1652. 
NMR assignments: 1H-NMR (500 MHz) δ 6.82 (s, 1 H, C3-H), 6.49 (s, 1 H, C6-H), 5.84 
(dd, J = 0.7, 2.3 Hz, 1 H, C1-H), 3.85 (s, 1 H, C13-H), 3.83 (s, 3 H, C12-H), 2.66 (d, J = 2.3 Hz, 
1 H, C15-H), 1.06 (s, 9 H, C11-H or C9-H), 1.03 (s, 9 H, C11-H or C9-H); 13C-NMR (125 MHz) 
δ 149.8 (C5), 147.1 (C7), 143.2 (C4), 116.5 (C3), 109.8 (C2), 103.6 (C6), 83.1 (C14), 74.1 
(C15), 64.5 (C1), 56.4 (C13), 55.9 (C12), 26.9 (C9 or C11), 26.9 (C9 or C11), 21.5 (C8 or C10), 





dihydrocyclobuta[a]naphthalen-2-ol  (4.151). (SB-VI-243). A solution of 4.112   (100 mg, 
0.236 mmol) in toluene (2 mL) was concentrated under reduced pressure (1 x), put under 
vacuum for 2 h, and dissolved in THF (1 mL). A separate round bottomed flask containing 4.147 
(164 mg, 0.471 mmol) was dissolved in toluene (2 mL), concentrated under reduced pressure (1 
x), and put under vacuum for 2 h. 4-(Phenylazo)diphenylamine (PDA) (4.118) (3 mg, 0.012 
mmol), and a solution of CeCl3•2LiCl in THF (0.33 M, 1.43 mL, 0.471 mmol)
167 was added to 
the flask containing 4.147 and the mixture was cooled to – 78 °C and the reaction vessel was 
degassed. A solution of n-BuLi in hexanes was added until the reaction mixture turned a 
persistent purple color. After the purple endpoint had been seen, an additional ammount of n-
BuLi in hexanes (2.27 M, 0.21 mL, 0.471 mmol) was added, the cooling bath was removed, and 
the reaction mixture was warmed to 0 °C. The solution of 4.112 was in THF (1 mL) was slurried 
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over NaH (60 % dispersion in mineral oil, ca. 6 mg, 0.15 mmol) before adding to the reaction 
mixture containing 4.147, and stirring continued for an additional 1 h. AcOH (0.13 mL, 136 mg, 
2.36 mmol) and de-ionized H2O (5 mL) were then added, and the mixture was extracted with 
EtOAc (3 x 10 mL). The combined organic extracts were dried (Na2SO4), filtered, and 
concentrated under reduced pressure. The crude oil was purified by flash chromatography eluting 
with a gradient of EtOAc/hexanes (1:4 → 1:2) to provide 145 mg (79%) of 4.151;    1H-NMR 
(600 MHz) δ 7.81 (d, J = 8.3 Hz, 2 H), 7.60 (d, J = 8.9 Hz, 2 H), 7.41 (d, J = 8.3 Hz, 1 H), 7.40 
(d, J = 8.3 Hz, 1 H), 7.39 (d, J = 8.8 Hz, 4 H), 7.31 (d, J = 9.0 Hz, 2 H), 6.90 (d, J = 9.7 Hz, 4 H), 
6.78 (s, 1 H), 6.69 (s, 1 H), 6.44 (s, 1 H), 6.43 (s, 1 H), 5.89 (d, J = 6.4 Hz, 2 H), 5.31 (dd, J = 
5.3, 6.8 Hz, 2 H), 5.18 (dq, J = 2.4, 11.4 Hz, 4 H), 5.10 (dd, J = 5.3, 8.3 Hz, 2 H), 3.82 (s, 3 H), 
3.81 (s, 6 H), 3.67 (s, 3 H), 3.66 (s, 3 H), 3.65 (s, 3 H), 3.61 (s, 3 H), 3.56 (s, 3 H), 3.53 (s, 3 H), 
3.52 (s, 3 H), 3.51 (s, 3 H), 3.50 (s, 3 H), 1.51 (s, 9 H), 1.03 (s, 9 H), 0.96 (s, 9 H), 0.90 (s, 9 H); 
13C-NMR (150 MHz) δ 159.5, 150.1, 150.0, 149.5, 149.4, 147.0, 146.3, 143.0, 142.9, 138.7, 
136.8, 136.7, 132.5, 131.0, 129.4, 128.8, 128.7, 126.3, 126.2, 117.1, 117.0, 116.6, 113.9, 109.9, 
109.8, 107.6, 107.5, 103.4, 99.8, 86.7, 83.8, 77.5, 71.6, 64.8, 57.6, 56.1, 55.9, 55.3, 53.2, 51.9, 
51.8, 26.9, 21.5, 21.0, 20.8;  IR (film) 3498 (O-H), 2937 (C-H), 2860 (C-H), 2353 (C≡C), 1732, 
1615, 1594, 1513, 1464, 1405, 1337, 1252, 1200, 1175, 1121, 1080, 1035, 1012, 938 cm-1; 
HRMS (ESI) m/z calc for NaC19H28O4Si
+ (M+Na), 795.3171; found, 795.3163. 
NMR assignments: 1H-NMR (600 MHz) δ 7.81 (d, J = 8.3 Hz, 2 H, C20-H), 7.60 (d, J = 
8.9 Hz, 2 H, C3-H), 7.41 (d, J = 8.3 Hz, 1 H, C1-H), 7.40 (d, J = 8.3 Hz, 1 H, C1-H), 7.39 (d, J = 
8.8 Hz, 4 H, C10-H), 7.31 (d, J = 9.0 Hz, 2 H, C4-H), 6.90 (d, J = 9.7 Hz, 4 H, C11-H), 6.78 (s, 1 
H, C29-H), 6.69 (s, 1 H, C29-H), 6.44 (s, 1 H, C32-H), 6.43 (s, 1 H, C32-H), 5.89 (d, J = 6.4 Hz, 
2 H, C26-H), 5.31 (dd, J = 5.3, 6.8 Hz, 2 H, C14-H), 5.18 (dq, J = 2.4, 11.4 Hz, 4 H, C8-H), 5.10 
(dd, J = 5.3, 8.3 Hz, 2 H, C14-H), 3.82 (s, 3 H, C33-H), 3.81 (s, 6 H, C33-H, C34-H), 3.67 (s, 3 
H, C34-H), 3.66 (s, 3 H, C13-H), 3.65 (s, 3 H, C13-H), 3.61 (s, 3 H, C21-H or C22-H), 3.56 (s, 3 
H, C21-H or C22-H), 3.53 (s, 3 H, C21-H or C22-H), 3.52 (s, 3 H, C21-H or C22-H), 3.51 (s, 3 
H, C15-H), 3.50 (s, 3 H, C15-H), 1.51 (s, 9 H, C36-H or C37-H), 1.03 (s, 9 H, C36-H or C37-H), 
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0.96 (s, 9 H, C36-H or C37-H), 0.90 (s, 9 H, C36-H or C37-H); 13C-NMR (150 MHz) δ 159.5 
(C12), 150.1 (C30), 150.0 (C30), 149.5 (C6), 149.4 (C6), 147.0 (C28), 146.3 (C5), 143.0 (C31), 
142.9 (C31), 138.7 (C16), 136.8 (C19), 136.7 (C19), 132.5 (C20), 131.0 (C2), 129.4 (C10), 
128.8 (C9), 128.7 (C9), 126.3 (C1), 126.2 (C1), 117.1 (C4), 117.0 (C4), 116.6 (C32), 113.9 
(C11), 109.9 (C27), 109.8 (C27), 107.6 (C17), 107.5 (C17), 103.4 (C29), 99.8 (C14), 86.7 (C24), 
83.8 (C25), 77.5 (C18), 71.6 (C8), 64.8 (C26), 57.6 (C15), 56.1 (C33), 55.9 (C33), 55.3 (C13), 
53.2 (C21 or C22), 51.9 (C21 or C22), 51.8 (C21 or C22), 26.9 (C37 or C38), 21.5 (C35 or C36), 



































yl)phenoxy)silyl)ethynyl)-6,7-dimethoxy-4H-benzo[d][1,3,2]dioxasiline. (SB-VII-295A).  
Isolated from the hydrolysis of 4.151 when contaminated with 4.153. Purified via flash 
chromatography eluting with a gradient of acetone/hexanes (1:10 → 3:10) to provide 96 mg (the 
named compound);    1H-NMR (600 MHz) δ 7.20 (s, 2 H), 7.06 (s, 2 H), 6.81 (s, 2 H), 6.47 (s, 2 
H), 5.94 (s, 2 H), 5.39 (app. t, J = 1.8 Hz, 2 H), 3.833 (s, 6 H), 3.832 (s, 6 H), 3.70 (s, 6 H), 3.69 
(s, 6 H), 3.40 (s, 3 H), 3.39 (s, 3 H), 2.54 (dd, J = 1.2, 2.4 Hz, 2 H), 1.121 (s, 9 H), 1.118 (s, 9 H), 
1.104 (s, 9 H), 1.101 (s, 9 H), 1.06 (s, 18 H), 0.98 (s, 18 H); 13C-NMR (150 MHz) δ 149.7, 
149.5, 147.45, 147.44, 146.9, 143.4, 143.2, 118.5, 115.8, 110.81, 110.79, 109.3, 108.35, 108.34, 
103.6, 102.93, 102.92, 85.60, 85.59, 82.1, 74.49, 74.48, 66.76, 66.75, 65.1, 56.23, 56.22, 56.14, 
56.11, 55.9, 55.7, 27.38, 27.36, 27.30, 27.28, 26.8, 26.7, 21.4, 21.1, 21.04, 21.02, 20.96;  IR 
(film) 3307, 2934 (C-H),  2255 (C≡C), 2174 (C≡C), 1614, 1505, 1470, 1404, 1364, 1327, 1262, 
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1213, 1124, 1077, 1014, 912 cm-1; HRMS (ESI) m/z calc for NaC39H58O8Si2
+ (M+Na), 
733.3562; found, 733.3562. 
NMR assignments: 1H-NMR (600 MHz) δ 7.20 (s, 2 H, C14-H), 7.06 (s, 2 H, C11-H), 
6.81 (s, 2 H, C3-H), 6.47 (s, 2 H, C6-H), 5.94 (s, 2 H, C2-H), 5.39 (app. t, J = 1.8 Hz, 2 H, C16-
H), 3.833 (s, 6 H, C19-H or C21-H), 3.832 (s, 6 H, C19-H or C21-H), 3.70 (s, 6 H, C20-H), 3.69 
(s, 6 H, C22-H), 3.40 (s, 3 H, C31-H), 3.39 (s, 3 H, C31-H), 2.54 (dd, J = 1.2, 2.4 Hz, 2 H, C18-
H), 1.121 (s, 9 H, C29-H or C30-H), 1.118 (s, 9 H, C29-H or C30-H), 1.104 (s, 9 H, C29-H or 
C30-H), 1.101 (s, 9 H, C29-H or C30-H), 1.06 (s, 18 H, C27-H or C28-H), 0.98 (s, 18 H, C27-H 
or C28-H); 13C-NMR (150 MHz) δ 149.7 (C4), 149.5 (C13), 147.45 (C10), 147.44 (C10), 146.9 
(C7), 143.4 (C12), 143.2 (C5), 118.5 (C15), 115.8 (C2), 110.81 (C11), 110.79 (C11), 109.3 (C3), 
108.35 (C8), 108.34 (C8), 103.6 (C6), 102.93 (C14), 102.92 (C14), 85.60 (C9), 85.59 (C9), 82.1 
(C18), 74.49 (C17), 74.48 (C17), 66.76 (C16), 66.75 (C16), 65.1 (C1), 56.23 (C19, C20, C21 or 
C22), 56.22 (C19, C20, C21 or C22), 56.14 (C19, C20, C21 or C22), 56.11 (C31), 55.9 (C19, 
C20, C21 or C22), 55.7 (C19, C20, C21 or C22), 27.38 (C29 or C30), 27.36, 27.30 (C29 or C30), 
27.28 (C29 or C30), 26.8 (C27 or C28), 26.7 (C27 or C28), 21.4 (C23 or C24), 21.1 (C25 or 
C26), 21.04 (C25 or C26), 21.02 (C25 or C26), 20.96 (C23 or C24). 
 
1-(2-((Di-tert-butyl((2,2-di-tert-butyl-6,7-dimethoxy-4H-benzo[d][1,3,2]dioxasilin-4-
yl)ethynyl)silyl)oxy)-4,5-dimethoxyphenyl)prop-2-yn-1-ol  (4.153). (SB-VIII-52A). By-
product isolated from the reaction of 4.110 with 4.147. Purified via flash chromatography eluting 
with a gradient of EtOAc/hexanes (1:4 → 1:2) to provide 90 mg (4.153);    1H-NMR (500 MHz) 
δ 7.22 (s, 2 H), 7.15 (s, 2 H), 6.84 (s, 2 H), 6.51 (s, 2 H), 5.98 (s, 2 H), 5.82 (bs, 2 H), 3.869 (s, 6 
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H), 3.867 (s, 6 H), 3.74 (s, 6 H), 3.73 (s, 6 H), 2.60 (d, J = 2.0 Hz, 2 H), 1.17 (s, 9 H), 1.13 (s, 9 
H), 1.09 (s, 9 H), 1.02 (s, 9 H); 13C-NMR (125 MHz) δ 149.8, 149.5, 147.1, 146.9, 143.5, 143.3, 
120.6, 115.8, 110.4, 109.3, 108.5, 103.6, 103.3, 85.5, 83.7, 73.9, 65.1, 59.3, 56.3, 56.2, 55.9, 
55.8, 27.44, 27.41, 26.9, 26.8, 21.5, 21.2, 21.04, 20.99;  IR (film) 3498 (O-H), 3309, 2935 (C-H), 
2860, 1614, 1512, 1469, 1449, 1405, 1261, 1204, 1122, 1087, 1013 cm-1; HRMS (ESI) m/z calc 
for NaC38H56O8Si2
+ (M+Na), 719.3406; found, 719.3407. 
NMR assignments: 1H-NMR (500 MHz) δ 7.22 (s, 2 H, C14-H), 7.15 (s, 2 H, C10-H), 
6.84 (s, 2 H, C3-H), 6.51 (s, 2 H, C6-H), 5.98 (s, 2 H, C1-H), 5.82 (bs, 2 H, C16-H), 3.869 (s, 6 
H, C19-H, C20-H, C21-H or C22-H), 3.867 (s, 6 H, C19-H, C20-H, C21-H or C22-H), 3.74 (s, 6 
H, C19-H, C20-H, C21-H or C22-H), 3.73 (s, 6 H, C19-H, C20-H, C21-H or C22-H), 2.60 (d, J 
= 2.0 Hz, 2 H, C18-H), 1.17 (s, 9 H, C27-H, C28-H, C29-H or C30-H), 1.13 (s, 9 H, C27-H, 
C28-H, C29-H or C30-H), 1.09 (s, 9 H, C27-H, C28-H, C29-H or C30-H), 1.02 (s, 9 H, C27-H, 
C28-H, C29-H or C30-H); 13C-NMR (125 MHz) δ 149.8 (C4), 149.5 (C13), 147.1 (C10), 146.9 
(C7), 143.5 (C12), 143.3 (C5), 120.6 (C15), 115.8 (C2), 110.4 (C11), 109.3 (C3), 108.5 (C8), 
103.6 (C6), 103.3 (C14), 85.5 (C9), 83.7 (C18), 73.9 (C17), 65.1 (C1), 59.3 (C16), 56.3 (C19, 
C20, C21 or C22), 56.2 (C19, C20, C21 or C22), 55.9 (C19, C20, C21 or C22), 55.8 (C19, C20, 
C21 or C22), 27.44 (C29, or C30), 27.41 (C29, or C30), 26.9 (C27, or C28), 26.8 (C27, or C28), 










(4.152). (SB-VII-38). H3PO4 (85%, 7 mg, 4 µL, 0.0697 mmol) and H2O (28 mg, 28 µL, 1.2546 
mmol) was added to a slurry of silica (280 mg) in CH2Cl2 (2.1 mL). The mixture was stirred 
vigorously for 1 h, whereupon 4.151 (54 mg, 0.0697 mmol), and CH2Cl2 (1 mL) were added and 
the mixture was stirred for an additional 1 h. Et3N (35 mg, 49 µL, 0.3485 mmol) was then added, 
and the mixture was filtered through a silica plug (~10 mL). The plug was eluted with 
EtOAc/hexanes (1:1, 1 x 100 mL) and the eluant was concentrated under reduced pressure (bath 
temp 30 °C) to provide 48 mg (95%) of 4.152 as an orange oil. The material was unstable, and so 
it was used directly in the next step withut further purification: 1H-NMR (600 MHz) δ 8.04 (d, J 
= 8.3 Hz, 1 H), 8.03 (d, J = 8.5 Hz, 1 H), 7.66 (d, J = 9.0 Hz, 1 H), 7.65 (d, J = 9.0 Hz, 1 H), 7.63 
(d, J = 8.2 Hz, 1 H), 7.61 (d, J = 8.2 Hz, 1 H), 7.41-7.37 (comp, 6 H), 6.91 (d, J = 8.7 Hz, 4 H), 
6.72 (s, 1 H), 6.68 (s, 1 H), 6.46 (s, 1 H), 6.44 (s, 1 H), 5.90 (d, J = 0.7 Hz, 1 H), 5.87 (d, J = 0.7 
Hz, 1 H), 5.40-5.36 (m, 4 H), 5.20 (d, J = 3.2 Hz, 4 H), 3.84 (s, 3 H), 3.82 (s, 3 H), 3.81 (s, 6 H), 
3.75 (s, 3 H), 3.73 (s, 3 H), 3.54 (s, 3 H), 3.52 (s, 3 H), 1.04 (s, 9 H), 1.03 (s, 9 H), 0.99 (s, 9 H), 
0.97 (s, 9 H); 13C-NMR (150 MHz) δ 182.9, 160.4, 160.3, 159.6, 151.6, 149.8, 149.7, 147.0, 
146.9, 143.2, 142.1, 140.4, 138.6, 130.9, 129.3, 128.3, 126.1, 124.1, 118.1, 116.6, 116.4, 116.3, 
114.0, 109.5, 103.6, 103.5, 99.6, 99.5, 90.0, 89.9, 85.5, 82.2, 82.1, 71.5, 64.7, 57.7, 56.3, 56.2, 
56.0, 55.9, 55.3, 27.0, 26.9, 26.8, 21.5, 20.8;  IR (neat) 3435 (O-H), 2935 (C-H), 2860 (C-H), 
1765 (C=O), 1615, 1587, 1512, 1465, 1406, 1336, 1251, 1216, 1200, 1175, 1120, 1080, 1034, 
941 cm-1; HRMS (ESI) m/z calc for NaC41H46O10Si
+ (M+Na), 749.2752; found, 749.2739. 
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NMR assignments: 1H-NMR (600 MHz) δ 8.04 (d, J = 8.3 Hz, 1 H, (C20-H), 8.03 (d, J 
= 8.5 Hz, 1 H, C20-H), 7.66 (d, J = 9.0 Hz, 1 H, C3-H), 7.65 (d, J = 9.0 Hz, 1 H, C3-H), 7.63 (d, 
J = 8.2 Hz, 1 H, C1-H), 7.61 (d, J = 8.2 Hz, 1 H, C1-H), 7.41-7.37 (comp, 6 H, C10-H, C4-H), 
6.91 (d, J = 8.7 Hz, 4 H, C11-H), 6.72 (s, 1 H, C27-H), 6.68 (s, 1 H, C27-H), 6.46 (s, 1 H, C30-
H), 6.44 (s, 1 H, C30-H), 5.90 (d, J = 0.7 Hz, 1 H, C24-H), 5.87 (d, J = 0.7 Hz, 1 H, C24-H), 
5.40-5.36 (m, 4 H, C14-H), 5.20 (d, J = 3.2 Hz, 4 H, C8-H), 3.84 (s, 3 H, C31-H), 3.82 (s, 3 H, 
C31-H), 3.81 (s, 6 H, C32-H), 3.75 (s, 3 H, C13-H), 3.73 (s, 3 H, C13-H), 3.54 (s, 3 H, C15-H), 
3.52 (s, 3 H, C15-H), 1.04 (s, 9 H, C35-H or C36-H), 1.03 (s, 9 H, C35-H or C36-H), 0.99 (s, 9 
H, C35-H or C36-H), 0.97 (s, 9 H, C35-H or C36-H); 13C-NMR (150 MHz) δ 182.9 (C17), 160.4 
(C19), 160.3 (C19), 159.6 (C12), 151.6 (C6), 149.8 (C28), 149.7 (C28), 147.0 (C26), 146.9 
(C26), 143.2 (C29), 142.1 (C5), 140.4 (C20), 138.6 (C16), 130.9 (C2), 129.3 (C10), 128.3 (C9), 
126.1 (C7), 124.1 (C1), 118.1 (C4), 116.6 (C3), 116.4 (C30), 116.3 (C30), 114.0 (C11), 109.5 
(C25), 103.6 (C27), 103.5 (C27), 99.6 (C14), 99.5 (C14), 90.0 (C22), 89.9 (C22), 85.5 (C23), 
82.2 (C18), 82.1 (C18), 71.5 (C8), 64.7 (C24), 57.7 (C15), 56.3 (C31), 56.2 (C31), 56.0 (C32), 
55.9 (C32), 55.3 (C13), 27.0 (C35 or C36), 26.9 (C35 or C36), 26.8 (C35 or C36), 21.5 (C33 or 









235). A solution of 4.152   (52 mg, 0.072 mmol) and Cu(OAc)2•H2O (57 mg, 0.286 mmol) in 
MeOH (3.6 mL) was heated to 70 °C in a sealed tube for 45 min. The reaction mixture was 
cooled to room temperature and then diluted with Et2O (5 mL), washed with de-ionized H2O (2 x 
5 mL) and the combined organic extracts were dried (Na2SO4), filtered, and concentrated under 
reduced pressure and the crude oil was purified by flash chromatography eluting with a gradient 
of EtOAc/hexanes (7:20 → 1:2) to provide 33 mg (63%) of 4.159: 1H-NMR (600 MHz) δ 8.14 
(d, J = 8.6 Hz, 1 H), 7.86 (d, J = 8.7 Hz, 1 H), 7.61 (d, J = 9.1 Hz, 1 H), 7.57 (d, J = 9.0 Hz, 1 H), 
7.38 (d, J = 8.7 Hz, 2 H), 6.91 (d, J = 8.7 Hz, 2 H), 6.78 (s, 1 H), 6.52 (s, 1 H), 6.11 (s, 1 H), 5.15 
(s, 4 H), 4.04 (s, 3 H), 3.87 (s, 3 H), 3.82 (s, 3 H), 3.82 (s, 3 H), 3.46 (s, 3 H), 1.08 (s, 9 H), 1.03 
(s, 9 H); 13C-NMR (150 MHz) δ 176.8, 170.0, 159.7, 150.1, 149.2, 147.1, 143.5, 140.1, 132.4, 
131.1, 130.6, 129.6, 129.3, 128.4, 126.1, 125.2, 124.4, 120.0, 114.5, 114.0, 109.2, 103.8, 98.8, 
93.6, 83.7, 71.8, 64.9, 57.9, 56.4, 56.0, 55.3, 52.7, 26.9, 26.8, 21.6, 20.9;   IR (film) 2935 (C-H), 
2860 (C-H), 2175 (C≡C), 1733 (C=O), 1656, 1613, 1513, 1444, 1405, 1367, 1333, 1250, 1213, 
1152, 1014, 908 cm-1; HRMS (ESI) m/z calc for NaC42H48O11Si
+ (M+Na), 779.2858; found, 
779.2840. 
NMR assignments: 1H-NMR (600 MHz) δ 8.14 (d, J = 8.6 Hz, 1 H, C20-H), 7.86 (d, J = 
8.7 Hz, 1 H, C1-H), 7.61 (d, J = 9.1 Hz, 1 H, C3-H), 7.57 (d, J = 9.0 Hz, 1 H, C4-H), 7.38 (d, J = 
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8.7 Hz, 2 H, C10-H), 6.91 (d, J = 8.7 Hz, 2 H, C11-H), 6.78 (s, 1 H, C30-H), 6.52 (s, 1 H, C27-
H), 6.11 (s, 1 H, C24-H), 5.15 (s, 4 H, C8-H, C14-H), 4.04 (s, 3 H, C21-H), 3.87 (s, 3 H, C31-
H), 3.82 (s, 3 H, C32-H), 3.82 (s, 3 H, C13-H), 3.46 (s, 3 H, C15-H), 1.08 (s, 9 H, C36-H or 
C35-H), 1.03 (s, 9 H, C36-H or C35-H); 13C-NMR (150 MHz) δ 176.8 (C18), 170.0 (C17), 159.7 
(C12), 150.1 (C28), 149.2 (C5), 147.1 (C26), 143.5 (C29), 140.1 (C6), 132.4 (C2), 131.1 (C16), 
130.6 (C19), 129.6 (C10), 129.3 (C1), 128.4 (C9), 126.1 (C7), 125.2 (C20), 124.4 (C3), 120.0 
(C4), 114.5 (C25), 114.0 (C11), 109.2 (C30), 103.8 (C27), 98.8 (C14), 93.6 (C22), 83.7 (C23), 
71.8 (C8), 64.9 (C24), 57.9 (C15), 56.4 (C32), 56.0 (C31), 55.3 (C13), 52.7 (C21), 26.9 (C35 or 













































methoxybenzyl)oxy)-5-(methoxymethoxy)phenanthrene-1,4-dione  (4.154). (SB-VII-43).  
Method A: A solution of crude 4.152   (35 mg, 0.0472 mmol) in tert-amyl alcohol (ppm 
H2O ≤ 500, 10 mL) was heated to 100 °C for 30 min. The mixture was cooled to room 
temperature, and the solvent was removed under reduced pressure and the crude oil was purified 
by flash chromatography eluting with a gradient of EtOAc/hexanes (3:20 → 1:2) to provide 10 
mg (29%) of 4.154 as a red solid and 15 mg (43%) of 4.161. 
Method B: A solution of crude 4.152   (35 mg, 0.0472 mmol) in MTBE (14 mL) was 
heated to 60 °C for 1 h. The reaction mixture was cooled to room temperature, the solvent was 
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removed under reduced pressure and the crude oil was purified by flash chromatography eluting 
with a gradient of acetone/hexanes (1:10 → 3:10) to provide 61 mg (37%) of 4.154 as a red solid 
and 48 mg (29%) of 4.161: 1H-NMR (600 MHz) δ 8.00 (d, J = 8.5 Hz, 1 H), 7.97 (d, J = 8.5 Hz, 
1 H), 7.63 (d, J = 8.9 Hz, 1 H), 7.48 (d, J = 8.9 Hz, 1 H), 7.40 (d, J = 8.7 Hz, 2 H), 6.91 (d, J = 
8.7 Hz, 2 H), 6.73 (s, 1 H), 6.56 (s, 1 H), 6.47 (s, 1 H), 6.37 (s, 1 H), 5.29-5.16 (comp, 4 H), 3.87 
(s, 3 H), 3.81 (s, 3 H), 3.66 (s, 3 H), 3.31 (s, 3 H), 1.09 (s, 9 H), 1.02 (s, 9 H); 13C-NMR (150 
MHz) δ 186.9, 185.4, 159.6, 154.8, 150.9, 149.8, 148.3, 143.3, 142.8, 133.6, 133.1, 133.0, 132.9, 
132.0, 129.4, 128.5, 125.3, 125.0, 120.1, 119.6, 117.8, 114.0, 110.6, 103.7, 98.9, 71.9, 69.4, 57.6, 
56.5, 56.0, 55.3, 27.1, 27.1, 21.9, 20.8;   IR (film) 2934 (C-H), 2859 (C-H), 1662 (C=O), 1614, 
1588, 1513, 1448, 1407, 1336, 1299, 1251, 1199, 1135, 1058, 919 cm-1; HRMS (ESI) m/z calc 
for NaC41H46O10Si
+ (M+Na), 749.2752; found, 749.2747. 
NMR assignments: 1H-NMR (600 MHz) δ 8.00 (d, J = 8.5 Hz, 1 H, C1-H), 7.97 (d, J = 
8.5 Hz, 1 H, C20-H), 7.63 (d, J = 8.9 Hz, 1 H, C3-H), 7.48 (d, J = 8.9 Hz, 1 H, C4-H), 7.40 (d, J 
= 8.7 Hz, 2 H, C10-H), 6.91 (d, J = 8.7 Hz, 2 H, C11-H), 6.73 (s, 1 H, C21-H), 6.56 (s, 1 H, C25-
H), 6.47 (s, 1 H, C23-H), 6.37 (s, 1 H, C28-H), 5.29-5.16 (comp, 4 H, C8-H, C14-H), 3.87 (s, 3 
H, C30-H), 3.81 (s, 3 H, C13-H), 3.66 (s, 3 H, C31-H), 3.31 (s, 3 H, C15-H), 1.09 (s, 9 H, C35-H 
or C35-H), 1.02 (s, 9 H, C35-H or C35-H); 13C-NMR (150 MHz) δ 186.9 (C17), 185.4 (C18), 
159.6 (C12), 154.8 (C22), 150.9 (C5), 149.8 (C26), 148.3 (C25), 143.3 (C27), 142.8 (C6), 133.6 
(C1), 133.1 (C16), 133.0 (C19), 132.9 (C20), 132.0 (C21), 129.4 (C10), 128.5 (C9), 125.3 (C2), 
125.0 (C3), 120.1 (C4), 119.6 (C7), 117.8 (C29), 114.0 (C11), 110.6 (C28), 103.7 (C25), 98.9 
(C14), 71.9 (C8), 69.4 (C23), 57.6 (C15), 56.5 (C31), 56.0 (C30), 55.3 (C13), 27.1 (C34 or C35), 








1H-cyclopenta[a]naphthalene-1,3(2H)-dione  (4.161). (SB-VI-252). Isolated from the 
rearrangement of 4.152 to 4.154. Purified via flash chromatography eluting with a gradient of 
EtOAc/hexanes (3:20 → 1:2): 1H-NMR (600 MHz) δ (major isomer) 8.18 (d, J = 8.2 Hz, 1 H), 
7.88 (d, J = 8.2 Hz, 1 H), 7.73 (d, J = 8.9 Hz, 1 H), 7.55 (d, J = 8.9 Hz, 1 H), 7.41 (d, J = 8.7 Hz, 
2 H), 7.19 (d, J = 9.5 Hz, 1 H), 7.01 (d, J = 9.5 Hz, 1 H), 6.91 (d, J = 8.7 Hz, 2 H), 6.53 (s, 1 H), 
6.52 (s, 1 H), 5.30-5.22 (comp, 4 H), 3.85 (s, 3 H), 3.82 (s, 3 H), 3.67 (s, 3 H), 3.49 (s, 3 H), 1.11 
(s, 9 H), 1.09 (s, 9 H); (minor isomer) 8.17 (d, J = 8.2 Hz, 1 H), 7.86 (d, J = 8.2 Hz, 1 H), 7.74 
(d, J = 8.9 Hz, 1 H), 7.54 (d, J = 8.9 Hz, 1 H), 7.42 (d, J = 8.7 Hz, 2 H), 7.14 (d, J = 9.5 Hz, 1 H), 
7.05 (d, J = 9.5 Hz, 1 H), 6.92 (d, J = 8.7 Hz, 2 H), 6.58 (s, 1 H), 6.53 (s, 1 H), 5.30-5.22 (comp, 
4 H), 3.85 (s, 3 H), 3.82 (s, 3 H), 3.64 (s, 3 H), 3.48 (s, 3 H), 1.11 (s, 9 H), 1.09 (s, 9 H); 13C-
NMR (150 MHz) δ (major isomer) 190.1, 186.6, 159.6, 152.5, 149.9, 147.8, 146.5, 145.3, 143.4, 
142.9, 137.9, 133.8, 130.0, 129.4, 128.3, 126.2, 125.0, 119.7, 116.4, 116.1, 114.0, 109.8, 104.0, 
99.9, 71.7, 68.5, 57.9, 56.5, 56.0, 55.3, 27.2, 27.0, 21.9, 20.3; (minor isomer) 189.2, 188.0, 
159.6, 152.3, 149.9, 147.8, 145.8, 144.0, 143.4, 143.1, 137.9, 137.8, 130.1, 129.4, 129.3, 126.2, 
124.7, 119.8, 116.4, 115.8, 114.0, 110.1, 103.9, 99.8, 71.7, 68.3, 57.9, 56.5, 56.0, 55.3, 27.2, 
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27.0, 21.9, 20.3;   IR (film) 2934 (C-H), 2860 (C-H), 1731 (C=O), 1694 (C=O), 1613, 1586, 
1513, 1454, 1405, 1250, 1219, 1200, 1155, 1072, 928 cm-1; HRMS (ESI) m/z calc for 
NaC41H46O10Si
+ (M+Na), 749.2752; found, 749.2740. 
NMR assignments: 1H-NMR (600 MHz) δ (major isomer) 8.18 (d, J = 8.2 Hz, 1 H, C1-
H), 7.88 (d, J = 8.2 Hz, 1 H, C20-H), 7.73 (d, J = 8.9 Hz, 1 H, C4-H), 7.55 (d, J = 8.9 Hz, 1 H, 
C3-H), 7.41 (d, J = 8.7 Hz, 2 H, C10-H), 7.19 (d, J = 9.5 Hz, 1 H, C22-H), 7.01 (d, J = 9.5 Hz, 1 
H, C23-H), 6.91 (d, J = 8.7 Hz, 2 H, C11-H), 6.53 (s, 1 H, C25-H), 6.52 (s, 1 H, C28-H), 5.30-
5.22 (comp, 4 H, C8-H, C14-H), 3.85 (s, 3 H, C30-H), 3.82 (s, 3 H, C13-H), 3.67 (s, 3 H, C31-
H), 3.49 (s, 3 H, C15-H), 1.11 (s, 9 H, C34-H or C25-H), 1.09 (s, 9 H, C34-H or C35-H); (minor 
isomer) 8.17 (d, J = 8.2 Hz, 1 H, C1-H), 7.86 (d, J = 8.2 Hz, 1 H, C20-H), 7.74 (d, J = 8.9 Hz, 1 
H, C4-H), 7.54 (d, J = 8.9 Hz, 1 H, C3-H), 7.42 (d, J = 8.7 Hz, 2 H, C10-H), 7.14 (d, J = 9.5 Hz, 
1 H, C22-H), 7.05 (d, J = 9.5 Hz, 1 H, C23-H), 6.92 (d, J = 8.7 Hz, 2 H, C11-H), 6.58 (s, 1 H, 
C25-H), 6.53 (s, 1 H, C28-H), 5.30-5.22 (comp, 4 H, C8-H, C14-H), 3.85 (s, 3 H, C30-H), 3.82 
(s, 3 H, C13-H), 3.64 (s, 3 H, C31-H), 3.48 (s, 3 H, C15-H), 1.11 (s, 9 H, C34-H or C25-H), 1.09 
(s, 9 H, C34-H or C25-H); 13C-NMR (150 MHz) δ (major isomer) 190.1 (C18), 186.6 (C17), 
159.6 (C12), 152.5 (C5), 149.9 (C6), 147.8 (C21), 146.5 (C22), 145.3 (C24), 143.4 (C26), 142.9 
(C27), 137.9 (C1), 133.8 (C2), 130.0 (C29), 129.4 (C10), 128.3 (C19), 126.2 (C4), 125.0 (C16), 
119.7 (C3), 116.4 (C20), 116.1 (C7), 114.0 (C11), 109.8 (C28), 104.0 (C25), 99.9 (C14), 71.7 
(C8), 68.5 (C23), 57.9 (C15), 56.5 (C31), 56.0 (C13), 55.3 (C30), 27.2 (C32 or C33), 27.0 (C32 
or C33), 21.9 (C34 or C35), 20.3 (C34 or C35); (minor isomer) 189.2 (C18), 188.0 (C17), 159.6 
(C12), 152.3 (C5), 149.9 (C6), 147.8 (C21), 145.8 (C22), 144.0 (C24), 143.4 (C26), 143.1 (C27), 
137.9 (C1), 137.8 (C2), 130.1 (C29), 129.4 (C10), 129.3 (C19), 126.2 (C4), 124.7 (C16), 119.8 
(C3), 116.4 (C20), 115.8 (C7), 114.0 (C11), 110.1 (C25), 103.9 (C28), 99.8 (C14), 71.7 (C8), 
68.3 (C23), 57.9 (C15), 56.5 (C31), 56.0 (C13), 55.3 (C30), 27.2 (C32 or C33), 27.0 (C32 or 





cyclopenta[a]naphthalene-1,3(2H)-dione  (4.162). (SB-VII-276B3). Isolated as a mixture (1:1) 
of diastereomers from the rearrangement of 4.152 to 4.154. Purified via flash chromatography 
eluting with a gradient of EtOAc/hexanes (3:20 → 1:2): 1H-NMR (600 MHz) δ 12.11 (s, 1 H), 
8.163 (d, J = 9.0 Hz, 0.5 H), 8.161 (d, J = 8.4 Hz, 0.5 H), 7.73 (d, J = 8.4 Hz, 0.5 H), 7.69 (d, J = 
8.4 Hz, 0.5 H), 7.49 (d, J = 8.4 Hz, 0.5 H), 7.48 (d, J = 8.4 Hz, 0.5 H), 7.44-7.40 (comp, 3 H), 
6.894 (d, J = 8.4 Hz, 1 H), 6.890 (d, J = 9.0 Hz, 1 H), 6.52 (s, 0.5 H), 6.51 (s, 0.5 H), 6.37 (s, 0.5 
H), 6.35 (s, 0.5 H), 5.70 (d, J = 3.6 Hz, 0.5 H), 5.67 (d, J = 3.6 Hz, 0.5 H), 5.274 (s, 1 H), 5.269 
(s, 1 H), 3.840 (s, 1.5 H), 3.837 (s, 1.5 H), 3.79 (s, 3 H), 3.75 (s, 1.5 H), 3.72 (s, 1.5 H), 3.63 (d, J 
= 8.4 Hz, 0.5 H), 3.61 (d, J = 5.6 Hz, 0.5 H), 2.34 (comp, 1 H), 1.94 (comp, 1 H), 1.35 (comp, 1 
H), 1.32 (s, 3 H), 1.11 (s, 9 H), 1.07 (s, 3 H); 13C-NMR (150 MHz) δ 206.2, 206.0, 198.5, 198.2, 
159.50, 159.48, 149.5, 147.66, 147.65, 146.59, 146.54, 145.2, 145.1, 144.9, 144.6, 142.74, 
142.72, 140.2, 140.1, 139.6, 139.0, 133.4, 133.3, 129.2, 128.9, 128.8, 121.3, 120.75, 120.71, 
120.25, 120.20, 119.9, 119.8, 115.7, 115.6, 114.04, 114.00, 109.63, 109.62, 103.41, 103.39, 
74.43, 74.39, 71.7, 71.6, 56.7, 56.6, 55.9, 55.3, 52.7, 52.4, 44.9, 44.8, 38.4, 38.3, 26.2, 26.1, 26.0, 
25.90, 23.0, 18.95, 18.94;   IR (film) 2936 (C-H), 2861 (C-H), 1727 (C=O), 1671 (C=O), 1615, 
1588, 1514, 1466, 1449, 1413, 1271, 1251, 1222, 1198, 1174, 1125, 1033, 1014, 912 cm-1; 
HRMS (ESI) m/z calc for NaC39H42O9Si+ (M+Na), 705.2490; found, 705.2488. 
NMR assignments: 1H-NMR (600 MHz) δ 12.11 (s, 1 H, O-H), 8.163 (d, J = 9.0 Hz, 0.5 
H, C1-H), 8.161 (d, J = 8.4 Hz, 0.5 H, C1-H), 7.73 (d, J = 8.4 Hz, 0.5 H, C16-H), 7.69 (d, J = 8.4 
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Hz, 0.5 H, C16-H), 7.49 (d, J = 8.4 Hz, 0.5 H, C3-H), 7.48 (d, J = 8.4 Hz, 0.5 H, C3-H), 7.44-
7.40 (comp, 3 H, C4-H, C10-H), 6.894 (d, J = 8.4 Hz, 1 H, C11-H), 6.890 (d, J = 9.0 Hz, 1 H, 
C11-H), 6.52 (s, 0.5 H, C27-H), 6.51 (s, 0.5 H, C27-H), 6.37 (s, 0.5 H, C24-H), 6.35 (s, 0.5 H, 
C24-H), 5.70 (d, J = 3.6 Hz, 0.5 H, C21-H), 5.67 (d, J = 3.6 Hz, 0.5 H, C21-H), 5.274 (s, 1 H, 
C8-H), 5.269 (s, 1 H, C8-H), 3.840 (s, 1.5 H, C28-H), 3.837 (s, 1.5 H, C28-H), 3.79 (s, 3 H, C13-
H), 3.75 (s, 1.5 H, C29-H), 3.72 (s, 1.5 H, C29-H), 3.63 (d, J = 8.4 Hz, 0.5 H, C19-H), 3.61 (d, J 
= 5.6 Hz, 0.5 H, C19-H), 2.34 (comp, 1 H, C20-H), 1.94 (comp, 1 H, C34-H), 1.35 (comp, 1 H, 
C34-H), 1.32 (s, 3 H, C33-H), 1.11 (s, 9 H, C18-H), 1.07 (s, 3 H, C33-H); 13C-NMR (150 MHz) 
δ 206.2 (C17), 206.0 (C17), 198.5 (C18), 198.2 (C18), 159.50 (C12), 159.48 (C12), 149.5 (C25), 
147.66 (C23), 147.65 (C23), 146.59 (C5), 146.54 (C5), 145.2 (C6), 145.1 (C6), 144.9 (C2), 
144.6 (C2), 142.74 (C26), 142.72 (C26), 140.2 (C1), 140.1 (C1), 139.6 (C14), 139.0 (C14), 
133.4 (C15), 133.3 (C15), 129.2 (C10), 128.9 (C9), 128.8 (C9), 121.3 (C3), 120.75 (C3), 120.71 
(C4), 120.25 (C4), 120.20 (C4), 119.9 (C22), 119.8 (C22), 115.7 (C16), 115.6 (C16), 114.04 
(C16), 114.00 (C16), 109.63 (C11), 109.62 (C11), 103.41 (C24), 103.39 (C24), 74.43 (C27), 
74.39 (C27), 71.7 (C8), 71.6 (C8), 56.7 (C29), 56.6 (C29), 55.9 (C28), 55.3 (C13), 52.7 (C19), 
52.4 (C19), 44.9 (C20), 44.8 (C20), 38.4 (C34), 38.3 (C34), 26.2 (C33), 26.1 (C33), 26.0 (C33), 











methoxybenzyl)oxy)-5-(methoxymethoxy)phenanthrene-1,4-diol  (4.160). (SB-VII-276B2). 
Isolated from the rearrangement of 4.152 to 4.154. Purified via flash chromatography eluting 
with a gradient of EtOAc/hexanes (3:20 → 1:2): 1H-NMR (500 MHz) δ 9.79 (s, 1 H), 8.03 (d, J 
= 9.0 Hz, 1 H), 7.68 (d, J = 9.0 Hz, 1 H), 7.57 (d, J = 9.5 Hz, 1 H), 7.41 (comp, 3 H), 7.16 (s, 1 
H), 6.94-6.92 (comp, 3 H), 6.58 (s, 1 H), 5.98 (s, 1 H), 5.23 (d, J = 11.5 Hz, 1 H), 5.18 (d, J = 
11.5 Hz, 1 H), 5.08 (d, J = 6.0 Hz, 1 H), 4.98 (d, J = 6.0 Hz, 1 H), 3.86 (s, 3 H), 3.83 (s, 3 H), 
3.45 (s, 3 H), 3.32 (s, 3 H), 1.18 (s, 9 H), 1.07 (s, 9 H); 13C-NMR (125 MHz) δ 159.6, 150.3, 
149.3, 148.8, 145.7, 144.6, 142.7, 140.4, 129.3, 128.6, 128.5, 125.9, 125.7, 125.5, 124.5, 124.0, 
121.5, 119.5, 119.0, 115.1, 114.0, 112.6, 111.6, 103.4, 100.9, 71.8, 69.8, 58.4, 56.6, 55.9, 55.3, 
27.4, 27.2, 21.8, 21.3;   IR (film) 3443 (O-H), 2936 (C-H), 3209 (O-H), 2935 (C-H), 2859 (C-H), 
1703, 1662, 1614, 1513, 1468, 1450, 1405, 1364, 1336, 1251, 1200, 1174, 1123, 1039, 1013, 907 
cm-1; HRMS (ESI) m/z calc for NaC41H46O10Si
+ (M+Na), 749.2752; found, 749.2755. 
NMR assignments: 1H-NMR (500 MHz) δ 9.79 (s, 1 H, O36-H), 8.03 (d, J = 9.0 Hz, 1 
H, C20-H), 7.68 (d, J = 9.0 Hz, 1 H, C3-H), 7.57 (d, J = 9.5 Hz, 1 H, C1-H), 7.41 (comp, 3 H, 
C4-H, C10-H), 7.16 (s, 1 H, C21-H), 6.94-6.92 (comp, 3 H, C11-H, C23-H), 6.58 (s, 1 H, C28-
H), 5.98 (s, 1 H, C25-H), 5.23 (d, J = 11.5 Hz, 1 H, C8-H), 5.18 (d, J = 11.5 Hz, 1 H, C8-H), 
5.08 (d, J = 6.0 Hz, 1 H, C14-H), 4.98 (d, J = 6.0 Hz, 1 H, C14-H), 3.86 (s, 3 H, C30-H), 3.83 (s, 
3 H, C13-H), 3.45 (s, 3 H, C31-H), 3.32 (s, 3 H, C15-H), 1.18 (s, 9 H, C34-H or C35-H), 1.07 (s, 
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9 H, C34-H or C35-H); 13C-NMR (125 MHz) δ 159.6 (C12), 150.3 (C5), 149.3 (C26), 148.8 
(C24), 145.7 (C17), 144.6 (C18), 142.7 (C27), 140.4 (C6), 129.3 (C10), 128.6 (C9), 128.5 (C22), 
125.9 (C1), 125.7 (C3), 125.5 (C7), 124.5 (C2), 124.0 (C19), 121.5 (C29), 119.5 (C20), 119.0 
(C16), 115.1 (C4), 114.0 (C11), 112.6 (C21), 111.6 (C25), 103.4 (C28), 100.9 (C14), 71.8 (C8), 
69.8 (C23), 58.4 (C15), 56.6 (C31), 55.9 (C30), 55.3 (C13), 27.4 (C34 or C35), 27.2 (C34 or 
C35), 21.8 (C32 or C33), 21.3 (C32 or C33). 
 
 
 (4.199/4.200). (SB-VII-278A and SB-VII-278B). 85% H3PO4 (2 µL, 3 mg, 0.0325 
mmol) was added to a slurry of silica (129 mg) in CH2Cl2 (1 mL) followed by H2O (13 µL) and 
the slurry was stirred vigorously for 1 h. 4.151 (25 mg, 0.0325 mmol) was added, and the 
reaction mixture was stirred for 1 h whereupon Et3N (16 mg, 22 µL, 0.161 mmol) was added and 
the slurry was filtered through a silica plug. The plug was eluted with EtOAc/hexanes (1:1, 1 x 
10 mL) and the eluent was concentrated under reduced pressure (bath temp 30 °C) to provide the 
crude 4.152 as a orange oil. 
The crude 4.152 was dissolved in C6D6 (~ 1 mL) followed by Fe2(CO)9 (9 mg, 0.244 
mmol) and the reaction mixture was sonicated for 2 h. The reaction was monitored by 1H-NMR 
and the fraction was determined to be complete after 24 h at room temperature. The mixture was 
concentrated under reduced pressure (bath temp 30 °C) and the crude oil was purified by flash 
chromatography eluting with a gradient of acetone/hexanes (1:10 → 1:2) to provide a mixture of 
4.199 and 4.200 (~100%). 
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Compound A: 1H-NMR (500 MHz) δ 8.74 (s, 1 H), 8.64 (s, 1 H), 7.45 (d, J = 8.5 Hz, 2 
H), 7.36 (d, J = 8.5 Hz, 1 H), 7.31 (d, J = 9.0 Hz, 2 H), 7.25 (d, J = 9.0 Hz, 1 H), 7.21 (d, J = 9.5 
Hz, 1 H), 6.96 (d, J = 8.5 Hz, 2 H), 6.61 (s, 1 H), 5.72 (d, J = 5.0 Hz, 1 H), 5.49 (d, J = 5.0 Hz, 1 
H), 5.19 (s, 2 H), 3.99 (s, 3 H), 3.96 (s, 3 H), 3.86 (s, 3 H), 3.54 (s, 3 H), 1.26 (s, 9 H), 1.06 (s, 9 
H); 13C-NMR (125 MHz) δ 208.4, 166.5, 159.7, 157.4, 155.2, 154.3, 151.0, 143.9, 142.8, 142.1, 
129.4, 129.3, 128.9, 128.7, 128.5, 128.2, 124.8, 120.0, 118.8, 117.2, 116.2, 114.1, 112.3, 110.4, 
105.3, 104.4, 98.1, 71.4, 58.2, 56.2, 56.1, 53.3, 27.6, 27.5, 21.01, 20.62;   IR (film) 3396 (O-H), 
2935 (C-H), 2859 (C-H), 2062 (C=O), 2006 (C=O), 1614, 1559, 1511, 1467, 1406, 1386, 1334, 
1284, 1251, 1217, 1175, 1087, 1012, 917 cm-1; HRMS (ESI) m/z calc for NaC45H46FeO14Si
+ 
(M+Na), 915.1945; found, 915.1950. 
NMR assignments: 1H-NMR (500 MHz) δ 8.74 (s, 1 H, C25-H), 8.64 (s, 1 H, C22-H), 
7.45 (d, J = 8.5 Hz, 2 H, C10-H), 7.36 (d, J = 8.5 Hz, 1 H, C3-H), 7.31 (d, J = 9.0 Hz, 2 H, C4-
H), 7.25 (d, J = 9.0 Hz, 1 H, C21-H), 7.21 (d, J = 9.5 Hz, 1 H, C1-H), 6.96 (d, J = 8.5 Hz, 2 H, 
C11-H), 6.61 (s, 1 H, C28-H), 5.72 (d, J = 5.0 Hz, 1 H, C14-H), 5.49 (d, J = 5.0 Hz, 1 H, C14-
H), 5.19 (s, 2 H, C8-H), 3.99 (s, 3 H, C30-H), 3.96 (s, 3 H, C31-H), 3.86 (s, 3 H, C13-H), 3.54 
(s, 3 H, C15-H), 1.26 (s, 9 H, C33-H or C35-H), 1.06 (s, 9 H, C33-H or C35-H); 13C-NMR (125 
MHz) δ 208.4 (C36), 166.5 (C17), 159.7 (C12), 157.4 (C18), 155.2 (C27), 154.3 (C29), 151.0 
(C5), 143.9 (C26), 142.8 (C6), 142.1 (C22), 129.4 (C10), 129.3 (C16), 128.9 (C20), 128.7 (C2), 
128.5 (C21), 128.2 (C9), 124.8 (C3), 120.0 (C1), 118.8 (C19), 117.2 (C24), 116.2 (C4), 114.1 
(C11), 112.3 (C25), 110.4 (C23), 105.3 (C7), 104.4 (C28), 98.1 (C14), 71.4 (C8), 58.2 (C15), 
56.2 (C30), 56.1 (C31), 53.3 (C13), 27.6 (C33 or C35), 27.5 (C33 or C35), 21.01 (C32 or C34), 
20.62 (C32 or C34). 
Compound B: 1H-NMR (500 MHz) δ 8.62 (s, 1 H), 8.56 (s, 1 H), 7.44 (d, J = 9.0 Hz, 2 
H), 7.36 (d, J = 8.5 Hz, 1 H), 7.32 (d, J = 8.5 Hz, 1 H), 7.23 (app. d, J = 2.0 Hz, 2 H), 6.95 (d, J 
= 8.5 Hz, 2 H), 6.88 (s, 1 H), 5.68 (d, J = 5.0 Hz, 1 H), 5.48 (d, J = 5.0 Hz, 1 H), 5.19 (s, 2 H), 
4.14 (s, 3 H), 3.93 (s, 3 H), 3.84 (s, 3 H), 3.56 (s, 3 H), 1.13 (s, 9 H), 1.12 (s, 9 H); 13C-NMR 
(125 MHz) δ 208.3, 171.0, 159.6, 159.3, 154.5, 154.3, 151.0, 145.2, 143.3, 138.9, 129.6, 129.4, 
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129.3, 129.1, 128.9, 128.1, 124.8, 119.3, 116.9, 116.0, 114.0, 113.9, 113.4, 110.0, 103.0, 98.4, 
71.4, 58.2, 52.4, 56.0, 55.2, 27.4, 27.3, 20.84, 20.82;   IR (film) 3492 (O-H), 2936 (C-H), 2860 
(C-H), 2061 (C=O), 2005 (C=O), 1784, 1644, 1597, 1561, 1512, 1468, 1406, 1373, 1349, 1312, 
1276, 1251, 1217, 1175, 1156, 1099, 1036, 1004, 964 cm-1; HRMS (ESI) m/z calc for 
NaC45H46FeO14Si
+ (M+Na), 915.1945; found, 915.1931. 
NMR assignments: 1H-NMR (500 MHz) δ 8.62 (s, 1 H, C25-H), 8.56 (s, 1 H, C22-H), 
7.44 (d, J = 9.0 Hz, 2 H, C10-H), 7.36 (d, J = 8.5 Hz, 1 H, C3-H), 7.32 (d, J = 8.5 Hz, 1 H, C4-
H), 7.23 (app. d, J = 2.0 Hz, 2 H, C21-H, C1-H), 6.95 (d, J = 8.5 Hz, 2 H, C11-H), 6.88 (s, 1 H, 
C28-H), 5.68 (d, J = 5.0 Hz, 1 H, C14-H), 5.48 (d, J = 5.0 Hz, 1 H, C14-H), 5.19 (s, 2 H, C8-H), 
4.14 (s, 3 H, C30-H), 3.93 (s, 3 H, C31-H), 3.84 (s, 3 H, C13-H), 3.56 (s, 3 H, C15-H), 1.13 (s, 9 
H, C33-H or C35-H), 1.12 (s, 9 H, C33-H or C35-H); 13C-NMR (125 MHz) δ 208.3 (C36), 171.0 
(C17), 159.6 (C12), 159.3 (C18), 154.5 (C27), 154.3 (C29), 151.1 (C5), 145.2 (C26), 143.3 (C6), 
138.9 , 129.6 (C16), 129.4 (C10, C1), 129.3 (C20), 129.1 (C21), 128.9 (C2), 128.1 (C), 124.8 
(C3), 119.3 (C4), 116.9 (C24), 116.0 (C19), 114.0 (C11), 113.9 (C7), 113.4 (C25), 110.0 (C23), 
103.0 (C28), 98.4 (C14), 71.4 (C8), 58.2 (C15), 52.4 (C30), 56.0 (C31), 55.2 C13), 27.4 (C33 or 








(methoxymethoxy)phenanthrene-1,4-dione  (4.208). (SB-VII-30B). One drop of HF•Pyridine 
was added to a solution of 4.154   (41 mg, 0.0565 mmol) and pyridine (49 mg, 50 µL, 0.621 
mmol) in THF (2 mL), and the reaction was stirred for 30 min. The mixture was diluted with 
EtOAc (5 mL), and washed with NH4Cl (1 x 2 mL) and de-ionized H2O (1 x 2 mL). The 
combined organic extracts were dried (Na2SO4), filtered, and concentrated under reduced 
pressure and the crude oil was purified by flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:2 → 3:4) to provide 24 mg (72%) of 4.208 as a red solid: 1H-NMR (600 
MHz) δ 7.97 (d, J = 8.5 Hz, 1 H), 7.90 (d, J = 8.5 Hz, 1 H), 7.68 (bs, 1 H), 7.63 (d, J = 8.9 Hz, 1 
H), 7.47 (d, J = 8.9 Hz, 1 H), 7.39 (d, J = 8.7 Hz, 2 H), 6.93 (d, J = 8.7 Hz, 2 H), 6.67 (s, 1 H), 
6.55 (s, 1 H), 6.47 (d, J = 1.6 Hz, 1 H), 6.17 (bs, 1 H), 5.19 (s, 2 H), 5.13 (d, J = 4.8 Hz, 1 H), 
5.19 (d, J = 4.8 Hz, 1 H), 4.40 (bs, 1 H), 3.86 (s, 3 H), 3.82 (s, 3 H), 3.82 (s, 3 H), 3.19 (s, 3 H); 
13C-NMR (150 MHz) δ 188.8, 185.0, 159.7, 152.7, 150.9, 150.3, 150.0, 143.0, 141.4, 133.8, 
133.2, 132.9, 132.7, 130.0, 129.4, 128.3, 125.3, 125.1, 119.6, 114.1, 114.0, 113.6, 111.2, 102.4, 
98.2, 71.7, 70.3, 57.6, 56.6, 56.0, 55.3;   IR (film) 3431 (O-H), 2933 (C-H), 2837 (C-H), 1659 
(C=O), 1614, 1588, 1514, 1449, 1335, 1302, 1250, 1197, 1137, 1112, 1055, 1035, 916 cm-1; 
HRMS (ESI) m/z calc for NaC33H39O10
+ (M+Na), 609.1731; found, 609.1722. 
NMR assignments: 1H-NMR (600 MHz) δ 7.97 (d, J = 8.5 Hz, 1 H, C1-H), 7.90 (d, J = 
8.5 Hz, 1 H, C20-H), 7.68 (bs, 1 H, O32-H), 7.63 (d, J = 8.9 Hz, 1 H, C3-H), 7.47 (d, J = 8.9 Hz, 
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1 H, C4-H), 7.39 (d, J = 8.7 Hz, 2 H, C10-H), 6.93 (d, J = 8.7 Hz, 2 H, C11-H), 6.67 (s, 1 H, 
C21-H), 6.55 (s, 1 H, C25-H), 6.47 (d, J = 1.6 Hz, 1 H, C23-H), 6.17 (bs, 1 H, C28-H), 5.19 (s, 2 
H, C8-H), 5.13 (d, J = 4.8 Hz, 1 H, C14-H), 5.19 (d, J = 4.8 Hz, 1 H, C14-H), 4.40 (bs, 1 H, 
O33-H), 3.86 (s, 3 H, C30-H), 3.82 (s, 3 H, C13-H), 3.82 (s, 3 H, C31-H), 3.19 (s, 3 H, C15-H); 
13C-NMR (150 MHz) δ 188.8 (C17), 185.0 (C18), 159.7 (C12), 152.7 (C22), 150.9 (C5), 150.3 
(C24), 150.0 (C26), 143.0 (C6), 141.4 (C27), 133.8 (C1), 133.2 (C16), 132.9 (C19), 132.7 (C20), 
130.0 (C21), 129.4 (C10), 128.3 (C9), 125.3 (C2), 125.1 (C3), 119.6 (C7), 114.1 (C11), 114.0 
(C4), 113.6 (C29), 111.2 (C28), 102.4 (C25), 98.2 (C14), 71.7 (C8), 70.3 (C23), 57.6 (C15), 56.6 







b]xanthene-7,13,14-trione  (4.210). (SB-VII-79). Activated manganese dioxide (MnO2) (445 
mg, 5.11 mmol) was added to a solution of 4.208 (20 mg, 0.341 mmol) in CH2Cl2 (2 mL) and 
pyridine (0.3 mL) at 0 °C. The reaction mixture was stirred for 48 h at 0 °C and then filtered 
through a silica plug, eluting with a mixture (1:1) of acetone/hexanes (20 mL). The combined 
filtrates were concentrated under reduced pressure, and purified by flash chromatography eluting 
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with a gradient of acetone/hexanes (7:20 → 1:2) to provide 7 mg (35%) of 4.210 as an orange 
solid and 6 mg (~30%) of a mixture of partially oxidized compounds. The partially oxidized 
compounds can be resubjected to the reaction mixture to provide another 3 mg (15%) of 4.210 
and 3 mg (~15%) of the partially oxidized compounds: 1H-NMR  (500 MHz) δ 8.04 (d, J = 8.5 
Hz, 1 H), 7.99 (d, J = 8.5 Hz, 1 H), 7.65 (s, 1 H), 7.61 (d, J = 9.1 Hz, 1 H), 7.50 (d, J = 9.0 Hz, 1 
H), 7.42 (d, J = 8.8 Hz, 2 H), 7.15 (s, 1 H), 6.92 (d, J = 8.8 Hz, 2 H), 5.26 (s, 2 H), 5.23 (s, 2 H), 
4.03 (s, 3 H), 4.01 (s, 3 H), 3.82 (s, 3 H), 3.44 (s, 3 H); 13C-NMR (125 MHz) δ 182.1, 179.1, 
172.6, 159.6, 155.6, 153.8, 151.2, 150.6, 148.8, 143.7, 135.2, 133.7, 133.3, 130.4, 129.4, 128.5, 
125.2, 124.7, 121.6, 121.0, 119.8, 119.1, 114.0, 105.1, 100.6, 99.2, 77.1, 57.8, 56.8, 56.5, 55.3; 
IR (film) 2928 (C-H), 1688 (C=O), 1641, 1620, 1600, 1512, 1467, 1450, 1428, 1402, 1334, 
1272, 1249, 1175, 1126, 1081, 1048, 992 cm-1; HRMS (ESI) m/z calc for NaC33H26O10
+ (M+Na), 
605.1418; found, 605.1410. 
NMR assignments: 1H-NMR (500 MHz) δ 8.04 (d, J = 8.5 Hz, 1 H, C20-H), 7.99 (d, J = 
8.5 Hz, 1 H, C1-H), 7.65 (s, 1 H, C28-H), 7.61 (d, J = 9.1 Hz, 1 H, C3-H), 7.50 (d, J = 9.0 Hz, 1 
H, C4-H), 7.42 (d, J = 8.8 Hz, 2 H, C10-H), 7.15 (s, 1 H, C25-H), 6.92 (d, J = 8.8 Hz, 2 H, C11-
H), 5.26 (s, 2 H, C14-H), 5.23 (s, 2 H, C8-H), 4.03 (s, 3 H, C30-H), 4.01 (s, 3 H, C31-H), 3.82 
(s, 3 H, C13-H), 3.44 (s, 3 H, C15-H); 13C-NMR (125 MHz) δ 182.1 (C17), 179.1 (C18), 172.6 
(C23), 159.6 (C12), 155.6 (C26), 153.8 (C21), 151.2 (C24), 150.6 (C5), 148.8 (C27), 143.7 (C6), 
135.2 (C16), 133.7 (C2), 133.3 (C1), 130.4 (C19), 129.4 (C10), 128.5 (C9), 125.2 (C7), 124.7 
(C3), 121.6 (C4), 121.0 (C22), 119.8 (C29), 119.1 (C20), 114.0 (C11), 105.1 (C28), 100.6 (C25), 






naphtho[1,2-b]xanthen-13-one  (4.237). (SB-VIII-78). Pd/C (ca. 1-2 mg) was added to a 
solution of 4.210 (7 mg, 0.12 mmol) in a mixture (1:1) of MeOH/PhMe (1 mL). The reaction 
mixture was sparged with a balloon of H2 for 5 min then stirred at room temperature for 24 h 
under a hydrogen atmosphere. The reaction mixture was filtered through a silica plug, eluting 
with a mixture (1:1) acetone/hexanes (5 mL). The solution was concentrated under reduced 
pressure and the crude material was purified by flash chromatography eluting with a gradient of 
acetone/hexanes (7:20 → 1:2) to provide 3 mg (53%) of 4.237 as yellow solid: 1H-NMR (500 
MHz) δ 13.06 (s, 1 H), 8.25 (s, 1 H), 6.98 (d, J = 8.5 Hz, 1 H), 6.944 (s, 1 H), 6.941 (d, J = 8.0 
Hz, 1 H), 5.39 (bs, 1 H), 5.29 (bs, 2 H), 4.07 (s, 3 H), 4.03 (s, 3 H), 3.62 (s, 3 H), 1.57 (bs, 4 H); 
13C-NMR (125 MHz) δ 180.9, 156.1, 151.9, 151.3, 148.1, 147.2, 143.9, 142.9, 136.5, 131.9, 
131.5, 124.6, 123.4, 115.8, 114.8, 113.4, 106.8, 104.7, 99.7, 99.3, 57.0, 56.6, 56.4, 29.2, 23.9;  
IR (film) 3396 (O-H), 2955 (C-H), 1644 (C=O), 1615, 1588, 1509, 1479, 1453, 1434, 1382, 
1361, 1299, 1277, 1237, 1211, 1175, 1147, 1115, 1073, 1030, 1003, 988 cm-1; HRMS (ESI) m/z 
calc for NaC25H22O9
+ (M+Na), 489.1156; found, 489.1154. 
NMR assignments: 1H-NMR (500 MHz) δ 13.06 (s, 1 H, O27-H), 8.25 (s, 1 H, O26-H), 
6.98 (d, J = 8.5 Hz, 1 H, C13-H), 6.944 (s, 1 H, C4-H), 6.941 (d, J = 8.0 Hz, 1 H, C16-H), 5.39 
(bs, 1 H, O28-H), 5.29 (bs, 2 H, C22-H), 4.07 (s, 3 H, C25-H), 4.03 (s, 3 H, C24-H), 3.62 (s, 3 H, 
C23-H), 1.57 (bs, 4 H, C1-H, C21-H); 13C-NMR (125 MHz) δ 180.9 (C11), 156.1 (C15), 151.9 
(C17), 151.3 (C5), 148.1 (C14), 147.2 (C9), 143.9 (C6), 142.9 (C18), 136.5 (C19), 131.9 (C10), 
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131.5 (C12), 124.6 (C7), 123.4 (C4), 115.8 (C3), 114.8 (C8), 113.4 (C20), 106.8 (C2), 104.7 
(C13), 99.7 (C22), 99.3 (C16), 57.0 (C23), 56.6 (C25), 56.4 (C24), 29.2 (C21), 23.9 (C1). 
 
 
1-((4-Methoxybenzyl)oxy)-2-(methoxymethoxy)benzene  (4.219). (SB-VIII-40/SB-
VIII-38). 2-(Methoxymethoxy)phenol (4.224) was prepared according to known literature 
procedures.588 K2CO3 (5.6 g, 40.9 mmol) was added to a solution of catechol (4.223) (3.0 g, 27.2 
mmol) in anhydrous acetone (90 mL) at room temperature and stirred for 20 min before adding a 
solution of MOMCl633 (1.18 M, 24.2 mL, 28.6 mmol) in methyl hexanoate. The reaction mixture 
was stirred for 8 h at room temperature and then filtered through Celite. The solution was 
concentrated under reduced pressure and crude material was purified by flash chromatography 
eluting with a gradient of acetone/hexanes (3:20 → 1:4) to provide 2.8 g (38%) of 2-
(methoxymethoxy)phenol (4.224) as a white waxy solid.  
2-(Methoxymethoxy)phenol (4.224) (1.6 g, 10.4 mmol), K2CO3 (2.1 g, 15.6 mmol) and 
sodium iodide (NaI) (0.47 g, 3.1 mmol) in anhydrous DMF (42 mL) was heated at 40 °C for 1 h. 
para-methoxybenzyl chloride (PMBCl)634 (3.2 g, 2.8 mL, 20.8 mmol) was added, and the 
mixture was stirred at 40 °C for an additional 24 h, whereupon the reaction was cooled to room 
temperature and H2O (80 mL) was added. The mixture was extracted with EtOAc (3 x 30 mL), 
and the combined organic extracts were washed with 13% aqueous brine solution (4 x 10 mL), 
dried (Na2SO4) and concentrated under reduced pressure. The crude material was purified by 
flash chromatography eluting with a gradient of acetone/hexanes (1:50 → 1:4) buffered with 1% 
Et3N to provide 1.2 g (42%) of 4.219 as white solid: mp 64-66 °C; 
1H-NMR (400 MHz) δ 7.30 
(d, J = 8.4 Hz, 2 H), 7.14 (d, J = 8.4 Hz, 1 H), 6.87-6.94 (comp, 4 H), 5.21 (s, 2 H), 5.08 (s, 2 H), 
3.81 (s, 3 H), 3.51 (s, 3 H); 13C-NMR (100 MHz) δ 159.3, 149.2, 147.0, 129.2, 128.9, 122.7, 
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121.4, 117.7, 114.7, 113.9, 95.7, 70.8, 56.2, 55.3;  IR (film) 2917 (C-H), 1613, 1515, 1455, 1379, 
1302, 1247, 1153, 1118, 1077, 995 cm-1; HRMS (ESI) m/z calc for NaC16H18O4
+ (M+Na), 
297.1097; found, 297.1095. 
NMR assignments: 1H-NMR (400 MHz) δ 7.30 (d, J = 8.4 Hz, 2 H, C9-H), 7.14 (d, J = 
8.4 Hz, 1 H, C4-H), 6.87-6.94 (comp, 4 H, C1-H, C2-H, C3-H, C10-H), 5.21 (s, 2 H, C13-H), 
5.08 (s, 2 H, C7-H), 3.81 (s, 3 H, C12-H), 3.51 (s, 3 H, C14-H); 13C-NMR (100 MHz) δ 159.3 
(C11), 149.2 (C6), 147.0 (C5), 129.2 (C8), 128.9 (C9), 122.7 (C3), 121.4 (C2), 117.7 (C1), 114.7 
(C4), 113.9 (C10), 95.7 (C13), 70.8 (C7), 56.2 (C14), 55.3 (C12). 
 
 
2-Bromo-6-methoxyphenol  (4.243). (SB-VII-76). Guiacol (4.242) (2.0 g, 16.11 mmol) 
was dissolved in CH2Cl2 (160 mL) and cooled to – 78 °C. In a separate flask, TMG (4.45 g, 4.85 
mL, 38.66 mmol) was added to a slurry of NBS (3.44 g, 19.33 mmol) in CH2Cl2 (43 mL) at 0 °C. 
The mixture was stirred until it became homogenous (~5 min), then it was added to the solution 
contining guiacol (4.242) at – 78 °C over 10 min. The reaction mixture was stirred for 30 min at 
– 78 °C whereupon AcOH (1.1 mL, 1.15 g, 19.33 mmol) was added, and the reaction was 
warmed to room temperature. The mixture was washed with H2O (1 x 100 mL), dried (Na2SO4), 
filtered, and concentrated under reduced pressure. The crude oil was purified by flash 
chromatography eluting with a gradient of acetone/hexanes (1:4 → 1:2) buffered with 1% Et3N 
to provide 2.74 g (84%) of 4.234 as a white solid: mp 49-53 °C; 1H-NMR (600 MHz) δ 7.09 (dd, 
J = 1.4, 8.1 Hz, 1 H), 6.81 (dd, J = 1.4, 8.1 Hz, 1 H), 6.74 (t, J = 8.1 Hz, 1 H), 3.90 (s, 3 H); 13C-
NMR (150 MHz) δ 147.4, 143.2, 124.8, 120.7, 109.9, 108.4, 56.3;   IR (film) 3409 (O-H), 2953 
(C-H), 2848 (C-H), 1601, 1490, 1471, 1442, 1354, 1287, 1263, 1234, 1201, 1147, 1072, 1027 
cm-1; HRMS (CI) m/z calc for C7H7O2Br
+ (M+), 201.9629; found, 201.9632. 
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NMR assignments: 1H-NMR (600 MHz) δ 1H-NMR (600 MHz) δ 7.09 (dd, J = 1.4, 8.1 
Hz, 1 H, C4-H), 6.81 (dd, J = 1.4, 8.1 Hz, 1 H, C2-H), 6.74 (t, J = 8.1 Hz, 1 H, C3-H), 3.90 (s, 3 
H, C7-H); 13C-NMR (150 MHz) δ 147.4 (C1), 143.2 (C6), 124.8 (C4), 120.7 (C3), 109.9 (C2), 
108.4 (C5), 56.3 (C7). 
 
2-Bromo-6-methoxyphenyl trifluoromethanesulfonate  (4.244). (SB-VII-73). A 
solution of phenol 4.243 (4.38 g, 21.57 mmol) and pyridine (3.41 g, 3.47 mL, 43.14 mmol) in 
CH2Cl2 (120 mL) was cooled to 0 °C. Neat triflic anhydride (Tf2O) (7.31 g, 4.35 mL, 25.88 
mmol) was added, and the reaction mixture was stirred for 1 h. H2O (100 mL) was added, and 
the layers were separated. The organic layer was washed with aqueous CuSO4 (1 M, 1 x 100 mL) 
dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude oil was purified by 
flash chromatography eluting with EtOAc/hexanes (1:10) to provide 6.83 g (94%) of 4.244 as a 
clear oil: 1H-NMR (600 MHz) δ 7.22 (dd, J = 1.5, 8.2 Hz, 1 H), 7.18 (t, J = 8.2 Hz, 1 H), 6.97 
(dd, J = 2.5, 8.2 Hz, 1 H), 3.91 (s, 3 H); 13C-NMR (150 MHz) δ 152.6, 137.0, 129.3, 125.3, 
118.6 (q, J = 321 Hz), 116.9, 112.0, 56.4;   IR (film) 1595, 1475, 1300, 1282, 1210, 1136, 1036, 
883 cm-1; HRMS (ESI) m/z calc for NaC8H6BrF3O4S
+ (M+Na), 356.9014; found, 356.9026. 
NMR assignments: 1H-NMR (600 MHz) δ 7.22 (dd, J = 1.5, 8.2 Hz, 1 H, C2-H), 7.18 (t, 
J = 8.2 Hz, 1 H, C3-H), 6.97 (dd, J = 2.5, 8.2 Hz, 1 H, C4-H), 3.91 (s, 3 H, C7-H); 13C-NMR 
(150 MHz) δ 152.6 (C1), 137.0 (C6), 129.3 (C4), 125.3 (C3), 118.6 (C8), 116.9 (C5), 112.0 




Butyl 2-bromo-6-methoxybenzoate (4.264). (SB-VII-148). Pd(OAc)2 (75 mg, 0.33 
mmol), 1,3-bis(diphenylphosphino)propane (DPPP) (270 mg, 0.65 mmol), K2CO3 (1.81 g, 13.08 
mmol) and tetrabutylammonium acetate (TBAA) (1.97 g, 6.54 mmol) were weighed in a glove-
box and added to a flame dried round bottomed flask. Pulverized 3 Å molecular sieves (1.1 g) 
were added, and the flask was put under vacuum and backfilled with N2 (3 x). Toluene (20 mL) 
was added and the reaction mixture was stirred for 10 min before adding 4.244   (2.19 g, 6.54 
mmol) and n-BuOH (1.46 g, 1.80 mL, 19.61 mmol). The reaction mixture was heated to 70 °C 
for 16 h. The mixture was cooled to room temperature and filtered through a silica plug. The 
plug was washed with 1:1 EtOAc/hexanes (200 mL), and the combined eluant was concentrated 
and purified by flash chromatography eluting with a gradient of CH2Cl2/hexanes (1:4 → 3:4) to 
provide 1.26 g (67%) of 4.264 as a clear oil. 
Procedure using DMSO as the solvent (SB-VII-211): 
Pd(OAc)2 (34 mg, 0.149 mmol), 1,3-bis(diphenylphosphino)propane (DPPP) (123 mg, 
0.298 mmol), and tetrabutylammonium acetate (TBAA) (900 mg, 2.98 mmol) were weighed in a 
glove-box, and added to a flame dried round bottomed flask. Pulverized 3 Å molecular sieves 
(1.5 g) were added and the flask was put under vacuum and backfilled with N2 (3 x). Degassed 
DMSO (20 mL) was added, and the reaction mixture was stirred for 10 min before adding 4.224   
(500 mg, 1.49 mmol) and n-BuOH (0.33 g, 0.41 mL, 4.47 mmol). The mixture was heated to 70 
°C for 16 h. The mixture was cooled to room temperature and filtered through a silica plug. The 
plug was washed with 1:1 EtOAc/hexanes (1 x 100 mL), and the combined eluant was washed 
with H2O (1 x 50 mL), dried (Na2SO4), filtered and concentrated under reduced pressure and the 
crude oil was purified by flash chromatography eluting with a gradient of CH2Cl2/hexanes (1:4 
→ 3:4) to provide 272 mg (69%) of 4.264 as a clear oil. 
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1H-NMR (500 MHz) δ 7.18 (dd, J = 8.1, 8.0 Hz, 1 H), 7.13 (dd, J = 1.0, 8.3 Hz, 1 H), 
6.85 (dd, J = 1.0, 8.0 Hz, 1 H), 4.36 (t, J = 6.6 Hz, 2 H), 3.81 (s, 3 H), 1.74 (quin, J = 6.6 Hz, 2 
H), 1.47 (sex, J = 7.6 Hz, 2 H), 0.96 (t, J = 7.3 Hz, 3 H); 13C-NMR (125 MHz) δ 166.3, 157.2, 
131.1, 126.4, 124.5, 119.7, 110.0, 65.6, 56.1, 30.6, 19.1, 13.7;   IR (film) 2960 (C-H), 2873 (C-
H), 1731 (C=O), 1591, 1573, 1464, 1433, 1267, 1187, 1157, 1107, 1066, 1035, 839 cm-1; HRMS 
(ESI) m/z calc for NaC12H15BrO3
+ (M+Na), 309.0097; found, 309.0102. 
NMR assignments: 1H-NMR (500 MHz) δ 7.18 (dd, J = 8.1, 8.0 Hz, 1 H, C3-H), 7.13 
(dd, J = 1.0, 8.3 Hz, 1 H, C4-H), 6.85 (dd, J = 1.0, 8.0 Hz, 1 H, C2-H), 4.36 (t, J = 6.6 Hz, 2 H, 
C9-H), 3.81 (s, 3 H, C7-H), 1.74 (quin, J = 6.6 Hz, 2 H, C10-H), 1.47 (sex, J = 7.6 Hz, 2 H, C11-
H), 0.96 (t, J = 7.3 Hz, 3 H, C12-H); 13C-NMR (125 MHz) δ 166.3 (C8), 157.2 (C1), 131.1 (C3), 




Dibutyl 3-methoxyphthalate  (4.266). (SB-VII-130C2). Isolated as a byproduct from the 
reaction mixture. The crude oil was purified by flash chromatography eluting with a gradient of 
EtOAc/hexanes (1:10 → 1:4) to provide 229 mg (11%) of 4.266 as a clear oil: 1H-NMR (500 
MHz) δ 5.79 (d, J = 7.8 Hz, 1 H), 7.40 (dd, J = 7.8, 8.3 Hz, 1 H), 7.11 (d, J = 8.3 Hz, 1 H), 4.36 
(t, J = 6.6 Hz, 2 H), 4.28 (t, J = 6.8 Hz, 2 H), 3.85 (s, 3 H), 1.76-1.68 (comp, 4 H), 1.49-1.40 
(comp, 4 H), 0.96 (app t, J = 7.6 Hz, 6 H); 13C-NMR (125 MHz) δ 167.5, 165.3, 156.4, 130.0, 
129.0, 125.7, 121.9, 115.3, 65.4, 65.3, 56.2, 30.6, 30.5, 19.13, 19.10, 13.7;   IR (film) 2961 (C-
H), 2874 (C-H), 1729 (C=O), 1592, 1470, 1439, 1384, 1279, 1186, 1160, 1113, 1068, 756 cm-1; 
HRMS (ESI) m/z calc for NaC17H24O5
+ (M+Na), 331.1516; found, 331.1517. 
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NMR assignments: 1H-NMR (500 MHz) δ 5.79 (d, J = 7.8 Hz, 1 H, C4-H), 7.40 (dd, J = 
7.8, 8.3 Hz, 1 H, C3-H), 7.11 (d, J = 8.3 Hz, 1 H, C2-H), 4.36 (t, J = 6.6 Hz, 2 H, C9-H or C14-
H), 4.28 (t, J = 6.8 Hz, 2 H, C9-H or C14-H), 3.85 (s, 3 H, C7-H), 1.76-1.68 (comp, 4 H, C10-H, 
C15-H), 1.49-1.40 (comp, 4 H, C11-H, C16-H), 0.96 (app t, J = 7.6 Hz, 6 H, C12-H, C17-H); 
13C-NMR (125 MHz) δ 167.5 (C8), 165.3 (C13), 156.4 (C1), 130.0 (C3), 129.0 (C5), 125.7 (C6), 
121.9 (C4), 115.3 (2), 65.4 (C9 or C14), 65.3 (C9 or C14), 56.2 (C7), 30.6 (C10 or C15), 30.5 
(C10 or C15), 19.13 (C11 or C16), 19.10 (C11 or C16), 13.7 (C12, C17). 
 
 
Butyl 2-butyl-6-methoxybenzoate  (4.276). (SB-VII-140). Isolated as a byproduct from 
the reaction mixture. The crude oil was purified by flash chromatography eluting with 
EtOAc/hexanes (1:4) to provide 10 mg (22%) of 4.276 as a clear oil: 1H-NMR (500 MHz) δ 7.52 
(dd, J = 7.8, 8.3 Hz, 1 H), 6.81 (dd, J = 0.5, 7.3 Hz, 1 H), 6.75 (dd, J = 0.5, 8.3 Hz, 1 H), 5.23 
(sex, J = 7.3 Hz, 2 H), 4.33 (t, J = 6.6 Hz, 2 H), 3.81 (s, 3 H), 2.56 (dd, J = 7.8, 8.1 Hz, 2 H), 
1.73 (quin, J = 6.6 Hz, 2 H), 1.57 (m, 2 H), 1.46 (sex, J = 7.6 Hz, 2 H), 0.96 (t, J = 7.3 Hz, 3 H), 
0.91 (t, J = 7.3 Hz, 3 H); 13C-NMR (125 MHz) δ 168.6, 156.2, 141.2, 130.0, 123.9, 121.5, 108.4, 
65.0, 55.8, 33.4, 33.1, 30.2, 22.6, 19.1, 13.9, 13.6;   IR (film) 2958 (C-H), 2931 (C-H), 2872 (C-
H), 1729 (C=O), 1585, 1470, 1379, 1271, 1113, 1076 cm-1; HRMS (ESI) m/z calc for 
NaC16H24O3
+ (M+Na), 287.1618; found, 287.1612. 
NMR assignments: 1H-NMR (500 MHz) δ 7.52 (dd, J = 7.8, 8.3 Hz, 1 H, C3-H), 6.81 
(dd, J = 0.5, 7.3 Hz, 1 H, C4-H), 6.75 (dd, J = 0.5, 8.3 Hz, 1 H, C2-H), 5.23 (sex, J = 7.3 Hz, 2 
H, C15-H), 4.33 (t, J = 6.6 Hz, 2 H, C9-H), 3.81 (s, 3 H, C7-H), 2.56 (dd, J = 7.8, 8.1 Hz, 2 H, 
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C10-H), 1.73 (quin, J = 6.6 Hz, 2 H, C13-H), 1.57 (m, 2 H, C14-H), 1.46 (sex, J = 7.6 Hz, 2 H, 
C11-H), 0.96 (t, J = 7.3 Hz, 3 H, C12-H), 0.91 (t, J = 7.3 Hz, 3 H, C16-H); 13C-NMR (125 MHz) 
δ 168.6 (C8), 156.2 (C1), 141.2 (C5), 130.0 (C3), 123.9 (C6), 121.5 (C4), 108.4 (C2), 65.0 (C9), 
55.8 (C7), 33.4 (C13), 33.1 (C14), 30.2 (C10), 22.6 (C15), 19.1 (C11), 13.9 (C16), 13.6 (C12). 
 
8-Methoxy-3-methyl-1H-isochromen-1-one (4.277). (SB-VII-178). Pd2(DBA)3•HCCl3 
(45 mg, 0.043 mmol), (2-biphenyl)di-tert-butylphosphine (52 mg, 0.174 mmol), K3PO4 (923 mg, 
4.35 mmol), para-methoxyphenol (43 mg, 0.348 mmol) and tetrabutylammonium acetate 
(TBAA) (525 mg, 1.74 mmol) were weighed in a glove-box and added to a flame dried round 
bottomed flask. Pulverized 3 Å molecular sieves (250 mg) was added and the flask was put 
under vacuum and backfilled with N2 (3 x). Toluene (5 mL) was added, and the reaction mixture 
was stirred for 10 min before adding a degassed solution of 4.294   (2.19 g, 6.54 mmol) in 
toluene (4 mL) and acetone (freshly distilled from CaH2, 0.61 g, 0.77 mL, 10.44 mmol) and the 
mixture was heated to 60 °C for 16 h. The mixture was then cooled to room temperature, and 
filtered through a silica plug. The plug was washed with 3:1 EtOAc/hexanes (100 mL) and the 
combined eluant was concentrated and purified by flash chromatography eluting with a gradient 
of EtOAc/hexanes (1:4 → 1:2) to provide 197 mg (59%) of 4.277 as a brown solid: 1H-NMR 
(600 MHz) δ 7.57 (dd, J = 7.77, 7.78 Hz, 1 H), 6.89 (d, J = 8.3 Hz, 1 H), 6.86 (d, J = 7.77 Hz, 1 
H), 6.15 (app d, J = 1 Hz, 1 H), 3.99 (s, 3 H), 2.23 (d, J = 1 Hz, 3 H); 13C-NMR (150 MHz) δ 
161.6, 159.8, 155.1, 140.7, 135.7, 117.0, 109.3, 108.0, 103.6, 56.3, 19.5;   IR (film) 3436, 1729 
(C=O), 1666, 1599, 1571, 1478, 1434, 1319, 1282, 1262, 1163, 1089, 1039, 980 cm-1; HRMS 
(ESI) m/z calc for NaC11H10O3
+ (M+Na), 213.0522; found, 213.0523. 
NMR assignments: 1H-NMR (600 MHz) δ 7.57 (dd, J = 7.77, 7.78 Hz, 1 H, C3-H), 6.89 
(d, J = 8.3 Hz, 1 H, C2-H), 6.86 (d, J = 7.77 Hz, 1 H, C4-H), 6.15 (app d, J = 1 Hz, 1 H, C9-H), 
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3.99 (s, 3 H, C7-H), 2.23 (d, J = 1 Hz, 3 H, C11-H); 13C-NMR (150 MHz) δ 161.6 (C8), 159.8 
(C1), 155.1 (C10), 140.7 (C5), 135.7 (C3), 117.0 (C4), 109.3 (C2), 108.0 (C6), 103.6 (C9), 56.3 















8-8-Methoxy-1,1,3-trimethyl-1H-isochromene  (4.290). (SB-VII–200). Isolated by-
product from the reaction mixture. The crude oil was purified by flash chromatography eluting 
with a gradient of EtOAc/hexanes (1:5 → 11:20) to provide 17 mg (32%) of 4.290 as a brown 
solid: 1H-NMR (600 MHz) δ 7.07 (dd, J = 7.6, 8.3 Hz, 1 H), 6.65 (dd, J = 0.9, 8.3 Hz, 1 H), 6.49 
(dd, J = 1.0, 7.5 Hz, 1 H), 5.51 (d, J = 0.9 Hz, 1 H), 3.78 (s, 3 H), 1.86 (d, J = 0.9 Hz, 3 H), 1.66 
(s, 6 H); 13C-NMR (150 MHz) δ 155.2, 151.9, 132.6, 128.1, 122.6, 116.3, 109.3, 99.1, 79.1, 55.3, 
27.7, 20.3;  IR (film) 2924 (C-H), 1669, 1574, 1471, 1377, 1356, 1267, 1160, 1135, 1090, 1063, 
1021, 985 cm-1; HRMS (CI) m/z calc for C13H16O2
+ (M+), 204.1150; found, 204.1154. 
NMR assignments: 1H-NMR (600 MHz) δ 7.07 (dd, J = 7.6, 8.3 Hz, 1 H, C3-H), 6.65 
(dd, J = 0.9, 8.3 Hz, 1 H, C4-H), 6.49 (dd, J = 1.0, 7.5 Hz, 1 H, C2-H), 5.51 (d, J = 0.9 Hz, 1 H, 
C9-H), 3.78 (s, 3 H, C7-H), 1.86 (d, J = 0.9 Hz, 3 H, C11-H), 1.66 (s, 6 H, C12-H); 13C-NMR 
(150 MHz) δ 155.2 (C1), 151.9 (C10), 132.6 (C5), 128.1 (C6), 122.6 (C3), 116.3 (C4), 109.3 










(S)-2-(8-Methoxy-3-methyl-1-oxoisoquinolin-2(1H)-yl)-3-phenylpropanoic acid   
(4.295). (SB-VII-212). A solution of AlMe3 (2 M, 3.44 mL, 6.89 mmol) in toluene was added to 
THF (10 mL), followed by a solution of MeLi (1.26 M, 5.5 mL, 6.89 mmol) in Et2O. The 
mixture was stirred for 10 min before adding to a degassed flask containg solid L-phenylalanine 
(487 mg, 2.95 mmol). The mixture was stirred for 10 min before heating to 50 °C and heating for 
an additional 30 min or until the mixture became homogeneous. A solution of 4.277   (187 mg, 
0.98 mmol) in toluene (10 mL) was then added and the mixture was stirred for 1 h at 50 °C, 
whereupon the reaction was cooled to room temperature and poured into cold 1 M HCl (20 mL). 
The layers were separated and the aqueous layer was extracted with EtOAc (3 x 10 mL). The 
combined organic layers were dried (Na2SO4), filtered, and concentrated under reduced pressure. 
The crude oil was purified by flash chromatography eluting with a gradient of MeCN/HCCl3 
(1:20 → 1:10) buffered with 2% AcOH to provide 262 mg (79%) of 4.295 as a yellow oil: 1H-
NMR (600 MHz) δ 7.50 (m, 1 H), 7.16 (comp, 3 H), 7.01 (m, 2 H), 6.92 (m, 1 H), 6.85 (m, 1 H), 
6.09 (app d, 1 H), 4.65 (m, 1 H), 3.98 (app d, 3 H), 3.67-3.60 (comp, 2 H), 2.64 (s, 3 H); 13C-
NMR (150 MHz) δ 175.9, 161.8, 160.9, 140.1, 140.0, 138.3, 133.4, 129.5, 128.6, 126.7, 117.5, 
113.8, 107.3, 106.6, 61.3, 56.0, 34.4, 20.8;  IR (film) 3443 (O-H), 2924 (C-H), 1730 (C=O), 
1653 (C=O), 1602, 1561, 1481, 1455, 1399, 1335, 1296, 1267, 1212, 1180, 1154, 1115, 1084, 
1065 cm-1; HRMS (ESI) m/z calc for NaC20H19NO4
+ (M+Na), 360.1206; found, 360.1208. 
NMR assignments: 1H-NMR (600 MHz) δ 7.50 (m, 1 H, C3-H), 7.16 (comp, 3 H, C17-
H, C18-H), 7.01 (m, 2 H, C16-H), 6.92 (m, 1 H, C4-H), 6.85 (m, 1 H, C2-H), 6.09 (app d, 1 H, 
C9-H), 4.65 (m, 1 H, C12-H), 3.98 (app d, 3 H, C7-H), 3.67-3.60 (comp, 2 H, C14-H), 2.64 (s, 3 
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H, C11-H); 13C-NMR (150 MHz) δ 175.9 (C13), 161.8 (C8), 160.9 (C1), 140.1 (C10), 140.0 
(C15), 138.3 (C5), 133.4 (C3), 129.5 (C16), 128.6 (C17) 126.7 (C18), 117.5 (C4), 113.8 (C6), 




acid. (SB-VII-227). N-Bromosuccinimide (NBS) (9 mg, 0.049 mmol) was added to a slurry of 
4.295 (16 mg, 0.044 mmol), Ph3P=S (1 mg, 0.004 mmol) and NaHCO4 (6 mg, 0.67 mmol) in 
THF (0.5 mL) at room temperature. The reaction mixture was stirred for 5 h whereupon a 
solution of saturated aqueous Na2S2O8 (0.5 mL) was added followed by cold 1 M HCl (0.5 mL). 
The layers were separated and the aqueous layer was extracted with CH2Cl2 (1 mL) and the 
organic layers were combined, dried (Na2SO4), filtered, and concentrated under reduced 
pressure. The crude material was purified by preparative TLC (10% MeCN/HCCl3 w/ 2% 
AcOH) to provide 16 mg (90%) of the named compound as a white solid: 1H-NMR (600 MHz) δ 
8.91 (bs, 1 H), 7.64 (t, J = 8.2 Hz, 1 H), 7.56 (d, J = 8.2 Hz, 1 H), 7.27-7.19 (comp, 3 H), 7.02 
(m, 2 H), 6.97 (d, J = 8.2 Hz, 1 H), 4.80 (bd, J = 6.5 Hz, 1 H), 4.00 (s, 3 H), 3.72-3.57 (comp, 2 
H), 1.26 (s, 3 H); 13C-NMR (150 MHz) δ 175.8, 161.1, 160.6, 139.3, 138.4, 138.0, 134.1, 129.4, 
128.7, 126.9, 118.6, 113.8, 108.7, 102.5, 62.6, 56.4, 34.6, 21.4;  IR (film) 3474 (O-H), 3211 (C-
H), 1776, 1712 (C=O), 1645, 1599, 1430, 1356, 1295, 1265, 1244, 1183 cm-1; HRMS (ESI) m/z 
calc for NaC20H18BrNO4
+ (M+Na), 438.0311; found, 438.0308. 
NMR assignments: 1H-NMR (600 MHz) δ 8.91 (bs, 1 H, O-H), 7.64 (t, J = 8.2 Hz, 1 H, 
C3-H), 7.56 (d, J = 8.2 Hz, 1 H, C4-H), 7.27-7.19 (comp, 3 H, C17-H, C18-H), 7.02 (m, 2 H, 
C16-H), 6.97 (d, J = 8.2 Hz, 1 H, C2-H), 4.80 (bd, J = 6.5 Hz, 1 H, C12-H), 4.00 (s, 3 H, C7-H), 
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3.72-3.57 (comp, 2 H, C14-H), 1.26 (s, 3 H, C11-H); 13C-NMR (150 MHz) δ 175.8 (C13), 161.1 
(C8), 160.6 (C1), 139.3 (C10), 138.4 (C15), 138.0 (C5), 134.1 (C3), 129.4 (C16), 128.7 (C17), 




b]isoquinoline-2,5(3H)-dione  (4.294). (SB-VII–207A). Isolated from a sample of 4.295 which 
was left on the bench at room temperature for ~ 1 week. Purified via preparative TLC (50% 
EtOAc/hexanes) to provide 9 mg (10%) of 4.294 as a white solid: 1H-NMR (600 MHz) δ 7.40 
(dd, J = 7.5, 8.5 Hz, 1 H), 7.27-7.20 (comp, 5 H), 6.96 (d, J = 8.6 Hz, 1 H), 6.76 (d, J = 7.4 Hz, 1 
H), 4.97 (dd, J = 2.6, 6.4 Hz, 1 H), 3.95 (s, 3 H), 3.52 (dd, J = 6.4, 13.9 Hz, 1 H), 3.42 (dd, J = 
2.6, 13.9 Hz, 1 H), 3.16 (d, J = 14.6 Hz, 1 H), 3.05 (d, J = 14.7 Hz, 1 H), 0.53 (d, J = 1.0 Hz, 3 
H); 13C-NMR (150 MHz) δ 171.3, 161.0, 159.9, 136.3, 136.0, 133.7, 130.5, 128.6, 127.3, 120.2, 
116.5, 111.9, 94.2, 69.6, 58.0, 56.3, 53.8, 24.6;  IR (film) 3436, 1729 (C=O), 1666 (C=O), 1599, 
1571, 1478, 1434, 1319, 1282, 1262, 1163, 1089, 1039, 980 cm-1; HRMS (CI) m/z calc for 
C20H19NO4
+ (M+), 337.1314; found, 337.131. 
NMR assignments: 1H-NMR (600 MHz) δ 7.40 (dd, J = 7.5, 8.5 Hz, 1 H, C3-H), 7.27-
7.20 (comp, 5 H, C16-H, C17-H, C18-H), 6.96 (d, J = 8.6 Hz, 1 H, C4-H), 6.76 (d, J = 7.4 Hz, 1 
H, C2-H), 4.97 (dd, J = 2.6, 6.4 Hz, 1 H, C12-H), 3.95 (s, 3 H, C7-H), 3.52 (dd, J = 6.4, 13.9 Hz, 
1 H, C14-H), 3.42 (dd, J = 2.6, 13.9 Hz, 1 H, C14-H), 3.16 (d, J = 14.6 Hz, 1 H, C9-H), 3.05 (d, 
J = 14.7 Hz, 1 H, C9-H), 0.53 (d, J = 1.0 Hz, 3 H, C11-H); 13C-NMR (150 MHz) δ 171.3 (C13), 
161.0 (C8), 159.9 (C1), 136.3 (C15), 136.0 (C5), 133.7 (C3), 130.5 (C17), 128.6 (C16), 127.3 
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(C18), 120.2 (C4), 116.5 (C6), 111.9 (C2), 94.2 (C10), 69.6 (C12), 58.0 (C9), 56.3 (C14), 53.8 





General procedure for titrating strong bases.  
To a solution of 4-(Phenylazo)diphenylamine (PDA) (4.118) (0.02–0.05 mmol) in 
Anhydrous THF (3 mL) was added 2-butanol or BHT  (~1 mmol). A solution of the base is then 
added at room temperature until the colored endpoint is reached. The titre is calculated using a 
1:1 molar ratio with the proton source. 
General procedure for titrating Lewis acids.  
To a solution of 4-(Phenylazo)diphenylamine (PDA) (4.118) (0.02–0.05 mmol) in 
anhydrous CH2Cl2 (3 mL) was added pyridine  (1 eq). A solution of the Lewis acid is then added 
at room temperature until the colored endpoint is reached. The titre is calculated using either a 
1:1 molar ratio of Lewis acid to pyridine for the weaker Lewis acids such as AlR3,AlR2H or 
R2AlX or a 1:2 molar ratio of Lewis acid to pyridine for the stronger Lewis acids such as R2BX 
or MXn. 
General procedure for titrating hydride reducing agents.  
To a solution of 4-(Phenylazo)diphenylamine (PDA) (4.118) (0.02–0.05 mmol) in 
anhydrous ether or CH2Cl2 (3 mL) was added benzophenone (1 eq). A solution of the reducing 
agent is then added at room temperature until the colored endpoint is reached. The titre is 
calculated using a 1:N molar ratio of benzophenone to active hydride in the reducing agent, 





Figure 5.1 View of 2.13 showing the atom labeling scheme.   
Displacement ellipsoids are scaled to the 50% probability level. 
X-ray Experimental for C18H24O7S:   Crystals grew as colorless plates by slow vapor 
diffusion from ethylacetate and pentanes.  The data crystal was cut from a larger crystal and had 
approximate dimensions; 0.20 x 0.20 x 0.06 mm.  The data were collected on a Nonius Kappa 
CCD diffractometer using a graphite monochromator with MoKa radiation (l = 0.71073Å).  A 
total of 340 frames of data were collected using w-scans with a scan range of 1.3° and a counting 
time of 186 seconds per frame.  The data were collected at 153 K using an Oxford Cryostream 
low temperature device.  Details of crystal data, data collection, and structure refinement are 
listed in Table 1.  Data reduction were performed using DENZO-SMN.637  The structure was 
solved by direct methods using SIR97638 and refined by full-matrix least-squares on F2 with 
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anisotropic displacement parameters for the non-H atoms using SHELXL-97.639  Structure 
analysis was aided by use of the programs PLATON98640 and WinGX.641  The hydrogen atoms 
calculated in idealized position with Uiso set to 1.2xUeq of the attached atom (1.5xUeq for 
methyl hydrogen atoms).   The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 
1/[(s(Fo))2 + (0.0494*P)2 + (1.6931*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.148, 
with R(F) equal to 0.0609 and a goodness of fit, S, = 1.07.  Definitions used for calculating 
R(F),Rw(F2) and the goodness of fit, S, are given below.636  The data were checked for 
secondary extinction but no correction was necessary.  Neutral atom scattering factors and values 
used to calculate the linear absorption coefficient are from the International Tables for X-ray 
Crystallography (1992).637  All figures were generated using SHELXTL/PC.638  Tables of 
positional and thermal parameters, bond lengths and angles, torsion angles and figures are found 
elsewhere. 
 Table 5.1.  Crystal data and structure refinement for 2.13. 
 
Empirical formula  C18 H24 O7 S  
Formula weight  384.43  
Temperature  153(2) K  
Wavelength  0.71075 Å  
Crystal system  Monoclinic  
Space group  P21/n  
Unit cell dimensions a = 8.4314 Å α= 90° 
 b = 9.5852 Å β= 90.343(3)° 
 c = 23.175(2) Å γ = 90° 
Volume 1872.9(4) Å3  
Z 4  
Density (calculated) 1.363 Mg/m3  
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Absorption coefficient 0.210 mm-1  
F 816  
Crystal size 0.20 x 0.20 x 0.06 mm  
Theta range for data collection 3.22 to 25.00°.  
Index ranges -9<=h<=10,-11<=k<=11, -
27<=l<=27 
 
Reflections collected 10495  
Independent reflections 3274 [R(int) = 0.0665]  
Completeness to theta = 25.00° 99.6 %   
Absorption correction None  
Refinement method Full-matrix least-squares on F2  
Data / restraints / parameters 3274 / 0 / 238  
Goodness-of-fit on F2 1.069  
Final R indices [I>2sigma(I)] R1 = 0.0609, wR2 = 0.1207  
R indices (all data) R1 = 0.1268, wR2 = 0.1479  
Largest diff. peak and hole 0.212 and -0.279 e.Å-3  
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 Table 5.2 Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for 2.13.   
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
S1 3886(1) 7716(1) 9658(1) 49(1) 
O1 3470(3) 6581(3) 9289(1) 57(1) 
O2 3201(3) 7768(3) 10219(1) 61(1) 
O3 3391(3) 9135(3) 9364(1) 51(1) 
O4 6804(2) 7288(2) 8798(1) 44(1) 
O5 9840(4) 3046(4) 7798(2) 105(1) 
O6 6012(3) 3055(3) 8226(1) 68(1) 
O7 3429(3) 11858(3) 8834(1) 65(1) 
C1 4035(4) 9365(4) 8781(2) 51(1) 
C2 5785(4) 9669(4) 8843(2) 51(1) 
C3 6694(4) 8536(4) 9138(1) 45(1) 
C4 5978(4) 7909(4) 9709(1) 42(1) 
C5 6818(4) 6485(4) 9741(1) 45(1) 
C6 7847(4) 6503(4) 9178(1) 42(1) 
C7 9127(4) 7589(4) 9304(1) 48(1) 
C8 8426(4) 8808(4) 9289(2) 51(1) 
C9 8191(4) 5088(4) 8930(1) 43(1) 
C10 8656(4) 5009(4) 8286(2) 55(1) 
C11 9469(5) 3581(5) 8251(2) 73(1) 
C12 9773(5) 3033(4) 8856(2) 69(1) 
C13 9513(4) 4288(4) 9246(2) 52(1) 
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C14 7248(4) 5120(5) 7864(2) 62(1) 
C15 5854(5) 4196(5) 7992(2) 61(1) 
C16 4241(6) 4736(6) 7845(3) 109(2) 
C17 9908(5) 6102(5) 8124(2) 71(1) 
C18 3102(5) 10592(4) 8536(2) 58(1) 
 
     
Table 5.3   Bond lengths [Å] and angles [°] for 2.13. 
  
S1-O1  1.426(3) H2A-C2-H2B 107.7 
S1-O2  1.427(2) O4-C3-C2 112.9(3) 
S1-O3  1.576(3) O4-C3-C8 101.8(3) 
S1-C4  1.776(3) C2-C3-C8 118.0(3) 
O3-C1  1.475(4) O4-C3-C4 99.8(3) 
O4-C3  1.436(4) C2-C3-C4 117.6(3) 
O4-C6  1.452(4) C8-C3-C4 104.1(3) 
O5-C11  1.210(5) C5-C4-C3 101.6(2) 
O6-C15  1.229(5) C5-C4-S1 111.5(2) 
O7-C18  1.422(4) C3-C4-S1 111.7(2) 
O7-H7O  0.84 C5-C4-H4 110.6 
C1-C2  1.510(5) C3-C4-H4 110.6 
C1-C18  1.523(5) S1-C4-H4 110.6 
C1-H1  1.00 C4-C5-C6 101.9(3) 
C2-C3  1.493(5) C4-C5-H5A 111.4 
C2-H2A  0.99 C6-C5-H5A 111.4 
C2-H2B  0.99 C4-C5-H5B 111.4 
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C3-C8  1.523(5) C6-C5-H5B 111.4 
C3-C4  1.576(5) H5A-C5-H5B 109.3 
C4-C5  1.540(5) O4-C6-C9 110.7(3) 
C4-H4  1.0000 O4-C6-C7 100.8(3) 
C5-C6  1.571(4) C9-C6-C7 123.4(3) 
C5-H5A  0.99 O4-C6-C5 100.0(2) 
C5-H5B  0.99 C9-C6-C5 114.6(3) 
C6-C9  1.502(5) C7-C6-C5 104.0(3) 
C6-C7  1.526(5) C8-C7-C6 106.6(3) 
C7-C8  1.310(5) C8-C7-H7 126.7 
C7-H7  0.95 C6-C7-H7 126.7 
C8-H8  0.95 C7-C8-C3 106.6(3) 
C9-C13  1.535(5) C7-C8-H8 126.7 
C9-C10  1.547(5) C3-C8-H8 126.7 
C9-H9  1.0000 C6-C9-C13 114.2(3) 
C10-C11  1.533(6) C6-C9-C10 117.7(3) 
C10-C17  1.535(5) C13-C9-C10 104.4(3) 
C10-C14  1.538(5) C6-C9-H9 106.6 
C11-C12  1.516(6) C13-C9-H9 106.6 
C12-C13  1.522(5) C10-C9-H9 106.6 
C12-H12A  0.99 C11-C10-C17 106.7(3) 
C12-H12B  0.99 C11-C10-C14 111.8(3) 
C13-H13A  0.99 C17-C10-C14 109.1(3) 
C13-H13B  0.99 C11-C10-C9 102.2(3) 
C14-C15  1.502(6) C17-C10-C9 112.4(3) 
C14-H14A  0.99 C14-C10-C9 114.3(3) 
C14-H14B  0.99 O5-C11-C12 127.7(4) 
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C15-C16  1.492(6) O5-C11-C10 122.8(5) 
C16-H16A  0.98 C12-C11-C10 109.5(3) 
C16-H16B  0.98 C11-C12-C13 104.6(3) 
C16-H16C  0.98 C11-C12-H12A 110.8 
C17-H17A  0.98 C13-C12-H12A 110.8 
C17-H17B  0.98 C11-C12-H12B 110.8 
C17-H17C  0.98 C13-C12-H12B 110.8 
C18-H18A  0.99 H12A-C12-H12B  108.9 
C18-H18B  0.99 C12-C13-C9 102.6(3) 
O1-S1-O2 118.31 C12-C13-H13A 111.3 
O1-S1-O3 109.61 C9-C13-H13A 111.3 
O2-S1-O3 104.78 C12-C13-H13B 111.3 
O1-S1-C4 111.12 C9-C13-H13B 111.3 
O2-S1-C4 110.05 H13A-C13-H13B  109.2 
O3-S1-C4 101.45 C15-C14-C10 115.8(3) 
C1-O3-S1 115.2(2) C15-C14-H14A 108.3 
C3-O4-C6 98.0(2) C10-C14-H14A 108.3 
C18-O7-H7O 109.5 C15-C14-H14B 108.3 
O3-C1-C2 107.9(3) C10-C14-H14B 108.3 
O3-C1-C18 105.4(3) H14A-C14-H14B  107.4 
C2-C1-C18 112.8(3) O6-C15-C16 120.4(4) 
O3-C1-H1 110.2 O6-C15-C14 122.0(4) 
C2-C1-H1 110.2 C16-C15-C14 117.6(4) 
C18-C1-H1 110.2 C15-C16-H16A 109.5 
C3-C2-C1 113.7(3) C15-C16-H16B 109.5 
C3-C2-H2A 108.8 H16A-C16-H16B  109.5 
C1-C2-H2A 108.8 C15-C16-H16C 109.5 
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C3-C2-H2B 108.8 H16A-C16-H16C  109.5 




 Table 5.4   Anisotropic displacement parameters (Å2x 103) for 2.13.   
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 
h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
S1 40(1)  62(1) 46(1)  3(1) 8(1)  6(1) 
O1 49(2)  57(2) 65(2)  -4(1) -1(1)  1(1) 
O2 52(2)  82(2) 48(2)  8(1) 19(1)  8(1) 
O3 43(1)  65(2) 46(2)  5(1) 11(1)  13(1) 
O4 40(1)  58(2) 34(1)  5(1) 4(1)  14(1) 
O5 77(2)  129(3) 108(3)  -60(2) 18(2)  20(2) 
O6 66(2)  70(2) 67(2)  -8(2) -9(1)  8(2) 
O7 57(2)  69(2) 68(2)  5(2) 4(1)  17(1) 
C1 49(2)  66(3) 39(2)  1(2) 5(2)  17(2) 
C2 49(2)  59(3) 46(2)  8(2) 11(2)  18(2) 
C3 42(2)  49(2) 43(2)  0(2) 9(2)  10(2) 
C4 39(2)  53(2) 34(2)  2(2) 5(2)  4(2) 
C5 43(2)  58(2) 34(2)  2(2) 1(2)  6(2) 
C6 39(2)  49(2) 38(2)  3(2) 2(2)  9(2) 
C7 38(2)  59(3) 47(2)  4(2) 4(2)  5(2) 
C8 43(2)  52(3) 58(2)  7(2) 10(2)  2(2) 
C9 36(2)  53(2) 41(2)  0(2) 3(2)  8(2) 
C10 49(2)  70(3) 47(2)  -13(2) 9(2)  8(2) 
C11 50(2)  86(3) 83(3)  -31(3) 12(2)  5(2) 
C12 48(2)  61(3) 99(3)  -8(3) 1(2)  18(2) 
C13 46(2)  51(2) 61(2)  -1(2) -3(2)  11(2) 
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C14 62(3)  86(3) 38(2)  -4(2) 8(2)  8(2) 
C15 69(3)  66(3) 48(2)  -10(2) -8(2)  13(2) 
C16 75(3)  112(5) 140(5)  40(4) -33(3)  9(3) 
C17 65(3)  95(4) 54(3)  -6(2) 25(2)  0(2) 
C18 54(2)  70(3) 50(2)  -3(2) 1(2)  16(2) 
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 Table 5.5   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) for 
2.13. 
    
 
 x y z U(eq) 
H7O 4126 12308 8656 97 
H1 3866 8517 8537 62 
H2A 6236 9817 8454 62 
H2B 5921 10545 9063 62 
H4 6271 8499 10049 51 
H5A 6045 5707 9735 54 
H5B 7490 6410 10091 54 
H7 10218 7414 9379 58 
H8 8906 9689 9359 61 
H9 7201 4524 8973 52 
H12A 10871 2678 8894 83 
H12B 9024 2273 8950 83 
H13A 10488 4859 9280 63 
H13B 9172 3996 9636 63 
H14A 6877 6100 7859 74 
H14B 7631 4898 7471 74 
H16A 3477 3966 7852 164 
H16B 4255 5153 7459 164 
H16C 3932 5444 8128 164 
H17A 10261 5938 7727 106 
H17B 10816 6027 8388 106 
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H17C 9446 7037 8153 106 
H18A 3369 10709 8124 70 
H18B 1954 10387 8561 70 
 
 
Table 5.6  Torsion angles [°] for 2.13. 
 
O1-S1-O3-C1 -55.1(3) C5-C6-C7-C8 -71.9(3) 
O2-S1-O3-C1 177.0(2) C6-C7-C8-C3 -1.5(4) 
C4-S1-O3-C1 62.5(3) O4-C3-C8-C7 -29.4(4) 
S1-O3-C1-C2 -72.3(3) C2-C3-C8-C7 -153.5(3) 
S1-O3-C1-C18 166.9(2) C4-C3-C8-C7 74.0(3) 
O3-C1-C2-C3 58.0(4) O4-C6-C9-C13 169.6(3) 
C18-C1-C2-C3 174.0(3) C7-C6-C9-C13 50.3(4) 
C6-O4-C3-C2 174.9(3) C5-C6-C9-C13 -78.2(4) 
C6-O4-C3-C8 47.4(3) O4-C6-C9-C10 46.7(4) 
C6-O4-C3-C4 -59.4(3) C7-C6-C9-C10 -72.6(4) 
C1-C2-C3-O4 69.0(4) C5-C6-C9-C10 158.9(3) 
C1-C2-C3-C8 -172.6(3) C6-C9-C10-C11 160.4(3) 
C1-C2-C3-C4 -46.4(4) C13-C9-C10-C11 32.7(4) 
O4-C3-C4-C5 36.4(3) C6-C9-C10-C17 46.4(4) 
C2-C3-C4-C5 158.8(3) C13-C9-C10-C17 -81.3(4) 
C8-C3-C4-C5 -68.5(3) C6-C9-C10-C14 -78.6(4) 
O4-C3-C4-S1 -82.5(3) C13-C9-C10-C14 153.7(3) 
C2-C3-C4-S1 39.8(4) C17-C10-C11-O5 -71.1(5) 
C8-C3-C4-S1 172.6(2) C14-C10-C11-O5 48.1(5) 
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O1-S1-C4-C5 -39.7(3) C9-C10-C11-O5 170.7(4) 
O2-S1-C4-C5 93.3(2) C17-C10-C11-C12 106.3(4) 
O3-S1-C4-C5 -156.2(2) C14-C10-C11-C12 -134.5(3) 
O1-S1-C4-C3 73.1(3) C9-C10-C11-C12 -11.8(4) 
O2-S1-C4-C3 -153.9(2) O5-C11-C12-C13 163.7(4) 
O3-S1-C4-C3 -43.3(3) C10-C11-C12-C13 -13.6(4) 
C3-C4-C5-C6 -1.3(3) C11-C12-C13-C9 33.6(4) 
S1-C4-C5-C6 117.7(2) C6-C9-C13-C12 -171.7(3) 
C3-O4-C6-C9 179.8(3) C10-C9-C13-C12 -41.8(4) 
C3-O4-C6-C7 -48.0(3) C11-C10-C14-C15 66.9(4) 
C3-O4-C6-C5 58.6(3) C17-C10-C14-C15 -175.3(3) 
C4-C5-C6-O4 -33.7(3) C9-C10-C14-C15 -48.5(5) 
C4-C5-C6-C9 -152.1(3) C10-C14-C15-O6 -30.9(5) 
C4-C5-C6-C7 70.3(3) C10-C14-C15-C16 146.6(4) 
O4-C6-C7-C8 31.4(3) O3-C1-C18-O7 67.1(4) 





 Table 5.7  Hydrogen bonds for 2.13 [Å and °]. 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O7-H7O...O6#1 0.84 2.01 2.843(4) 170 
  
Symmetry transformations used to generate equivalent atoms: #1 x,y+1,z 
 
 
Figure 5.2 View of molecule 1 of 2.14 showing the atom labeling scheme.   




Figure 5.3 View of molecule 2 of 2.14 showing the atom labeling scheme.   
Displacement ellipsoids are scaled to the 50% probability level. 
  
 
Figure 5.4 View of the fit by least-squares of selected atoms of molecule 2 (dashed lines) onto 
the equivalent atoms of molecule 1 (solid lines).  The coordinates of molecule 2 







X-ray Experimental for C21H30SSiO6:  Crystals grew as colorless prisms by slow 
evaporation from ethyl acetate, pentane and chloroform.  The data crystal was cut from a larger 
crystal and had approximate dimensions; 0.36 x 0.26 x 0.17 mm.  The data were collected on a 
Rigaku AFC12 diffractometer with a Saturn 724+ CCD using a graphite monochromator with 
MoKα radiation (λ = 0.71073Å).  A total of 1398 frames of data were collected using ω-scans 
with a scan range of 0.5° and a counting time of 10 seconds per frame.  The data were collected 
at 100 K using a Rigaku XStream low temperature device.  Details of crystal data, data collection 
and structure refinement are listed in Table 1.  Data reduction were performed using the Rigaku 
Americas Corporation’s Crystal Clear version 1.40.637  The structure was solved by direct 
methods using SIR97638 and refined by full-matrix least-squares on F2 with anisotropic 
displacement parameters for the non-H atoms using SHELXL-97.639  Structure analysis was 
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aided by use of the programs PLATON98640 and WinGX.641  The hydrogen atoms were 
calculated in ideal positions with isotropic displacement parameters set to 1.2xUeq of the 
attached atom (1.5xUeq for methyl hydrogen atoms).  The function, Σw(|Fo|2 - |Fc|2)2, was 
minimized, where w = 1/[(σ(Fo))2 + (0.0564*P)2 + (1.3034*P)] and P = (|Fo|2 + 2|Fc|2)/3.  
Rw(F2) refined to 0.134, with R(F) equal to 0.0487 and a goodness of fit, S, = 1.06.  Definitions 
used for calculating R(F), Rw(F2) and the goodness of fit, S, are given below.636  The data were 
checked for secondary extinction effects but no correction was necessary.  Neutral atom 
scattering factors and values used to calculate the linear absorption coefficient are from the 
International Tables for X-ray Crystallography (1992).637  All figures were generated using 
SHELXTL/PC.638  Tables of positional and thermal parameters, bond lengths and angles, torsion 
angles and figures are found elsewhere. 
Table 5.8 Crystal data and structure refinement for 2.14. 
 
Empirical formula  C21 H30 O6 S Si  
Formula weight  438.60  
Temperature  100(2) K  
Wavelength  0.71075 Å  
Crystal system  Triclinic  
Space group  P-1  
Unit cell dimensions a = 11.8357 Å α= 96.830(2)°. 
 b = 12.829(2) Å β= 98.351(2)°. 
 c = 17.194(2) Å γ = 115.442(3)°. 
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Volume 2284.0(5) Å3  
Z 4  
Density (calculated) 1.275 Mg/m3  
Absorption coefficient 0.227 mm-1  
F 936  
Crystal size 0.36 x 0.26 x 0.17 mm  
Theta range for data 
collection 




Reflections collected 36450  
Independent reflections 10405 [R(int) = 0.0752]  
Completeness to theta = 
27.48° 
99.2 %   
Absorption correction Semi-empirical from 
equivalents 
 
Max. and min. 
transmission 
1.00 and 0.809  




Data / restraints / 
parameters 
10405 / 0 / 533  
Goodness-of-fit on F2 1.060  
Final R indices 
[I>2sigma(I)] 
R1 = 0.0487, wR2 = 0.1283  
R indices (all data) R1 = 0.0567, wR2 = 0.1338  
Largest diff. peak and 
hole 
0.651 and -0.370 e.Å-3  
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 Table 5.9  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for 2.14.   
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
S1 8781(1) 4254(1) 6266(1) 23(1) 
Si1 8017(1) 8061(1) 4594(1) 25(1) 
O1 7938(1) 3763(1) 6891(1) 23(1) 
O2 9996(1) 4327(1) 6601(1) 32(1) 
O3 8718(1) 5291(1) 6094(1) 30(1) 
O4 6226(1) 3265(1) 4827(1) 19(1) 
O5 6729(2) 4280(2) 8059(1) 39(1) 
O6 4856(1) 4602(1) 2152(1) 34(1) 
C1 8000(2) 3069(2) 5416(1) 21(1) 
C2 8210(2) 3498(2) 4622(1) 22(1) 
C3 6795(2) 3087(2) 4167(1) 19(1) 
C4 6206(2) 1745(2) 3959(1) 25(1) 
C5 6046(2) 1392(2) 4641(1) 25(1) 
C6 6491(2) 2496(2) 5282(1) 20(1) 
C7 5909(2) 2385(2) 6006(1) 23(1) 
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C8 6574(2) 3485(2) 6663(1) 23(1) 
C9 6068(2) 3298(2) 7417(1) 30(1) 
C10 6667(2) 3795(2) 3549(1) 19(1) 
C11 5322(2) 3683(2) 3232(1) 21(1) 
C12 5520(2) 4208(2) 2483(1) 25(1) 
C13 6656(2) 4160(2) 2213(1) 29(1) 
C14 7108(2) 3523(2) 2783(1) 24(1) 
C15 4273(2) 2402(2) 2946(1) 27(1) 
C16 4865(2) 4355(2) 3809(1) 24(1) 
C17 5790(2) 5605(2) 4070(1) 23(1) 
C18 6613(2) 6608(2) 4261(1) 26(1) 
C19 7931(2) 8798(2) 5558(2) 45(1) 
C20 8012(2) 8942(2) 3804(2) 44(1) 
C21 9447(2) 7790(2) 4693(2) 51(1) 
S2 12202(1) 9169(1) 2553(1) 24(1) 
Si2 9273(1) 11913(1) 1764(1) 27(1) 
O7 13328(1) 9317(1) 2112(1) 26(1) 
O8 11758(1) 10007(1) 2389(1) 28(1) 
O9 12689(1) 9176(1) 3365(1) 32(1) 
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O10 10053(1) 7994(1) 894(1) 22(1) 
O11 5363(2) 7717(2) -230(1) 43(1) 
O12 15104(2) 10927(1) 1309(1) 42(1) 
C22 11014(2) 7721(2) 2073(1) 23(1) 
C23 9664(2) 7552(2) 2132(1) 26(1) 
C24 8995(2) 7270(2) 1223(1) 23(1) 
C25 8841(2) 6041(2) 906(1) 28(1) 
C26 9999(2) 6179(2) 867(1) 29(1) 
C27 10891(2) 7493(2) 1140(1) 24(1) 
C28 12108(2) 7993(2) 836(1) 27(1) 
C29 13016(2) 9264(2) 1240(1) 27(1) 
C30 14273(2) 9721(2) 971(1) 36(1) 
C31 7917(2) 7607(2) 1080(1) 25(1) 
C32 7354(2) 7598(2) 212(1) 26(1) 
C33 6046(2) 7540(2) 280(1) 33(1) 
C34 5741(2) 7227(2) 1065(2) 39(1) 
C35 6744(2) 6852(2) 1405(1) 33(1) 
C36 7070(2) 6481(2) -394(1) 38(1) 
C37 8158(2) 8691(2) -114(1) 27(1) 
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C38 8467(2) 9800(2) 424(1) 25(1) 
C39 8739(2) 10678(2) 910(1) 27(1) 
C40 8278(3) 11318(2) 2498(2) 42(1) 
C41 9054(2) 13148(2) 1423(1) 35(1) 
C42 10992(2) 12402(2) 2206(2) 44(1) 
 
Table 5.10  Bond lengths [Å] and angles [°] for 2.14. 
 
S1-O3  1.4273 C36-H36A  0.98 
S1-O2  1.4283 C36-H36B  0.98 
S1-O1  1.5749 C36-H36C  0.98 
S1-C1  1.7810 C37-C38  1.468(3) 
Si1-C18  1.836(2) C37-H37A  0.99 
Si1-C19  1.846(2) C37-H37B  0.99 
Si1-C21  1.858(2) C38-C39  1.206(3) 
Si1-C20  1.868(3) C40-H40A  0.98 
O1-C8  1.474(2) C40-H40B  0.98 
O4-C6  1.435(2) C40-H40C  0.98 
O4-C3  1.443(2) C41-H41A  0.98 
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O5-C9  1.411(3) C41-H41B  0.98 
O5-H5  0.84 C41-H41C  0.98 
O6-C12  1.215(2) C42-H42A  0.98 
C1-C2  1.545(2) C42-H42B  0.98 
C1-C6  1.580(2) C42-H42C  0.98 
C1-H1  1 O3-S1-O2 119.16(9) 
C2-C3  1.567(2) O3-S1-O1 109.60(8) 
C2-H2A  0.99 O2-S1-O1 104.29(8) 
C2-H2B  0.99 O3-S1-C1 111.17(9) 
C3-C10  1.510(2) O2-S1-C1 109.20(9) 
C3-C4  1.527(2) O1-S1-C1 101.81(8) 
C4-C5  1.315(3) C18-Si1-C19 109.40 
C4-H4  0.95 C18-Si1-C21 106.31 
C5-C6  1.523(3) C19-Si1-C21 111.88 
C5-H5A  0.95 C18-Si1-C20 108.18 
C6-C7  1.502(3) C19-Si1-C20 110.69 
C7-C8  1.515(3) C21-Si1-C20 110.22 
C7-H7A  0.99 C8-O1-S1 116.56 
C7-H7B  0.99 C6-O4-C3 97.59 
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C8-C9  1.508(3) C9-O5-H5 109.5 
C8-H8  1 C2-C1-C6 101.41 
C9-H9A  0.99 C2-C1-S1 111.96 
C9-H9B  0.99 C6-C1-S1 112.32 
C10-C14  1.540(3) C2-C1-H1 110.3 
C10-C11  1.545(2) C6-C1-H1 110.3 
C10-H10  1 S1-C1-H1 110.3 
C11-C12  1.525(3) C1-C2-C3 101.32 
C11-C15  1.537(2) C1-C2-H2A 111.5 
C11-C16  1.540(3) C3-C2-H2A 111.5 
C12-C13  1.509(3) C1-C2-H2B 111.5 
C13-C14  1.526(3) C3-C2-H2B 111.5 
C13-H13A  0.99 H2A-C2-H2B 109.3 
C13-H13B  0.99 O4-C3-C10 111.32 
C14-H14A  0.99 O4-C3-C4 101.41 
C14-H14B  0.99 C10-C3-C4 121.77 
C15-H15A  0.98 O4-C3-C2 100.78 
C15-H15B  0.98 C10-C3-C2 114.17 
C15-H15C  0.98 C4-C3-C2 104.73 
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C16-C17  1.466(3) C5-C4-C3 105.81 
C16-H16A  0.99 C5-C4-H4 127.1 
C16-H16B  0.99 C3-C4-H4 127.1 
C17-C18  1.201(3) C4-C5-C6 106.54 
C19-H19A  0.98 C4-C5-H5A 126.7 
C19-H19B  0.98 C6-C5-H5A 126.7 
C19-H19C  0.98 O4-C6-C7 112.03 
C20-H20A  0.98 O4-C6-C5 101.87 
C20-H20B  0.98 C7-C6-C5 118.28 
C20-H20C  0.98 O4-C6-C1 100.62 
C21-H21A  0.98 C7-C6-C1 118.35 
C21-H21B  0.98 C5-C6-C1 103.08 
C21-H21C  0.98 C6-C7-C8 113.58 
S2-O8  1.4230 C6-C7-H7A 108.8 
S2-O9  1.4277 C8-C7-H7A 108.8 
S2-O7  1.5808 C6-C7-H7B 108.8 
S2-C22  1.7789 C8-C7-H7B 108.8 
Si2-C39  1.840(2) H7A-C7-H7B 107.7 
Si2-C41  1.857(2) O1-C8-C9 105.70 
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Si2-C42  1.858(3) O1-C8-C7 108.11 
Si2-C40  1.858(2) C9-C8-C7 112.21 
O7-C29  1.477(2) O1-C8-H8 110.2 
O10-C27  1.437(2) C9-C8-H8 110.2 
O10-C24  1.444(2) C7-C8-H8 110.2 
O11-C33  1.214(3) O5-C9-C8 113.57 
O12-C30  1.419(3) O5-C9-H9A 108.9 
O12-H12  0.84 C8-C9-H9A 108.9 
C22-C23  1.538(3) O5-C9-H9B 108.9 
C22-C27  1.569(3) C8-C9-H9B 108.9 
C22-H22  1 H9A-C9-H9B 107.7 
C23-C24  1.568(3) C3-C10-C14 113.48 
C23-H23A  0.99 C3-C10-C11 117.72 
C23-H23B  0.99 C14-C10-C11 104.11 
C24-C31  1.510(3) C3-C10-H10 107 
C24-C25  1.528(3) C14-C10-H10 107 
C25-C26  1.317(3) C11-C10-H10 107 
C25-H25  0.95 C12-C11-C15 106.55 
C26-C27  1.522(3) C12-C11-C16 110.89 
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C26-H26  0.95 C15-C11-C16 109.00 
C27-C28  1.505(3) C12-C11-C10 100.96 
C28-C29  1.518(3) C15-C11-C10 113.65 
C28-H28A  0.99 C16-C11-C10 115.22 
C28-H28B  0.99 O6-C12-C13 125.11 
C29-C30  1.511(3) O6-C12-C11 124.94 
C29-H29  1 C13-C12-C11 109.95 
C30-H30A  0.99 C12-C13-C14 105.26 
C30-H30B  0.99 C12-C13-H13A 110.7 
C31-C32  1.540(3) C14-C13-H13A 110.7 
C31-C35  1.542(3) C12-C13-H13B 110.7 
C31-H31  1 C14-C13-H13B 110.7 
C32-C33  1.540(3) H13A-C13-H13B 108.8 
C32-C36  1.543(3) C13-C14-C10 102.86 
C32-C37  1.544(3) C13-C14-H14A 111.2 
C33-C34  1.502(3) C10-C14-H14A 111.2 
C34-C35  1.529(3) C13-C14-H14B 111.2 
C34-H34A  0.99 C10-C14-H14B 111.2 
C34-H34B  0.99 H14A-C14-H14B  109.1 
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C35-H35A  0.99 C11-C15-H15A 109.5 




 Table 5.11   Anisotropic displacement parameters  (Å2x 103) for 2.14.   
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + 
...  + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
S1 18(1)  22(1) 25(1)  7(1) 3(1)  7(1) 
Si1 20(1)  20(1) 31(1)  -2(1) 3(1)  8(1) 
O1 21(1)  28(1) 24(1)  9(1) 4(1)  13(1) 
O2 17(1)  38(1) 34(1)  9(1) 1(1)  8(1) 
O3 37(1)  20(1) 31(1)  7(1) 6(1)  11(1) 
O4 15(1)  19(1) 23(1)  6(1) 5(1)  8(1) 
O5 41(1)  50(1) 29(1)  2(1) 7(1)  25(1) 
O6 36(1)  32(1) 28(1)  5(1) -6(1)  16(1) 
C1 17(1)  20(1) 27(1)  7(1) 5(1)  9(1) 
C2 16(1)  24(1) 25(1)  6(1) 5(1)  8(1) 
C3 14(1)  16(1) 22(1)  3(1) 4(1)  5(1) 
C4 21(1)  17(1) 33(1)  1(1) 6(1)  6(1) 
C5 22(1)  16(1) 37(1)  7(1) 8(1)  6(1) 
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C6 16(1)  18(1) 26(1)  8(1) 4(1)  8(1) 
C7 18(1)  26(1) 28(1)  10(1) 7(1)  10(1) 
C8 21(1)  29(1) 28(1)  11(1) 7(1)  16(1) 
C9 30(1)  40(1) 28(1)  10(1) 10(1)  20(1) 
C10 15(1)  15(1) 23(1)  3(1) 3(1)  4(1) 
C11 16(1)  16(1) 26(1)  3(1) 1(1)  4(1) 
C12 25(1)  18(1) 24(1)  0(1) -4(1)  4(1) 
C13 31(1)  28(1) 24(1)  8(1) 7(1)  10(1) 
C14 21(1)  23(1) 26(1)  5(1) 7(1)  7(1) 
C15 17(1)  19(1) 37(1)  1(1) 0(1)  3(1) 
C16 16(1)  21(1) 32(1)  4(1) 3(1)  8(1) 
C17 22(1)  24(1) 25(1)  3(1) 3(1)  13(1) 
C18 24(1)  24(1) 30(1)  2(1) 3(1)  13(1) 
C19 39(1)  37(1) 44(1)  -8(1) 11(1)  7(1) 
C20 41(1)  34(1) 44(1)  9(1) 7(1)  5(1) 
C21 25(1)  43(1) 75(2)  -10(1) 0(1)  16(1) 
S2 28(1)  19(1) 23(1)  1(1) -1(1)  12(1) 
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Si2 35(1)  23(1) 26(1)  5(1) 7(1)  16(1) 
O7 27(1)  25(1) 25(1)  3(1) -1(1)  13(1) 
O8 29(1)  19(1) 34(1)  3(1) 1(1)  12(1) 
O9 39(1)  30(1) 22(1)  -1(1) -4(1)  17(1) 
O10 27(1)  18(1) 21(1)  6(1) 2(1)  10(1) 
O11 35(1)  41(1) 48(1)  11(1) -6(1)  16(1) 
O12 32(1)  38(1) 41(1)  10(1) 1(1)  6(1) 
C22 31(1)  16(1) 21(1)  4(1) 0(1)  11(1) 
C23 31(1)  20(1) 22(1)  6(1) 3(1)  9(1) 
C24 29(1)  16(1) 22(1)  4(1) 3(1)  7(1) 
C25 38(1)  16(1) 24(1)  3(1) 0(1)  9(1) 
C26 40(1)  18(1) 25(1)  1(1) 0(1)  13(1) 
C27 30(1)  18(1) 23(1)  2(1) 0(1)  13(1) 
C28 35(1)  24(1) 23(1)  2(1) 3(1)  16(1) 
C29 33(1)  25(1) 25(1)  6(1) 2(1)  15(1) 
C30 32(1)  36(1) 38(1)  7(1) 6(1)  15(1) 
C31 30(1)  19(1) 22(1)  4(1) 3(1)  8(1) 
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C32 31(1)  21(1) 22(1)  2(1) -1(1)  11(1) 
C33 29(1)  23(1) 38(1)  3(1) -2(1)  8(1) 
C34 32(1)  39(1) 46(1)  13(1) 10(1)  14(1) 
C35 33(1)  30(1) 36(1)  12(1) 9(1)  11(1) 
C36 49(1)  28(1) 27(1)  -5(1) -9(1)  18(1) 
C37 37(1)  25(1) 20(1)  5(1) 4(1)  17(1) 
C38 28(1)  23(1) 25(1)  10(1) 6(1)  13(1) 
C39 31(1)  24(1) 30(1)  10(1) 10(1)  13(1) 
C40 65(2)  43(1) 40(1)  20(1) 26(1)  36(1) 
C41 55(1)  28(1) 28(1)  6(1) 9(1)  23(1) 
C42 41(1)  38(1) 46(1)  -5(1) -2(1)  20(1) 
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 Table 5.12   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 
10 3) for 2.14. 
 
 x y z U(eq) 
H5 6388 4733 8037 59 
H1 8301 2457 5470 25 
H2A 8636 3117 4325 26 
H2B 8722 4365 4717 26 
H4 5998 1263 3444 30 
H5A 5717 602 4718 30 
H7A 5939 1716 6226 28 
H7B 4996 2201 5839 28 
H8 6489 4157 6469 28 
H9A 5150 3112 7297 36 
H9B 6128 2608 7586 36 
H10 7239 4644 3799 23 
H13A 7344 4965 2249 35 
H13B 6403 3721 1651 35 
 500 
H14A 8051 3835 2889 29 
H14B 6700 2664 2564 29 
H15A 3483 2392 2669 41 
H15B 4111 2027 3410 41 
H15C 4555 1970 2576 41 
H16A 4031 4286 3538 28 
H16B 4732 3990 4286 28 
H19A 7141 8885 5489 68 
H19B 8674 9578 5733 68 
H19C 7932 8322 5963 68 
H20A 8008 8515 3291 67 
H20B 8781 9706 3957 67 
H20C 7246 9067 3751 67 
H21A 9445 7338 5114 76 
H21B 10226 8545 4834 76 
H21C 9423 7343 4181 76 
H12 14918 11348 1029 62 
 501 
H22 11198 7120 2309 28 
H23A 9691 8278 2425 31 
H23B 9228 6890 2397 31 
H25 8067 5324 765 34 
H26 10230 5577 701 35 
H28A 11886 7945 251 32 
H28B 12555 7504 922 32 
H29 12594 9776 1134 33 
H30A 14714 9246 1121 43 
H30B 14093 9612 379 43 
H31 8264 8433 1386 30 
H34A 4865 6573 979 47 
H34B 5806 7915 1432 47 
H35A 6451 6000 1211 40 
H35B 6941 7028 2000 40 
H36A 6553 5780 -196 56 
H36B 7879 6480 -457 56 
 502 
H36C 6598 6475 -914 56 
H37A 8965 8675 -188 32 
H37B 7677 8657 -646 32 
H40A 7377 11076 2261 63 
H40B 8562 11928 2984 63 
H40C 8371 10635 2637 63 
H41A 9551 13408 1013 53 
H41B 9353 13805 1881 53 
H41C 8144 12882 1195 53 
H42A 11114 11721 2316 65 
H42B 11258 12979 2708 65 
H42C 11512 12764 1828 65 
 
Table 5.13 Torsion angles [°] for 2.14. 
 
O3-S1-O1-C8 57.03 O8-S2-O7-C29 -54.08 
O2-S1-O1-C8 -174.33 O9-S2-O7-C29 176.52 
C1-S1-O1-C8 -60.75 C22-S2-O7-C29 62.44 
 503 
O3-S1-C1-C2 37.10 O8-S2-C22-C23 -40.31 
O2-S1-C1-C2 -96.38 O9-S2-C22-C23 93.11 
O1-S1-C1-C2 153.76 O7-S2-C22-C23 -156.40 
O3-S1-C1-C6 -76.24 O8-S2-C22-C27 72.82 
O2-S1-C1-C6 150.28 O9-S2-C22-C27 -153.75 
O1-S1-C1-C6 40.41 O7-S2-C22-C27 -43.26 
C6-C1-C2-C3 -0.62 C27-C22-C23-C24 -0.65 
S1-C1-C2-C3 -120.57 S2-C22-C23-C24 118.90 
C6-O4-C3-C10 179.55 C27-O10-C24-C31 178.53 
C6-O4-C3-C4 48.60 C27-O10-C24-C25 -48.93 
C6-O4-C3-C2 -59.01 C27-O10-C24-C23 57.99 
C1-C2-C3-O4 35.46 C22-C23-C24-O10 -34.22 
C1-C2-C3-C10 154.87 C22-C23-C24-C31 -153.16 
C1-C2-C3-C4 -69.51 C22-C23-C24-C25 70.29 
O4-C3-C4-C5 -32.01 O10-C24-C25-C26 31.96 
C10-C3-C4-C5 -156.15 C31-C24-C25-C26 156.56 
C2-C3-C4-C5 72.49 C23-C24-C25-C26 -72.57 
 504 
C3-C4-C5-C6 1.7(2) C24-C25-C26-C27 -1.2(2) 
C3-O4-C6-C7 -175.06 C24-O10-C27-C28 175.72 
C3-O4-C6-C5 -47.66 C24-O10-C27-C26 48.44 
C3-O4-C6-C1 58.28 C24-O10-C27-C22 -58.23 
C4-C5-C6-O4 29.42 C25-C26-C27-O10 -30.1(2) 
C4-C5-C6-C7 152.67 C25-C26-C27-C28 -153.87 
C4-C5-C6-C1 -74.59 C25-C26-C27-C22 74.12 
C2-C1-C6-O4 -34.58 C23-C22-C27-O10 35.48 
S1-C1-C6-O4 85.11 S2-C22-C27-O10 -83.40 
C2-C1-C6-C7 -156.91 C23-C22-C27-C28 158.19 
S1-C1-C6-C7 -37.22 S2-C22-C27-C28 39.3(2) 
C2-C1-C6-C5 70.40 C23-C22-C27-C26 -69.55 
S1-C1-C6-C5 -169.91 S2-C22-C27-C26 171.57 
O4-C6-C7-C8 -71.64 O10-C27-C28-C29 70.5(2) 
C5-C6-C7-C8 170.35 C26-C27-C28-C29 -171.35 
C1-C6-C7-C8 44.7(2) C22-C27-C28-C29 -45.8(2) 
S1-O1-C8-C9 -167.88 S2-O7-C29-C30 166.04 
 505 
S1-O1-C8-C7 71.79 S2-O7-C29-C28 -72.61 
C6-C7-C8-O1 -57.14 C27-C28-C29-O7 58.2(2) 
C6-C7-C8-C9 -173.31 C27-C28-C29-C30 175.75 
O1-C8-C9-O5 58.2(2) O7-C29-C30-O12 -65.0(2) 
C7-C8-C9-O5 175.81 C28-C29-C30-O12 176.64 
O4-C3-C10-C14 -172.91 O10-C24-C31-C32 55.5(2) 
C4-C3-C10-C14 -53.5(2) C25-C24-C31-C32 -64.5(2) 
C2-C3-C10-C14 73.80 C23-C24-C31-C32 168.52 
O4-C3-C10-C11 -51.0(2) O10-C24-C31-C35 179.04 
C4-C3-C10-C11 68.4(2) C25-C24-C31-C35 59.0(2) 
C2-C3-C10-C11 -164.29 C23-C24-C31-C35 -68.0(2) 
C3-C10-C11-C12 -164.28 C24-C31-C32-C33 160.65 
C14-C10-C11-C12 -37.68 C35-C31-C32-C33 32.68 
C3-C10-C11-C15 –50.6(2) C24-C31-C32-C36 46.4(2) 
C14-C10-C11-C15 75.99 C35-C31-C32-C36 -81.6(2) 
C3-C10-C11-C16 76.2(2) C24-C31-C32-C37 -79.4(2) 
C14-C10-C11-C16 -157.21 C35-C31-C32-C37 152.62 
 506 
C15-C11-C12-O6 82.0(2) C31-C32-C33-O11 166.7(2) 
C16-C11-C12-O6 -36.5(2) C36-C32-C33-O11 -73.8(2) 
C10-C11-C12-O6 -159.06 C37-C32-C33-O11 44.2(3) 
C15-C11-C12-C13 -97.69 C31-C32-C33-C34 -13.5(2) 
C16-C11-C12-C13 143.83 C36-C32-C33-C34 105.90 
C10-C11-C12-C13 21.25 C37-C32-C33-C34 -136.08 
O6-C12-C13-C14 -176.33 O11-C33-C34-C35 168.8(2) 
C11-C12-C13-C14 3.4(2) C32-C33-C34-C35 -11.0(2) 
C12-C13-C14-C10 -26.81 C33-C34-C35-C31 31.0(2) 
C3-C10-C14-C13 169.95 C24-C31-C35-C34 -170.93 
C11-C10-C14-C13 40.74 C32-C31-C35-C34 -40.2(2) 
C12-C11-C16-C17 -59.7(2) C33-C32-C37-C38 62.8(2) 
C15-C11-C16-C17 -176.67 C31-C32-C37-C38 -52.0(2) 
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